STOCK TITAN

CCC Intelligent Solutions’ proposed $7.75-a-share merger

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
PREM14A

Rhea-AI Filing Summary

CCC Intelligent Solutions Holdings Inc. has agreed to a proposed merger under which each eligible common share would convert, if the deal closes, into $7.75 per share in cash, without interest. Treasury shares, shares owned by Parent or its subsidiaries, shares with properly exercised appraisal rights and Company restricted stock awards are excluded. The price is approximately 44% above CCC’s unaffected $5.38 closing price on July 9, 2026, and approximately 59% above its 30-day average price as of that date. At closing, CCC would remain as Parent’s wholly owned subsidiary.

The board recommends votes “FOR” the merger, advisory compensation and adjournment proposals. Merger approval requires the affirmative vote of holders of a majority of outstanding shares entitled to vote; the advisory compensation vote is non-binding. Closing also requires expiration or termination of the HSR Act waiting period. Parent and Merger Sub obtained commitments of up to $3.4785 billion in equity and up to $2.075 billion in senior secured first-lien facilities, plus a bridge facility of up to $1.1 billion. The merger is not subject to a financing condition.

Filing Explained

Specified qualifying job separations can accelerate vesting and payment of restricted cash awards.

The November 20, 2026 preliminary proxy describes an amended merger that remains incomplete: stockholder approval is still required and the HSR waiting period has not expired; if completed, unvested RSAs, RSUs and PSUs convert into restricted cash awards rather than equity awards.

For unvested RSAs and RSUs, payment of the restricted cash award remains subject to the corresponding award’s terms; for unvested PSUs, the award amount is based on the greater of actual performance through the effective time or target-level performance. Options with an exercise price below $7.75 convert into cash equal to the per-share difference, while options priced at or above $7.75 are canceled without payment.

The proxy says appraisal eligibility requires continuous ownership through the effective time, not voting in favor, a written demand before the merger vote and compliance with Delaware procedures; court-determined fair value may be higher than, equal to or lower than the merger consideration.

Per-share merger consideration $7.75 per share in cash For eligible common shares if the merger closes; without interest
Premium to unaffected closing price Approximately 44% Compared with CCC’s $5.38 closing price on July 9, 2026
Premium to 30-day average price Approximately 59% 30-day average price as of July 9, 2026
Equity financing commitment Up to $3.4785 billion Commitment to invest in Parent, subject to its terms and conditions
Senior secured first-lien facilities Up to $2.075 billion Debt financing commitments for term loan and revolving facilities
Senior secured bridge facility Up to $1.1 billion Debt financing commitment; Merger Sub may issue notes in lieu of all or part of the facility
Company Termination Fee $149.52 million Payable by the Company in specified termination circumstances
Parent Termination Fee $313.992 million Payable by Parent in specified termination circumstances
Per Share Price financial
"the Per Share Price of $7.75 in cash"
HSR Act waiting period regulatory
"the waiting period under the HSR Act has not expired"
appraisal rights regulatory
"properly exercised in accordance with the DGCL"
A legal right that lets shareholders who dislike the price or terms of a buyout, merger or other major corporate change ask for an independent determination of the fair value of their shares instead of accepting the deal price. Think of it like asking a neutral referee to set the payout if you believe the offered price is too low. For investors, appraisal rights can provide a way to recover a higher cash value but can be slow, costly and create uncertainty around deal outcomes.
Restricted Cash Awards financial
"payment of the Restricted Cash Awards"
Requisite Stockholder Approval technical
"the affirmative vote of the holders of a majority"
Superior Proposal technical
"enter into a definitive agreement providing for a Superior Proposal"
A superior proposal is a competing offer to buy or merge with a company that is materially better than an existing deal, typically offering higher cash, stronger terms, or fewer conditions. It matters to investors because it can raise the expected payout or change deal certainty—like getting a higher bid at an auction, a superior proposal can increase share value or prompt renegotiation of the transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is CCC’s proposed merger price per share?

If the merger closes, eligible CCC common shares would convert into the right to receive $7.75 per share in cash, without interest. Treasury shares, shares owned by Parent or its subsidiaries, shares with properly exercised appraisal rights and Company restricted stock awards are excluded.

What premium does CCC’s proposed merger price represent?

The $7.75 per-share price represents an approximately 44% premium to CCC’s unaffected $5.38 closing price on July 9, 2026, and an approximately 59% premium to its 30-day average price as of July 9, 2026.

What vote is required to approve CCC’s merger?

Holders of a majority of CCC’s outstanding shares entitled to vote must vote in favor of adopting the merger agreement. Closing also requires the HSR Act waiting period to expire or be terminated; the merger is not subject to a financing condition.

What happens to CCC stock options if the merger closes?

Options with an exercise price below the $7.75 per-share consideration would be cancelled for cash equal to the option shares multiplied by the difference between $7.75 and the exercise price. Options priced at or above $7.75 would be cancelled without a cash payment.

How can CCC shareholders seek appraisal instead of merger consideration?

Eligible shareholders must deliver a written appraisal demand before the merger vote, not vote their shares in favor of the merger, continuously hold the shares through the Effective Time and comply with the applicable requirements of Section 262 of the Delaware General Corporation Law.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
 
 
 
 
Filed by the Registrant
 
 
☒
Filed by a Party other than the Registrant
 
 
 ☐
 
 
 
 
Check the appropriate box:
☒
Preliminary Proxy Statement
 ☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 ☐
Definitive Proxy Statement
 ☐
Definitive Additional Materials
 ☐
Soliciting Material under §240.14a-12
 
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
 ☐
No fee required.
 ☐
Fee paid previously with preliminary materials.
☒
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

TABLE OF CONTENTS

PRELIMINARY PROXY MATERIALS DATED NOVEMBER 20, 2026 — SUBJECT TO COMPLETION

 
Dear Stockholders:
You are cordially invited to attend a special meeting of stockholders of CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company”), which will be held virtually on [•], 2026, at [•] [a.m.]/[p.m.], Central Time (including any adjournments or postponements thereof, the “Special Meeting”). Stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and using the 16-digit control number included in your proxy materials. You will not be able to attend the Special Meeting physically in person. For purposes of attendance at the Special Meeting, all references in the accompanying proxy statement to “present in person” or “in person” shall mean virtually present at the Special Meeting. Please note that the accompanying proxy statement is dated [•], 2026 and the form of proxy is first being mailed to holders (“Company stockholders”) of shares of common stock, par value $0.0001 per share, of the Company (“Company Common Stock”) on or about [•], 2026.
At the Special Meeting, you will be asked to consider and vote upon the adoption of the Agreement and Plan of Merger, dated as of October 14, 2026, as amended on November 20, 2026 (and as it may be further amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, Mozart Parent, LLC, a Delaware limited liability company (“Parent”), and Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), which provides for the merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Parent (the “Merger”) in accordance with the General Corporation Law of the State of Delaware (the “DGCL”) on the terms and conditions set forth in the Merger Agreement. Parent and Merger Sub are affiliated with certain investment funds or other vehicles managed or advised by GTCR LLC (“GTCR”) and, following the consummation of the transactions contemplated by the Merger Agreement, will be indirectly owned by investment funds affiliated with GTCR and Elliott Investment Management L.P. (together with its affiliates, “Elliott”).
If the Merger is completed, at the effective time of the Merger (the “Effective Time”), each share of Company Common Stock (including, for the avoidance of doubt, (a) any SPAC Merger Earnout Shares (as defined in the accompanying proxy statement) and (b) any Sponsor Earnout Shares (as defined in the accompanying proxy statement)) that is issued and outstanding as of immediately prior to the Effective Time, other than (i) shares of Company Common Stock held by the Company as treasury stock or owned by Parent or any of its subsidiaries (including Merger Sub), (ii) shares of Company Common Stock as to which appraisal rights have been properly exercised in accordance with the DGCL and (iii) shares of Company Common Stock that are subject to awards of restricted stock of the Company, will be converted into the right to receive $7.75 per share in cash, without interest.
Concurrently with the execution of the Merger Agreement, Mozart Topco, LP (“Topco”), an indirect parent of Parent, entered into a Rollover and Support Agreement (each, a “Rollover Agreement”) with each of (i) Githesh Ramamurthy, the Company’s Chairman and Chief Executive Officer, and (ii) Tim Welsh, the Company’s President (collectively, the “Rollover Investors”) pursuant to which Mr. Ramamurthy has agreed to roll over certain shares of Company Common Stock held by him (or his affiliates), and Mr. Welsh has agreed to roll over certain proceeds under the Merger Agreement. Under the Rollover Agreements, each Rollover Investor has agreed, among other things, subject to the terms and conditions contained therein, to vote (or act by written consent with respect to) all shares of Company Common Stock held by such Rollover Investor in favor of the adoption of the Merger Agreement.
The board of directors of the Company (the “Company Board”) has unanimously (with respect to all directors present) (i) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger upon the terms and subject to the conditions set forth therein; (ii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iii) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (iv) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at the Special Meeting. The Company Board acted upon the unanimous recommendation of a committee of disinterested directors.

TABLE OF CONTENTS

Accordingly, the Company Board recommends a vote “FOR” the proposal to adopt the Merger Agreement and “FOR” each of the other proposals to be voted on at the Special Meeting.
The proxy statement accompanying this letter provides you with more specific information concerning the Special Meeting, the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement. A copy of the Merger Agreement is attached as Annex A-1 and the first amendment to the Merger Agreement is attached as Annex A-2 to the proxy statement. We encourage you to read the proxy statement, the accompanying annexes and any documents incorporated by reference in the proxy statement carefully and in their entirety.
Your vote is important, regardless of the number of shares of Company Common Stock you own. The Merger cannot be completed unless the Merger Agreement is adopted by Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting. Only stockholders of record as of the close of business on [•], 2026, the record date for the Special Meeting, or those holding a valid proxy, are entitled to receive notice of and to vote the shares of Company Common Stock they held on the record date at the Special Meeting. Regardless of whether you plan to attend the Special Meeting, we urge you to vote or submit a proxy via the Internet at www.proxyvote.com, submit a proxy via telephone at +1 (800) 690-6903 by following the instructions on the physical proxy card you received in the mail and which are also provided on that website or submit a proxy via mail by signing, voting and returning the accompanying proxy card to the Company in the prepaid reply envelope. We encourage you to submit your vote as soon as possible. If you have Internet access, we encourage you to record your vote via the Internet. If you attend the Special Meeting, you may vote electronically at the Special Meeting even if you have previously returned your proxy card or have submitted a proxy via the Internet or by telephone and your electronic vote at the Special Meeting will revoke any proxy that you have previously submitted.
If you are a beneficial owner of shares of Company Common Stock (i.e., you hold in “street name”), you should instruct your bank, broker or other nominee how to vote your shares in accordance with the voting instruction form provided to you by your bank, broker or other nominee. Your bank, broker or other nominee cannot vote on any of the proposals, including the proposal to adopt the Merger Agreement, without your instructions.
If you have any questions or need assistance voting your shares, please contact the Company’s proxy solicitor at:
Georgeson LLC
51 W 52nd St 6th Floor
New York, NY 10019
Stockholders, Banks, and Brokers may call toll-free: (877) 467-5518
Outside the US may call: (908) 396-7859
On behalf of the Company Board, I thank you for your ongoing support and appreciate your consideration of these matters.
Very truly yours,
[Insert signature here]
Githesh Ramamurthy
Chairman of the Board and CEO
Neither the Securities and Exchange Commission nor any state securities regulatory agency has approved or disapproved the Merger, passed upon the merits or fairness of the Merger or the Merger Agreement or passed upon the adequacy or accuracy of the disclosure in this document (including the proxy statement) and any documents incorporated by reference. Any representation to the contrary is a criminal offense.

TABLE OF CONTENTS

THIS PROXY STATEMENT IS DATED [•], 2026 AND IS FIRST BEING MAILED TO STOCKHOLDERS
OF CCC INTELLIGENT SOLUTIONS HOLDINGS INC. ON OR ABOUT [•], 2026

 
167 N. Green Street, 9th Floor
Chicago, Illinois 60607
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
 
To Be Held at [•] [a.m.]/[p.m.], Central Time, on [•], 2026
To the stockholders of CCC Intelligent Solutions Holdings Inc.:
Notice is hereby given that a special meeting (including any adjournments or postponements thereof, the “Special Meeting”) of stockholders of CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company”), will be held virtually on [•], 2026, at [•] [a.m.]/[p.m.], Central Time, for the following purposes:
1.
To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of October 14, 2026, as amended on November 20, 2026 (and as it may be further amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, Mozart Parent, LLC, a Delaware limited liability company (“Parent”), and Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the terms of the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Parent (the “Merger”) (the “Merger Proposal”);
2.
To consider and vote on a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and
3.
To consider and vote on a proposal to approve the adjournment of the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).
Only holders (“Company stockholders”) of shares of common stock, par value $0.0001 per share, of the Company (“Company Common Stock”) as of the close of business on [•], 2026, are entitled to notice of, and to vote at, the Special Meeting.
All Company stockholders are cordially invited to attend the Special Meeting. Similar to annual stockholder meetings, the Company will conduct the Special Meeting solely via the Internet through a live webcast. Stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and by using the 16-digit control number included in their proxy materials. You will not be able to attend the Special Meeting physically in person. For purposes of attendance at the Special Meeting, all references in the accompanying proxy statement to “present in person” or “in person” shall mean virtually present at the Special Meeting.
The board of directors of the Company recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
Under Delaware law, Company stockholders of record and beneficial owners of shares of Company Common Stock held either in a voting trust or by a nominee on behalf of such persons who do not vote in favor of the adoption of the Merger Agreement and who otherwise comply with the requirements under Section 262 of the Delaware General Corporation Law (the “DGCL”) will have the right to seek appraisal of the “fair value” of their shares of Company Common Stock (exclusive of any element of value arising from the accomplishment or expectation of the Merger and together with interest (if any) thereon, as described in the accompanying proxy statement), as determined by Section 262 of the DGCL. To do so, a Company stockholder of record or beneficial owner of shares of Company Common Stock must properly deliver a written demand for appraisal to the Company

TABLE OF CONTENTS

before the vote is taken on the Merger Agreement and comply with all applicable requirements of the DGCL, including the requirements of Section 262 of the DGCL, which are summarized in the section of the accompanying proxy statement titled “Appraisal Rights.” A copy of Section 262, which details the applicable Delaware appraisal statute, may be accessed without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262 and is incorporated in this notice by reference.
Regardless of whether you plan to attend the Special Meeting, we urge you to vote or submit a proxy via the Internet at www.proxyvote.com, submit a proxy via telephone at +1 (800) 690-6903 by following the instructions on the physical proxy card you received in the mail and which are also provided on that website or submit a proxy via mail by signing, voting and returning the accompanying proxy card to the Company in the prepaid reply envelope. We encourage you to submit your vote as soon as possible. If you have Internet access, we encourage you to record your vote via the Internet. If you attend the Special Meeting, you may vote electronically at the Special Meeting even if you have previously returned your proxy card or have submitted a proxy via the Internet or by telephone and your electronic vote at the Special Meeting will revoke any proxy that you have previously submitted.
If you are a beneficial owner of shares of Company Common Stock (i.e., you hold in “street name”), you should instruct your bank, broker or other nominee how to vote your shares in accordance with the voting instruction form provided to you by your bank, broker or other nominee. Your bank, broker or other nominee cannot vote on any of the proposals, including the Merger Proposal, without your instructions.
If you sign, date and mail your proxy card without indicating how you wish to vote, your proxy will be counted as a vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
By Order of the Board of Directors,
[Insert signature here]
Kevin Kane, Senior Vice President, Chief Legal Officer

TABLE OF CONTENTS

YOUR VOTE IS IMPORTANT
Regardless of whether you plan to attend the Special Meeting, we urge you to vote or submit a proxy via the Internet at www.proxyvote.com, submit a proxy via telephone at +1 (800) 690-6903 by following the instructions on the physical proxy card you received in the mail and which are also provided on that website or submit a proxy via mail by signing, voting and returning the accompanying proxy card to the Company in the prepaid reply envelope. We encourage you to submit your vote as soon as possible. If you have Internet access, we encourage you to record your vote via the Internet. You may revoke your proxy or change your vote at any time before it is voted at the Special Meeting.
If you are a beneficial owner of shares of Company Common Stock (i.e., you hold in “street name”), you should instruct your bank, broker or other nominee how to vote your shares in accordance with the voting instruction form provided to you by your bank, broker or other nominee. Your bank, broker or other nominee cannot vote on any of the proposals, including the proposal to adopt the Merger Agreement, without your instructions.
If you are a holder of record of Company Common Stock, voting electronically at the Special Meeting will revoke any proxy that you previously submitted. If you hold your shares through a bank, broker or other nominee, you must obtain a “legal proxy” to vote in person at the Special Meeting.
If you fail to (a) return your proxy card, (b) grant your proxy electronically over the Internet or by telephone or (c) vote by virtual ballot in person at the Special Meeting, your shares will not be counted for purposes of determining whether a quorum is present at the Special Meeting and, if a quorum is present, will have the same effect as a vote “AGAINST” the Merger Proposal but will have no effect on the other proposals.
You should carefully read and consider the entire proxy statement and the accompanying annexes, including the Merger Agreement attached as Annex A-1 and the first amendment to the Merger Agreement attached as Annex A-2, along with all of the documents incorporated by reference in this proxy statement, as they contain important information about, among other things, the Merger and how it affects you. Please contact our proxy solicitor if you have any questions concerning the Merger Agreement, the Merger or the other transactions contemplated by the Merger Agreement; the Special Meeting or the accompanying proxy statement; would like additional copies of the accompanying proxy statement; or need help submitting a proxy to have your shares of Company Common Stock voted:
Georgeson LLC
51 W 52nd St 6th Floor
New York, NY 10019
Stockholders, Banks, and Brokers may call toll-free: (877) 467-5518
Outside the US may call: (908) 396-7859

TABLE OF CONTENTS

TABLE OF CONTENTS
 
 
 
 
 
 
 
Page
SUMMARY
 
 
1
The Parties (page 24)
 
 
1
The Merger (page 33)
 
 
2
The Special Meeting (page 25)
 
 
3
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board (page 47)
 
 
4
Opinion of the Company Financial Advisor (page 56, Annex B)
 
 
4
Certain Effects of the Merger (page 68)
 
 
5
Effects on the Company if the Merger Is Not Completed (page 69)
 
 
5
Treatment of Company Equity Awards in the Merger (page 85)
 
 
5
Interests of the Company’s Directors and Executive Officers in the Merger (page 71)
 
 
7
Voting by the Company's Directors and Executive Officers (page 29)
 
 
7
Financing of the Merger (page 70)
 
 
7
Conditions to Consummation of the Merger (page 104)
 
 
8
Regulatory Approvals Required for the Merger (page 80)
 
 
8
No Solicitation of Other Offers (page 97)
 
 
9
Termination of the Merger Agreement (page 106)
 
 
9
Termination Fees (page 107)
 
 
10
Legal Proceedings Regarding the Merger (page 80)
 
 
10
Delisting and Deregistration of Company Common Stock (page 81)
 
 
11
Appraisal Rights (page 116)
 
 
11
Material U.S. Federal Income Tax Considerations (page 77)
 
 
12
Additional Information (page 125)
 
 
12
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
 
 
13
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
 
22
THE PARTIES
 
 
24
THE SPECIAL MEETING
 
 
25
Date, Time and Place
 
 
25
Purpose of the Special Meeting
 
 
25
Recommendation of the Transaction Committee and the Company Board
 
 
25
Record Date and Company Stockholders Entitled to Vote
 
 
25
Quorum
 
 
26
Vote Required
 
 
26
Tabulation of Votes; Results
 
 
26
Voting Procedures
 
 
26
Revocation of Proxies
 
 
28
Voting at the Special Meeting
 
 
28
Solicitation of Proxies
 
 
28
Adjournments
 
 
29
Voting by the Company’s Directors and Executive Officers
 
 
29
Assistance
 
 
29
PROPOSAL 1: ADOPTION OF THE MERGER AGREEMENT
 
 
30
PROPOSAL 2: APPROVAL OF THE ADVISORY COMPENSATION PROPOSAL
 
 
31
PROPOSAL 3: ADJOURNMENT PROPOSAL
 
 
32
THE MERGER
 
 
33
General Description of the Merger
 
 
33
Background of the Merger
 
 
33
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board
 
 
47
Opinion of the Company Financial Advisor
 
 
56
 
 
 
 
i

TABLE OF CONTENTS

 
 
 
 
 
 
 
Page
Certain Company Management Projections
 
 
64
Certain Effects of the Merger
 
 
68
Effects on the Company if the Merger Is Not Completed
 
 
69
Financing of the Merger
 
 
70
Interests of the Company’s Directors and Executive Officers in the Merger
 
 
71
Material U.S. Federal Income Tax Considerations
 
 
77
Regulatory Approvals Required for the Merger
 
 
80
Legal Proceedings Regarding the Merger
 
 
80
Delisting and Deregistration of Company Common Stock
 
 
81
THE MERGER AGREEMENT
 
 
82
Explanatory Note Regarding the Merger Agreement
 
 
82
Structure of the Merger
 
 
82
Consummation and Effectiveness of the Merger
 
 
82
Consideration to Be Received in the Merger
 
 
83
Procedures for Receiving Per Share Price
 
 
83
Treatment of Company Equity Awards in the Merger
 
 
85
Effect on Other Company Securities; Company Earnout Shares
 
 
87
Dissenting Company Shares
 
 
87
Effects of the Merger; Certificate of Incorporation; Bylaws; Directors and Officers
 
 
88
Representations and Warranties
 
 
88
Conduct of Business by the Company Prior to Consummation of the Merger
 
 
92
Regulatory Filings; Efforts
 
 
95
No Solicitation of Other Offers
 
 
97
Financing Cooperation
 
 
99
Indemnification of Directors and Officers and Insurance
 
 
101
Employee Matters
 
 
102
Other Covenants and Agreements
 
 
104
Conditions to Consummation of the Merger
 
 
104
Termination of the Merger Agreement
 
 
106
Termination Fees
 
 
107
Superior Proposal and Change of Recommendation
 
 
108
Amendment and Waiver
 
 
110
Governing Law; Jurisdiction and Waiver of Jury Trial
 
 
110
Specific Performance
 
 
111
MARKET INFORMATION AND DIVIDENDS
 
 
113
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
 
114
APPRAISAL RIGHTS
 
 
116
General
 
 
116
How to Exercise and Perfect Your Appraisal Rights
 
 
117
Who May Exercise Appraisal Rights
 
 
118
Surviving Corporation’s Actions After Completion of the Merger
 
 
119
HOUSEHOLDING
 
 
123
FUTURE STOCKHOLDER PROPOSALS
 
 
124
WHERE YOU CAN FIND ADDITIONAL INFORMATION
 
 
125
Annex A-1 — Merger Agreement
 
 
A-1
Annex A-2 — First Amendment to Merger Agreement
 
 
A-80
Annex B — Opinion of the Company Financial Advisor
 
 
B-1
 
 
 
 
ii

TABLE OF CONTENTS

SUMMARY
This summary highlights selected information in this proxy statement and may not contain all of the information about the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement that are important to you. You should carefully read this proxy statement in its entirety, including the annexes hereto and the other documents to which we have referred you, for a more complete understanding of the matters being considered at the Special Meeting. You may obtain, without charge, copies of any of the documents we file with the Securities and Exchange Commission (the “SEC”) by following the instructions under the section of this proxy statement titled “Where You Can Find Additional Information.”
In this proxy statement: (1) the terms “we,” “us,” “our,” the “Company” and similar words refer to CCC Intelligent Solutions Holdings Inc.; (2) the term “Parent” refers to Mozart Parent, LLC; (3) the term “Merger Sub” refers to Mozart Merger Sub (DE), Inc.; (4) the term “GTCR” refers to GTCR LLC, together with certain of its affiliated funds; (5) the term “Elliott” refers to Elliott Investment Management L.P., together with certain of its affiliates; (6) the term “Merger Agreement” refers to the Agreement and Plan of Merger, dated as of October 14, 2026, as amended on November 20, 2026, by and among the Company, Parent and Merger Sub, and as it may be further amended, supplemented or otherwise modified from time to time; (7) the term “Merger” refers to the merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Parent as described in the Merger Agreement; (8) the term “Transactions” refers to the Merger and the other transactions contemplated by the Merger Agreement; (9) the term “Closing” refers to the consummation of the Merger and the term “Closing Date” refers to the date on which the Closing occurs; (10) the term “Company Common Stock” refers to the shares of common stock, par value $0.0001 per share, of the Company; (11) the term “Company stockholder” means a holder of Company Common Stock; and (12) the term “Special Meeting” refers to the special meeting of the Company stockholders described in this proxy statement, including any adjournments or postponements thereof.
The Parties (page 24)
CCC Intelligent Solutions Holdings Inc.
Founded in 1980, the Company is a leading Software-as-a-Service (“SaaS”) and artificial intelligence (“AI”) platform provider for the multi-trillion-dollar insurance economy, powering operations for insurers, repairers, automakers, parts suppliers and others. The Company’s cloud technology connects more than 35,000 businesses and digitizes mission-critical workflows, commerce and customer experiences.
The Company’s business has been built upon two foundational pillars: automotive insurance claims and automotive collision repair. For decades, the Company has delivered leading software solutions to both the insurance and repair industries, including pioneering Direct Repair Programs (“DRP”) in the United States beginning in 1992. DRP connects auto insurers and collision repair shops to create business value for both parties, and requires digital tools to facilitate interactions and manage partner programs. Insurer-to-shop DRP connections have created a strong network effect for the Company’s platform, as insurers and repairers both benefit by joining the largest network to maximize opportunities. This has led to a virtuous cycle in which more insurers on the platform drives more value for the collision shops on the platform, and vice versa.
The Company’s insurance solutions help insurance carriers manage mission-critical workflows across the claims lifecycle, while building intelligent experiences for their customers. The Company’s software integrates seamlessly with both legacy and modern systems and enables insurers to rapidly innovate on the Company’s platform. Our repair solutions help collision repair facilities achieve better performance throughout the collision repair cycle by digitizing processes to drive business growth, streamline operations, and improve repair quality. The Company has more than 300 insurers on its network, connecting with more than 30,500 repair facilities through our multi-tenant cloud platform. The Company believes its software is the architectural backbone of insurance DRP systems and is a primary driver of material revenue for the Company’s collision repair shop customers and a source of material efficiencies for our insurance carrier customers.
The Company completed its acquisition of EvolutionIQ in January 2025, expanding its capabilities into disability and workers’ compensation claims management. The Company continues to develop its cloud platform, artificial intelligence and network ecosystem for customers across the insurance economy.
The Company’s technology, data and network capabilities support a broad base of customers across the insurance economy. As of September 30, 2026, the Company had customer agreements with more than 300 insurers, including
1

TABLE OF CONTENTS

27 of the top 30 U.S. automotive insurance carriers and 9 of the top 15 U.S. disability insurance carriers (in each case, based on direct written premiums), and more than 35,000 total customers, including more than 30,500 automotive collision repair facilities, more than 6,500 parts and diagnostics suppliers and 15 of the top 15 automotive manufacturers (based on vehicles in operation).
Shares of Company Common Stock are listed on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “CCC.” Our principal executive offices are located at 167 N. Green Street, 9th Floor, Chicago, Illinois 60607. Our telephone number is (800) 621-8070. Our investor relations website address is https://ir.cccis.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into or otherwise part of this proxy statement. Additional information about the Company is contained in our public filings. See the section of this proxy statement titled “Where You Can Find Additional Information.”
Mozart Parent, LLC
Parent is a Delaware limited liability company formed on September 18, 2026 solely for the purpose of engaging in the Transactions. Parent is affiliated with certain investment funds or other investment vehicles managed or advised by GTCR. Parent has not engaged in any business activities other than in connection with the Transactions. After the Closing, the Company will be a wholly owned subsidiary of Parent, which will be indirectly owned by certain investment funds or other investment vehicles affiliated with GTCR and Elliott and by the Rollover Investors (as defined below), through their equity interests in Mozart Topco, LP, an indirect parent of Parent (“Topco”).
Mozart Merger Sub (DE), Inc.
Merger Sub is a Delaware corporation and wholly owned subsidiary of Parent formed on September 25, 2026 solely for the purpose of engaging in the Transactions. Merger Sub has not engaged in any business activities other than in connection with the Transactions. Upon the Closing, Merger Sub will merge with and into the Company and will cease to exist. Following the effective time of the Merger (the “Effective Time”), the surviving corporation (i.e., the Company) will be indirectly owned by certain investment funds or other investment vehicles affiliated with GTCR and Elliott and by the Rollover Investors through their equity interests in Topco.
The Merger (page 33)
The Company, Parent and Merger Sub entered into the Merger Agreement. A copy of the Merger Agreement is included as Annex A-1 and the first amendment to the Merger Agreement is included as Annex A-2 to this proxy statement. On the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the General Corporation Law of the State of Delaware (the “DGCL”), at the Effective Time, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will thereupon cease, and the Company will continue as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent. From time to time in this proxy statement, we refer to the Company as it will exist after the completion of the Merger as the “surviving corporation.”
At the Effective Time, and without any action by any Company stockholder, each share of Company Common Stock (including, for the avoidance of doubt, (a) any shares of Company Common Stock issuable in accordance with that certain Business Combination Agreement, dated as of February 2, 2021, by and among Dragoneer Growth Opportunities Corp., a Cayman Islands exempted company, Chariot Opportunity Merger Sub, Inc., a Delaware corporation, and Cypress Holdings, Inc., a Delaware corporation (the “SPAC Merger Agreement” and such shares, the “SPAC Merger Earnout Shares”) and (b) any shares of Company Common Stock issued to Dragoneer Growth Opportunities Holdings and subject to forfeiture based on the occurrence of certain triggering events as provided in the SPAC Merger Agreement (“Sponsor Earnout Shares”)) that is issued and outstanding as of immediately prior to the Effective Time, other than (i) shares of Company Common Stock held by the Company as treasury stock or owned by Parent or any of its subsidiaries (including Merger Sub) (“Owned Company Shares”), (ii) shares of Company Common Stock as to which appraisal rights have been properly exercised in accordance with the DGCL (“Dissenting Company Shares”) and (iii) Company RSAs (as defined below), will be automatically cancelled, extinguished and converted into the right to receive cash in an amount equal to $7.75, without interest thereon (the “Per Share Price”), subject to the terms and conditions of the Merger Agreement.
2

TABLE OF CONTENTS

The Special Meeting (page 25)
Date, Time and Place
The Special Meeting will be held virtually on [•], 2026, at [•] [a.m.] / [p.m.], Central Time. At the Special Meeting, Company stockholders will be asked to, among other things, vote for the adoption of the Merger Agreement. All stockholders are cordially invited to attend the Special Meeting. The Company is conducting the Special Meeting solely via the Internet through a live webcast. Stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and by using the 16-digit control number included in their proxy materials. You will not be able to attend the Special Meeting physically in person. For purposes of attendance at the Special Meeting, all references in this proxy statement to “present in person” or “in person” shall mean virtually present at the Special Meeting.
Record Date and Company Stockholders Entitled to Vote
The record date for the Special Meeting (the “Record Date”) is [•], 2026. Only Company stockholders of record as of the Record Date are entitled to receive notice of and to vote the shares of Company Common Stock they held on the Record Date at the Special Meeting. As of the close of business on the Record Date, [•] shares of Company Common Stock were issued and outstanding and entitled to vote at the Special Meeting.
Quorum
In order to have a quorum at the Special Meeting, holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting must be present in person or represented by proxy. Abstentions are counted for purposes of determining whether a quorum is present. The Company does not expect any broker non-votes at the Special Meeting because the rules applicable to banks, brokers and other nominees only provide brokers with discretionary authority to vote on proposals that are considered routine, whereas each of the proposals to be presented at the Special Meeting is expected to be considered non-routine.
If a quorum is not present, the only business that can be transacted at the Special Meeting is the adjournment of the meeting to another date or time, subject to the terms of the Merger Agreement.
Vote Required
On each of the proposals presented at the Special Meeting, each Company stockholder is entitled to one vote for each share of Company Common Stock held by such Company stockholder on the Record Date. The approval of the proposal to adopt the Merger Agreement (the “Merger Proposal”) requires the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting as of the close of business on the Record Date. Assuming a quorum is present, the approval of the proposal to approve the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”) requires a majority of the votes properly cast for and against such proposal. The approval of the Advisory Compensation Proposal is advisory and non-binding and is not a condition to the completion of the Merger. Assuming a quorum is present, the approval of the proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement (the “Adjournment Proposal”) requires a majority of the votes properly cast for and against such proposal. If a quorum is not present, the approval of the Adjournment Proposal requires the affirmative vote of the holders of a majority of the voting power present at the Special Meeting. In addition, the chair of the Special Meeting may adjourn the Special Meeting, subject to the terms of the Merger Agreement.
Rollover Agreements (page 75)
Concurrently with the execution of the Merger Agreement, on October 14, 2026, Githesh Ramamurthy, the Company’s Chairman and Chief Executive Officer, and Tim Welsh, the Company’s President (together, the “Rollover Investors”), each entered into a Rollover and Support Agreement (each, a “Rollover Agreement”) with Topco. Mr. Ramamurthy has agreed to roll over certain shares of Company Common Stock held by him (or his affiliates), and Mr. Welsh has agreed to roll over certain proceeds from the transaction. Under the Rollover Agreements, each Rollover Investor has agreed, until the earliest of the termination of the Merger Agreement, the Effective Time or mutual written consent, to vote (or act by written consent with respect to) all shares of Company Common Stock held by such Rollover Investor in favor of the adoption of the Merger Agreement and against any Acquisition Proposal (as defined in the
3

TABLE OF CONTENTS

section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”) and certain other actions that would reasonably be expected to impede or delay the Merger. The adoption of the Merger Agreement by the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting (the “Requisite Stockholder Approval”) is the only vote of the holders of any of the Company’s capital stock necessary to adopt the Merger Agreement and consummate the Merger.
The Rollover Agreements terminate automatically if the Merger Agreement is terminated. The Rollover Investors’ obligations are subject to the terms and conditions of the Rollover Agreements, including their commitments to vote in favor of the Merger and contribute specified shares of Company Common Stock held by such Rollover Investor to Topco immediately prior to the Effective Time in exchange for equity interests of Topco. For more information, see the section of this proxy statement titled “The Merger – Interests of the Company’s Directors and Executive Officers in the Merger.”
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board (page 47)
The Transaction Committee, which consists solely of directors who are disinterested with respect to the Sponsor Earnout Shares and the SPAC Merger Earnout Shares (together, the “Company Earnout Shares”) as well as the Rollover Agreements, (a) determined that the Transactions and the terms and conditions of the Merger, including the Per Share Price payable to Company stockholders, are fair to, and in the best interests of, the Company and the Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements and (b) unanimously recommended that the Company Board (i) approve, adopt and authorize the Transactions, the Merger Agreement and the transactions contemplated thereby, (ii) direct the Company to enter into and deliver the Merger Agreement and any related documents required to be delivered in connection therewith and (iii) recommend that the Company stockholders vote to adopt the Merger Agreement and approve the Merger, the Merger Agreement and the transactions contemplated thereby.
The Company Board, based on the information it received and reviewed, including the Transaction Committee’s recommendation, unanimously (with respect to all directors present) (i) determined that the terms of the Merger Agreement and the Transactions are fair to, and in the best interests of, the Company and the Company stockholders; (ii) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger, upon the terms and subject to the conditions set forth therein; (iii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iv) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (v) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at the Special Meeting.
Accordingly, the Company Board recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
For a discussion of the material factors that the Transaction Committee and the Company Board considered in making their respective determinations and recommendations, see the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board.”
Opinion of the Company Financial Advisor (page 56)
The Company retained Morgan Stanley & Co. LLC, which is referred to in this proxy statement as “Morgan Stanley,” as financial advisor to the Company Board in connection with the Transactions. In connection with this engagement, the Company Board requested that Morgan Stanley evaluate the fairness, from a financial point of view, to the holders of shares of Company Common Stock (other than Owned Company Shares, Dissenting Company Shares or Company RSAs (as defined in the section of this proxy statement titled “The Merger Agreement – Treatment of Company Equity Awards in the Merger”)) of the Per Share Price proposed to be paid to such holders pursuant to the Merger Agreement. On October 14, 2026, Morgan Stanley rendered to the Company Board its oral opinion, which was subsequently confirmed by delivery of a written opinion dated October 14, 2026, that, as of such date and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations upon the review undertaken by Morgan Stanley in preparing its opinion, the Per Share Price proposed to be paid to the holders of shares of Company Common Stock (other than Owned Company Shares, Dissenting Company Shares and Company RSAs) pursuant to the Merger Agreement was fair, from a financial point of view, to such holders.
The full text of Morgan Stanley’s written opinion, dated October 14, 2026, which describes the assumptions made, procedures followed, matters considered, and qualifications and limitations upon the review undertaken by Morgan
4

TABLE OF CONTENTS

Stanley in preparing its opinion, is attached as Annex B and is incorporated herein by reference. Morgan Stanley’s financial advisory services and opinion were provided for the information and assistance of the Company Board (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the Transactions and Morgan Stanley’s opinion addressed only the fairness, from a financial point of view, as of the date thereof, to the holders of shares of Company Common Stock (other than Owned Company Shares, Dissenting Company Shares and Company RSAs) of the Per Share Price to be paid to such holders pursuant to the Merger Agreement. Morgan Stanley’s opinion did not address any other term or aspect of the Merger Agreement or the Transactions and does not constitute a recommendation to any Company stockholder or any other person as to how such stockholder or other person should vote with respect to the Merger or otherwise act with respect to the Transactions or any other matter.
The full text of Morgan Stanley’s written opinion should be read carefully in its entirety for a description of the assumptions made, procedures followed, matters considered, and qualifications and limitations upon the review undertaken by Morgan Stanley in preparing its opinion.
Certain Effects of the Merger (page 68)
Upon the Closing, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will thereupon cease, and the Company will continue to exist as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent.
Following the Closing, shares of Company Common Stock will be delisted from Nasdaq, and the registration of shares of Company Common Stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be terminated.
Effects on the Company if the Merger Is Not Completed (page 69)
In the event that the Merger Proposal does not receive the required approval from the Company stockholders, or if the Merger is not completed for any other reason, the Company stockholders will continue to own their shares of Company Common Stock and will not receive any payment for their shares of Company Common Stock in connection with the Merger. Instead, the Company will remain an independent public company, with Company Common Stock listed and traded on Nasdaq. In addition, if the Merger is not completed, the Company stockholders will continue to be subject to the same risks and opportunities to which they are currently subject. Under certain circumstances, if the Merger Agreement is terminated, the Company may be obligated to pay to Parent a termination fee of $149,520,000 (the “Company Termination Fee”) or Parent may be obligated to pay to the Company a termination fee of $313,992,000 (the “Parent Termination Fee”), as applicable. See the section of this proxy statement titled “The Merger Agreement — Termination Fees.”
Treatment of Company Equity Awards in the Merger (page 85)
Company Options. At the Effective Time, each option to purchase shares of Company Common Stock granted pursuant to the CCC Intelligent Solutions Holdings Inc. 2021 Incentive Equity Plan (such plan, the “Company Equity Plan”, and each such option, a “Company Option”) that is outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will, automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess of the Per Share Price over the exercise price per share of such Company Option. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof.
Vested Company RSAs. At the Effective Time, each unvested share of restricted Company Common Stock granted pursuant to the Company Equity Plan (a “Company RSA”) that vests in accordance with its terms as a result of the consummation of the Merger (each, a “Vested Company RSA”) outstanding as of immediately prior to the Effective Time will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the Per Share Price.
Unvested Company RSAs. At the Effective Time, each outstanding Company RSA as of immediately prior to the Effective Time that is not a Vested Company RSA (each, an “Unvested Company RSA”) will automatically, without
5

TABLE OF CONTENTS

any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSA Restricted Cash Award”), with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time, except as described below.
Vested Company RSUs. At the Effective Time, each time-based award of restricted stock units of the Company granted pursuant to the Company Equity Plan (a “Company RSU”) that is unexpired, outstanding, vested and unsettled as of immediately prior to the Effective Time or that vests in accordance with its terms, as in effect on the date of the Merger Agreement, as a result of the consummation of the Merger (each, a “Vested Company RSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.
Unvested Company RSUs. At the Effective Time, each outstanding Company RSU as of immediately prior to the Effective Time that is not a Vested Company RSU (each, an “Unvested Company RSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company RSUs and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSU Restricted Cash Award”), with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time, except as described below.
Vested Company PSUs. At the Effective Time, each award of performance-based restricted stock units of the Company granted pursuant to the Company Equity Plan (each, a “Company PSU”) that is unexpired and outstanding as of immediately prior to the Effective Time and for which the applicable performance conditions have been satisfied as of immediately prior to the Effective Time (a “Vested Company PSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU.
Unvested Company PSUs. At the Effective Time, each outstanding Company PSU as of immediately prior to the Effective Time that is not a Vested Company PSU (each, an “Unvested Company PSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (a) actual performance achieved through the Effective Time and (b) target-level performance, in accordance with the terms of such Unvested Company PSU, and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company PSU Restricted Cash Award” and, together with the Company RSA Restricted Cash Award and the Company RSU Restricted Cash Award, the “Restricted Cash Awards”), with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time, except as described below.
Restricted Cash Awards. All amounts payable in respect of the Restricted Cash Awards will be subject to any required withholding of taxes and will be paid, without interest, no later than the second regularly scheduled payroll date following the date on which the applicable portion of such award vests; provided that, if a holder of a Restricted Cash Award (i)(a) incurs a termination of employment or service without cause, (b) resigns for good reason, or (c) incurs a termination of employment or service due to death or disability, in each case, within 24 months following the Effective Time, or (ii) incurs a “good leaver” termination at any time following the Effective Time, any then-unvested portion of the Restricted Cash Award will vest in full upon such termination and will be paid within 60 days following the date of such termination, subject to any required withholding of taxes.
6

TABLE OF CONTENTS

Please also see the section of this proxy statement titled “The Merger Agreement — Treatment of Company Equity Awards in the Merger.”
Interests of the Company’s Directors and Executive Officers in the Merger (page 71)
The Company’s directors and executive officers have interests in the Merger that may be different from, or in addition to, the interests of the Company stockholders generally. The Company Board was aware of and considered these interests (a) in reaching the determination to approve the Merger Agreement and deem the Merger Agreement, the Merger and the other transactions and agreements contemplated by the Merger Agreement to be advisable, fair to and in the best interests of the Company and the Company stockholders, and (b) in recommending that stockholders vote for the adoption of the Merger Agreement. These interests include:
•
the Company’s executive officers and directors hold equity-based awards that will be afforded the treatment described immediately above and under the section of this proxy statement titled “The Merger Agreement — Treatment of Company Equity Awards in the Merger”;
•
the Company’s executive officers are party to existing employment agreements with the Company that provide for certain severance benefits if their employment terminates in certain circumstances; and
•
the Company’s directors and executive officers are entitled to continued indemnification and insurance coverage following the Merger under the Merger Agreement. See the section of this proxy statement titled “The Merger Agreement — Indemnification of Directors and Officers and Insurance.”
For additional information, see the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger” beginning on page 71.
Voting by the Company’s Directors and Executive Officers (page 29)
As of the Record Date, the directors and executive officers of the Company beneficially owned in the aggregate approximately [•] shares of Company Common Stock, or approximately [•]% of the outstanding shares of Company Common Stock. We currently expect that our directors and executive officers will vote all of their respective shares of Company Common Stock “FOR” the proposal to adopt the Merger Agreement and “FOR” each of the other proposals to be voted on at the Special Meeting.
Financing of the Merger (page 70)
In connection with the execution of the Merger Agreement, Parent and Merger Sub obtained financing commitments for the Transactions as further described below. Together with cash on hand, the proceeds of such financings will be sufficient for Parent to pay the aggregate Per Share Price, repay Company indebtedness and pay related fees and expenses. The Merger is not subject to any financing condition.
Each of GTCR Fund XIV/A LP, GTCR Fund XIV/C LP, GTCR Co-Invest XIV/A LP, GTCR Co-Invest XIV/B LP (such funds, collectively, the “GTCR Funds”), Elliott Associates, L.P. and Elliott International, L.P. (such funds, collectively, the “Elliott Funds”) (each, a “Guarantor” and collectively, the “Guarantors”) delivered an equity commitment letter dated October 14, 2026 (in the case of the GTCR Funds, as amended on November 20, 2026) pursuant to which the GTCR Funds and the Elliott Funds committed, severally and not jointly and subject to the terms and conditions therein, to invest in Parent, directly or indirectly, an aggregate amount of up to $3,478,500,000 (the “Equity Financing”), consisting of $2,978,500,000 committed by the GTCR Funds and $500,000,000 committed by the Elliott Funds.
Pursuant to an amended and restated debt commitment letter (which amended and restated the debt commitment letter entered into concurrently with the execution of the Merger Agreement), dated as of October 28, 2026 (the “Debt Commitment Letter”), the commitment parties thereunder (collectively, the “Debt Financing Sources”), consisting of JPMorgan Chase Funding Inc., JPMorgan Chase Bank, N.A., Citigroup Global Markets Inc., Jefferies Finance LLC, Royal Bank of Canada, UBS Securities LLC, UBS AG, Stamford Branch, Ares Capital Management LLC, Blackstone Alternative Credit Advisors LP, Antares Capital LP, Antares Holdings LP and Capital One, National Association, committed to provide debt financing consisting of senior secured first lien facilities of up to $2,075,000,000, comprising a $1,750,000,000 term loan facility and a $325,000,000 revolving facility, and a senior secured bridge facility of up to $1,100,000,000 (collectively, the “Debt Financing”). As part of the Debt Financing, Merger Sub may issue up to $1,100,000,000 of Rule 144A-for-life senior secured notes in lieu of all or a portion of the bridge facility. The proceeds
7

TABLE OF CONTENTS

of the Debt Financing, together with the Equity Financing, and cash on hand, are intended to fund the Transactions, repay Company indebtedness and pay related fees and expenses. The obligations of Parent and Merger Sub to consummate the Merger are not subject to a financing condition.
In connection with the execution of the Merger Agreement, each Guarantor delivered a limited guarantee dated October 14, 2026 in favor of the Company (collectively, the “Limited Guarantees” and each, a “Limited Guarantee”). The Limited Guarantees cover, severally and not jointly and subject to their terms and applicable caps, Parent’s obligation to pay the Parent Termination Fee, specified reimbursement obligations and any costs, expenses and interest relating to the Parent Termination Fee subject to an agreed aggregate cap (such costs, expenses and interest, as applicable, the “Enforcement Costs”). The aggregate liability under the Limited Guarantees delivered by the GTCR Funds is capped at $264,310,020, the aggregate liability under the Limited Guarantees delivered by the Elliott Funds is capped at $58,181,980, and Enforcement Costs are capped at $7,500,000 under the Merger Agreement. See the section of this proxy statement titled “The Merger — Financing of the Merger — Guarantee.”
Conditions to Consummation of the Merger (page 104)
The obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction or waiver of various conditions on or prior to the Effective Time, including the following:
•
the adoption of the Merger Agreement by the Company stockholders;
•
no law, injunction or order by any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger will have been enacted, entered or promulgated and be continuing in effect; and
•
the waiting periods (including any extension thereof, including any agreement with a governmental authority to delay the Closing) applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) will have expired or otherwise been terminated.
Each party’s obligation to consummate the Merger is also subject to the satisfaction or waiver of certain additional conditions, including:
•
subject to certain materiality and other qualifiers, the accuracy of the representations and warranties of the other party;
•
the other party has complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by such party at or prior to the Closing;
•
the delivery of a customary closing certificate signed on behalf of the respective party by an officer of such party certifying certain conditions have been satisfied;
•
in the case of Parent’s and Merger Sub’s obligations, the absence of a Company Material Adverse Effect (as defined in the Merger Agreement and which term is described in the section of this proxy statement titled “The Merger Agreement — Representations and Warranties”); and
•
in the case of Parent’s and Merger Sub’s obligations, the delivery of a certificate from the Company to Parent, in a form reasonably satisfactory to Parent, certifying that the Company is not, and has not been during the applicable period described in the U.S. Internal Revenue Code of 1986 (the “Code”), a “United States real property holding corporation” (as defined in the Code), together with a copy of the notice to the U.S. Internal Revenue Service (the “IRS”).
Before the Closing, each of the Company, Parent and Merger Sub may waive any of the conditions to its obligation to consummate the Merger even though one or more of the conditions described above has not been met, except where waiver is not permissible under applicable law.
Regulatory Approvals Required for the Merger (page 80)
Antitrust
Under the HSR Act, certain transactions, including the Merger, may not be completed until notifications have been given and information furnished to the Antitrust Division of the U.S. Department of Justice (the “DOJ”) and the Federal Trade Commission (the “FTC”) and the applicable waiting period has expired or been terminated. Pursuant to the Merger Agreement, each of Parent and Merger Sub, on the one hand, and the Company, on the other hand, agreed to file,
8

TABLE OF CONTENTS

to the extent required, within ten business days following October 14, 2026 (i.e., by October 28, 2026), a notification and report form relating to the Merger as required by the HSR Act. The Company and Parent filed their respective notification and report forms under the HSR Act on October 28, 2026.
General
No regulatory approval other than the expiration or termination of the HSR Act waiting period is identified as a condition to the Closing in the Merger Agreement.
As of the date of this proxy statement, the waiting period under the HSR Act has not expired or been terminated. The Merger cannot be completed until the HSR waiting period has expired or been terminated.
No Solicitation of Other Offers (page 97)
From the date of the Merger Agreement until the earlier of the Effective Time and the termination of the Merger Agreement, the Company and its subsidiaries (and their respective representatives) are generally prohibited from soliciting Acquisition Proposals, furnishing non-public information to third parties in connection with an Acquisition Proposal, engaging in discussions or negotiations with third parties regarding an Acquisition Proposal, otherwise knowingly assisting or knowingly facilitating the making of any Acquisition Proposal (including granting a waiver, amendment or release under any pre-existing standstill or similar provision to allow for an Acquisition Proposal to be made), approving, endorsing or recommending an Acquisition Proposal, or approving, endorsing, recommending or entering into (or proposing to approve, recommend or enter into) any letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract relating to an Acquisition Proposal. Prior to receipt of the Requisite Stockholder Approval, the Company may, under the circumstances and subject to the requirements set forth in the Merger Agreement, engage with a third party that has made an unsolicited Acquisition Proposal that the Company Board determines in good faith (after consultation with its financial advisors and outside legal counsel) constitutes, or could reasonably be expected to lead to, a Superior Proposal (as defined in the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”) and that failure to do so would reasonably be likely to be inconsistent with its fiduciary duties under applicable law. The Company must notify Parent of an Acquisition Proposal within 48 hours and provide the material terms and relevant agreements; Parent has four business days to match, or three business days following a material modification, during which the Company must negotiate with Parent in good faith, and any non-public information provided to the third party must be provided to Parent within 24 hours if it was not previously provided. Prior to effecting a Company Board Recommendation Change in response to an Acquisition Proposal, the Company Board must have considered in good faith any proposals for amendments committed to by Parent in writing and have determined in good faith (after consultation with its financial advisors and outside legal counsel), that (x) such Acquisition Proposal continues to constitute a Superior Proposal and (y) the failure to take such action would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable law if such changes proposed by Parent were to be given effect. In addition, prior to receipt of the Requisite Stockholder Approval, the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event (each as defined in the section of this proxy statement titled “The Merger Agreement — Superior Proposal and Change of Recommendation”) if the Company Board (or a committee thereof) determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law, subject to at least four business days’ prior written notice to Parent (or three business days following a material change to the Intervening Event) during which the Company must negotiate with Parent in good faith, and only if the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing and has determined in good faith (after consultation with its financial advisors and outside legal counsel), that the failure to effect a Company Board Recommendation Change would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable law if such changes proposed by Parent were to be given effect.
Termination of the Merger Agreement (page 106)
The Merger Agreement contains certain customary termination rights for the Company and Parent, including:
•
if the Merger is not consummated on or before 11:59 p.m. (New York City time) on April 14, 2027 (the “Termination Date”);
•
if the Requisite Stockholder Approval is not obtained at the Special Meeting at which a vote is taken on the Merger;
9

TABLE OF CONTENTS

•
if the other party (or, in the case of the Company’s termination right, Parent or Merger Sub) breaches or fails to perform any of its representations, warranties, covenants or other agreements contained in the Merger Agreement in a manner that would cause the conditions to Closing to not be satisfied and, if capable of being cured, such party fails to cure such breach within the applicable cure period;
•
if there is a final and non-appealable permanent injunction or other judgment or order issued by any court or other governmental authority of competent jurisdiction preventing the consummation of the Merger, or any statute, rule or regulation that has been enacted, entered or enforced, which, in each case, prohibits, makes illegal or enjoins the consummation of the Merger; and
•
by mutual written agreement of Parent and the Company at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval).
In addition, subject to compliance with certain terms of the Merger Agreement, the Merger Agreement may be terminated by (x) the Company (prior to obtaining the Requisite Stockholder Approval) in order to enter into a definitive agreement providing for a Superior Proposal, (y) Parent (prior to obtaining the Requisite Stockholder Approval) if the Company Board changes its recommendation to the Company stockholders to vote to adopt the Merger Agreement, and (z) the Company if (i) all conditions (save for conditions to be satisfied at Closing) to the Merger have been satisfied or waived, (ii) the Company has irrevocably confirmed to Parent in writing that the Company is prepared to consummate the Merger and (iii) Parent fails to consummate the Merger by the date that is three (3) business days after the later of the first date on which Parent is required to consummate the Merger and the date of the Company’s notice.
Termination Fees (page 107)
The Company will be required to pay Parent the Company Termination Fee of $149,520,000 if the Merger Agreement is terminated in specified circumstances, including if Parent terminates because the Company Board changes its recommendation to the Company stockholders to vote to adopt the Merger Agreement or if the Company terminates to enter into an alternative acquisition agreement providing for a Superior Proposal received after the date of the Merger Agreement. The Company may also be required to pay the Company Termination Fee if (i) the Merger Agreement is terminated pursuant to certain specified termination events, (ii) following the execution and delivery of the Merger Agreement and prior to such termination, any person has publicly announced or provided to the Company Board or management of the Company an Acquisition Proposal and has not publicly (in the case of an Acquisition Proposal that has been publicly announced) withdrawn such Acquisition Proposal at least five (5) business days prior to the Special Meeting or, in the case of certain of such termination events, prior to the date of termination, and (iii) within twelve (12) months following such termination, either an Acquisition Transaction (as defined in the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers,” except that all references to “20%” in such definition will be deemed to be references to “50%”) is consummated or the Company enters into a definitive agreement providing for the consummation of an Acquisition Transaction.
Parent will be required to pay the Parent Termination Fee if the Merger Agreement is validly terminated by (i) the Company due to Parent or Merger Sub breaching or failing to perform certain of its representations, warranties, covenants or other agreements contained in the Merger Agreement causing the conditions to the Closing to not be satisfied and, if capable of being cured, failing to cure such breach within the applicable cure period, (ii) the Company because Parent fails to consummate the Merger within the specified period after all conditions (other than for conditions to be satisfied at Closing) to the Merger have been satisfied or waived and the Company has irrevocably confirmed to Parent in writing that the Company is prepared to consummate the Merger, or (iii) either the Company or Parent because the Merger has not been consummated by the Termination Date, at a time at which the Company had, or would have had upon completion of the applicable notice and waiting periods, the right to terminate the Merger Agreement pursuant to clause (i) or (ii).
A more detailed description of the termination fees is provided in the section of this proxy statement titled “The Merger Agreement — Termination Fees.”
Legal Proceedings Regarding the Merger (page 80)
As of the date of this proxy statement, the Company has received one demand letter on behalf of a purported stockholder of the Company pursuant to Section 220 of the DGCL, requesting access to certain books and records of the Company for the stated purposes of, among other things, investigating the events leading to the Merger Agreement, the independence and disinterestedness of certain members of the Company Board, and potential wrongdoing or
10

TABLE OF CONTENTS

mismanagement in connection with the Merger. The Company believes the claims asserted in the demand are without merit. As of the date of this proxy statement, there are no pending lawsuits challenging the Merger. However, potential plaintiffs may send additional demand letters or file lawsuits challenging the Merger. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could prevent or delay the Closing and result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers. One of the conditions to the Closing is the absence of any law, injunction or order (whether temporary, preliminary or permanent) from any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger. Therefore, if a plaintiff were successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from being consummated, or from being consummated within the expected time frame.
Delisting and Deregistration of Company Common Stock (page 81)
If the Merger is completed, the shares of Company Common Stock will be delisted from Nasdaq and deregistered under the Exchange Act, and shares of Company Common Stock will no longer be publicly traded.
Appraisal Rights (page 116)
Pursuant to Section 262 of the DGCL, the Company stockholders that are holders of record and beneficial owners of shares of Company Common Stock who continuously hold shares of Company Common Stock through the Effective Time and who do not vote such shares in favor of the adoption of the Merger Agreement, and beneficial owners of shares of Company Common Stock held either in voting trust or by a nominee on behalf of such person who beneficially owns shares of Company Common Stock through the Effective Time that are not voted in favor of the adoption of the Merger Agreement, and in either case who properly demand appraisal of their shares, who have neither failed to perfect, nor withdrawn their demands or lost rights to appraisal under the DGCL, and otherwise comply with the applicable requirements of Section 262 of the DGCL, will be entitled to seek appraisal of their shares of Company Common Stock if certain conditions set forth in Section 262 of the DGCL are satisfied. Persons considering seeking appraisal should be aware that the fair value of their shares as determined pursuant to Section 262 of the DGCL and the Delaware Court of Chancery could be greater than, the same as, or less than the value of the Per Share Price that holders of record or beneficial owners would otherwise be entitled to receive under the terms of the Merger Agreement if they did not seek appraisal of their shares of Company Common Stock.
This means that these holders of record and beneficial owners may be entitled to have their shares of Company Common Stock appraised by the Delaware Court of Chancery and to receive payment in cash of the “fair value” of their shares of Company Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid on the amount determined by the Delaware Court of Chancery to be fair value. Due to the complexity of the appraisal process, any persons who wish to seek appraisal of their shares are encouraged to seek the advice of legal and financial advisors with respect to the exercise of appraisal rights. For more information, see the section of this proxy statement titled “Appraisal Rights.”
The right to seek appraisal will be lost with respect to shares that a holder of record and beneficial owner of Company Common Stock votes “FOR” the proposal to adopt the Merger Agreement. However, abstaining or voting against adoption of the Merger Agreement is not in itself sufficient to perfect appraisal rights because additional actions must also be taken to perfect such rights. To exercise appraisal rights, the Company stockholders (or beneficial owners of shares of Company Common Stock held either in voting trust or by a nominee on behalf of such person) who wish to exercise the right to seek an appraisal of their shares must so advise the Company by submitting a written demand for appraisal to the Company prior to the taking of the vote on the Merger Proposal at the Special Meeting, and must otherwise strictly follow the applicable procedures and requirements prescribed by Section 262 of the DGCL. Any demand for appraisal made by a holder of record or beneficial owner of shares of Company Common Stock with respect to shares held of record in the name of a voting trust or nominee, such as a bank, broker or other nominee, on behalf of such person must (a) reasonably identify the holder of record of the shares for which the demand is made, (b) provide documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (c) provide an address at which such beneficial owner consents to receive notices given by the Company and the office of the Register in Chancery and to be set forth on the verified list required by Section 262(f) of the DGCL. However, after an appraisal petition has been filed under Section 262 of the DGCL, the Delaware Court of Chancery, at a hearing to determine persons entitled to appraisal rights, will dismiss any appraisal proceedings as to all Company stockholders that are holders of record and beneficial owners who are otherwise entitled to appraisal rights unless (i) the total number of shares entitled to appraisal exceeds 1% of the
11

TABLE OF CONTENTS

outstanding shares of the class of Company Common Stock eligible for appraisal, (ii) the value of the consideration provided by the Per Share Price for such total number of shares of Company Common Stock entitled to appraisal rights exceeds $1 million or (iii) the Merger was approved pursuant to Sections 253 or 267 of the DGCL.
In view of the complexity of Section 262 of the DGCL, the Company stockholders who are either holders of record or beneficial owners of Company Common Stock who may wish to pursue appraisal rights are urged to consult their legal and financial advisors.
Material U.S. Federal Income Tax Considerations (page 77)
The receipt of cash by a holder of Company Common Stock who is a U.S. holder (as defined in the section of this proxy statement titled “The Merger — Material U.S. Federal Income Tax Considerations”) in exchange for shares of Company Common Stock pursuant to the Merger will generally be a taxable transaction for U.S. federal income tax purposes. Generally, for U.S. federal income tax purposes, if you are a U.S. holder, you will recognize gain or loss equal to the difference, if any, between the amount of cash you receive (or are deemed to receive) in the Merger (determined before the deduction of any applicable withholding taxes) and your adjusted tax basis in the shares of Company Common Stock converted into the right to receive cash in the Merger. If you are a holder of Company Common Stock who is a non-U.S. holder (as defined in the section of this proxy statement titled “The Merger — Material U.S. Federal Income Tax Considerations”), you generally will not be subject to U.S. federal income tax on the Merger unless you have certain connections to the United States, or the Company is, or was during the relevant period, a “United States real property holding corporation” (as described in “The Merger — Material U.S. Federal Income Tax Considerations”). However, the Merger could be a taxable transaction to a non-U.S. holder under non-U.S. tax laws applicable to such holder. Holders may be subject to backup withholding tax unless the holder complies with certain certification procedures or otherwise establishes a valid exemption from backup withholding. Because individual circumstances may differ, we urge you to consult your own tax advisor to determine the particular tax effects to you.
You are urged to read the section of this proxy statement titled “The Merger — Material U.S. Federal Income Tax Considerations” for a more complete discussion of the material U.S. federal income tax consequences of the Merger. You are encouraged to consult your own tax advisors concerning the U.S. federal income tax consequences relating to the Merger in light of your particular circumstances and any consequences arising under U.S. federal non-income tax laws or the laws of any state, local or non-U.S. taxing jurisdiction.
Additional Information (page 125)
You can find more information about the Company in the periodic reports and other information the Company files with the SEC. The information is available on the SEC’s website at www.sec.gov and on the Company’s investor relations website at https://ir.cccis.com. See the section of this proxy statement titled “Where You Can Find Additional Information.”
If you have any questions concerning the Merger Agreement or the Transactions, the Special Meeting or the accompanying proxy statement, would like additional copies of this proxy statement, or need help submitting a proxy to have your shares of Company Common Stock voted, please contact our proxy solicitor:
Georgeson LLC
51 W 52nd Street 6th Floor
New York, NY 10019
Stockholders, Banks, and Brokers may call toll-free: (877) 467-5518
Outside the US may call: (908) 396-7859
12

TABLE OF CONTENTS

QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
The following questions and answers are intended to briefly address some commonly asked questions regarding the Special Meeting and the Merger. These questions and answers may not address all questions that may be important to you as a holder of shares of Company Common Stock. You should read the more detailed information contained elsewhere in this proxy statement, the annexes to this proxy statement and the documents referred to and incorporated by reference in this proxy statement.
Why am I receiving this proxy statement?
On October 14, 2026, the Company entered into the Merger Agreement with Parent and Merger Sub. Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent. On November 20, 2026, the Company entered into the first amendment to the Merger Agreement with Parent and Merger Sub.
You are receiving this proxy statement in connection with the solicitation of proxies by the Company Board in favor of the Merger Proposal and the other matters to be voted on at the Special Meeting as described in this proxy statement.
As a Company stockholder, what will I receive in the Merger?
Each share of Company Common Stock (including, for the avoidance of doubt, any SPAC Merger Earnout Shares and any Sponsor Earnout Shares) that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company Shares, Dissenting Company Shares or Company RSAs) will be automatically cancelled, extinguished and converted into the right to receive the Per Share Price of $7.75 in cash, without interest.
The exchange of shares of Company Common Stock for cash pursuant to the Merger will generally be a taxable transaction for U.S. federal income tax purposes. For a more detailed description of the U.S. federal income tax consequences of the Merger, see the section of this proxy statement titled “The Merger — Material U.S. Federal Income Tax Considerations.” You are urged to consult your own tax advisor for a full understanding of how the Merger will affect you for federal, state, local and/or non-U.S. tax purposes.
How does the Per Share Price compare to the recent trading price of Company Common Stock?
The Per Share Price of $7.75 per share of Company Common Stock in cash represents a premium of approximately 44% to the Company’s unaffected closing stock price of $5.38 on July 9, 2026, the last trading day prior to media speculation regarding a potential sale of the Company, and a premium of approximately 59% to the 30-day average price of Company Common Stock as of July 9, 2026. On [•], 2026, the most recent practicable date before the filing of this proxy statement, the closing price of Company Common Stock was $[•] per share. You are encouraged to obtain current market quotations for Company Common Stock in connection with voting your shares of Company Common Stock.
What will happen to outstanding Company equity awards in the Merger?
At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will, automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess of the Per Share Price over the exercise price per share of such Company Option. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof. At the Effective Time, each Vested Company RSA will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the Per Share Price.
At the Effective Time, each Unvested Company RSA will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash
13

TABLE OF CONTENTS

award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time, except as described below.
At the Effective Time, each Vested Company RSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.
At the Effective Time, each Unvested Company RSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company RSUs and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time, except as described below.
At the Effective Time, each Vested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU.
At the Effective Time, each Unvested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (a) actual performance achieved through the Effective Time and (b) target-level performance, in accordance with the terms of such Unvested Company PSU, and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time, except as described below.
Each Restricted Cash Award described above will be paid, without interest, no later than the second regularly scheduled payroll date after the applicable portion of such award vests. However, any unvested portion will vest in full if, within 24 months following the Effective Time, the holder’s employment or service is terminated without cause, the holder resigns for good reason or the holder’s employment or service terminates due to death or disability, or if the holder incurs a “good leaver” termination at any time following the Effective Time, and such amount will be paid within 60 days following the date of such termination, subject to any required withholding of taxes.
In addition, the Company’s employee stock purchase plan (the “Company ESPP”) will terminate immediately prior to the Effective Time, and (i) no individual who was not a participant in the Company ESPP as of the date of the Merger Agreement may enroll in the Company ESPP, (ii) no participant may increase the percentage amount of their payroll deduction election from that in effect on the date of the Merger Agreement or make separate non-payroll contributions to the Company ESPP, (iii) no new offering period will be commenced under the Company ESPP prior to the Effective Time, (iv) the final exercise date for the offering period under the Company ESPP in effect as of the date of the Merger Agreement (the “ESPP Offering Period”) will be the earlier of the regularly scheduled final exercise date for such ESPP Offering Period and a date that is no later than ten calendar days prior to the Effective Time (the “Final Exercise Date”) and (v) each Company ESPP participant’s accumulated contributions under the Company ESPP will be used to purchase shares of Company Common Stock in accordance with the terms of the Company ESPP as of the Final Exercise Date. Any accumulated contributions remaining after such purchase, including any amounts exceeding what is required to purchase the maximum number of shares of Company Common Stock that may be purchased under the terms of the Company ESPP, shall be returned to such participant, without interest, as promptly as practicable thereafter.
Immediately prior to the Effective Time, all Sponsor Earnout Shares will vest in full and the Company will issue the maximum number of SPAC Merger Earnout Shares issuable under the SPAC Merger Agreement. At the Effective
14

TABLE OF CONTENTS

Time, those shares will be converted into the right to receive the Per Share Price, except that amounts payable in respect of SPAC Merger Earnout Shares issued to holders of Company Options will be funded by Parent to the Company and paid by the Company or the surviving corporation through its payroll system or payroll provider, less any required withholding, no later than five business days following the Closing Date, rather than through the Payment Agent (as defined in the section of this proxy statement titled "The Merger Agreement — Procedures for Receiving Per Share Price"). For more information, see the sections of this proxy statement titled “The Merger Agreement — Treatment of Company Equity Awards in the Merger” and “The Merger Agreement — Effect on Other Company Securities; Company Earnout Shares.”
When and where is the Special Meeting of our stockholders?
The Special Meeting will be held virtually on [•], 2026, at [•] [a.m.]/[p.m.], Central Time (unless adjourned or postponed to a different date and time). The Company is conducting the Special Meeting solely via the Internet through a live webcast. Company stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and by using the 16-digit control number included in their proxy materials.
Who is entitled to vote at the Special Meeting?
The record date for the Special Meeting is [•], 2026. Only stockholders of record as of the close of business on the Record Date, or those holding a valid proxy, are entitled to vote the shares of Company Common Stock they held as of the Record Date at the Special Meeting. As of the close of business on the Record Date, there were [•] shares of Company Common Stock issued and outstanding and entitled to vote. On each of the proposals presented at the Special Meeting, each Company stockholder is entitled to one vote for each share of Company Common Stock held by such stockholder on the Record Date.
May I attend the Special Meeting and vote in person?
The Company is hosting the Special Meeting virtually. There will be no physical location for Company stockholders to attend. Company stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and by using the 16-digit control number included in their proxy materials.
Stockholders of record: If your shares of Company Common Stock were registered directly in your name with our transfer agent, Fidelity Stock Transfer, in order to participate in the Special Meeting, you will need your 16-digit control number included on the proxy card previously distributed to you. If you are a holder of record, you may vote electronically during the Special Meeting by following the instructions available at www.virtualshareholdermeeting.com/[•].
Stockholders holding shares in “street” name: If your shares of Company Common Stock are beneficially held in “street name” through a brokerage firm, bank, trust or other similar organization and you do not have a 16-digit control number, in order to participate in the Special Meeting, you must first obtain a legal proxy from your broker, bank or other nominee reflecting the number of shares of Company Common Stock you held as of the Record Date, your name and email address. If you beneficially hold your shares of Company Common Stock in “street name,” you must obtain the appropriate documents from your broker, bank, trustee, or nominee, giving you the right to vote the shares at the Special Meeting.
Instructions on how to attend and participate in the Special Meeting via the webcast are posted at www.virtualshareholdermeeting.com/[•].
You should ensure that you have a strong Internet connection and allow plenty of time to log in and ensure that you can hear streaming audio prior to the start of the Special Meeting. We encourage you to access the meeting at least fifteen (15) minutes prior to the start time to allow ample time to complete the online check-in process. If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be provided on the log-in page.
What proposals will be considered at the Special Meeting?
At the Special Meeting, Company stockholders will be asked to consider and vote on the following proposals:
•
a proposal to adopt the Merger Agreement (the “Merger Proposal”);
•
a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and
15

TABLE OF CONTENTS

•
a proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).
What constitutes a quorum for purposes of the Special Meeting?
In order to have a quorum at the Special Meeting, holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting must be present in person or represented by proxy. Abstentions are counted for purposes of determining whether a quorum is present. The Company does not expect any broker non-votes at the Special Meeting because the rules applicable to banks, brokers and other nominees only provide brokers with discretionary authority to vote on proposals that are considered routine, whereas each of the proposals to be presented at the Special Meeting is expected to be considered non-routine.
If a quorum is not present, the only business that can be transacted at the Special Meeting is the adjournment of the meeting to another date or time, subject to the terms of the Merger Agreement.
What vote of the Company stockholders is required to approve each of the proposals?
On each of the proposals presented at the Special Meeting, each Company stockholder is entitled to one vote for each share of Company Common Stock held by such stockholder on the Record Date.
The table below illustrates the voting options, vote required, and effect of abstentions and broker non-votes for each proposal, assuming a quorum is present at the Special Meeting (except as otherwise indicated):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Voting Matter
 
 
Voting
Options
 
 
Vote Required
 
 
Broker
Discretionary
Voting Allowed
 
 
Effect of
Broker
Non-Votes
 
 
Effect of
Abstentions
Proposal 1: The Merger Proposal
 
 
For, against, or abstain
 
 
Affirmative vote of the Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote
 
 
No
 
 
N/A(1)(2)
 
 
Against
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proposal 2: The Advisory Compensation Proposal
 
 
For, against, or abstain
 
 
With a quorum present, majority of the votes properly cast for and against the proposal
 
 
No
 
 
N/A(1)(3)
 
 
No effect
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proposal 3: The Adjournment Proposal(4)
 
 
For, against, or abstain
 
 
With a quorum present: Majority of the votes properly cast for and against the proposal
 
 
No
 
 
N/A(1)(3)
 
 
With a quorum: No effect
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Without a quorum: Holders of a majority of the voting power present at the Special Meeting
 
 
 
 
 
 
 
 
Without a quorum: Against
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Each proposal to be considered at the Special Meeting is expected to be deemed a “non-routine” matter. As a result, if you do not provide any voting instructions to your broker, bank, or other nominee, your shares will not be deemed present for any purpose at the Special Meeting, including for purposes of determining whether a quorum exists. Accordingly, no broker non-votes are expected in connection with the Special Meeting.
(2)
Although no broker non-votes are expected, a failure to provide any instructions to the broker, bank, or other nominee holding your shares of Company Common Stock will, without resulting in a broker non-vote, have the same effect as a vote “Against” the Merger Proposal.
(3)
Although no broker non-votes are expected, a failure to provide any instructions to the broker, bank, or other nominee holding your shares of Company Common Stock will, without resulting in a broker non-vote and assuming a quorum is present, have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal.
16

TABLE OF CONTENTS

(4)
Subject to the terms of the Merger Agreement, the Company retains authority, to the extent set forth in its Bylaws and Delaware law, to adjourn the Special Meeting for any other purpose, or to postpone the Special Meeting before it is convened, without the vote or consent of any of the Company stockholders. Please be advised that the Company does not intend to call a vote on the Adjournment Proposal if the Merger Proposal is approved at the Special Meeting.
What is a “broker non-vote”?
A “broker non-vote” occurs when a bank, broker or other nominee holding shares in “street name” for a beneficial owner returns a proxy but does not vote on a particular proposal because it has not received voting instructions from the beneficial owner and does not have discretionary authority to vote on that proposal. Under applicable stock exchange rules, banks, brokers and other nominees holding shares in “street name” have discretionary authority to vote such shares only on matters that are considered “routine,” and may not vote such shares on “non-routine” matters, such as the Merger Proposal, the Advisory Compensation Proposal and the Adjournment Proposal, without voting instructions from the beneficial owner. If you do not provide your bank, broker or other nominee with voting instructions, your shares will not be voted on those proposals.
Although the determination of whether a bank, broker or other nominee will have discretionary authority to vote on a particular proposal is typically made only after proxy materials are filed with the SEC, the Company does not expect any broker non-votes at the Special Meeting because the rules applicable to banks, brokers and other nominees only provide brokers with discretionary authority to vote on proposals that are considered routine, whereas each of the proposals to be presented at the Special Meeting is expected to be considered non-routine. As a result, no bank, broker or other nominee will be permitted to vote your shares of Company Common Stock at the Special Meeting without receiving instructions. Failure to provide any instructions to your bank, broker or other nominee as to how to vote your shares of Company Common Stock will have the same effect as a vote “AGAINST” the Merger Proposal but will have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal.
What is the Transaction Committee and what role did it play in evaluating the Merger?
The Company Board formed the Transaction Committee as certain members of the Company Board are entitled to receive SPAC Merger Earnout Shares pursuant to the terms and conditions set forth in the SPAC Merger Agreement upon the occurrence of certain triggering events (including a potential sale of the Company) and Parent’s written non-binding proposal required, among other things, that certain executive officers of the Company agree to roll over a portion of their equity interests in connection with the Transactions. See the section of this proxy statement titled “The Merger - Interests of the Company’s Directors and Executive Officers in the Merger.” The Transaction Committee was formed for the purpose of evaluating and determining whether a potential sale of the Company, including the Per Share Price payable to the Company stockholders in connection therewith, is fair to and in the best interests of the Company stockholders who are not entitled to receive SPAC Merger Earnout Shares or are not party to the Rollover Agreements. In connection with the formation of the Transaction Committee, the Company Board resolved that it would not approve any potential sale of the Company without a recommendation in favor of the Transactions by the Transaction Committee. The Transaction Committee is comprised solely of disinterested members of the Company Board for such purpose. As more fully described in the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board”, the Transaction Committee evaluated the Merger Agreement, the Rollover Agreements and the Transactions, including the Merger. At the conclusion of its review, the Transaction Committee unanimously (a) determined that the Transactions and the terms and conditions of the Merger, including the Per Share Price payable to the Company stockholders, are fair to, and in the best interests of, the Company and the Company stockholders who are not entitled to receive SPAC Merger Earnout Shares or are not party to the Rollover Agreements and (b) recommended that the Company Board (i) approve, adopt and authorize the Merger Agreement and the Transactions, (ii) direct the Company to enter into and deliver the Merger Agreement and any related documents required to be delivered in connection therewith and (iii) recommend that the Company stockholders vote to adopt the Merger Agreement.
Did the Company Board approve and recommend the Merger Agreement?
Yes. After careful consideration and acting on the unanimous recommendation of the Transaction Committee, the Company Board has unanimously (with respect to all directors present) (i) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger upon the terms and subject to the conditions set forth therein; (ii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth
17

TABLE OF CONTENTS

therein; (iii) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (iv) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at the Special Meeting. Accordingly, the Company Board recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
For a discussion of the factors that the Transaction Committee and the Company Board considered in making their respective determinations and recommendations, see the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board.”
Do any of the Company’s directors or executive officers have interests in the Merger that may differ from or be in addition to my interests as a Company stockholder?
Yes, in considering the recommendation of the Company Board with respect to the Merger Agreement, you should be aware that certain of the Company’s directors and executive officers have interests that may be different from, or in addition to, the interests of Company stockholders generally. These interests include the Rollover Agreements entered into by Githesh Ramamurthy, the Company’s Chairman and Chief Executive Officer, and Tim Welsh, the Company’s President, with Topco and the right of certain directors and executive officers to receive the Per Share Price in respect of SPAC Merger Earnout Shares in connection with the Merger. The Transaction Committee and the Company Board were aware of and considered these interests, among other matters, in evaluating the Merger and in making their respective determinations and recommendations. See the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.”
Why am I being asked to cast an advisory, non-binding vote to approve the compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger?
The SEC, in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, adopted rules that require the Company to seek an advisory (non-binding) vote with respect to certain payments that may be made to the Company’s named executive officers in connection with the Merger.
What will happen if the Company stockholders do not approve the Advisory Compensation Proposal?
The vote on the Advisory Compensation Proposal is a vote separate and apart from the vote to adopt the Merger Agreement. Because the vote on the Advisory Compensation Proposal is advisory only, it will not be binding on the Company, the Company Board, Parent or the surviving corporation. Accordingly, if the Merger Agreement is adopted by the Company stockholders and the Merger is completed, the compensation will be payable, subject only to the conditions applicable thereto, regardless of the outcome of this advisory, non-binding vote.
What happens if I sell my shares of Company Common Stock before the Special Meeting?
The Record Date is earlier than the date of the Special Meeting. If you sell or transfer your shares of Company Common Stock after the Record Date, but before the Special Meeting, you will retain your right to vote such shares at the Special Meeting. However, the right to receive the Per Share Price will pass to the person to whom you transferred your shares. In order to receive the Per Share Price in connection with the Merger, you must hold your shares of Company Common Stock through the Effective Time. In addition, if you demand appraisal for any of your shares of Company Common Stock, you will lose your right to appraisal with respect to any such shares that you thereafter sell or transfer prior to the Effective Time.
What is a proxy?
A proxy is your legal designation of another person to vote your shares of Company Common Stock. The written document describing the matters to be considered and voted on at the Special Meeting is called a “proxy statement.” The document used to designate a proxy to vote your shares of Company Common Stock is called a “proxy card.”
If a Company stockholder gives a proxy, how are the shares voted?
Regardless of the method you choose to vote, the individuals named on the accompanying proxy card, or your proxies, will vote your shares of Company Common Stock in the way that you indicate. When completing the Internet or telephone process or the proxy card, you may specify whether your shares of Company Common Stock should be voted for or against or to abstain from voting on all, some or none of the specific items of business to come before the Special Meeting.
18

TABLE OF CONTENTS

If you properly sign your proxy card but do not mark the boxes showing how your shares of Company Common Stock should be voted on a matter, the shares of Company Common Stock represented by your properly signed proxy will be voted “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
Can I change my vote after I have delivered my proxy or my voting instructions?
If you are a holder of record, you may change your vote or revoke your proxy at any time before your shares of Company Common Stock are voted at the Special Meeting, as applicable, by (i) mailing a proxy card dated later than your last submitted proxy card, so long as it is received prior to the Special Meeting, (ii) authorizing a new proxy to vote on a later date on the Internet or by telephone (it being understood that only your latest Internet or telephone proxy submitted prior to the Special Meeting will be counted), (iii) notifying the Corporate Secretary of the Company in writing, so long as such notice is received prior to the Special Meeting, or (iv) voting during the Special Meeting (attendance at the Special Meeting will not, by itself, revoke the proxy). If your shares of Company Common Stock are held beneficially in “street name,” you should follow the instructions provided by your broker, bank or other nominee to change your vote or revoke your proxy.
How do I cast my vote if I am a Company stockholder that is a holder of record?
If your shares are registered directly in your name with our transfer agent, Fidelity Stock Transfer, you are considered, with respect to those shares, to be the “holder of record.” In that case, this proxy statement and your proxy card have been sent directly to you by the Company.
If you are a holder of record as of the Record Date, you may vote by submitting your proxy via the Internet, by telephone or by completing, signing and returning the accompanying proxy card by mail in the prepaid reply envelope. You may also vote your shares of Company Common Stock by ballot via the Internet during the Special Meeting. Even if you plan to attend the Special Meeting, you are encouraged to submit your vote by proxy as early as possible to ensure that your shares of Company Common Stock will be represented. For more detailed instructions on how to vote using one of these methods, see the section of this proxy statement titled “The Special Meeting — Voting Procedures.”
If you are a holder of record of shares of Company Common Stock and you submit a proxy card or voting instructions but do not direct how to vote on each item, the persons named as proxies will vote your shares “FOR” each of the Merger Proposal, the Advisory Compensation Proposal and, if necessary or appropriate, the Adjournment Proposal.
How do I cast my vote if my shares of Company Common Stock are beneficially held in “street name” by my bank, broker or other nominee?
If your shares are held through a bank, broker or other nominee, you are considered the “beneficial owner” of shares of Company Common Stock (i.e., you hold in “street name”). In that case, this proxy statement has been forwarded to you by your bank, broker or other nominee who is considered, with respect to those shares, to be the holder of record.
If you are a beneficial owner of shares of Company Common Stock (i.e., you hold in “street name”), you must follow the instructions from your bank, broker or other nominee in order to vote such shares. Your bank, broker or other nominee will vote your shares of Company Common Stock only if you provide instructions on how to vote by properly completing the voting instruction form sent to you by your bank, broker or other nominee with this proxy statement. Without providing any such instructions, your shares will not be voted or counted as present for purposes of determining whether a quorum exists, which will have the same effect as a vote “AGAINST” the Merger Proposal but will have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal.
What will happen if I abstain from voting or fail to vote on any of the proposals?
If you abstain from voting on the Merger Proposal, your abstention will have the same effect as a vote “AGAINST” the Merger Proposal. Abstentions will have no effect on the outcome of the Advisory Compensation Proposal or, if a quorum is present, the Adjournment Proposal.
If you fail to cast your vote via the Internet during the Special Meeting or by proxy or fail to give any voting instructions to your bank, broker or other nominee, any such failure will have the same effect as a vote “AGAINST” the Merger Proposal but will have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal.
19

TABLE OF CONTENTS

What should I do if I receive more than one set of voting materials?
You may receive more than one set of voting materials, including multiple copies of this proxy statement or multiple proxy or voting instruction cards. For example, if you hold your shares of Company Common Stock in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares of Company Common Stock. If you are a holder of Company Common Stock of record and your shares of Company Common Stock are registered in more than one name, you will receive more than one proxy card. Please submit your proxy and/or voting instructions for each set of materials that you receive to ensure that all your shares of Company Common Stock are voted.
Where can I find the voting results of the Special Meeting?
If available, we may announce preliminary voting results at the conclusion of the Special Meeting. We intend to publish final voting results in a Current Report on Form 8-K to be filed with the SEC following the Special Meeting. All reports that the Company files with the SEC are publicly available when filed. For more information, see the section of this proxy statement titled “Where You Can Find Additional Information.”
Am I entitled to rights of appraisal under the DGCL?
If the Merger is completed, and certain conditions set forth in Section 262(g) of the DGCL are satisfied, the Company stockholders that are holders of record and beneficial owners of Company Common Stock who continuously hold shares of Company Common Stock through the Effective Time and who do not vote such shares in favor of the adoption of the Merger Agreement, and beneficial owners of shares of Company Common Stock held either in voting trust or by a nominee on behalf of such person who beneficially owns shares of Company Common Stock through the Effective Time that are not voted in favor of the adoption of the Merger Agreement, and in either case who properly demand appraisal of their applicable shares and do not withdraw their demands or otherwise lose their rights to appraisal, and who otherwise comply with the applicable requirements of Section 262 of the DGCL, will be entitled to seek appraisal of their shares of Company Common Stock in connection with the Merger under Section 262 of the DGCL. This means such holders of record and beneficial owners of shares of Company Common Stock will be entitled to have their shares appraised by the Delaware Court of Chancery and to receive payment in cash of the “fair value” of their shares of Company Common Stock, exclusive of any elements of value arising from the accomplishment or expectation of the Merger, together with interest on the amount determined to be fair value, if any, as determined by the court (or, in certain circumstances described below, on the difference between the amount determined to be the fair value and the amount paid to each stockholder entitled to appraisal prior to the entry of judgment in the appraisal proceeding). Holders of record and beneficial owners of Company Common Stock who wish to seek appraisal of their shares are in any case encouraged to seek the advice of their legal counsel and financial advisors with respect to the exercise of appraisal rights due to the complexity of the appraisal process. The requirements under Section 262 of the DGCL for exercising appraisal rights are described in additional detail in this proxy statement, and Section 262 of the DGCL regarding appraisal rights is accessible without subscription or cost at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262. Failure to comply with the provisions of Section 262 of the DGCL in a timely and proper manner may result in the loss of appraisal rights. See the section of this proxy statement titled “Appraisal Rights.”
When is the Merger expected to be completed?
We are working toward completing the Merger as promptly as possible and currently expect the Merger to close in the first quarter of 2027, subject to the adoption of the Merger Agreement by Company stockholders, the expiration or termination of the applicable waiting period under the HSR Act, and the satisfaction or waiver of the other closing conditions. However, the exact timing of completion of the Merger cannot be accurately predicted, because the Merger is subject to the satisfaction (or, to the extent permitted by applicable law, waiver) of the conditions to Parent’s, Merger Sub’s and the Company’s respective obligations to consummate the Merger, some of which are not within the parties’ control. If the Merger has not been completed by 11:59 p.m., New York City time, on April 14, 2027, either the Company or Parent may generally terminate the Merger Agreement.
What effect will the Merger have on the Company?
If the Merger is consummated, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will thereupon cease, and the Company will continue to exist following the Merger as a wholly owned subsidiary of Parent. Following completion of the Merger, shares of Company Common Stock will be delisted from Nasdaq, and the registration of shares of Company Common Stock under the Exchange Act will be terminated.
20

TABLE OF CONTENTS

What happens if the Merger is not completed?
If the Merger Proposal is not approved by the Company stockholders, or if the Merger is not completed for any other reason, the Company stockholders will not receive any payment for their shares of Company Common Stock in connection with the Merger. Instead, the Company will remain an independent public company and Company stockholders will continue to own their shares of Company Common Stock. Company Common Stock will continue to be registered under the Exchange Act and listed and traded on Nasdaq. In addition, if the Merger is not completed, the Company stockholders will continue to be subject to the same risks and opportunities to which they are currently subject. Under certain circumstances, if the Merger Agreement is terminated, the Company may be obligated to pay to Parent the Company Termination Fee of $149,520,000 or Parent may be obligated to pay to the Company the Parent Termination Fee of $313,992,000, as applicable. For more information, see the section of this proxy statement titled “The Merger Agreement — Termination Fees.”
What is householding and how does it affect me?
The SEC permits companies to send a single set of proxy materials to any household at which two or more stockholders reside, unless contrary instructions have been received, but only if we provide advance notice and follow certain procedures. In such cases, each stockholder continues to receive a separate notice of the Special Meeting and proxy card. If your shares of Company Common Stock are beneficially held in “street name,” you will receive your proxy card or other voting information from your bank, broker or other nominee and you will return your proxy card(s) to your bank, broker or other nominee. You should vote on and sign each proxy card you receive as discussed above. To request that only one copy of any of these materials be mailed to your household, please contact your bank, broker or other nominee.
Who can help answer my questions?
If you need assistance in completing your proxy card or have questions regarding the Special Meeting, please contact our proxy solicitor:
Georgeson LLC
51 W 52nd Street 6th Floor
New York, NY 10019
Stockholders, Banks, and Brokers may call toll-free: (877) 467-5518
Outside the US may call: (908) 396-7859
21

TABLE OF CONTENTS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This proxy statement contains “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, including those relating to the future financial performance and business strategies and expectations for our business. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include information concerning our possible or assumed future results of operations, client demand, business strategies, technology developments, financing and investment plans, competitive position, our industry and regulatory environment, potential growth opportunities and the effects of competition. For example, all statements we make relating to our expectations relating to the Transactions, our estimated and projected costs, expenditures, cash flows, growth rates, and financial results or our plans and objectives for future operations, growth initiatives, or strategies are forward-looking statements.
Important factors that could cause actual results to differ materially from our expectations include:
•
the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, including circumstances requiring us to pay the Company Termination Fee pursuant to the Merger Agreement;
•
failure to satisfy the conditions precedent to consummate the Merger, including the failure to receive the Requisite Stockholder Approval or obtain required regulatory approvals;
•
the risk that required regulatory approvals may not be obtained in a timely manner or at all, or may be obtained subject to conditions that are not anticipated;
•
the risk that restrictions on the operation of our business during the pendency of the Merger may impact our ability to pursue certain business opportunities or strategic transactions or undertake certain actions we might otherwise have taken;
•
potential litigation relating to, or other unexpected costs resulting from, the Merger;
•
the effect of the announcement or pendency of the Merger on our business relationships, operating results and business generally, including the risk of disruption of management’s attention from our ongoing business operations;
•
the possibility that a competing Acquisition Proposal which constitutes, or could reasonably be expected to lead to, a Superior Proposal will be made, and the risk that announcements relating to the Merger could have adverse effects on the market price of Company Common Stock;
•
our revenues, the concentration of our customers and the ability to retain our current customers;
•
our ability to negotiate with our customers on favorable terms;
•
our ability to maintain and grow our brand and reputation cost-effectively;
•
the execution of our growth strategy;
•
the impact of factors outside of our control including public health outbreaks, natural catastrophes, war and terrorism;
•
our projected financial information, growth rate and market opportunity;
•
the health of our industry, claim volumes, and market conditions;
•
changes in the insurance and automotive collision industries, including the adoption of new technologies;
•
global economic conditions and geopolitical events;
•
competition in our market and our ability to retain and grow market share;
•
our ability to develop, introduce and market new enhanced versions of our solutions;
22

TABLE OF CONTENTS

•
our sales and implementation cycles;
•
the ability of our research and development efforts to create significant new revenue streams;
•
changes in applicable laws or regulations;
•
changes in international economic, political, social and governmental conditions and policies, including corruption risks in China and other countries;
•
our reliance on third-party data, technology and intellectual property;
•
our ability to protect our intellectual property;
•
our ability to keep our data and information systems secure from data security breaches;
•
changes in our customers’ or the public’s perceptions regarding the use of AI;
•
our ability to acquire or invest in companies or pursue business partnerships;
•
our ability to raise financing in the future and improve our capital structure;
•
our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
•
our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;
•
our ability to expand or maintain our existing customer base;
•
our ability to service our indebtedness; and
•
other factors set forth in our SEC filings.
The forward-looking statements contained in this proxy statement are based on current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2025 and “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in any subsequent Quarterly Reports on Form 10-Q. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. There may be additional risks that we consider immaterial or which are unknown. It is not possible to predict or identify all such risks. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
23

TABLE OF CONTENTS

THE PARTIES
CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc.
167 N. Green Street, 9th Floor
Chicago, IL 60607
(800) 621-8070
Founded in 1980, the Company is a leading SaaS and AI platform provider for the multi-trillion-dollar insurance economy, powering operations for insurers, repairers, automakers, parts suppliers and others. The Company’s cloud technology connects more than 35,000 businesses, digitizing mission-critical workflows, commerce and customer experiences. The Company’s business has been built upon two foundational pillars: automotive insurance claims and automotive collision repair. As of September 30, 2026, the Company had customer agreements with more than 300 insurers (including carriers, self-insurers and other entities processing insurance claims), including 27 of the top 30 automotive insurance carriers and 9 of the top 15 disability insurance carriers in the U.S., based on P&C Direct Written Premium, and hundreds of regional carriers. The Company has more than 35,000 total customers, including more than 30,500 automotive collision repair facilities (including repairers and other entities that estimate damaged vehicles), more than 6,500 parts and diagnostics suppliers, 15 of the top 15 automotive manufacturers based on vehicles in operation, and numerous other companies that participate in the insurance economy.
Shares of Company Common Stock are listed on Nasdaq under the symbol “CCC.” Our principal executive offices are located at 167 N. Green Street, 9th Floor, Chicago, Illinois 60607. Our telephone number is (800) 621-8070. Our investor relations website address is https://ir.cccis.com. The information contained on, or that can be accessed through, our website is not incorporated by reference into or otherwise part of this proxy statement. Additional information about the Company is contained in our public filings. See the section of this proxy statement titled “Where You Can Find Additional Information.”
Mozart Parent, LLC
Mozart Parent, LLC c/o GTCR LLC
300 N. LaSalle Street, Suite 5600
Chicago, IL 60654
Parent is a Delaware limited liability company formed on September 18, 2026 solely for the purpose of engaging in the Transactions. Parent is affiliated with certain investment funds or other investment vehicles managed or advised by GTCR. Parent has not engaged in any business activities other than in connection with the Transactions. After the Closing, the Company will be a wholly owned subsidiary of Parent, which will be indirectly owned by certain investment funds or other investment vehicles affiliated with GTCR and Elliott and by the Rollover Investors, through their equity interests in Topco.
Mozart Merger Sub (DE), Inc.
Mozart Merger Sub (DE), Inc. c/o GTCR LLC
300 N. LaSalle Street, Suite 5600
Chicago, IL 60654
Merger Sub is a Delaware corporation and wholly owned subsidiary of Parent formed on September 25, 2026 solely for the purpose of engaging in the Transactions. Merger Sub has not engaged in any business activities other than in connection with the Transactions. Upon the Closing, Merger Sub will merge with and into the Company and will cease to exist. Following the Effective Time, the surviving corporation will be indirectly owned by certain investment funds or other investment vehicles affiliated with GTCR and Elliott and by the Rollover Investors, through their equity interests in Topco.
For more information, see the section of this proxy statement titled “The Merger — Financing of the Merger.”
24

TABLE OF CONTENTS

THE SPECIAL MEETING
We are furnishing this proxy statement to the Company stockholders as part of the solicitation of proxies by the Company Board for use at the Special Meeting and at any adjournments or postponements thereof.
Date, Time and Place
The Special Meeting will be held virtually on [•], 2026, at [•] [a.m.] / [p.m.], Central Time (unless adjourned or postponed to a different date and time). Company stockholders will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and by using the 16-digit control number included in your proxy materials, where you, or your proxy, will be able to vote electronically. The Company is conducting the Special Meeting solely via the Internet through a live webcast.
Purpose of the Special Meeting
At the Special Meeting, Company stockholders will be asked to consider and vote on the following proposals:
•
a proposal to adopt the Merger Agreement (the “Merger Proposal”);
•
a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and
•
a proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).
A copy of the Merger Agreement is attached as Annex A-1 and the first amendment to the Merger Agreement is attached as Annex A-2 to this proxy statement.
Recommendation of the Transaction Committee and the Company Board
The Company Board has unanimously (with respect to all directors present) (i) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger upon the terms and subject to the conditions set forth therein; (ii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iii) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (iv) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at a meeting thereof. The Company Board acted upon the unanimous recommendation of the Transaction Committee. Accordingly, the Company Board recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
For a discussion of the material factors that the Company Board considered in determining to recommend the adoption of the Merger Agreement, see the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board.”
Record Date and Company Stockholders Entitled to Vote
Only Company stockholders of record as of the close of business on [•], 2026, the Record Date, are entitled to receive notice of and to vote the shares of Company Common Stock they held on the Record Date at the Special Meeting. As of the close of business on the Record Date, [•] shares of Company Common Stock were issued and outstanding and entitled to be voted at the Special Meeting. On each of the proposals presented at the Special Meeting, each Company stockholder is entitled to one vote for each share of Company Common Stock held by such stockholder on the Record Date. The adoption of the Merger Agreement by the Company stockholders requires the affirmative vote of Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote thereon as of the close of business on the Record Date.
A list of Company stockholders of record entitled to vote at the Special Meeting will be available for examination by any Company stockholder, for any purpose germane to the Special Meeting, for at least ten days prior to the Special Meeting at our principal executive offices at 167 N. Green Street, 9th Floor, Chicago, Illinois 60607.
25

TABLE OF CONTENTS

Quorum
In order to have a quorum at the Special Meeting, holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Special Meeting must be present in person or represented by proxy. Abstentions are counted for purposes of determining whether a quorum is present. The Company does not expect any broker non-votes at the Special Meeting because the rules applicable to banks, brokers and other nominees only provide brokers with discretionary authority to vote on proposals that are considered routine, whereas each of the proposals to be presented at the Special Meeting is expected to be considered non-routine.
If a quorum is not present, the only business that can be transacted at the Special Meeting is the adjournment of the meeting to another date or time, subject to the terms of the Merger Agreement.
Vote Required
Adoption of the Merger Proposal
The approval of the Merger Proposal requires the affirmative vote of the Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote as of the close of business on the Record Date. Accordingly, shares deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) and abstentions will have the same effect as a vote “AGAINST” the Merger Proposal.
Under the Merger Agreement, approval of the Merger Proposal by the Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote as of the close of business on the Record Date is a condition to the consummation of the Merger.
Approval of the Advisory Compensation Proposal
Assuming a quorum is present, approval of the Advisory Compensation Proposal, on an advisory, non-binding basis, requires a majority of the votes properly cast for and against the proposal. Accordingly, abstentions and shares deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) will have no effect on the outcome of the Advisory Compensation Proposal.
The vote on the Advisory Compensation Proposal is a vote separate and apart from the vote to adopt the Merger Agreement. Because the vote on the Advisory Compensation Proposal is advisory only, it will not be binding on the Company, the Company Board, Parent or the surviving corporation. Accordingly, because the Company is contractually obligated to pay the compensation, if the Merger Agreement is adopted by the Company stockholders and the Merger is completed, the compensation will be payable, subject only to the conditions applicable thereto, regardless of the outcome of the advisory, non-binding vote.
Approval of the Adjournment Proposal
Assuming a quorum is present, approval of the Adjournment Proposal requires a majority of the votes properly cast for and against the proposal. Accordingly, abstentions (if a quorum is present) and shares deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) will have no effect on the outcome of the Adjournment Proposal. If there is no quorum present, abstentions will have the same effect as a vote “AGAINST” the Adjournment Proposal. Under the Bylaws, the presiding officer of the Special Meeting may also adjourn the meeting in certain circumstances, including if no quorum is present.
The vote on the Adjournment Proposal is a vote separate and apart from the vote to adopt the Merger Agreement. The Company does not intend to call a vote on this proposal if the Merger Proposal is approved at the Special Meeting.
Tabulation of Votes; Results
The Company will retain an independent party to receive and tabulate the proxies and ballots, and to serve as the inspector of election to certify the results of the Special Meeting.
Voting Procedures
Regardless of whether you plan to attend the Special Meeting and regardless of the number of shares of Company Common Stock you own, your careful consideration of, and vote on, the Merger Agreement is important and we encourage you to vote promptly.
26

TABLE OF CONTENTS

If you are a registered owner of shares of Company Common Stock, to ensure that your shares of Company Common Stock are voted at the Special Meeting, we recommend that you promptly submit your proxy, even if you plan to attend the Special Meeting virtually, using one of the following three methods:
•
By Internet. If you have Internet access, you may submit your proxy by going to www.proxyvote.com and following the instructions on how to complete an electronic proxy card. You will need the control number included on your proxy card in order to authorize a proxy to vote by Internet. Internet voting is available until 11:59 p.m., Eastern Time, on [•], 2026.
•
By Telephone. If you have access to a touch-tone telephone, you may submit your proxy by calling +1 (800) 690-6903 and following the recorded instructions. You will need the control number included on your proxy card in order to authorize a proxy to vote by telephone. Telephone voting is available until 11:59 p.m., Eastern Time, on [•], 2026.
•
By Mail. You may authorize a proxy to vote by mail by completing, signing and dating the accompanying proxy card and returning it in the prepaid reply envelope provided so that it is received prior to the Special Meeting. You should sign your name exactly as it appears on the proxy card. If you are signing in a representative capacity (for example, as guardian, executor, trustee, custodian, attorney or officer of a corporation), please indicate your name and title or capacity.
The Internet and telephone procedures for submitting proxies are designed to authenticate your identity and to allow you to cause your shares of Company Common Stock to be voted for the matters brought before the Special Meeting as described in this proxy statement and confirm that your proxy has been properly recorded.
If you submit your proxy via the Internet, by telephone or by completing, signing and returning the accompanying proxy card by mail, the persons named as proxies will vote your shares according to your instructions. If you are a stockholder with shares of Company Common Stock registered in your name and you submit your proxy but do not direct the persons named as proxies how to vote your shares on a proposal to be brought before the Special Meeting, the persons named as proxies will vote your shares “FOR” the Merger Proposal, the Advisory Compensation Proposal and the Adjournment Proposal.
If a beneficial owner of shares of Company Common Stock held in “street name” by a bank, broker or other nominee does not provide the organization that holds its shares with specific voting instructions, then, under applicable rules, the organization that holds its shares may generally vote on “discretionary” matters but cannot vote on “non-discretionary” matters. A so-called “broker non-vote” results when banks, brokers and other nominees return a valid proxy voting upon one or more matters for which the applicable rules provide discretionary authority or for which voting instructions have been provided but do not vote on a particular proposal because they do not have discretionary authority to vote on that matter and have not received specific voting instructions on that matter from the beneficial owner of relevant shares. Although the determination of whether a bank, broker or other nominee will have discretionary authority to vote on a particular proposal is typically made only after proxy materials are filed with the SEC, the Company does not expect any broker non-votes at the Special Meeting because the rules applicable to banks, brokers and other nominees only provide brokers with discretionary authority to vote on proposals that are considered routine, whereas each of the proposals to be presented at the Special Meeting is expected to be considered non-routine. As a result, no broker will be permitted to vote your shares of Company Common Stock at the Special Meeting without receiving instructions. Failure to instruct your bank, broker or other nominee as to how to vote your shares of Company Common Stock will have the same effect as a vote “AGAINST” the proposal to adopt the Merger Agreement but will have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal.
If you are a beneficial owner of shares of Company Common Stock held in “street name” by a bank, broker or other nominee, you must follow the instructions from your bank, broker or other nominee in order to vote your shares. If you follow the instructions from your bank, broker or other nominee for voting your shares, then your bank, broker or other nominee will vote your shares according to your instructions. Under applicable rules, your bank, broker or other nominee has authority to vote your shares only if you provide instructions on how to vote by properly completing the voting instruction form sent to you by your bank, broker or other nominee with this proxy statement. If you do not provide voting instructions to your bank, broker or other nominee on a proposal to be brought before the Special Meeting, your shares will not be voted on that proposal, and if you do not provide voting instructions on any of the proposals to be brought before the Special Meeting, your shares will not be deemed to be in attendance at the meeting.
27

TABLE OF CONTENTS

Revocation of Proxies
If you are a holder of record, you may change your vote or revoke your proxy at any time before your shares are voted at the Special Meeting, as applicable, by (i) mailing a proxy card dated later than your last submitted proxy card, so long as it is received prior to the Special Meeting, (ii) authorizing a new proxy to vote on a later date on the Internet or by telephone (it being understood that only your latest Internet or telephone proxy submitted prior to the Special Meeting will be counted), (iii) notifying the Company’s Corporate Secretary in writing, so long as such notice is received prior to the Special Meeting, or (iv) voting during the Special Meeting (attendance at the Special Meeting will not, by itself, revoke the proxy). If your shares are held beneficially in “street name,” you should follow the instructions provided by your broker, bank or other nominee to change your vote or revoke your proxy.
Any adjournment, postponement or other delay of the Special Meeting, including for the purpose of soliciting additional proxies for the Merger Proposal, will allow stockholders who have already sent in their proxies to revoke them at any time prior to their use at the Special Meeting as adjourned, postponed or delayed.
Voting at the Special Meeting
The Special Meeting will be held virtually at www.virtualshareholdermeeting.com/[•]. There will be no physical location for stockholders to attend. You will be able to attend the Special Meeting by visiting www.virtualshareholdermeeting.com/[•] and using the 16-digit control number included in your proxy materials.
•
Stockholders of record: If you are a holder of record, in order to participate in the Special Meeting, you will need your 16-digit control number included on the proxy card previously distributed to you. If you are a holder of record, you may vote electronically during the Special Meeting by following the instructions available on www.virtualshareholdermeeting.com/[•].
•
Stockholders holding shares in “street” name: If your shares are beneficially held in “street name” through a brokerage firm, bank, trust or other similar organization and you do not have a 16-digit control number, in order to participate in the Special Meeting, you must first obtain a legal proxy from your broker, bank or other nominee reflecting the number of shares of Company Common Stock you held as of the Record Date, your name and email address. If you beneficially hold your shares of Company Common Stock in “street name,” you must obtain the appropriate documents from your broker, bank, trustee, or nominee, giving you the right to vote the shares at the Special Meeting.
Instructions on how to attend and participate in the Special Meeting via the webcast are posted at www.virtualshareholdermeeting.com/[•].
You should ensure that you have a strong Internet connection and allow plenty of time to log in and ensure that you can hear streaming audio prior to the start of the Special Meeting. We encourage you to access the meeting at least fifteen (15) minutes prior to the start time to allow ample time to complete the online check-in process. If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be provided on the log-in page.
If you beneficially hold your Company Common Stock in “street name,” you must obtain the appropriate documents from your broker, bank, trustee, or nominee, giving you the right to vote the shares at the Special Meeting. For beneficial owners of shares of Company Common Stock held in “street name,” in addition to providing identification as outlined for holders of record above, you will need a legal proxy from your broker or a recent brokerage statement or letter from your broker reflecting your stock ownership as of the Record Date. Please note, however, that unless you have a legal proxy from your bank, broker or other nominee, you will not be able to vote any shares beneficially held in “street name” virtually at the Special Meeting. Please note that even if you plan to attend the Special Meeting, we recommend that you submit a proxy by Internet, telephone or by mail, using the accompanying proxy card in advance, to ensure that your shares of Company Common Stock will be represented.
Solicitation of Proxies
The Company will bear the cost of soliciting proxies, including the expense of preparing, printing and distributing this proxy statement. The Company may request banks, brokers and other nominees to solicit their customers who have Company Common Stock registered in their names and will reimburse them for reasonable out-of-pocket forwarding costs in accordance with customary practice and SEC and Nasdaq regulations. The Company may also use its directors,
28

TABLE OF CONTENTS

officers and employees to solicit proxies without additional compensation. In addition, the Company has retained Georgeson LLC to solicit proxies at a total cost to the Company of approximately $48,500, plus reimbursement of out-of-pocket expenses.
Adjournments
The presiding officer of the Special Meeting may adjourn the Special Meeting if no quorum is present, if, subject to the terms of the Merger Agreement, the Company Board determines that adjournment is necessary or appropriate to enable Company stockholders to consider fully the information that the Company Board determines has not been made sufficiently or timely available, or if, subject to the terms of the Merger Agreement, the Company Board determines that adjournment is otherwise in the best interests of the Company. If a quorum is not present, the holders of a majority of the voting power present at the Special Meeting may also adjourn the meeting. Under the Merger Agreement, the Company may postpone or adjourn the Special Meeting, in consultation with Parent, to solicit additional votes, address an insufficient quorum, comply with applicable law or an SEC request, or give stockholders time to evaluate information or disclosure, subject to limitations including no more than two adjournments for an insufficient quorum without Parent’s consent, no more than two such postponements or adjournments for new information without Parent’s consent and a maximum five-business-day period for the latter, and no postponement or adjournment beyond the date that is five business days before the Termination Date. The Company is not required to hold the Special Meeting prior to the twentieth business day following the mailing of this proxy statement. The Company will also conduct a broker search in accordance with Rule 14a-13 under the Exchange Act. Once fixed, the Record Date may not be changed without Parent’s consent. At an adjourned meeting at which a quorum is present, the Company may transact any business that might have been transacted at the original meeting.
The Adjournment Proposal set forth in this proxy statement relates only to an adjournment of the Special Meeting for the purposes described in the Adjournment Proposal. Subject to the terms of the Merger Agreement, including the limitations described above, the Company retains authority, to the extent set forth in its Bylaws and Delaware law, to adjourn the Special Meeting for any other purpose, or to postpone the Special Meeting before it is convened, without the vote or consent of any of the Company stockholders. Please be advised that the Company does not intend to call a vote on the Adjournment Proposal if the Merger Proposal is approved at the Special Meeting.
Voting by the Company’s Directors and Executive Officers
As of the Record Date, the directors and executive officers of the Company beneficially owned in the aggregate approximately [•] shares of Company Common Stock, or approximately [•]% of the outstanding shares of Company Common Stock. We currently expect that our directors and executive officers will vote all of their respective shares of Company Common Stock (1) “FOR” the Merger Proposal, (2) “FOR” the Advisory Compensation Proposal and (3) “FOR” the Adjournment Proposal. In addition, Mr. Ramamurthy and Mr. Welsh have agreed, pursuant to the Rollover Agreements, to vote all shares of Company Common Stock held by them in favor of the adoption of the Merger Agreement, as described below under “— Rollover Agreements.”
Other than the Rollover Investors pursuant to the Rollover Agreements, none of the Company’s directors or executive officers is obligated to vote his or her shares of Company Common Stock in favor of the Merger Proposal or any other proposal.
Certain of the Company’s directors and executive officers have interests in the Merger that may be different from, or in addition to, those of the Company stockholders generally. For more information, see the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.”
Assistance
If you need assistance in completing your proxy card or have questions regarding the Special Meeting, please contact our proxy solicitor:
Georgeson LLC
51 W 52nd Street 6th Floor
New York, NY 10019
Stockholders, Banks, and Brokers may call toll-free: (877) 467-5518
Outside the US may call: (908) 396-7859
29

TABLE OF CONTENTS

PROPOSAL 1: ADOPTION OF THE MERGER AGREEMENT
As discussed elsewhere in this proxy statement, at the Special Meeting, Company stockholders will consider and vote on a proposal to adopt the Merger Agreement (referred to as the “Merger Proposal”). The Merger cannot be completed without the adoption of the Merger Agreement by the requisite vote of the Company stockholders. You are urged to carefully read this proxy statement in its entirety for more detailed information concerning the Merger Agreement and the Merger, including the information set forth under the sections of this proxy statement titled “The Merger” and “The Merger Agreement.” A copy of the Merger Agreement is attached as Annex A-1 and the first amendment to the Merger Agreement is attached as Annex A-2 to this proxy statement. You are urged to read the Merger Agreement carefully and in its entirety.
Approval of the Merger Proposal requires the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote thereon as of the close of business on the Record Date. Accordingly, shares deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) and abstentions will have the same effect as a vote “AGAINST” the Merger Proposal.
The Company Board recommends a vote “FOR” the Merger Proposal.
30

TABLE OF CONTENTS

PROPOSAL 2: APPROVAL OF THE ADVISORY COMPENSATION PROPOSAL
Pursuant to Section 14A of the Exchange Act, the Company is required to submit a proposal to the Company stockholders to approve, on an advisory, non-binding basis, the “golden parachute” compensation payments that will or may be made by the Company to its named executive officers in connection with the Merger. This proposal, commonly known as a “say on golden parachute” proposal, gives the Company stockholders the opportunity to vote on an advisory, non-binding basis on the “golden parachute” compensation payments that will or may be paid by the Company to its named executive officers in connection with the Merger (referred to as the “Advisory Compensation Proposal”).
The “golden parachute” compensation that the Company’s named executive officers will or may be entitled to receive from the Company in connection with the Merger is summarized in the table that appears in the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger — Quantification of Payments and Benefits.” Such summary, in tabular form, includes the compensation and benefits that will or may be paid by the Company to its named executive officers in connection with the Merger.
The Company Board encourages you to review carefully the “golden parachute” compensation information disclosed in this proxy statement.
The Company Board unanimously (with respect to all directors present) recommends that the Company stockholders approve the following resolution:
“RESOLVED, that the stockholders approve, on an advisory (non-binding) basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger, as disclosed pursuant to Item 402(t) of Regulation S-K in the Quantification of Payments and Benefits table and the related narrative disclosures.”
Assuming a quorum is present, approval of the Advisory Compensation Proposal requires a majority of the votes properly cast for and against the proposal. Accordingly, abstentions and shares of Company Common Stock deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) will have no effect on the outcome of the Advisory Compensation Proposal.
The vote on the Advisory Compensation Proposal is a vote separate and apart from the vote on the Merger Proposal. Since the vote on the Advisory Compensation Proposal is advisory only, it will not be binding on the Company, the Company Board, Parent or the surviving corporation. Accordingly, if the Merger Proposal is approved and the Merger is consummated, the compensation payments that are contractually required to be paid by the Company to its named executive officers will or may be paid, subject only to the conditions applicable thereto, regardless of the outcome of the advisory (non-binding) vote of the Company stockholders on the Advisory Compensation Proposal.
The Company Board recommends a vote “FOR” the Advisory Compensation Proposal.
31

TABLE OF CONTENTS

PROPOSAL 3: ADJOURNMENT PROPOSAL
We are asking that you approve a proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (referred to as the “Adjournment Proposal”). 
The Company is asking Company stockholders to authorize the holder of any proxy solicited by the Company Board to vote in favor of any adjournment of the Special Meeting, for the purposes described above, in accordance with the terms of the Merger Agreement.
Assuming a quorum is present, approval of the Adjournment Proposal requires a majority of the votes properly cast for and against the proposal. Accordingly, abstentions (if a quorum is present) and shares deemed not in attendance at the Special Meeting (whether due to a holder of record’s failure to vote or a “street name” beneficial holder’s failure to provide any voting instructions to such holder’s bank, broker or other nominee) will have no effect on the outcome of the Adjournment Proposal. If a quorum is not present, abstentions will have the same effect as a vote “AGAINST” the Adjournment Proposal.
The vote on the Adjournment Proposal is a vote separate and apart from the vote to adopt the Merger Agreement. The Company does not intend to call a vote on this proposal if the Merger Proposal is approved at the Special Meeting.
The Company Board recommends a vote “FOR” the Adjournment Proposal.
32

TABLE OF CONTENTS

THE MERGER
General Description of the Merger
The Company, Parent and Merger Sub entered into the Merger Agreement on October 14, 2026, as amended on November 20, 2026. A copy of the Merger Agreement is included as Annex A-1 and the first amendment to the Merger Agreement is included as Annex A-2 to this proxy statement. On the terms and subject to the conditions set forth in the Merger Agreement and in accordance with the DGCL, Merger Sub will merge with and into the Company, the separate corporate existence of Merger Sub will thereupon cease, and the Company will continue as the surviving corporation of the Merger and a wholly owned subsidiary of Parent.
At the Effective Time, each share of Company Common Stock (including, for the avoidance of doubt, the SPAC Merger Earnout Shares and the Sponsor Earnout Shares) issued and outstanding immediately prior to the Effective Time, other than Owned Company Shares, Dissenting Company Shares and Company RSAs, will be automatically cancelled, extinguished and converted into the right to receive the Per Share Price, without interest, subject to the terms and conditions of the Merger Agreement.
Background of the Merger
The following chronology summarizes the key meetings and events that led to the signing of the Merger Agreement. The following chronology does not purport to catalogue every conversation among the Company Board, the Transaction Committee or the representatives of the Company and other parties.
The Company Board and the Company’s senior management periodically review the Company’s long-term strategy and objectives in light of market and industry conditions. These reviews have included, among other things, consideration of organic growth initiatives, acquisitions, divestitures and potential business combination transactions, as well as other strategic opportunities, in each case, with a view towards enhancing stockholder value.
In 2023, the Company Board explored strategic alternatives to enhance stockholder value, including a potential strategic transaction involving the Company (the “2023 Strategic Review”), with the assistance of Morgan Stanley & Co. LLC (“Morgan Stanley”), in which the Company contacted and engaged with numerous parties. The 2023 Strategic Review did not result in a transaction. Following the conclusion of the 2023 Strategic Review, and from time to time thereafter, including in early 2026, the Company engaged in discussions with industry participants regarding recent market developments and received unsolicited, preliminary expressions of interest from third parties with respect to a potential investment in, or strategic transaction involving, the Company, including an unsolicited, non-binding proposal from a financial sponsor to make a minority preferred equity investment in the Company. None of these expressions of interest constituted, or resulted in, a proposal to acquire the Company, and, after consideration, the Company Board determined not to pursue any of them. That financial sponsor did not ultimately participate in the sale process described below.
In February 2026, Elliott contacted the Company to request a meeting and, on March 30, 2026, representatives of Elliott met with members of the Company’s senior management and presented Elliott’s perspectives on the Company, including with respect to investor communications, operations, board composition and a potential investment by Elliott to fund share repurchases. At that meeting, representatives of Elliott informed the Company that Elliott had accumulated an economic interest in the Company comparable to that of one of the Company’s five largest stockholders, but declined to disclose to the Company the size of that interest. Following that meeting, members of the Company’s senior management updated the Company Board regarding the meeting, and the Company informed Elliott that it would continue discussions after the announcement of the Company’s first quarter results.
On April 22 and 23, 2026, the Company Board held a regularly scheduled meeting, which convened on April 22, 2026 and reconvened on April 23, 2026, at which, in addition to the matters on its regular agenda, the Company Board considered the potential strategic alternatives that may be available to the Company. Members of the Company’s senior management attended, and on April 23, 2026, representatives of Kirkland & Ellis LLP (“Kirkland”), the Company’s outside legal counsel, and of Morgan Stanley attended portions of the meeting. Morgan Stanley had advised the Company in connection with the 2023 Strategic Review and was invited to discuss its perspectives on market and business trends and strategic alternatives that may be available to the Company in advance of a potential engagement as the Company’s financial advisor. Representatives of Kirkland reviewed with the Company Board what the Board’s fiduciary duties were in connection with the potential exploration of strategic alternatives and in connection with certain directors’ and executive officers’ (or their respective affiliates’) entitlement to receive the SPAC Merger Earnout Shares
33

TABLE OF CONTENTS

upon a change of control. Representatives of Morgan Stanley reviewed potential factors to consider in weighing strategic alternatives, including the trading environment for software companies, the likelihood and timing of a recovery in software trading multiples and the challenges of executing on the Company’s standalone business plan as a public company in light of the longer-term investments required to address competitive threats such as artificial intelligence and autonomous vehicles, as well as potential counterparties to consider in weighing strategic alternatives and an illustrative timeline. Representatives of Kirkland and the financial institution advising the Company with respect to stockholder engagement matters also reviewed with the Company Board Elliott’s interests in the Company and its recent meeting with senior management. Following these presentations, and prior to the Company Board’s discussion of a potential transaction process, Eric Wei, a director, recused himself from the meeting given the possibility that the investment firm with which he is affiliated might be interested in participating in a potential transaction, if the Board decided to proceed with a potential transaction process. Mr. Wei remained recused from all subsequent Company Board discussions regarding consideration of strategic alternatives and a potential transaction. The Company Board then discussed, among other things, the Company’s historical interactions with parties that had expressed preliminary interest in a potential transaction and the valuation of software companies in the public markets and business and market trends that could impact the Company and its valuation. Following discussion, the Company Board determined to explore a potential sale of the Company and directed management to solicit proposed engagement terms from Morgan Stanley. The Company Board also determined that management could participate in the process, but that the process would be directed and overseen by the Company Board, and that no management discussions regarding post-closing employment, compensation or treatment of equity would be permitted unless and until approved by the Company Board at a later stage of the process.
On May 5, 2026, members of the Company’s senior management met again with representatives of Elliott, who proposed that a representative of Elliott be added to the Company Board and that the Company work with Elliott to identify an additional independent director. The Company Board referred the proposed Elliott director candidate to the Nominating and Corporate Governance Committee for evaluation through its ordinary course process. As part of that process, the Elliott director candidate began initial interviews with members of the Nominating and Corporate Governance Committee. The interview process was paused following Elliott’s entry into a confidentiality agreement with the Company in connection with a potential transaction on July 2, 2026.
On May 8, 2026, Githesh Ramamurthy, the Company’s Chairman and Chief Executive Officer, met with representatives of GTCR, as part of his ordinary course discussions with industry participants, to discuss recent business and market trends. No potential transaction involving the Company and GTCR, or any terms thereof, were discussed.
On May 21, 2026, the Company Board held a regularly scheduled meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Members of the Company’s senior management reviewed with the Company Board the Company’s unaudited prospective financial projections for the Company on a standalone basis for fiscal years 2026 through 2030 (the “May Management Case”), and the Company Board approved the May Management Case for use by Morgan Stanley in its financial analyses and for presentation to potential counterparties. For additional information, see the section of this proxy statement titled “The Merger — Certain Company Management Projections.” Representatives of Morgan Stanley then reviewed with the Company Board a proposed process to explore strategic alternatives, including proposed initial outreach to four strategic parties that had expressed interest in the Company over time or for which a combination with the Company might present a compelling strategic fit, and ten financial sponsors that had expressed interest in the Company over time or that owned portfolio companies for which a combination with the Company might be attractive, and noted that a financial sponsor may require one or more equity financing partners given the size of the potential transaction. Following discussion, the Company Board also determined that, in light of the possibility that Elliott might wish to participate in the potential sale process, the Company would, at an appropriate stage of the process, provide Elliott with the opportunity to enter into a confidentiality agreement with the Company. Taking into account objectives to maximize stockholder value and competition, as well as to minimize the risk of leaks and management distraction, the Company Board authorized Morgan Stanley to conduct the outreach as proposed. The Company Board also approved the engagement of Morgan Stanley as the Company’s financial advisor on terms reviewed with the Company Board, and the Company and Morgan Stanley subsequently entered into an engagement letter dated May 29, 2026. For additional information regarding Morgan Stanley’s fees, see the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor.” The Company Board also considered whether to engage another financial advisor, including the financial institution advising the Company with respect to stockholder engagement matters as an additional financial advisor in connection with the sale process and, following discussion, determined, in the interest of keeping the sale process focused, that Morgan Stanley would serve as the Company’s sole financial advisor for the sale process.
34

TABLE OF CONTENTS

Beginning on May 26, 2026, as directed by the Company Board, representatives of Morgan Stanley contacted the four strategic parties identified at the May 21, 2026 meeting, including a strategic party referred to in this proxy statement as “Party A” and a strategic party referred to in this proxy statement as “Party J.” Party A and Party J each entered into a confidentiality agreement with the Company on the terms described below. On June 2, 2026, Mr. Ramamurthy spoke with the chief executive officer of one of the other two strategic parties regarding its potential interest in a transaction. No terms of a potential transaction, including the post-closing employment or compensation of any member of management or any equity rollover, were discussed. Later in June 2026, each of that strategic party and the other remaining strategic party declined to enter into a confidentiality agreement with the Company and informed representatives of Morgan Stanley that it would not proceed with exploring a potential transaction. Party J also informed representatives of Morgan Stanley that it would not proceed with exploring a potential transaction.
Beginning on June 9, 2026, as directed by the Company Board, representatives of Morgan Stanley contacted the ten financial sponsors identified at the May 21, 2026 meeting, including a financial sponsor referred to in this proxy statement as “Party K,” and additional financial sponsors, including GTCR, a financial sponsor referred to in this proxy statement as “Party B” and a financial sponsor referred to in this proxy statement as “Party E.” Also during this period, consistent with the Company Board’s determination at its May 21, 2026 meeting, representatives of Morgan Stanley contacted Elliott on June 16, 2026 to offer Elliott the opportunity to enter into a confidentiality agreement with the Company, which Elliott entered into on July 2, 2026. On June 25, 2026, a financial sponsor referred to in this proxy statement as “Party G” and another financial sponsor each contacted representatives of Morgan Stanley on an unsolicited basis to express interest in exploring a potential transaction. Party G was invited to participate in the process.
On July 1, 2026, a strategic party referred to in this proxy statement as “Party L” contacted representatives of Morgan Stanley on an unsolicited basis to express interest in a potential transaction. On July 2, 2026, Mr. Ramamurthy spoke with an executive at Party L to discuss Party L’s interest in exploring a potential transaction, and Mr. Ramamurthy subsequently reported on that conversation to the Company Board at its July 15, 2026 meeting. No terms of a potential transaction, including the post-closing employment or compensation of any member of management or any equity rollover, were discussed. Following that conversation, Morgan Stanley representatives contacted Party L on July 3, 2026 and invited it to participate in the process. In early July 2026, a strategic party referred to in this proxy statement as “Party C” also contacted representatives of Morgan Stanley on an unsolicited basis to express interest in a potential transaction. Morgan Stanley representatives invited Party C to participate in the process on July 8, 2026.
Between June 3, 2026 and July 16, 2026, the Company entered into confidentiality agreements with 20 potential counterparties, including Party J on June 3, 2026, Party A on June 11, 2026, Party K on June 13, 2026, GTCR on June 16, 2026, a financial sponsor and its portfolio company referred to in this proxy statement together as “Party D” on June 16, 2026, a financial sponsor referred to in this proxy statement as “Party F” on June 22, 2026, Party B on June 30, 2026, Elliott on July 2, 2026, Party G on July 6, 2026, Party E on July 10, 2026, Party L on July 13, 2026 and Party C on July 16, 2026. Each of the confidentiality agreements contained customary non-disclosure and non-use provisions and a customary standstill provision. Each counterparty that executed a confidentiality agreement was provided financial due diligence information regarding the Company, including the May Management Case.
Between June 4, 2026 and July 15, 2026, members of the Company’s senior management, with representatives of Morgan Stanley in attendance, held management presentations with the potential counterparties that had entered into confidentiality agreements, other than Party C and Party E, which reviewed due diligence materials without a management presentation (in the case of Party E, given its contemplated role as a potential equity financing partner rather than a lead buyer, and in the case of Party C, because its entry into its confidentiality agreement on July 16, 2026 did not allow sufficient time for a management presentation before the first-round deadline of July 27, 2026). These included management presentations with each of the parties that were later advanced to the second round of the process, including Party A on June 12, 2026 (following a dinner on June 11, 2026 among members of the Company’s senior management and representatives of Party A), GTCR on June 19, 2026, Elliott on July 7, 2026, Party B on July 9, 2026 and Party G on July 15, 2026. Members of the Company’s senior management also held follow-up due diligence sessions at the request of certain of those parties, including GTCR.
On July 9, 2026, after the close of trading, Reuters published a report regarding a potential transaction involving the Company. The closing price of Company Common Stock on July 9, 2026 prior to publication of the report was $5.38 per share (the “Unaffected Trading Price”). Following the publication of that report, the Company and representatives of Morgan Stanley received unsolicited inquiries from a number of parties that had not been contacted as part of the outreach, and, while the Company Board remained open to considering any credible potential buyer, none of the parties that made unsolicited inquiries ultimately submitted an indication of interest.
35

TABLE OF CONTENTS

On July 15, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reported that 22 potential counterparties, consisting of 16 financial sponsors and six strategic parties, had been contacted and that 12 additional parties had made unsolicited inquiries. In light of the risk of further press reports, the demands on management’s time and the fact that none of the inbound parties had demonstrated the same depth of interest as the 19 parties already engaged in the process (consisting of each party that had entered into a confidentiality agreement with the Company, other than Party J, which, as described above, had informed representatives of Morgan Stanley that it would not proceed with exploring a potential transaction), the Company Board directed Morgan Stanley not to proactively solicit those parties that had made unsolicited inquiries at that time but to revisit the question if any of them demonstrated a level of interest in exploring a transaction comparable to that of the parties already engaged in the process. The Company Board also approved providing indicative debt financing terms to potential counterparties and directed Morgan Stanley to request first-round indications of interest by July 27, 2026.
On July 16 and 17, 2026, at the direction of the Company Board, representatives of Morgan Stanley distributed process letters, dated July 16, 2026, requesting that first-round indications of interest be submitted by July 27, 2026, to the 19 potential counterparties.
On July 23, 2026, the Company Board held a regularly scheduled meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reported that, of the 22 potential counterparties contacted, 15 financial sponsors and three strategic parties remained actively engaged. In light of the number of parties already engaged in the process and the additional management time and resources that would be required, which could distract management from the operation of the Company’s business, the Company Board reaffirmed its determination not to proactively engage with the unsolicited inbound parties at that time while remaining open to considering any potential credible buyer, and directed Morgan Stanley to revisit the question if any such party demonstrated a level of interest comparable to that of the parties already engaged in the process. Representatives of Morgan Stanley also reviewed with the Company Board their preliminary financial analyses of the Company, which reflected the May Management Case. For additional information regarding the May Management Case, see the section of this proxy statement titled “The Merger — Certain Company Management Projections.”
Between July 27, 2026 and July 29, 2026, eight parties submitted written indications of interest, four as potential lead buyers and four as potential equity financing partners to a lead buyer. Of the potential lead buyers, Party A indicated a price range of $7.75 to $8.25 per share in cash, supported by cash on hand, existing credit facilities and potential bank financing; GTCR indicated a price range of $7.25 to $8.00 per share in cash and that it would require one or more equity financing partners; Party C indicated a price of $6.70 per share, to be funded by its existing investors and debt financing; and Party D indicated a price of $6.50 per share and that it would require equity financing from other financial sponsors and limited partner co-investors. Of the potential equity financing partners, Elliott indicated a price of $7.50 per share, with an equity commitment of $500 million to $1.0 billion; Party B indicated a price range of $7.00 to $8.25 per share, with an equity commitment dependent on the size of the lead buyer’s equity commitment; Party E indicated a price range of $6.75 to $7.25 per share, with an equity commitment of $150 million to $200 million; and Party F indicated a price of $6.50 per share, with an equity commitment of $1.0 billion. The indications of interest represented premiums of approximately 21% to 53% over the Unaffected Trading Price. Between July 21, 2026 and July 29, 2026, nine other parties that had entered into confidentiality agreements, including Party L, informed representatives of Morgan Stanley that they would not submit an indication of interest, citing, among other things, valuation, the size of the required equity investment and fund-related considerations.
On July 29, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reviewed the indications of interest received and reported that none of the parties that had made unsolicited inbound inquiries had submitted an indication of interest, and that one additional party had made an inquiry but had not demonstrated an understanding of the Company’s business or a level of interest comparable to that of the other parties actively engaged in the process, or indicated an intention to make a proposal, and, as a result, the Company did not pursue further discussions with that party. Following discussion, at the direction of the Company Board, representatives of Morgan Stanley informed each of Party D and Party F that its indicated valuation was not compelling but that it could submit a revised proposal, and awaited feedback from Party G and Party K, neither of which had yet responded, before the Company Board determined next steps.
36

TABLE OF CONTENTS

On July 31, 2026, representatives of Morgan Stanley received an indication of interest from Party G as a potential lead buyer with a price range of $7.00 to $7.50 per share in cash, in which Party G indicated that it would not require an equity financing partner, and were informed by Party K that it would not submit an indication of interest. Representatives of Morgan Stanley were also informed by Party D that it would not submit a revised proposal.
On August 2, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley updated the Company Board on the developments since the July 29, 2026 meeting described above, including that Party G had submitted an indication of interest, that Party K had declined to submit an indication of interest and that Party D had declined to submit a revised proposal, and reported that Party F was still considering whether to submit an improved indication and that Party B was interested in participating as an equity financing partner. Representatives of Morgan Stanley also reviewed with the Company Board their preliminary financial analyses of the Company, which reflected the May Management Case and extrapolations of the May Management Case for an additional five years prepared by Morgan Stanley, which the Company’s senior management reviewed and approved for Morgan Stanley’s use on July 29, 2026 (the “May Extrapolations”). For additional information regarding the May Extrapolations, see the section of this proxy statement titled “The Merger — Certain Company Management Projections.”
Following discussion, the Company Board determined to advance GTCR, Elliott, Party A, Party B and Party G to the next stage of the process. In light of the lower values reflected in the indications of interest submitted by Party C, Party E and Party F relative to those of the other parties, the Company Board directed Morgan Stanley to inform Party E that it could submit an improved indication of interest if it wished to remain in the process and to inform Party C and Party F that they would not be moving forward in the process. The Company Board determined that Party B could continue to participate as a potential equity financing partner in order to preserve optionality for any other parties that might require additional equity capital, but that Party B would not be permitted to partner with any specific party at that time. In addition, after discussing, among other things, the appropriate timing for any such partnership, Elliott’s experience with acquisition transactions and the importance of maintaining competitive tension among the leading parties in order to generate the highest possible price for the Company’s stockholders, the Company Board authorized Morgan Stanley to facilitate a partnership between GTCR, which sought to act as a lead buyer but required an equity financing partner, and Elliott, which sought to participate as an equity financing partner. The Company Board also discussed again with representatives of Kirkland that certain directors were entitled to, or were affiliated with entities entitled to, SPAC Merger Earnout Shares, which would be issued upon the consummation of a potential transaction. Following discussion, which included representatives of Kirkland, the Company Board formed a transaction committee comprised of Neil de Crescenzo, Barak Eilam and John A. Schweitzer, none of whom is entitled to, or affiliated with an entity entitled to, SPAC Merger Earnout Shares (the “Transaction Committee”), for the purpose of evaluating and determining, without the participation of any interested directors, whether a potential transaction, including the consideration payable to the Company’s stockholders in connection therewith, would be fair to and in the best interests of the Company’s stockholders not entitled to SPAC Merger Earnout Shares. The Company Board determined that each member of the Transaction Committee was disinterested with respect to that purpose and free from any relationship that, in the opinion of the Company Board, would interfere with his exercise of independent judgment as a member of the Transaction Committee. The Company Board also determined that it would not approve a transaction without first receiving a favorable recommendation from the Transaction Committee. Representatives of Kirkland noted that a conflicts questionnaire with respect to the parties advancing in the process would be circulated to the directors and that Morgan Stanley and Kirkland would each provide relationship disclosure to the Company Board with respect to those parties.
On August 3, 2026, as directed by the Company Board, representatives of Morgan Stanley informed each of GTCR, Elliott, Party A, Party B and Party G that it had been advanced to the second round of the process. Also on August 3, 2026, as directed by the Company Board, representatives of Morgan Stanley discussed with representatives of GTCR a potential partnership with Elliott and, with GTCR’s agreement, introduced GTCR to Elliott, and, on August 12, 2026, GTCR and Elliott confirmed to representatives of Morgan Stanley that they would explore a potential transaction together. Also on August 3, 2026, as directed by the Company Board, representatives of Morgan Stanley informed Party C that it would not be advanced to the next stage of the process, and Party F informed representatives of Morgan Stanley that it would not submit a revised indication of interest. In addition, on August 3, 2026, representatives of Morgan Stanley informed Party E that its indication of interest was below the competitive range and invited Party E to reconsider its valuation. Party E indicated that it would not revise its indication at that time, but could re-engage if a lead buyer sought its participation as an equity financing partner.
In early August 2026, GTCR, Elliott, Party A, Party B and Party G were granted access to additional due diligence materials in the virtual data room.
37

TABLE OF CONTENTS

On August 18, 2026, Bloomberg published a report stating that GTCR and certain other parties were pursuing a potential acquisition of the Company.
On August 19, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland in attendance and representatives of Morgan Stanley in attendance for a portion of the meeting. The Company Board reviewed the responses to the conflicts questionnaires submitted by members of the Company Board with respect to GTCR, Elliott, Party A, Party B and Party G and determined that no disclosed relationship warranted the recusal of any director other than the continuing recusal of Mr. Wei. The Company Board also reviewed Morgan Stanley’s relationship disclosure letter, dated August 17, 2026, and determined that, based on the information provided in that letter, none of the relationships disclosed by Morgan Stanley impaired its ability to serve as the Company’s financial advisor. Representatives of Kirkland then disclosed that GTCR, Party B, Party G and certain affiliates of Elliott were active clients of Kirkland on various concurrent engagements unrelated to the potential transaction, and that certain of the Kirkland partners leading the Company’s deal team had performed, and continued to perform, work for GTCR, Party B and Party G on matters unrelated to the potential transaction. Representatives of Kirkland also disclosed that certain partners of Kirkland are members of limited partnerships that maintain passive investments in funds managed by a number of private equity firms, including each of GTCR, Party B and Party G, and that those investments were not material to the net worth of any member of the Kirkland deal team advising the Company. Based on that information and following a discussion, during which representatives of Kirkland answered questions from the Company Board regarding these relationships, the Company Board determined that none of the relationships disclosed by Kirkland impaired its ability to serve as the Company’s outside counsel. Representatives of Kirkland also reviewed with the Company Board the key terms of two forms of auction draft merger agreement, one for financial sponsor buyers and one for strategic buyers, and the Company Board authorized their distribution to the potential buyers. Representatives of Morgan Stanley then provided an update on the process. In order to ensure that the potential buyers in the second round of the process would have access to sufficient equity capital to support their final proposals, the Company Board authorized Morgan Stanley to contact five additional parties as potential sources of equity financing. The Company Board also authorized GTCR to contact additional sources of debt financing but, in order to preserve the confidentiality and competitive dynamics of the process, declined a request made by Elliott on August 6, 2026 to contact two other potential sources of capital. The Company Board further approved a timeline providing for the submission of final proposals in mid-September 2026 and directed Morgan Stanley to proceed in accordance with that timeline. Finally, to facilitate the efficient administration of the process, the Company Board requested that Mr. Ramamurthy, Mr. Eilam and William Ingram, a director, provide input to the Company’s advisors and management on matters relating to the potential transaction as necessary between meetings of the Company Board. The Company Board selected Mr. Ramamurthy in light of his role as the Company’s Chief Executive Officer, and Messrs. Eilam and Ingram in light of their extensive experience as directors and senior executives of software and technology companies, and their willingness to engage with the Company’s advisors and management between meetings of the Company Board. Messrs. Ramamurthy, Eilam and Ingram served in an advisory capacity only and did not have any authority to approve, or to commit the Company to, any transaction, which authority remained exclusively with the Company Board, subject to the Company Board’s determination that it would not approve a transaction without first receiving a favorable recommendation from the Transaction Committee. For additional information regarding Morgan Stanley’s relationships, see the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor.”
Later on August 19, 2026, the Transaction Committee held its first meeting, with representatives of Kirkland and members of the Company’s senior management in attendance, to discuss the process by which it would conduct its work.
Between August 12, 2026 and September 11, 2026, members of the Company’s senior management, with representatives of Morgan Stanley and, as applicable, Kirkland in attendance, held numerous business and confirmatory due diligence sessions with representatives of GTCR and Elliott, Party A and Party G and their respective advisors, including legal due diligence sessions with Simpson Thacher & Bartlett LLP (“Simpson Thacher”), outside legal counsel to GTCR, on August 26, 2026, September 4, 2026 and September 11, 2026, and other advisors to the potential buyers. These included a joint in-person due diligence session with representatives of GTCR and Elliott at the Company’s headquarters on August 20, 2026, following which Mr. Ramamurthy and Tim Welsh, the Company’s President, attended a dinner with representatives of GTCR. No terms of a potential transaction, including the post-closing employment or compensation of any member of management or any equity rollover, were discussed.
38

TABLE OF CONTENTS

On September 1, 2026, the Transaction Committee held a meeting, with representatives of Kirkland and members of the Company’s senior management in attendance, to discuss the SPAC Merger Earnout Shares. The Transaction Committee considered that the SPAC Merger Earnout Shares would be issued upon consummation of the potential transaction, and that assuming a buyer would pay the same aggregate consideration for an acquisition of the Company irrespective of their issuance, the resulting increase in the Company’s fully diluted share count would reduce the per share price. Given that all directors entitled to the SPAC Merger Earnout Shares owned shares of Company Common Stock, the Transaction Committee considered that the issuance would result in a net detriment to each director entitled to SPAC Merger Earnout Shares other than Mr. Wei and Eileen Schloss, a director, and in the case of Ms. Schloss the net benefit would be approximately $13,000 based on a price of $8.25 per share, the highest price indicated in the indications of interest received to date. The Transaction Committee also considered that the SPAC Merger Earnout Shares could be earned during the remaining five-year earnout period absent a transaction, and that triggering the SPAC Merger Earnout Shares would reduce the per share consideration payable to the directors in respect of their Company Common Stock. The Transaction Committee viewed these considerations as mitigating any incentive based on SPAC Merger Earnout Shares to pursue a transaction prematurely or at a lower price than might otherwise be achievable.
Of the five additional potential sources of equity financing that the Company Board had authorized representatives of Morgan Stanley to contact, which included Party E (which had previously entered into a confidentiality agreement with the Company), the Company entered into confidentiality agreements with two financial sponsors referred to in this proxy statement as “Party H” and “Party I” on September 1 and September 3, 2026, respectively, each of which contained customary non-disclosure and non-use provisions and a customary standstill provision. Of the remaining two potential sources of equity financing, one declined to participate, citing fund-cycle considerations, and the other was not pursued in light of the limited size of its proposed investment.
On September 2, 2026, at the direction of the Company Board, representatives of Morgan Stanley distributed second-round process letters to GTCR and Elliott, Party A, Party B and Party G, together with the applicable form of auction draft merger agreement, requesting initial markups of the auction draft merger agreement by September 9, 2026 and final proposals, together with final markups of the merger agreement and the Company disclosure letter, by September 14, 2026.
On August 21 and August 27, 2026, members of the Company’s senior management met with representatives of Party G, with representatives of Morgan Stanley in attendance, to discuss business due diligence matters. On September 3, 2026, Mr. Ramamurthy met with representatives of GTCR, with representatives of Morgan Stanley in attendance, to discuss the Company’s business and outstanding diligence items. No terms of a potential transaction, including any equity rollover or the post-closing employment or compensation of any member of management, were discussed at any of these meetings.
On September 9, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reported that GTCR and Elliott, Party A and Party G remained actively engaged in advance of the September 14, 2026 final proposal deadline. Their principal open transaction considerations included the Company’s growth prospects, the Company’s potential entry into a significant commercial agreement, certain legal diligence matters and, for the financial sponsors, the size of the required equity commitment and potential exit opportunities. Representatives of Morgan Stanley also reported that Party E, Party H and Party I remained interested in providing equity financing to a lead buyer. Representatives of Kirkland and Morgan Stanley then reviewed with the Company Board the deal protection provisions in the auction draft merger agreements, and the Company Board determined that a go-shop provision was not necessary in light of the breadth of the market outreach conducted to date.
On September 9, 2026, representatives of Simpson Thacher delivered to representatives of Kirkland a markup of the auction draft merger agreement, which provided for, among other things, a no-shop provision with a fiduciary out and matching rights, a company termination fee of 3.0% and a reverse termination fee of 6.0% of the Company’s equity value.
On September 10, 2026, Party A’s outside legal counsel delivered to representatives of Kirkland a markup of the auction draft merger agreement, which, among other things, proposed an antitrust reverse termination fee of 5.0% of the Company’s equity value and a more limited regulatory efforts covenant than in the auction draft.
Also on September 10, 2026, representatives of Morgan Stanley delivered an auction draft of the Company disclosure letter to the outside legal counsel of each of GTCR and Elliott, Party A, Party B and Party G.
39

TABLE OF CONTENTS

On September 10, 2026, the Transaction Committee held a meeting, with representatives of Kirkland and members of the Company’s senior management in attendance, and discussed with representatives of Kirkland the legal framework applicable to transactions involving interested directors. The Transaction Committee also discussed whether it was an appropriate time to pursue a sale of the Company, taking into account, among other things, the trading environment for software companies, the challenges of executing the Company’s standalone business plan as a public company and the premiums to the Unaffected Trading Price reflected in the indications of interest received. Following discussion, the Transaction Committee determined to continue its evaluation and to meet with representatives of Morgan Stanley and Mr. Ramamurthy to discuss the public market environment and the opportunities, challenges and risks associated with the Company’s standalone business plan.
On September 12, 2026, representatives of Kirkland held calls with representatives of Simpson Thacher and of Party A’s outside legal counsel to provide feedback on their respective merger agreement markups.
On September 14, 2026, GTCR and Elliott submitted a joint written proposal to acquire the Company for $7.35 per share in cash, representing a premium of approximately 37% over the Unaffected Trading Price, together with a revised markup of the merger agreement, a markup of the Company disclosure letter and drafts of the related financing documents. The proposal was supported by equity commitments from GTCR and Elliott and committed debt and preferred equity financing and was not subject to a financing condition. The proposal remained subject to the completion of due diligence regarding certain outstanding legal matters and to the Company’s entry into a significant commercial agreement.
Also on September 14, 2026, Party G informed representatives of Morgan Stanley that it would not submit a final proposal, and Party A’s financial advisor informed representatives of Morgan Stanley that Party A had not completed its due diligence but remained interested in continuing to explore a potential transaction. Party B did not submit a final proposal and continued to indicate to Morgan Stanley that it would participate only as an equity financing partner. Following consultation with Messrs. Ramamurthy, Eilam and Ingram and representatives of Kirkland on September 15, 2026, representatives of Morgan Stanley encouraged Party A to submit a proposal in advance of the Company Board’s next meeting on September 16, 2026.
On September 16, 2026, representatives of Morgan Stanley spoke with representatives of GTCR, who stated that their September 14, 2026 proposal would also require Mr. Ramamurthy to roll over all of his equity in the Company, with the ability to obtain liquidity for a portion of that equity upon the Company’s entry into the significant commercial agreement.
On September 16, 2026, Party A submitted a written proposal to acquire the Company for $8.00 per share in cash, representing a premium of approximately 49% over the Unaffected Trading Price, which was not subject to a financing condition, contemplated a signing on October 4, 2026 and requested exclusivity through that date.
Later on September 16, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reviewed the proposals submitted by GTCR and Elliott on September 14, 2026 and by Party A on September 16, 2026, and certain preliminary financial information regarding those proposals. Representatives of Morgan Stanley noted that GTCR and Elliott’s proposal remained subject to the completion of due diligence regarding certain outstanding legal matters, the Company’s entry into the significant commercial agreement and GTCR and Elliott’s requirement that Mr. Ramamurthy roll over his equity on the terms described above. Mr. Ramamurthy noted that he had not had any discussions with GTCR or Elliott regarding an equity rollover and would not do so without the Company Board’s authorization. Representatives of Kirkland reviewed GTCR and Elliott’s revised merger agreement markup, including the terms described above, and noted that Party A had not yet submitted a revised markup. Representatives of Morgan Stanley also reported that, earlier that day, Party A’s financial advisor had requested permission for Party A to speak with Party B and another party that Party A did not identify. Following consultation with Messrs. Ramamurthy, Eilam and Ingram, Morgan Stanley declined the request because Party A had indicated that it did not require additional equity financing. Mr. Ramamurthy also reported that Party A’s chief executive officer had called him after Party A submitted its proposal to reiterate Party A’s interest in a potential transaction, and that they had not discussed price or other transaction terms. Following discussion, the Company Board determined that neither proposal was actionable at that time, because GTCR and Elliott’s proposal remained subject to further due diligence regarding certain outstanding legal matters, the requested equity rollover and the Company’s entry into the significant commercial agreement, and Party A’s proposal remained subject to further due diligence, and declined Party A’s request for exclusivity. In order to facilitate an improved proposal, the Company Board authorized Mr. Ramamurthy to discuss with GTCR and Elliott the requested
40

TABLE OF CONTENTS

equity rollover, which would require Mr. Ramamurthy to roll over all of his equity in the Company, with the ability to obtain liquidity for a portion of that equity upon the Company’s entry into the significant commercial agreement, provided that any such discussion occur in the presence of a member of the Transaction Committee, none of whom had been requested to roll over any of their equity. In addition, given GTCR and Elliott’s request that Mr. Ramamurthy roll over equity, at the direction of the Company Board, representatives of Morgan Stanley requested an improved proposal from GTCR and Elliott and explored whether Party B might join GTCR as an additional equity financing partner in order to support an improved proposal. The Company Board also directed Morgan Stanley to request that Party A complete its due diligence and submit a revised markup of the merger agreement.
On September 18, 2026, GTCR and Elliott submitted a revised proposal to acquire the Company for $7.55 per share in cash, representing a premium of approximately 40% over the Unaffected Trading Price, and indicated that they had completed their due diligence, such that the revised proposal remained subject only to the Company’s entry into the significant commercial agreement and to the requirement that Mr. Ramamurthy roll over all of his equity in the Company, with the ability to obtain liquidity for a portion of that equity upon the Company’s entry into that agreement. On September 20, 2026, at the direction of the Company Board, representatives of Morgan Stanley informed GTCR and Elliott that their proposal was insufficient and would need to be increased and encouraged GTCR and Elliott to submit a revised proposal at a price of $8.00 per share or higher in order to be competitive. Representatives of Morgan Stanley also introduced Party B to GTCR as a potential additional equity financing partner, although Party B did not ultimately join the buyer group.
Between September 20, 2026 and the execution of the Merger Agreement, representatives of Kirkland and Simpson Thacher exchanged multiple drafts of the merger agreement, the Company disclosure letter, the Equity Commitment Letters, the Limited Guarantees and the other transaction documents, and held numerous calls regarding those drafts. Among other items, the parties negotiated, and the Company obtained improvements to the terms initially proposed by GTCR and Elliott with respect to, the terms of the no-shop covenant and the related fiduciary exception and matching rights, the outside date, the Company’s financing cooperation covenants, the regulatory efforts covenant and related restrictions on Parent, the treatment of the Company’s outstanding equity awards, the conditions to closing, the circumstances in which the merger agreement could be terminated and an increase to the reverse termination fee.
In parallel, between September 10, 2026 and October 9, 2026, representatives of Kirkland and Party A’s outside legal counsel exchanged multiple drafts of the merger agreement and related transaction documents. Among other items, the parties negotiated the amount of the antitrust reverse termination fee, the regulatory efforts standard and provisions relating to certain diligence matters.
On September 22, 2026, Party A’s financial advisor again requested permission for Party A to discuss a potential business relationship with and/or possible investment from Party B, as well as a potential investment from another potential equity financing source, which Party A had also referenced in its September 16, 2026 request. Following consultation with Messrs. Ramamurthy, Eilam and Ingram, representatives of Morgan Stanley again declined the request because Party A had indicated that it did not require additional equity financing.
On September 25, 2026, Mr. Ramamurthy met with representatives of GTCR, with Mr. Schweitzer and representatives of Morgan Stanley in attendance, to discuss the Company’s business plan and, consistent with the Company Board’s authorization at its September 16, 2026 meeting, the equity rollover requested by GTCR and Elliott. GTCR and Elliott proposed that Mr. Ramamurthy roll over all of his equity in the Company at signing, reducing to 50% upon the Company’s entry into the significant commercial agreement, and Mr. Ramamurthy indicated a willingness to consider a rollover of approximately $150 million of his equity, reducing to approximately $75 million upon the Company’s entry into that agreement. No other terms of a potential transaction, including the post-closing employment or compensation of any member of management, were discussed. It was generally understood, however, that Mr. Ramamurthy was expected to continue to provide services to the Company following the closing of a potential transaction.
On September 26, 2026, Party A’s financial advisor informed representatives of Morgan Stanley that Party A reaffirmed its $8.00 per share proposal as its best and final proposal and had completed its outstanding due diligence, but that, for reasons unrelated to the Company, Party A would not be in a position to sign a definitive agreement until mid-October 2026 at the earliest.
On September 28, 2026, the Transaction Committee held a meeting, with representatives of Kirkland and Morgan Stanley and members of the Company’s senior management in attendance. Representatives of Morgan Stanley updated the Transaction Committee on the status of the proposals, including Party A’s reaffirmation of its $8.00 per share
41

TABLE OF CONTENTS

proposal as its best and final proposal, which was not subject to a financing condition, and Party A’s position that it would not be in a position to sign a definitive agreement until mid-October 2026 at the earliest, for reasons unrelated to the Company. Representatives of Morgan Stanley also reported that GTCR and Elliott’s proposal remained subject to the Company’s entry into the significant commercial agreement and to the requested equity rollover by Mr. Ramamurthy (which GTCR and Elliott had proposed be all of his equity at signing, reducing to 50% upon the Company’s entry into that agreement). Representatives of Morgan Stanley also reviewed their updated preliminary financial analyses, which reflected management’s September 2026 updates of the May Management Case and the May Extrapolations, as described below in connection with the Company Board’s September 29, 2026 meeting. Mr. Ramamurthy then joined the meeting at the invitation of the Transaction Committee and noted that the requested rollover would result in reduced liquidity for him in comparison to the Company’s other stockholders, but that he was willing to consider the requested rollover in order to facilitate an improved proposal. Mr. Ramamurthy also discussed the challenges and risks associated with the Company’s standalone business plan, including competitive threats such as artificial intelligence and autonomous vehicles, and noted that the Company’s stock price had not improved despite the Company’s recent outperformance of market expectations. Following discussion, the Transaction Committee determined to continue to evaluate each of GTCR and Elliott’s proposal and Party A’s proposal against the Company’s standalone business plan.
On September 29, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley updated the Company Board on the status of each proposal. Representatives of Morgan Stanley reported that GTCR and Elliott were unwilling to improve their proposal without a better understanding of the status of the significant commercial agreement, and noted that, in their view, the uncertainty regarding that agreement had already been reflected in the price proposed by GTCR and Elliott and would also affect whether GTCR and Elliott’s proposal would become actionable. Representatives of Morgan Stanley also updated the Company Board on the discussions with GTCR regarding the equity rollover that GTCR and Elliott continued to require as a condition of their proposal, in which Mr. Schweitzer had participated. Following discussion, the Company Board authorized Mr. Ramamurthy to continue the rollover discussions with GTCR in the presence of a member of the Transaction Committee. Representatives of Morgan Stanley also reviewed Party A’s reaffirmation of its $8.00 per share proposal as its best and final proposal and the related timing considerations, and noted that progress had been made on Party A’s merger agreement, including with respect to the antitrust reverse termination fee, the regulatory efforts standard and provisions relating to certain diligence matters. Members of the Company’s senior management then reviewed with the Company Board an update of the May Management Case reflecting the Company’s actual results through the second quarter of fiscal year 2026 and senior management’s then-current estimates for the remainder of fiscal year 2026 (the “September Management Case”). Morgan Stanley also prepared an update of the May Extrapolations reflecting the September Management Case, which the Company’s senior management reviewed and approved for Morgan Stanley’s use (the “September Extrapolations” and, together with the September Management Case, the “September Projections”). The Company Board approved the September Projections for use by Morgan Stanley in its financial analyses and opinion. For additional information, see the section of this proxy statement titled “The Merger — Certain Company Management Projections.” Representatives of Morgan Stanley then reviewed with the Company Board their updated preliminary financial analyses and noted that the Company’s then-current trading price likely reflected, in part, market speculation regarding a potential transaction. The Company Board also discussed the Company’s potential standalone trading price absent a transaction, including in light of its expected third quarter performance, and whether to defer a decision regarding a potential transaction until after the Company’s announcement of its third quarter results in late October 2026. Following discussion, the Company Board directed the Company’s advisors to continue to negotiate with each of GTCR and Elliott and Party A.
On September 30, 2026, Mr. Ramamurthy and Mr. Schweitzer held a follow-up discussion at the request of GTCR, with representatives of GTCR and Morgan Stanley in attendance, regarding the requested equity rollover and the significant commercial agreement. Also on September 30, 2026, Party E, one of the potential sources of equity financing that the Company Board had authorized representatives of Morgan Stanley to contact at its August 19, 2026 meeting, submitted a written indication of interest to participate in a transaction as a potential equity financing partner at $7.50 to $7.75 per share with an equity commitment of $200 million. Representatives of Morgan Stanley encouraged Party E to submit a revised proposal at a valuation of $8.00 per share or higher. Party E declined to submit any revised proposal.
On October 5, 2026, at the request of GTCR, Messrs. Ramamurthy and Welsh met with GTCR’s investment committee, with Mr. Eilam in attendance. Consistent with guidance provided by Messrs. Eilam and Ingram, the
42

TABLE OF CONTENTS

discussion was limited to the Company’s business and outlook and did not address post-closing roles, equity rollover or compensation. During the same period, the Company continued to advance discussions with Party A. Representatives of Kirkland and Party A’s outside legal counsel continued to negotiate the merger agreement, including through Party A’s delivery of a revised markup on October 2, 2026 and Kirkland’s delivery of a revised draft on October 8, 2026, and representatives of Morgan Stanley continued to engage with Party A’s financial advisor regarding Party A’s additional follow-up confirmatory due diligence requests received in early October and the timing of a potential signing.
On October 6, 2026, GTCR and Elliott informed representatives of Morgan Stanley that they would require further information regarding the significant commercial agreement before revising their proposal and, on October 7, 2026, reiterated to representatives of Morgan Stanley that they were still awaiting further information regarding that agreement. On October 9, 2026, Messrs. Ramamurthy and Welsh, with representatives of Morgan Stanley in attendance, provided GTCR with an update on the status of that agreement.
Earlier in October 2026, Party H, one of the potential sources of equity financing, indicated that it was prepared to provide up to $1 billion of preferred equity financing to a buyer group. Consistent with the Company Board’s authorization of that outreach in order to enable the potential buyers to assemble sufficient equity capital to support their proposals, representatives of Morgan Stanley shared Party E’s and Party H’s indications with GTCR, and on October 11, 2026, GTCR informed representatives of Morgan Stanley that it had financing commitments sufficient for the consummation of the potential transaction and therefore did not require either Party E’s participation or Party H’s preferred equity financing. Representatives of Morgan Stanley relayed this feedback to each of Party E and Party H.
On October 9, 2026, Bloomberg and Reuters published reports stating that GTCR and Elliott were in advanced discussions regarding an acquisition of the Company.
On October 11, 2026, GTCR informed representatives of Morgan Stanley that, as part of considering an increased proposal, it would also require Mr. Welsh to roll over his equity. GTCR proposed that, consistent with the structure of the rollover it had requested of Mr. Ramamurthy, Mr. Welsh roll over all of his equity in the Company, with the amount of the required rollover to be reduced to 50% of his equity upon the Company’s entry into the significant commercial agreement. After consulting with representatives of Kirkland, representatives of Morgan Stanley asked Mr. Welsh whether he would be willing to roll over his equity, and Mr. Welsh noted that the requested rollover would also result in reduced liquidity for him in comparison to the Company’s other stockholders, but that he was willing to consider the requested rollover in order to facilitate an improved proposal. Representatives of Morgan Stanley then briefed Messrs. Ramamurthy, Eilam and Ingram and informed GTCR of Mr. Welsh’s response.
On October 12, 2026, GTCR orally informed representatives of Morgan Stanley of a revised proposal to acquire the Company for $7.75 per share in cash, representing a premium of approximately 44% over the Unaffected Trading Price, which GTCR described as its best and final proposal, and later that day provided a written proposal reflecting these terms addressed to the Company Board. GTCR indicated that it was prepared to fund all of the required equity without Elliott if necessary, that Elliott had not yet indicated whether it would participate at the proposed price, and that it was prepared to sign a definitive agreement the following day and announce the transaction before the opening of trading on October 14, 2026. GTCR’s revised proposal was conditioned on Mr. Ramamurthy rolling over his equity, as well as on Mr. Welsh rolling over his equity, on the same terms as GTCR had required on October 11, 2026. GTCR also indicated that no changes to the merger agreement or its financing would enable it to increase its price, citing continued uncertainty regarding the Company’s entry into the significant commercial agreement and noting that its lenders had requested additional pricing flexibility in light of recent increases in interest rates.
Also on October 12, 2026, prior to the meeting of the Company Board described below, Party A’s chief executive officer requested a call with Mr. Ramamurthy. After consulting with representatives of Morgan Stanley and Kirkland, Mr. Ramamurthy took the call. Party A’s chief executive officer stated that, for reasons unrelated to anything Party A had learned about the Company during its due diligence on the Company, Party A would not proceed with exploring a potential transaction, and subsequently confirmed the same by email.
Later on October 12, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Representatives of Morgan Stanley reviewed GTCR’s revised proposal and their preliminary financial analyses, reported on Party A’s withdrawal and noted that GTCR had stated that the proposal was its best and final proposal. Representatives of Morgan Stanley also reported to the Company Board, including the members of the Transaction Committee, that, as a condition to its proposal, GTCR continued to require that Mr. Ramamurthy roll over his equity and, as described above, had required that Mr. Welsh also roll over his equity, that Mr. Welsh had indicated that he would be willing to do so, that they had briefed
43

TABLE OF CONTENTS

Messrs. Ramamurthy, Eilam and Ingram on October 11, 2026 and that the terms and parameters of each rollover remained subject to negotiation. Having previously considered at its September 29, 2026 meeting whether to defer a decision until after the announcement of the Company’s third quarter results, and after weighing the Company’s standalone prospects, including its expected near-term performance, against the risks of delaying a decision until after that announcement, the Company Board determined not to defer its decision until after the announcement of the Company’s third quarter results and directed management and the Company’s advisors to seek to finalize a transaction within GTCR’s proposed timeframe, subject to the recommendation of the Transaction Committee and the approval of the Company Board. Representatives of Morgan Stanley also noted that GTCR had confirmed that its proposal was not subject to any purchase price adjustment or signing or closing condition relating to certain legal matters. The Company Board also discussed the equity rollovers required by GTCR, including that the rollovers would result in reduced liquidity for Messrs. Ramamurthy and Welsh in comparison to the Company’s other stockholders. Representatives of Morgan Stanley noted that GTCR had reiterated that it would not proceed with a transaction without the rollovers. Representatives of Morgan Stanley also noted that, because the Company had not yet entered into the significant commercial agreement, the rollovers served principally as a signal of management’s confidence that the Company would enter into that agreement, with the proposed rollover amounts to be reduced upon the Company’s entry into that agreement. The Company Board authorized Messrs. Ramamurthy and Welsh and their legal counsel to engage in discussions directly with GTCR regarding their respective rollovers. The Company Board also expanded the mandate of the Transaction Committee to include evaluating whether a potential transaction would be fair to and in the best interests of the Company’s stockholders who are not party to any rollover arrangement.
On October 13, 2026, Messrs. Ramamurthy and Welsh retained McDonald Hopkins LLC as their counsel and commenced negotiation of the rollover arrangements with representatives of Simpson Thacher.
Also on October 13, 2026, GTCR indicated to representatives of Morgan Stanley that Elliott would participate in the proposed transaction on the same terms proposed by GTCR.
Also on October 13, 2026, Party A’s financial advisor informed representatives of Morgan Stanley that Party A’s decision not to proceed with exploring a potential transaction was due to Party A’s uncertainty regarding its ability to achieve the anticipated benefits of a potential transaction. Representatives of Morgan Stanley indicated that the Company would be willing to consider a future proposal from Party A if its circumstances changed.
Also on October 13, 2026, the Transaction Committee held a meeting, with representatives of Kirkland and Morgan Stanley and members of the Company’s senior management in attendance. Representatives of Kirkland provided the Transaction Committee with an update on the status of the rollover negotiations with respect to each of Messrs. Ramamurthy and Welsh and summarized the key terms of the merger agreement. Representatives of Morgan Stanley reviewed their preliminary financial analyses, which were based on the September Projections, and representatives of Kirkland reviewed with the Transaction Committee its fiduciary duties. The Transaction Committee then discussed, among other things, the premium represented by the $7.75 per share price relative to the Unaffected Trading Price, the certainty of value of an all-cash transaction as compared to the execution risks of the Company’s multi-year standalone plan, the Company’s standalone prospects, including the competitive and other risks to the Company’s business from artificial intelligence and autonomous vehicles and whether the Company’s stock would be expected to trade closer to the Unaffected Trading Price if no transaction were announced. The Transaction Committee also discussed the dilutive effect of the SPAC Merger Earnout Shares and that the rollover arrangements were required by GTCR as a condition to its proposal and would result in reduced liquidity for Messrs. Ramamurthy and Welsh relative to the Company’s other stockholders. Following discussion, the Transaction Committee indicated that, subject to the finalization of the transaction documents on the terms presented, it was prepared to recommend that the Company Board approve the Merger Agreement and the Merger. For additional information regarding the September Projections, see the section of this proxy statement titled “The Merger — Certain Company Management Projections.”
Later on October 13, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance, at which representatives of Kirkland summarized the key terms of the proposed final form of the merger agreement, which had been circulated to the Company Board in advance. Mr. Ramamurthy provided the Company Board, including Messrs. de Crescenzo and Schweitzer, members of the Transaction Committee, with an update on the status of the rollover negotiations with respect to each of Messrs. Ramamurthy and Welsh and discussed the significant amount of equity he would be required to roll over, the extended duration of the rollover and the resulting liquidity implications for him relative to the cash consideration to be received by the Company’s other stockholders, and stated that he was willing to consider them, subject to agreeing on the rollover amounts and appropriate liquidity protection in the event his employment were
44

TABLE OF CONTENTS

terminated without cause. Representatives of Morgan Stanley reported that GTCR was open to addressing Mr. Ramamurthy’s concerns. Representatives of Morgan Stanley and Kirkland noted that no member of management had been offered post-closing employment, that no post-closing roles or compensation had been discussed with any member of management and that the only request then being made of management was the rollover by Messrs. Ramamurthy and Welsh. It was generally understood, however, that Messrs. Ramamurthy and Welsh were expected to continue to provide services to the Company following the closing of the potential transaction. Representatives of Kirkland reported that Simpson Thacher had delivered a revised merger agreement reflecting Elliott’s participation but otherwise on the same terms. Representatives of Kirkland also disclosed that GTCR had requested that Kirkland’s investment funds group, which customarily represents GTCR, represent GTCR in connection with its arrangements with its equity co-investors, which did not affect the terms of the proposed transaction or involve any negotiation with the Company. Representatives of Kirkland noted that Messrs. Ramamurthy, Eilam and Ingram had been informed of the request several weeks earlier in order to facilitate GTCR’s ability to secure the equity financing necessary to submit its most competitive proposal, that the investment funds group was screened from the Kirkland team representing the Company and that Kirkland was raising the matter at this meeting so that the full Company Board was aware of it. Following discussion, the Company Board determined that the representation did not impair Kirkland’s ability to serve as the Company’s outside counsel in connection with the proposed transaction. The Company Board also determined that, based on the information provided orally by representatives of Kirkland, which was substantially similar to the relationship disclosure Kirkland had provided at the Company Board’s August 19, 2026 meeting, none of the other relationships previously disclosed by Kirkland impaired its ability to serve as the Company’s outside counsel and that, based on the information provided in Morgan Stanley’s updated customary relationship disclosure letter dated October 12, 2026, none of the relationships disclosed by Morgan Stanley impaired its ability to serve as the Company’s financial advisor. Representatives of Morgan Stanley then reviewed their financial analyses of the $7.75 per share proposal, which were based on the September Projections, representatives of Kirkland again reviewed the Company Board’s fiduciary duties and Mr. de Crescenzo reported on the Transaction Committee’s meeting earlier that day. Because certain terms of the rollover required by GTCR and Elliott remained open, the Company Board determined to reconvene once there was greater certainty regarding the rollover arrangements.
Between the evening of October 13, 2026 and October 14, 2026, Messrs. Ramamurthy and Welsh and their counsel continued to negotiate the rollover arrangements with GTCR and Simpson Thacher, and representatives of Kirkland and Simpson Thacher finalized the merger agreement and the other transaction documents.
On October 14, 2026, the Transaction Committee held a meeting, with representatives of Kirkland and Morgan Stanley and members of the Company’s senior management in attendance. Representatives of Morgan Stanley and Kirkland confirmed that the price and other material terms of the proposed transaction were unchanged and that the merger agreement was in final form and had been circulated to the Company Board (including all members of the Transaction Committee) in advance of the meeting. They also reported that, following negotiations with Messrs. Ramamurthy and Welsh and their counsel, GTCR had agreed to reduce the committed rollover amounts to approximately $75 million of Mr. Ramamurthy’s equity and 50% of Mr. Welsh’s equity, as compared to GTCR’s prior requirements of approximately $150 million and 100% of their respective equity, together with certain liquidity rights for Mr. Ramamurthy, including with respect to his rolled equity in the event his employment is terminated without cause, and that the rollover terms did not affect the merger agreement or the consideration payable to the Company’s stockholders. For additional information regarding the rollover arrangements, see the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.” Following discussion, and taking into account the factors discussed at its October 13, 2026 meeting (including the factors described in the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board”) and Morgan Stanley’s indication at that meeting that it was prepared to deliver its opinion to the Company Board if the proposed transaction was finalized, the Transaction Committee unanimously determined that the proposed transaction is fair to, and in the best interests of, the Company’s stockholders who are not (i) entitled to SPAC Merger Earnout Shares or (ii) party to any rollover arrangement, and recommended that the Company Board approve the Merger Agreement and the Merger.
Later on October 14, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland and Morgan Stanley in attendance. Mr. Ramamurthy reported that the rollover arrangements had been substantially agreed, including the rollover amounts and liquidity protection for his rollover equity in the event his employment is terminated without cause, and representatives of Kirkland reported the Transaction Committee’s determination and recommendation and reviewed the Company Board’s fiduciary duties. Representatives of Morgan Stanley then referred to their review of Morgan Stanley’s financial analyses with the
45

TABLE OF CONTENTS

Company Board at its October 13, 2026 meeting and rendered to the Company Board Morgan Stanley’s oral opinion, subsequently confirmed by delivery of a written opinion dated October 14, 2026, to the effect that, as of the date of such opinion and based upon and subject to the various assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken by Morgan Stanley as set forth in its written opinion, the Per Share Price in cash to be received by the holders of shares of Company Common Stock pursuant to the Merger Agreement was fair from a financial point of view to such holders. Morgan Stanley’s opinion is more fully described in the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor,” and the full text of Morgan Stanley’s written opinion is attached as Annex B to this proxy statement.
Following discussion and consideration of the Merger Agreement and the transactions contemplated thereby (including the factors described in the section of this proxy statement titled “The Merger — Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board”), and acting upon the unanimous recommendation of the Transaction Committee, the Company Board unanimously (with respect to all directors present, with Mr. Schweitzer having been unavailable to attend the meeting and Mr. Wei having recused himself) (i) determined that it is in the best interests of the Company and its stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger upon the terms and subject to the conditions set forth therein; (ii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iii) resolved to recommend that Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (iv) directed that the adoption of the Merger Agreement be submitted for consideration by Company stockholders at a meeting thereof.
Shortly thereafter, on October 14, 2026, the Company, Parent and Merger Sub executed the Merger Agreement, and Parent delivered the executed Equity Commitment Letters, the Limited Guarantees, the Debt Commitment Letter and the Preferred Equity Commitment Letter, and Messrs. Ramamurthy and Welsh entered into the Rollover Agreements. Before the opening of trading on the Nasdaq Global Select Market on October 15, 2026, the Company issued a press release announcing the entry into the Merger Agreement.
On November 17, 2026, representatives of Simpson Thacher informed representatives of Kirkland that Parent proposed to terminate the Preferred Equity Commitment Letter and that GTCR would increase its commitment under its Equity Commitment Letter by an aggregate amount of $500,000,000 to replace the financing that had been contemplated by the Preferred Equity Commitment Letter.
On November 18, 2026, the Transaction Committee held a meeting, with members of the Company’s senior management and representatives of Kirkland in attendance. Representatives of Kirkland reviewed with the Transaction Committee the proposed termination of the Preferred Equity Commitment Letter, the corresponding increase in the commitment under GTCR’s Equity Commitment Letter and the proposed amendment to the Merger Agreement to reflect the revised financing structure. Following discussion, the Transaction Committee unanimously recommended that the Company Board approve the amendment to the Merger Agreement.
Later on November 18, 2026, the Company Board held a special meeting, with members of the Company’s senior management and representatives of Kirkland in attendance. Representatives of Kirkland reviewed with the Company Board the proposed termination of the Preferred Equity Commitment Letter, the corresponding increase in the GTCR commitment under its Equity Commitment Letter and the proposed amendment to the Merger Agreement to reflect the revised financing structure. Following discussion, and acting upon the unanimous recommendation of the Transaction Committee, the Company Board unanimously (with respect to all directors present) approved the amendment to the Merger Agreement.
On November 19, 2026, in connection with the anticipated execution and delivery of the amendment to the Merger Agreement and the amendment to GTCR’s Equity Commitment Letter and the related documents, Parent granted a waiver, pursuant to the terms of the Merger Agreement, of the 25-business day deadline for filing the preliminary proxy statement, extending that deadline from November 19, 2026 to November 20, 2026.
On November 20, 2026, the Company, Parent and Merger Sub entered into the First Amendment to the Merger Agreement (the “Merger Agreement Amendment”) to reflect the termination of the Preferred Equity Commitment Letter and the corresponding increase in the equity financing to be provided by GTCR under its Equity Commitment
46

TABLE OF CONTENTS

Letter pursuant to an amendment to such Equity Commitment Letter entered into by Parent, the Company and affiliates of GTCR. The Merger Agreement Amendment did not change the Per Share Price or any other economic terms of the Merger, or the conditions to the closing of the Merger. For additional information, see the section of this proxy statement titled “The Merger — Financing of the Merger.”
During the process described above, the Company entered into confidentiality agreements with 22 parties, including GTCR and Elliott. Each of these confidentiality agreements included a standstill provision, with terms ranging from 12 to 18 months (or, in the case of Elliott, through December 31, 2026). Under the terms of these confidentiality agreements, upon the Company’s entry into the Merger Agreement, each such standstill provision either ceased to apply or permits the applicable party to make an acquisition proposal to the Company Board.
Other than the Rollover Agreements, no discussions or negotiations regarding post-closing employment arrangements or compensation with the surviving corporation in the Merger occurred between GTCR or Elliott and the Company’s senior management prior to the approval and execution of the Merger Agreement, or have occurred subsequent to such approval and execution, through the date of this proxy statement. It is generally understood, however, that Messrs. Ramamurthy and Welsh are expected to continue to provide services to the Company following the closing. For additional information, see the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.”
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board
The Transaction Committee, which consists solely of directors who are disinterested with respect to the Company Earnout Shares as well as the Rollover Agreements, (a) determined that the Transactions and the terms and conditions of the Merger, including the Per Share Price payable to Company stockholders, are fair to, and in the best interests of, the Company and the Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements and (b) unanimously recommended that the Company Board (i) approve, adopt and authorize the Transactions, the Merger Agreement and the transactions contemplated thereby, (ii) direct the Company to enter into and deliver the Merger Agreement and any related documents required to be delivered in connection therewith and (iii) recommend that the Company stockholders vote to adopt the Merger Agreement and approve the Merger, the Merger Agreement and the transactions contemplated thereby.
The Company Board, based on the information it received and reviewed, including the Transaction Committee’s recommendation, unanimously (with respect to all directors present) (i) determined that the terms of the Merger Agreement and the Transactions are fair to, and in the best interests of, the Company and the Company stockholders; (ii) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger, upon the terms and subject to the conditions set forth therein; (iii) approved the execution and delivery of the Merger Agreement by the Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iv) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (v) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at the Special Meeting.
Accordingly, the Company Board recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
The Transaction Committee
The Transaction Committee, in reviewing and evaluating whether the Merger, including the Per Share Price payable to Company stockholders, is fair to, and in the best interests of, the Company and the Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, consulted with and received the advice of the Company’s legal and financial advisors, discussed certain matters with the Company’s senior management, and considered a variety of factors weighing positively in favor of the Merger, including the following non-exhaustive list of material factors (not necessarily in order of relative importance):
•
the fact that the Per Share Price of $7.75 is all cash, which provides certainty, immediate value and liquidity to Company stockholders (other than the Rollover Investors, with respect to the shares of Company Common Stock to be contributed to Topco pursuant to the Rollover Agreements) upon consummation of the Merger, while eliminating exposure to business and execution risk, compared to continuing to operate the Company as a standalone company;
47

TABLE OF CONTENTS

•
the historical market prices, volatility and trading information with respect to Company Common Stock, including the fact that $7.75 per share to be received by Company stockholders represents a premium of approximately (a) 44% over the unaffected closing price of Company Common Stock of $5.38 on July 9, 2026, the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company, (b) 59% over the unaffected 30-trading day volume-weighted average price of Company Common Stock of $4.87 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company and (c) 48% over the unaffected 90-trading day average price of Company Common Stock of $5.24 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company;
•
the belief that the Per Share Price of $7.75 is more favorable to Company stockholders on a risk-adjusted basis than the potential value that might result from other alternatives reasonably available to the Company, including continuing as an independent public company, based upon the Transaction Committee members’ knowledge of the Company’s business, assets, financial condition and results of operations as well as the industry in which the Company operates, the execution challenges that the Company potentially faces and general market dynamics, and taking into account:
•
the Company’s historical and projected financial performance, including the Projections described in the section of this proxy statement titled “The Merger — Certain Company Management Projections,” and the fact that the full realization of the Projections was subject to significant execution risk;
•
the challenges and risks that the Company has faced, and would likely continue to face, if it remained an independent public company, including, among other things, the need for further proof points for the Company’s AI-led growth, the need to adopt and integrate evolving technologies, including AI, the possibility that advanced driver-assistance systems and other vehicle technology could reduce accident frequency, the Company’s concentration among insurance carrier customers, the competitive landscape, financial and execution risks associated with the Company’s standalone plan, and the potential impact of those factors on the trading price of Company Common Stock (which cannot be quantified numerically);
•
the impact and status of general industry, economic and market conditions and trends relevant to the Company’s business, including information regarding recent AI-related developments affecting software companies more broadly and the potential impact that advancements in AI could have on the Company’s industry and long-term business prospects, and, in light of such conditions and trends, the risks and challenges to value creation associated with continuing to operate the Company as a standalone public company; and
•
the risk that, absent the Merger, the trading price of Company Common Stock would not achieve a value comparable to the Per Share Price within a reasonable timeframe, including due to the potential negative impact of stock market disruptions relating to advancements in AI on the relative trading performance of software businesses or, more generally, recent market volatility;
•
the sale process conducted by the Company, with the assistance of Morgan Stanley and Kirkland, including that the Company (i) discussed possible interest in a potential transaction with 39 potential counterparties (consisting of 31 financial sponsors and 8 strategic parties), of which 22 were contacted by Morgan Stanley at the direction of the Company and 17 contacted the Company or its representatives on an unsolicited basis, and (ii) entered into confidentiality agreements with 22 of those counterparties;
•
the fact that, on July 9, 2026 and again on August 18, 2026 and October 9, 2026, there were published media reports regarding a potential acquisition of the Company, which provided any third party not otherwise contacted by the Company or its representatives an opportunity to put forward a proposal;
•
the increase in Parent’s proposed price from $7.35 per share on September 14, 2026 to $7.55 per share on September 18, 2026 and then to $7.75 per share on October 12, 2026, which Parent stated was its “best and final” proposal;
•
the belief that, in light of the course of negotiations with Parent, $7.75 per share is the highest price that Parent is willing to pay and that the terms of the Merger Agreement include the most favorable terms to the Company, in the aggregate, to which Parent is willing to agree;
•
the financial analyses of Morgan Stanley reviewed with the Transaction Committee on October 13, 2026, including that the Per Share Price was within the ranges indicated by such analyses, and the fact that Morgan
48

TABLE OF CONTENTS

Stanley advised the Transaction Committee that it is prepared to deliver an opinion to the Company Board that, subject to the assumptions, limitations, qualifications and other matters set forth in such opinion, the Per Share Price to be paid to the holders of Company Common Stock (other than holders of Owned Company Shares, Dissenting Company Shares or Company RSAs) was fair, from a financial point of view, to such holders (see the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor”);
•
the terms and conditions of the Merger Agreement permitting the Company to respond to unsolicited Acquisition Proposals, including permitting the Company to furnish non-public information to, and engage in discussions and negotiations with, a third party that has made an Acquisition Proposal that the Company Board determines in good faith constitutes, or could reasonably be expected to lead to, a Superior Proposal (see the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”), and the ability of the Company Board, under certain circumstances, to make a Company Board Recommendation Change or to terminate the Merger Agreement to enter into a definitive agreement providing for a Superior Proposal, subject to payment of the Company Termination Fee of $149,520,000 (representing approximately 3.0% of the equity value implied by the Per Share Price), which amount the Transaction Committee believes to be reasonable under the circumstances and unlikely to serve as a meaningful deterrent to other acquisition proposals (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”);
•
the terms of the Merger Agreement, which were the product of arm’s-length negotiations between the Company and Parent and reflect terms and conditions that are, in the Transaction Committee’s view, advisable and favorable to the Company and Company stockholders, and the likelihood that the Merger would be completed in a timely manner in view of such terms, including:
•
the limited number and nature of the conditions to Parent’s obligation to consummate the Merger, including that the expiration or termination of the waiting period under the HSR Act is the only regulatory approval condition to the Closing;
•
the covenants by the parties to use their respective reasonable best efforts to consummate the Closing, Parent’s commitment, subject to certain limitations, to take all actions necessary to obtain the expiration or termination of the applicable waiting period under the HSR Act prior to the Termination Date (as defined in the section of this proxy statement titled “The Merger Agreement — Termination of the Merger Agreement”), including agreeing to divestitures and other remedies with respect to the Company and its subsidiaries (but not with respect to Parent’s affiliates or their respective portfolio companies), and the parties’ assessment of the likelihood of obtaining required regulatory approvals prior to the Termination Date;
•
Parent’s and Merger Sub’s representations and covenants contained in the Merger Agreement relating to the Financing, the fact that the Merger is not subject to a financing condition and the Company’s entitlement, under certain circumstances pursuant to the Merger Agreement and the Equity Commitment Letters, to specific performance of Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing pursuant to the Equity Commitment Letters, and, other than with respect to consummation of the Closing, to specific performance to prevent breaches of, and to enforce specifically the terms of, the Merger Agreement (see the section of this proxy statement titled “The Merger — Financing of the Merger”);
•
the requirement that, in certain circumstances, Parent is obligated to pay the Company the Parent Termination Fee of $313,992,000 (representing approximately 6.3% of the equity value implied by the Per Share Price), which is guaranteed, severally and not jointly on a pro rata basis, by the GTCR Funds and the Elliott Funds (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”);
•
the representations, warranties and covenants of the parties, the conditions to the parties’ obligations to complete the Merger and their ability to terminate the Merger Agreement;
•
the fact that the definition of “Company Material Adverse Effect” has a number of customary exceptions; and
•
the fact that the Merger Agreement’s restrictions on the Company’s ability to take certain actions during the pendency of the Merger will not unduly interfere with the Company’s ability to operate its business in the ordinary course between the execution of the Merger Agreement and the consummation of the Merger;
•
the fact that the Merger is subject to the Requisite Stockholder Approval, and that Company stockholders are free to vote for or against the Merger Proposal;
49

TABLE OF CONTENTS

•
the fact that appraisal rights are available to Company stockholders who properly exercise their statutory rights under Section 262 of the DGCL (see the section of this proxy statement titled “Appraisal Rights”);
•
the fact that the Company’s legal and financial advisors were involved throughout the process and negotiations and updated the Transaction Committee directly and regularly, thereby providing the Transaction Committee with additional perspectives on the negotiations; and
•
the fact that the termination date of April 14, 2027 is expected to allow for sufficient time to complete the Merger.
The Transaction Committee also considered a number of uncertainties, risks and potentially negative factors in making its determination and recommendation, including the following non-exhaustive list of material factors (not necessarily in order of relative importance):
•
that, following the completion of the Merger, the Company will no longer exist as an independent public company and that the consummation of the Merger and receipt of the Per Share Price, while providing certainty of value, will not allow Company stockholders (other than, indirectly, the Rollover Investors with respect to their equity interests in Topco) to participate in potential further growth in the Company’s assets, future earnings growth or future appreciation in value of Company Common Stock, including the possibility that the trading price or value of Company Common Stock might in the future have exceeded the Per Share Price;
•
the risk that the Transactions, including the Merger, may not be consummated in a timely manner or at all, and the consequences thereof, including (a) the potential loss of value to Company stockholders, (b) the potential negative impact on the business, operations, financial results, stock price and prospects of the Company, and (c) the potential adverse effect on the market’s perception of the Company’s prospects if such transactions were delayed or were not consummated;
•
the risk that, while the Merger is expected to be completed, there can be no guarantee that all conditions to the parties’ obligations to complete the Merger will be satisfied, and as a result, it is possible that the Merger may not be completed even if approved by Company stockholders at the Special Meeting;
•
the possible negative effects of the public announcement of the Merger on the Company’s sales, operating results and stock price, its ability to retain key management, sales, engineering and other personnel and its relationships with customers and partners;
•
the significant costs involved in connection with negotiating the Merger Agreement and completing the Merger (including certain costs and expenses if the Merger is not consummated), the substantial management time and effort required to effectuate the Merger and the related disruption to the Company’s day-to-day operations during the pendency of the Merger;
•
that the terms of the Merger Agreement place restrictions on the conduct of the Company’s business prior to completion of the Merger, which may delay or prevent the Company from undertaking business opportunities that may arise pending completion of the Merger, and the resultant risk if the Merger is not consummated;
•
the restrictions imposed by the Merger Agreement on the Company’s solicitation of acquisition proposals from third parties and that potential bidders may perceive Parent’s right under the Merger Agreement to negotiate with the Company to match the terms of any acquisition proposal prior to the Company being able to terminate the Merger Agreement and accept an acquisition proposal to be a deterrent to making alternative proposals, and the possibility that the Company may be obligated to pay Parent the Company Termination Fee of $149,520,000 upon the termination of the Merger Agreement under certain circumstances;
•
the fact that, in certain circumstances, the Company’s remedies are limited to the Parent Termination Fee of $313,992,000, plus Enforcement Costs of up to $7,500,000 and certain Reimbursement Obligations, which may be inadequate to compensate the Company, and that the Company’s right to specific performance of Parent’s obligation to close is conditioned on, among other things, the Debt Financing having been funded or being funded at the Closing;
•
the possible effects of the pendency or consummation of the transactions contemplated by the Merger Agreement, including the potential for suits, actions or proceedings in respect of the Merger Agreement or the Transactions, including the Merger;
50

TABLE OF CONTENTS

•
the fact that the Per Share Price consists of cash and will therefore be taxable to Company stockholders who are subject to taxation for U.S. federal income tax purposes; and
•
the fact that certain directors and executive officers have interests in the Merger that differ from, or are in addition to, those of Company stockholders generally, including (i) the issuance of SPAC Merger Earnout Shares to certain directors and officers of the Company (and/or their affiliates), which is triggered by the Merger as a “Change in Control” under the SPAC Merger Agreement, (ii) the Rollover Agreements entered into by Mr. Ramamurthy, the Company’s Chairman and Chief Executive Officer (and his affiliated entity), and Mr. Welsh, the Company’s President, and (iii) the treatment of equity awards, 2026 annual bonuses and severance and other compensation arrangements, each as described in the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.”
The Transaction Committee also considered a number of factors discussed below relating to the procedural safeguards that it believes were and are present to ensure the fairness of the Merger and to permit the Transaction Committee to effectively represent the best interests of the Company and its stockholders. The Transaction Committee believes these factors support its determination and recommendation and provide assurance of the procedural fairness of the Merger to Company stockholders:
•
that the Transaction Committee consists solely of directors who are disinterested with respect to the Company Earnout Shares and the Rollover Agreements;
•
the power and authority delegated to the Transaction Committee by the Company Board, in accordance with Section 144(a) of the DGCL, with respect to evaluating and determining whether the Merger, including the Per Share Price, is fair to and in the best interests of Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and making a recommendation to the Company Board with respect thereto;
•
the fact that the Company Board resolved that it would not approve a potential sale of the Company without a favorable recommendation by the Transaction Committee, and that the Company Board approved the Merger Agreement only after receiving the Transaction Committee’s unanimous recommendation;
•
the recognition by the Transaction Committee that it had no obligation to recommend the Merger Agreement or any other transaction to the Company Board;
•
that the Transaction Committee met regularly to discuss and evaluate the overall transaction process as well as the Merger, and its members were actively engaged in the process; and
•
that the Transaction Committee made its evaluation with full knowledge of the interests of the holders of Company Earnout Shares and of the Rollover Investors in the Merger.
The foregoing discussion of the information and factors considered by the Transaction Committee is not meant to be exhaustive but addresses the material information and factors considered by the Transaction Committee in consideration of its determination and recommendation. In view of the wide variety of factors considered by the Transaction Committee in connection with its evaluation of the Merger and the complexity of these matters, the Transaction Committee did not find it practicable to, and did not, quantify or otherwise assign relative weights to the specific factors considered in reaching its determination and recommendation. Rather, in considering the information and factors described above, individual members of the Transaction Committee each applied his or her own personal business judgment to the process and may have given differing weights to differing factors. The Transaction Committee based its unanimous recommendation on the totality of the information presented. The explanation of the factors and reasoning set forth above contains forward-looking statements that should be read in conjunction with the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements.”
The Company Board
The Company Board reviewed and considered the proposed Merger in consultation with the Company’s senior management and legal and financial advisors and, based on the information it received and reviewed, including the Transaction Committee’s recommendation, the Company Board unanimously (with respect to all directors present) (i) determined that the terms of the Merger Agreement and the Transactions are fair to, and in the best interests of, the Company and the Company stockholders; (ii) determined that it is in the best interests of the Company and the Company stockholders, and declared it advisable, to enter into the Merger Agreement and consummate the Merger, upon the terms and subject to the conditions set forth therein; (iii) approved the execution and delivery of the Merger Agreement by the
51

TABLE OF CONTENTS

Company, the performance by the Company of its covenants and other obligations thereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth therein; (iv) resolved to recommend that the Company stockholders adopt the Merger Agreement in accordance with the DGCL; and (v) directed that the adoption of the Merger Agreement be submitted for consideration by the Company stockholders at the Special Meeting.
Accordingly, the Company Board recommends that Company stockholders vote “FOR” the Merger Proposal, “FOR” the Advisory Compensation Proposal and “FOR” the Adjournment Proposal.
In deciding to authorize and approve the execution, delivery and performance by the Company of the Merger Agreement, the consummation by the Company of the transactions contemplated by it and the recommendations to Company stockholders set forth above, the Company Board consulted with and received the advice of its legal and financial advisors, discussed certain matters with the Company’s senior management, and considered a variety of factors weighing positively in favor of the Merger, including the following non-exhaustive list of material factors (not necessarily in order of relative importance):
•
the Transaction Committee’s analysis (as to both the substantive and procedural aspects of the Merger), conclusions and determination that the Transactions and the terms and conditions of the Merger, including the Per Share Price payable to Company stockholders, are fair to, and in the best interests of, the Company and the Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and its unanimous recommendation that the Company Board (i) approve, adopt and authorize the Transactions, the Merger Agreement and the transactions contemplated thereby, (ii) direct the Company to enter into and deliver the Merger Agreement and any related documents required to be delivered in connection therewith and (iii) recommend that the Company stockholders vote to adopt the Merger Agreement and approve the Merger, the Merger Agreement and the transactions contemplated thereby, without which the Company Board had resolved it would not approve a potential sale of the Company;
•
the fact that the Per Share Price of $7.75 is all cash, which provides certainty, immediate value and liquidity to Company stockholders (other than the Rollover Investors, with respect to the shares of Company Common Stock to be contributed to Topco pursuant to the Rollover Agreements) upon consummation of the Merger, while eliminating exposure to business and execution risk, compared to continuing to operate the Company as a standalone company;
•
the historical market prices, volatility and trading information with respect to Company Common Stock, including the fact that $7.75 per share to be received by Company stockholders represents a premium of approximately (a) 44% over the unaffected closing price of Company Common Stock of $5.38 on July 9, 2026, the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company, (b) 59% over the unaffected 30-trading day volume-weighted average price of Company Common Stock of $4.87 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company and (c) 48% over the unaffected 90-trading day average price of Company Common Stock of $5.24 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company;
•
the belief that the Per Share Price of $7.75 is more favorable to Company stockholders on a risk-adjusted basis than the potential value that might result from other alternatives reasonably available to the Company, including continuing as an independent public company, based upon the Company Board members’ knowledge of the Company’s business, assets, financial condition and results of operations as well as the industry in which the Company operates, the execution challenges that the Company potentially faces and general market dynamics, and taking into account:
•
the Company’s historical and projected financial performance, including the Projections described in the section of this proxy statement titled “The Merger — Certain Company Management Projections,” and the fact that the full realization of the Projections was subject to significant execution risk;
•
the challenges and risks that the Company has faced, and would likely continue to face, if it remained an independent public company, including, among other things, the need for further proof points for the Company’s AI-led growth, the need to adopt and integrate evolving technologies, including AI, the possibility that advanced driver-assistance systems and other vehicle technology could reduce accident frequency, the Company’s concentration among insurance carrier customers, the competitive landscape, financial and execution risks associated with the Company’s standalone plan, and the potential impact of those factors on the trading price of Company Common Stock (which cannot be quantified numerically);
52

TABLE OF CONTENTS

•
the impact and status of general industry, economic and market conditions and trends relevant to the Company’s business, including information regarding recent AI-related developments affecting software companies more broadly and the potential impact that advancements in AI could have on the Company’s industry and long-term business prospects, and, in light of such conditions and trends, the risks and challenges to value creation associated with continuing to operate the Company as a standalone public company; and
•
the risk that, absent the Merger, the trading price of Company Common Stock would not achieve a value comparable to the Per Share Price within a reasonable timeframe, including due to the potential negative impact of stock market disruptions relating to advancements in AI on the relative trading performance of software businesses or, more generally, recent market volatility;
•
the sale process conducted by the Company, with the assistance of Morgan Stanley and Kirkland, including that the Company (i) discussed possible interest in a potential transaction with 39 potential counterparties (consisting of 31 financial sponsors and 8 strategic parties), of which 22 were contacted by Morgan Stanley at the direction of the Company and 17 contacted the Company or its representatives on an unsolicited basis, and (ii) entered into confidentiality agreements with 22 of those counterparties;
•
the fact that, on July 9, 2026 and again on August 18, 2026 and October 9, 2026, there were published media reports regarding a potential acquisition of the Company, which provided any third party not otherwise contacted by the Company or its representatives an opportunity to put forward a proposal;
•
the increase in Parent’s proposed price from $7.35 per share on September 14, 2026 to $7.55 per share on September 18, 2026 and then to $7.75 per share on October 12, 2026, which Parent stated was its “best and final” proposal;
•
the belief that, in light of the course of negotiations with Parent, $7.75 per share is the highest price that Parent is willing to pay and that the terms of the Merger Agreement include the most favorable terms to the Company, in the aggregate, to which Parent is willing to agree;
•
the oral opinion of Morgan Stanley rendered to the Company Board on October 14, 2026, which was subsequently confirmed by delivery of a written opinion, as to whether, as of its date and subject to the assumptions, limitations, qualifications and other matters stated in it, the Per Share Price to be paid to the holders of Company Common Stock (other than holders of Owned Company Shares, Dissenting Company Shares or Company RSAs) was fair, from a financial point of view, to such holders (see the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor”);
•
the terms and conditions of the Merger Agreement permitting the Company to respond to unsolicited Acquisition Proposals, including permitting the Company to furnish non-public information to, and engage in discussions and negotiations with, a third party that has made an Acquisition Proposal that the Company Board determines in good faith constitutes, or could reasonably be expected to lead to, a Superior Proposal (see the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”), and the ability of the Company Board, under certain circumstances, to make a Company Board Recommendation Change or to terminate the Merger Agreement to enter into a definitive agreement providing for a Superior Proposal, subject to payment of the Company Termination Fee of $149,520,000 (representing approximately 3.0% of the equity value implied by the Per Share Price) (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”);
•
the terms of the Merger Agreement, which were the product of arm’s-length negotiations between the Company and Parent and reflect terms and conditions that are, in the Company Board’s view, advisable and favorable to the Company and Company stockholders, and the likelihood that the Merger would be completed in a timely manner in view of such terms, including:
•
the limited number and nature of the conditions to Parent’s obligation to consummate the Merger, including that the expiration or termination of the waiting period under the HSR Act is the only regulatory approval condition to the Closing;
•
the covenants by the parties to use their respective reasonable best efforts to consummate the Closing, Parent’s commitment, subject to certain limitations, to take all actions necessary to obtain the expiration or termination of the applicable waiting period under the HSR Act prior to the Termination Date (as defined in the section of this proxy statement titled “The Merger Agreement — Termination of the Merger Agreement”),
53

TABLE OF CONTENTS

including agreeing to divestitures and other remedies with respect to the Company and its subsidiaries (but not with respect to Parent’s affiliates or their respective portfolio companies), and the likelihood of obtaining required regulatory approvals prior to the Termination Date;
•
Parent’s and Merger Sub’s representations and covenants contained in the Merger Agreement relating to the Financing, the fact that the Merger is not subject to a financing condition and the Company’s entitlement, under certain circumstances pursuant to the Merger Agreement and the Equity Commitment Letters, to specific performance of Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing pursuant to the Equity Commitment Letters, and, other than with respect to consummation of the Closing, to specific performance to prevent breaches of, and to enforce specifically the terms of, the Merger Agreement (see the section of this proxy statement titled “The Merger — Financing of the Merger”);
•
the requirement that, in certain circumstances, Parent is obligated to pay the Company the Parent Termination Fee of $313,992,000 (representing approximately 6.3% of the equity value implied by the Per Share Price), which is guaranteed, severally and not jointly on a pro rata basis, by the GTCR Funds and the Elliott Funds (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”);
•
the representations, warranties and covenants of the parties, the conditions to the parties’ obligations to complete the Merger and their ability to terminate the Merger Agreement;
•
the fact that the definition of “Company Material Adverse Effect” has a number of customary exceptions; and
•
the fact that the Merger Agreement’s restrictions on the Company’s ability to take certain actions during the pendency of the Merger will not unduly interfere with the Company’s ability to operate its business in the ordinary course between the execution of the Merger Agreement and the consummation of the Merger;
•
the fact that the Merger is subject to the Requisite Stockholder Approval, and that Company stockholders are free to vote for or against the Merger Proposal;
•
the fact that appraisal rights are available to Company stockholders who properly exercise their statutory rights under Section 262 of the DGCL (see the section of this proxy statement titled “Appraisal Rights”); and
•
the procedural fairness of the Merger, including that (i) the Transaction Committee consists solely of directors who are disinterested with respect to the Company Earnout Shares and the Rollover Agreements, (ii) the Transaction Committee was delegated the power and authority of the Company Board, in accordance with Section 144(a) of the DGCL, with respect to evaluating and determining whether the Merger, including the Per Share Price, is fair to and in the best interests of Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and making a recommendation to the Company Board with respect thereto, (iii) the Company Board resolved that it would not approve a potential sale of the Company without a favorable recommendation by the Transaction Committee, (iv) the Transaction Committee recognized that it had no obligation to recommend the Merger Agreement or any other transaction to the Company Board, (v) the Transaction Committee held six meetings to discuss and evaluate the Merger, and its members were actively engaged in the process, and (vi) the Transaction Committee made its evaluation with full knowledge of the interests of the holders of Company Earnout Shares and of the Rollover Investors in the Merger.
The Company Board also considered a number of uncertainties, risks and potentially negative factors in making its determination with respect to the Merger, including the following non-exhaustive list of material factors (not necessarily in order of relative importance):
•
that, following the completion of the Merger, the Company will no longer exist as an independent public company and that the consummation of the Merger and receipt of the Per Share Price, while providing certainty of value, will not allow Company stockholders (other than, indirectly, the Rollover Investors with respect to their equity interests in Topco) to participate in potential further growth in the Company’s assets, future earnings growth or future appreciation in value of Company Common Stock, including the possibility that the trading price or value of Company Common Stock might in the future have exceeded the Per Share Price;
54

TABLE OF CONTENTS

•
the risk that the Transactions, including the Merger, may not be consummated in a timely manner or at all, and the consequences thereof, including (a) the potential loss of value to Company stockholders, (b) the potential negative impact on the business, operations, financial results, stock price and prospects of the Company, and (c) the potential adverse effect on the market’s perception of the Company’s prospects if such transactions were delayed or were not consummated;
•
the risk that, while the Merger is expected to be completed, there can be no guarantee that all conditions to the parties’ obligations to complete the Merger will be satisfied, and as a result, it is possible that the Merger may not be completed even if approved by Company stockholders at the Special Meeting;
•
the possible negative effects of the public announcement of the Merger on the Company’s sales, operating results and stock price, its ability to retain key management, sales, engineering and other personnel and its relationships with customers and partners;
•
the significant costs involved in connection with negotiating the Merger Agreement and completing the Merger (including certain costs and expenses if the Merger is not consummated), the substantial management time and effort required to effectuate the Merger and the related disruption to the Company’s day-to-day operations during the pendency of the Merger;
•
that the terms of the Merger Agreement place restrictions on the conduct of the Company’s business prior to completion of the Merger, which may delay or prevent the Company from undertaking business opportunities that may arise pending completion of the Merger, and the resultant risk if the Merger is not consummated;
•
the restrictions imposed by the Merger Agreement on the Company’s solicitation of acquisition proposals from third parties and that potential bidders may perceive Parent’s right under the Merger Agreement to negotiate with the Company to match the terms of any acquisition proposal prior to the Company being able to terminate the Merger Agreement and accept an acquisition proposal to be a deterrent to making alternative proposals, and the possibility that the Company may be obligated to pay Parent the Company Termination Fee of $149,520,000 upon the termination of the Merger Agreement under certain circumstances;
•
the fact that, in certain circumstances, the Company’s remedies are limited to the Parent Termination Fee of $313,992,000, plus Enforcement Costs of up to $7,500,000 and certain Reimbursement Obligations, which may be inadequate to compensate the Company, and that the Company’s right to specific performance of Parent’s obligation to close is conditioned on, among other things, the Debt Financing having been funded or being funded at the Closing;
•
the possible effects of the pendency or consummation of the transactions contemplated by the Merger Agreement, including the potential for suits, actions or proceedings in respect of the Merger Agreement or the Transactions, including the Merger;
•
the fact that the Per Share Price consists of cash and will therefore be taxable to Company stockholders who are subject to taxation for U.S. federal income tax purposes; and
•
the fact that certain directors and executive officers have interests in the Merger that differ from, or are in addition to, those of Company stockholders generally, including (i) the issuance of SPAC Merger Earnout Shares to certain directors and officers of the Company (and/or their affiliates), which is triggered by the Merger as a “Change in Control” under the SPAC Merger Agreement, (ii) the Rollover Agreements entered into by Mr. Ramamurthy, the Company’s Chairman and Chief Executive Officer (and his affiliated entity), and Mr. Welsh, the Company’s President, and (iii) the treatment of equity awards, 2026 annual bonuses and severance and other compensation arrangements, each as described in the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.”
The foregoing discussion of the information and factors considered by the Company Board is not meant to be exhaustive but addresses the material information and factors considered by the Company Board in consideration of its determination and recommendation. In view of the wide variety of factors considered by the Company Board in connection with its evaluation of the Merger and the complexity of these matters, the Company Board did not find it practicable to, and did not, quantify or otherwise assign relative weights to the specific factors considered in reaching its determination and recommendation. Rather, in considering the information and factors described above, individual members of the Company Board each applied his or her own personal business judgment to the process and may have given differing weights to differing factors. The Company Board based its unanimous (with respect to all directors
55

TABLE OF CONTENTS

present) recommendation on the totality of the information presented. The explanation of the factors and reasoning set forth above contains forward-looking statements that should be read in conjunction with the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements.”
Opinion of the Company Financial Advisor
The Company retained Morgan Stanley to act as financial advisor to the Company Board in connection with a possible sale of the Company. The Company Board selected Morgan Stanley to act as its financial advisor based on Morgan Stanley’s qualifications, expertise and reputation and its knowledge of the Company’s industry, market and regulatory environment and the Company’s business and affairs. Morgan Stanley rendered to the Company Board at its meeting on October 14, 2026, its oral opinion, subsequently confirmed by delivery of a written opinion dated October 14, 2026, that, as of that date, and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of review undertaken by Morgan Stanley as set forth therein, the Per Share Price to be received by the holders of Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to the Merger Agreement was fair from a financial point of view to the holders of shares of Company Common Stock.
The full text of the written opinion of Morgan Stanley, dated October 14, 2026, is attached as Annex B and incorporated by reference into this proxy statement. The opinion sets forth, among other things, the assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of the review undertaken by Morgan Stanley in rendering its opinion. Company stockholders are urged to, and should, read the opinion carefully and in its entirety. Morgan Stanley’s opinion was for the information of the Company Board in its capacity as such and was directed to the Company Board and addressed only the fairness, from a financial point of view, to the holders of shares of Company Common Stock of the Per Share Price to be received by such holders (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to the Merger Agreement as of the date of the opinion. Morgan Stanley’s opinion did not address any other aspect of the Merger Agreement or the transactions contemplated thereby. Morgan Stanley’s opinion did not address the relative merits of the Merger as compared to other business or financial strategies that might be available to the Company, nor did it address the underlying business decision of the Company to enter into the Merger Agreement or proceed with any other transaction contemplated by the Merger Agreement. In addition, Morgan Stanley expressed no opinion or recommendation as to how Company stockholders should vote at the Special Meeting. The summary of Morgan Stanley’s opinion set forth in this proxy statement is qualified in its entirety by reference to the full text of the opinion.
In connection with rendering its opinion, Morgan Stanley, among other things:
1)
Reviewed certain publicly available financial statements and other business and financial information of the Company;
2)
Reviewed certain internal financial statements and other financial and operating data concerning the Company;
3)
Reviewed certain financial projections prepared by the management of the Company;
4)
Discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company;
5)
Reviewed the reported prices and trading activity for Company Common Stock;
6)
Compared the financial performance of the Company and the prices and trading activity of Company Common Stock with that of certain other publicly-traded companies comparable with the Company and their securities;
7)
Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions;
8)
Participated in certain discussions and negotiations among representatives of the Company and Parent and their financial and legal advisors;
9)
Reviewed (a) a draft of the Merger Agreement dated October 14, 2026, (b) the draft equity commitment letters and preferred equity commitment letter from certain investors substantially in the forms of the drafts dated October 14, 2026 and October 12, 2026, respectively, the executed Debt Commitment Letter from certain debt financing sources dated October 12, 2026 (collectively, the documents in this clause (b), the
56

TABLE OF CONTENTS

“Commitment Letters”), and (c) the draft limited guarantees substantially in the form of the drafts dated October 14, 2026, and certain related documents; and
10)
Performed such other analyses and considered such other factors as Morgan Stanley deemed appropriate.
In arriving at its opinion, Morgan Stanley assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to Morgan Stanley by the Company, and that formed a substantial basis for the opinion. With respect to the financial projections, Morgan Stanley assumed that they had been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of the Company of the future financial performance of the Company. In addition, Morgan Stanley assumed that the Merger would be consummated in accordance with the terms set forth in the Merger Agreement without any waiver, amendment or delay of any terms or conditions, including, among other things, that Parent would obtain financing in accordance with the terms set forth in the Commitment Letters and that the definitive Merger Agreement would not differ in any material respect from the draft thereof furnished to Morgan Stanley. Morgan Stanley assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the proposed Merger, no delays, limitations, conditions or restrictions would be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed Merger. Morgan Stanley is not a legal, tax, or regulatory advisor. Morgan Stanley is a financial advisor only and relied upon, without independent verification, the assessment of the Company and its legal, tax, or regulatory advisors with respect to legal, tax, or regulatory matters. Morgan Stanley expressed no opinion with respect to the fairness of the amount or nature of the compensation to any of the Company’s officers, directors or employees, or any class of such persons, relative to the Per Share Price to be received by the holders of shares of Company Common Stock in the transaction. Morgan Stanley did not express any view on, and the opinion did not address, any other term or aspect of the Merger Agreement or the transactions contemplated thereby other than with respect to the fairness, from a financial point of view, of the Per Share Price to be received by the holders of shares of Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) or any term or aspect of any other agreement or instrument contemplated by the Merger Agreement or entered into or amended in connection therewith. The opinion did not address the relative merits of the transactions contemplated by the Merger Agreement as compared to other business or financial strategies that might be available to the Company, nor did it address the underlying business decision of the Company to enter into the Merger Agreement or proceed with any other transaction contemplated by the Merger Agreement. Morgan Stanley did not make any independent valuation or appraisal of the assets or liabilities of the Company, nor was Morgan Stanley furnished with any such valuations or appraisals. Morgan Stanley’s opinion was necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to Morgan Stanley as of, October 14, 2026. Events occurring after such date may affect Morgan Stanley’s opinion and the assumptions used in preparing such opinion, and Morgan Stanley has not assumed any obligation to update, revise or reaffirm its opinion.
Summary of Financial Analyses
The following is a summary of the material analyses performed by Morgan Stanley in connection with its oral opinion and the preparation of its written opinion letter dated October 14, 2026. The following summary is not a complete description of Morgan Stanley’s opinion, or the financial analyses performed and factors considered by Morgan Stanley in connection with its opinion, nor does the order of analyses described represent the relative importance or weight given to those analyses. Some of these summaries of financial analyses include information presented in tabular format. In order to fully understand the financial analyses used by Morgan Stanley, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses.
57

TABLE OF CONTENTS

In performing the financial analyses summarized below and arriving at its opinion, Morgan Stanley utilized and was directed by the Company Board to rely upon, among other matters, (1) the September Projections (including the September Extrapolations) and (2) the average of estimates by equity research analysts as of October 12, 2026 (which we refer to as the “Street Case”). The September Projections are more fully described in the section of this proxy statement titled “The Merger — Certain Company Management Projections.” In accordance with direction from the Company Board, Morgan Stanley utilized the September Projections and Street Case in its financial analyses described below.
Public Trading Comparables Analysis
Morgan Stanley performed a selected public trading comparables analysis, which attempts to provide an implied value of a company by comparing it to similar companies that are publicly traded. Morgan Stanley reviewed and compared certain financial estimates for the Company with comparable publicly available consensus equity analyst research estimates for companies, selected based upon Morgan Stanley’s professional judgment and experience, that share similar business characteristics and have certain comparable operating characteristics, based on Morgan Stanley’s experience and professional judgment, including, among other things, similarly sized revenue and/or revenue growth rates, market capitalizations, profitability, scale and/or other similar operating or business characteristics (which are referred to as the “comparable companies” in this summary of Morgan Stanley’s opinion). The following is the list of the comparable companies:
•
Guidewire Software, Inc.
•
Bentley Systems, Inc.
•
Tyler Technologies, Inc.
•
Verisk Analytics, Inc.
•
Veeva Systems Inc.
•
Copart, Inc.
•
Doximity, Inc.
•
SS&C Technologies Holdings, Inc.
•
Blackbaud, Inc.
•
Salesforce, Inc.
•
Workday, Inc.
•
Adobe Inc.
•
Autodesk, Inc.
•
Trimble Inc.
•
FactSet Research Systems Inc.
•
Dassault Systèmes SE
•
Waystar Holding Corp.
For purposes of this analysis, Morgan Stanley analyzed the following statistics of each of these companies for comparison purposes:
•
the ratio of aggregate value (“AV”), defined as market capitalization plus total debt less cash and cash equivalents, to estimated calendar year 2027 revenues;
•
the ratio of AV to estimated calendar year 2027 unburdened EBITDA (“EBITDA”); and
•
the ratio of AV to estimated calendar year 2027 unburdened unlevered free cash flow (“UFCF”).
Based on the analysis of the relevant metrics for each of the comparable companies, Morgan Stanley selected a representative range of financial multiples of the comparable companies and applied this range of multiples to the relevant Company financial statistic. For purposes of estimated calendar year 2027 revenues, EBITDA and UFCF,
58

TABLE OF CONTENTS

Morgan Stanley calculated a range of estimates using both the September Projections and the Street Case. Based on the Company’s current outstanding shares and options, Morgan Stanley estimated the implied value per share of Company Common Stock as of October 12, 2026 as follows:
 
 
 
 
 
 
 
Calendar Year Financial Statistic
 
 
Comparable Company Multiple
Statistic
 
 
Implied Value Per Share Range for
the Company
Aggregate Value to Estimated 2027 Revenues (Street Case)
 
 
3.5x - 5.5x
 
 
$5.42 - $9.47
Aggregate Value to Estimated 2027 Revenues (September Projections)
 
 
3.5x - 5.5x
 
 
$5.59 - $9.73
Aggregate Value to Estimated 2027 EBITDA (Street Case)
 
 
8.0x - 13.0x
 
 
$5.24 - $9.55
Aggregate Value to Estimated 2027 EBITDA (September Projections)
 
 
8.0x - 13.0x
 
 
$5.57 - $10.07
Aggregate Value to Estimated 2027 UFCF (Street Case)
 
 
12.0x - 18.0x
 
 
$5.33 - $8.82
Aggregate Value to Estimated 2027 UFCF (September Projections)
 
 
12.0x - 18.0x
 
 
$5.63 - $9.27
 
 
 
 
 
 
 
No company utilized in the comparable company analysis is identical to the Company. In evaluating comparable companies, Morgan Stanley made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond the control of the Company, such as the impact of competition on the businesses of the Company and the industry generally, industry growth and the absence of any adverse material change in the financial condition and prospects of the Company or the industry or in the financial markets in general. Mathematical analysis (such as determining the average or median) is not in itself a meaningful method of using comparable company data.
Discounted Equity Value Analysis
Morgan Stanley performed a discounted equity value analysis, which is designed to provide insight into the potential future equity value of a company as a function of the Company’s estimated future earnings. The resulting equity value is subsequently discounted to arrive at an estimate of the implied present value for such company’s potential future equity value.
To calculate the discounted equity values for the Company, Morgan Stanley utilized (i) estimated unburdened EBITDA and (ii) estimated unburdened UFCF, in each case for calendar year 2028 and under both the Street Case and the September Projections. With respect to estimated unburdened EBITDA, based upon the application of its professional judgment and experience, Morgan Stanley applied a range of one-year forward unburdened EBITDA multiples of 8.0x – 13.0x to the Company’s estimated calendar year 2028 unburdened EBITDA under the Street Case and the September Projections. Morgan Stanley adjusted the resulting range of implied future aggregate values for the Company’s net debt to calculate a range of implied future equity values, then divided the range of implied future equity values by the number of estimated fully diluted shares of Company Common Stock as of September 2027 to determine a range of implied future per share equity values. Morgan Stanley then discounted this range of implied future per share equity values for one year to arrive at a present value, at a discount rate of 12.5%, with such discount rate being selected by Morgan Stanley based on the Company’s estimated cost of equity (estimated based on Morgan Stanley’s professional judgment and experience). This analysis indicated a range of implied equity values per share of Company Common Stock of $5.65 to $10.33 under the Street Case and $6.42 to $11.40 under the September Projections.
With respect to estimated unburdened UFCF, based upon the application of its professional judgment and experience, Morgan Stanley applied a range of one-year forward unburdened UFCF multiples of 12.0x – 18.0x to the Company’s estimated calendar year 2028 unburdened UFCF under the Street Case and the September Projections. Morgan Stanley adjusted the resulting range of implied future aggregate values for the Company’s net debt to calculate a range of implied future equity values, then divided the range of implied future equity values by the number of estimated fully diluted shares of Company Common Stock as of September 2027 to determine a range of implied future per share equity values. Morgan Stanley then discounted this range of implied future per share equity values for one year to arrive at a present value, at a discount rate of 12.5%, with such discount rate being selected by Morgan Stanley based
59

TABLE OF CONTENTS

on the Company’s estimated cost of equity (estimated based on Morgan Stanley’s professional judgment and experience). This analysis indicated a range of implied equity values per share of Company Common Stock of $5.72 to $9.50 under the Street Case and $6.60 to $10.82 under the September Projections.
Discounted Cash Flow Analysis
Morgan Stanley performed a discounted cash flow analysis, which is designed to provide an implied value of a company by calculating the present value of the estimated future cash flows and terminal value of such company. Morgan Stanley calculated a range of fully diluted equity values per share for Company Common Stock based on a discounted cash flow analysis to value the Company as a stand-alone public company. Morgan Stanley utilized estimates from the September Projections for purposes of its discounted cash flow analysis, as more fully described below.
Morgan Stanley first calculated the estimated burdened unlevered free cash flow, which is defined as unburdened earnings before interest, taxes, depreciation and amortization, (1) less stock-based compensation expense; (2) less taxes; (3) less capital expenditures; and (4) plus or minus changes in net working capital, for the fourth quarter of calendar year 2026 through calendar year 2035, which estimated burdened unlevered free cash flows were reviewed and approved by the Company’s senior management for Morgan Stanley’s use. To calculate terminal values, Morgan Stanley utilized perpetual growth rates of 1.0% to 3.0% as part of its analyses, with such rates selected upon the application of Morgan Stanley’s professional judgment and experience. The burdened free cash flows and terminal value were then discounted, using a mid-year convention, to present values as of October 12, 2026, at a discount rate ranging from 9.7% to 11.1%, which discount rates were selected upon the application of Morgan Stanley’s professional judgment and experience, to reflect an estimate of the Company’s weighted average cost of capital. The resulting aggregate value was then adjusted to subtract net debt as of September 30, 2026 as provided by the Company’s senior management.
Based on the outstanding shares of Company Common Stock on a fully diluted basis as provided by the Company’s senior management on September 30, 2026, Morgan Stanley calculated the estimated implied value per share of Company Common Stock as follows:
 
 
 
 
Forecast Scenario
 
 
Implied Equity Value Per
Share of the Company
September Projections
 
 
$6.58 - $9.84
 
 
 
 
Selected Precedent Transactions Multiples Analysis
Morgan Stanley performed a selected precedent transactions analysis, which is designed to provide an implied value of a company based on publicly available financial terms for selected transactions. In connection with its analysis, Morgan Stanley compared publicly available statistics for fifteen selected transactions in the software industry since 2015. For purposes of this analysis, Morgan Stanley analyzed the ratio of aggregate value to estimated unburdened EBITDA for the next twelve months (“NTM EBITDA”) of the target company (“AV/NTM EBITDA”) for each selected transaction.
60

TABLE OF CONTENTS

The selected transactions for Morgan Stanley’s analysis, together with their respective multiples, were:
 
 
 
 
 
 
 
Target / Acquiror
 
 
Date Announced
 
 
AV / NTM EBITDA
PowerSchool / Bain Capital
 
 
June 2024
 
 
21.0x
Black Knight / ICE
 
 
March 2023
 
 
19.9x
Dayforce / Thoma Bravo
 
 
August 2025
 
 
18.4x
Cornerstone OnDemand / Clearlake Capital
 
 
August 2021
 
 
18.3x
PTC / Schneider Electric
 
 
October 2026
 
 
18.1x
McAfee / Advent, Permira, Crosspoint
 
 
November 2021
 
 
17.5x
Avast / NortonLifeLock
 
 
August 2021
 
 
17.2x
Citrix / Vista Equity Partners (TIBCO), Evergreen (Elliott)
 
 
January 2022
 
 
16.2x
Informatica / Salesforce
 
 
May 2025
 
 
15.1x
Solera / Vista Equity Partners
 
 
September 2015
 
 
13.3x
CDK / Brookfield
 
 
April 2022
 
 
12.0x
SolarWinds / Turn/River Capital
 
 
February 2025
 
 
11.6x
CA Technologies / Broadcom
 
 
July 2018
 
 
10.8x
LogMeIn / Francisco Partners; Evergreen (Elliott)
 
 
December 2019
 
 
10.6x
Dun & Bradstreet / Clearlake Capital
 
 
March 2025
 
 
8.0x
 
 
 
 
 
 
 
Based on its experience and professional judgment and taking into consideration the relevant multiples from the selected transactions, Morgan Stanley applied a range of AV/NTM EBITDA multiples of 9.0x to 15.0x to the Company’s estimated unburdened NTM EBITDA under the Street Case. Based on this analysis and the number of fully diluted shares of Company Common Stock, as estimated and provided by the senior management of the Company as of September 30, 2026, Morgan Stanley calculated an estimated range of implied values per share of Company Common Stock of $5.98 to $11.06.
No company or transaction utilized in the precedent transactions analysis is identical to the Company or the Merger. In evaluating the precedent transactions, Morgan Stanley made numerous judgments and assumptions with regard to general business, market and financial conditions, and other matters, which are beyond the control of the Company, such as the impact of competition on the business of the Company or the industry generally, industry growth and the absence of any adverse material change in the financial condition of the Company or the industry or in the financial markets in general, which could affect the public trading value of the companies and the aggregate value of the transactions to which they are being compared.
Other Information
Morgan Stanley observed additional factors that were not considered as part of Morgan Stanley’s financial analyses with respect to its opinion, but which were noted as reference data for the Company Board, including the following information described in the sections titled “Precedent Transactions – Premia Paid Analysis,” “Analysts’ Price Targets” and “Historical Trading Range.”
Precedent Transactions – Premia Paid Analysis
For reference only, and not as a component of its fairness analysis, Morgan Stanley considered, based on publicly available transaction information, transactions involving businesses Morgan Stanley judged to be sufficiently analogous to the Company’s business. For these transactions, Morgan Stanley noted the percentage premia paid over unaffected stock price. Based on its analysis of the premia for these transactions and the application of its professional judgment and experience, Morgan Stanley selected a range of premia to unaffected stock price of 20% to 60%. Morgan Stanley applied this range to (i) the Company’s closing stock price of $5.38 on July 9, 2026 (the last trading day prior to media speculation regarding a potential sale of the Company) and (ii) the Company’s 30-day unaffected volume weighted average stock price of $4.87 for the period ending on July 9, 2026 (the last trading day prior to media speculation regarding a potential sale of the Company), which resulted in implied price ranges per share of Company Common Stock of $6.46 to $8.61 and $5.85 to $7.79, respectively. Morgan Stanley noted that the premia paid analysis was presented merely for reference and informational purposes only and not as a component of its fairness analysis.
No company or transaction utilized in the premia paid analysis is identical to the Company or the Merger. In evaluating the precedent transactions, Morgan Stanley made numerous assumptions with respect to industry
61

TABLE OF CONTENTS

performance, general business, regulatory, economic, market and financial conditions and other matters, which are beyond the Company’s control. These include, among other things, the impact of competition on the Company’s business and the industry generally, industry growth and the absence of any adverse material change in the financial condition and prospects of the Company and the industry, and in the financial markets in general, any or all of which could affect the public trading value of the companies and the transaction value and fully diluted equity value of the transactions to which the Merger is being compared.
Analysts’ Price Targets
For reference only, and not as a component of its fairness analysis, Morgan Stanley reviewed and analyzed future public market trading price targets for Company Common Stock that were prepared and published by equity research analysts as of October 12, 2026. These price targets reflect each analyst’s estimate of the future public market trading price of Company Common Stock. The range of undiscounted analyst price targets was $6.50 to $10.00 per share of Company Common Stock.
In order to better compare the equity analysts’ future stock price targets with the Per Share Price, based on its professional judgment and experience, Morgan Stanley discounted each analyst’s price target for one year using a discount rate of 12.5%, which rate was selected by Morgan Stanley based on Morgan Stanley’s estimate of the Company’s cost of equity. This analysis resulted in a discounted analyst price target range of $5.78 to $8.89 per share of Company Common Stock.
Morgan Stanley compared each of the foregoing to the Per Share Price.
The public market trading price targets published by securities research analysts do not necessarily reflect current market trading prices for Company Common Stock and these estimates are subject to uncertainties, including the future financial performance of the Company and future financial market conditions.
Historical Trading Range
For reference only, and not as a component of its fairness analysis, Morgan Stanley reviewed the historical trading data of Company Common Stock for each of the (i) 30-day, (ii) 90-day and (iii) 52-week periods ending on July 9, 2026 (the last trading day prior to media speculation regarding a potential sale of the Company). Morgan Stanley noted that the highest closing trading price of Company Common Stock for each such period was, respectively, (i) $5.69, (ii) $6.26 and (iii) $10.03, and the lowest closing trading price of Company Common Stock for each such period was, respectively, (i) $4.29, (ii) $4.22 and (iii) $4.22. Morgan Stanley compared these ranges to the Per Share Price.
General
In connection with the review of the Merger by the Company Board, Morgan Stanley performed a variety of financial and comparative analyses for purposes of rendering its opinion. The preparation of a financial opinion is a complex process and is not necessarily susceptible to a partial analysis or summary description. In arriving at its opinion, Morgan Stanley considered the results of all of its analyses as a whole and did not attribute any particular weight to any analysis or factor it considered. Morgan Stanley believes that selecting any portion of its analyses, without considering all analyses as a whole, would create an incomplete view of the process underlying its analyses and opinion. In addition, Morgan Stanley may have given various analyses and factors more or less weight than other analyses and factors, and may have deemed various assumptions more or less probable than other assumptions. As a result, the ranges of valuations resulting from any particular analysis described above should not be taken to be Morgan Stanley’s view of the actual value of the Company.
In performing its analyses, Morgan Stanley made numerous assumptions with respect to industry performance, general business, regulatory, economic, market and financial conditions, and other matters. Many of these assumptions are beyond the control of the Company. Any estimates contained in Morgan Stanley’s analyses are not necessarily indicative of future results or actual values, which may be significantly more or less favorable than those suggested by such estimates.
Morgan Stanley conducted the analyses described above solely as part of its analysis of the fairness from a financial point of view of the Per Share Price to be received by the holders of shares of Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to the Merger Agreement and in connection with the delivery of its opinion dated as of October 14, 2026, to the Company Board. These analyses do not purport to be appraisals or to reflect the prices at which shares of Company Common Stock might actually trade.
62

TABLE OF CONTENTS

The Per Share Price was determined through arm’s-length negotiations between the Company and Parent and was approved by the Company Board. Morgan Stanley provided advice to the Company Board during these negotiations. Morgan Stanley did not, however, recommend any specific merger consideration to the Company or that any specific merger consideration constituted the only appropriate merger consideration for the proposed Merger.
Morgan Stanley’s opinion and its presentation to the Company Board was one of many factors taken into consideration by the Company Board in deciding to approve and adopt the Merger Agreement. Consequently, the analyses as described above should not be viewed as determinative of the opinion of the Company Board with respect to the merger consideration or of whether the Company Board would have been willing to agree to a different merger consideration.
The Company Board selected Morgan Stanley based upon Morgan Stanley’s qualifications, experience and expertise. Morgan Stanley is a global financial services firm engaged in the securities, investment management and individual wealth management businesses. Its securities business is engaged in securities underwriting, trading, hedging and brokerage activities, foreign exchange, commodities and derivatives trading, prime brokerage, as well as providing investment banking, financing and financial advisory services. Morgan Stanley, its affiliates, directors and officers may at any time invest on a principal basis or manage funds that invest, hold long or short positions, finance positions, and may trade or otherwise structure and effect transactions, for their own account or the accounts of its customers, in debt or equity securities or loans of the Company, or any other company, or any currency or commodity, or instrument that may be involved in this transaction, or any related derivative instrument.
Under the terms of its engagement letter, Morgan Stanley acted as financial advisor to the Company Board and provided a financial opinion in connection with the Merger, and the Company agreed to pay Morgan Stanley a fee of $5.0 million (the “Opinion Fee”), which became payable in connection with the delivery of Morgan Stanley’s opinion, and a transaction fee of approximately $65 million against which the Opinion Fee paid will be offset, to the extent not previously offset, which is contingent upon consummation of the Merger. The Company has also agreed to reimburse Morgan Stanley for its expenses incurred in performing its services. In addition, the Company has agreed to indemnify Morgan Stanley and its affiliates, its and their respective officers, directors, employees and agents and each other entity or person, if any, controlling Morgan Stanley or any of its affiliates against certain losses, claims, damages, liabilities and expenses related to, arising out of or in connection with Morgan Stanley’s engagement, including certain liabilities under the federal securities laws. Morgan Stanley’s opinion was approved by a committee of Morgan Stanley investment banking and other professionals in accordance with its customary practice.
In the two years prior to the date of Morgan Stanley’s opinion, Morgan Stanley has provided financial advisory services for the Company and has received aggregate fees of less than $2,000,000 in connection with such services. In the two years prior to the date of Morgan Stanley’s opinion, Morgan Stanley has provided financial advisory and financing services for GTCR (which Morgan Stanley understands ultimately holds a significant equity ownership interest in Parent) and certain of its affiliates and their affiliated funds’ respective majority-controlled portfolio companies (collectively, the “GTCR Related Entities”) and has received fees between $85,000,000 and $115,000,000 in connection with such services. In the two years prior to the date of Morgan Stanley’s opinion, Morgan Stanley has not provided financial advisory or financing services for Elliott or certain controlled affiliates of Elliott (collectively, the “Elliott Related Entities”), nor has Morgan Stanley received fees in connection with such services. In addition, as of the date of Morgan Stanley’s opinion, Morgan Stanley or an affiliate thereof is a lender to the Company, GTCR and certain GTCR Related Entities, and certain entities over which Elliott may have significant influence, with respect to revolving credit facilities. As of October 14, 2026, so far as Morgan Stanley was aware, Morgan Stanley and/or its affiliates held an aggregate interest of (x) between 3% and 4% in Company Common Stock, (y) between 3% and 4% in the common stock of GTCR and certain GTCR Related Entities and (z) less than 1% in the common stock of Elliott and certain Elliott Related Entities, which interests were held in connection with Morgan Stanley’s and/or its affiliates’ investment management business, wealth management business, including client discretionary accounts, or ordinary course trading activities, including hedging activities. Morgan Stanley may also seek to provide financial advisory and financing services to Parent, GTCR, the GTCR Related Entities, Elliott, the Elliott Related Entities and the Company and their respective affiliates in the future unrelated to the Merger and would expect to receive fees for the rendering of these services. In addition, Morgan Stanley, its affiliates, directors or officers, including individuals working with the Company in connection with this transaction, may have committed and may commit in the future to invest in private equity funds managed by the controlling sponsor of Parent.
63

TABLE OF CONTENTS

Certain Company Management Projections
The Company does not, as a matter of course, publicly disclose long-term forecasts or internal projections as to its future performance, revenue, earnings or other results given, among other reasons, the uncertainty, unpredictability and subjectivity of the underlying assumptions and estimates, including the difficulty of predicting general economic and market conditions, though the Company has in the past provided investors with financial guidance covering certain operating measures and expenses, which it may update from time to time during the relevant year.
In connection with the evaluation of the Merger, the Company’s senior management prepared unaudited, non-public prospective financial projections for the Company on a stand-alone basis, without giving effect to the Transactions, for the fiscal years 2026 through 2030 (the “May Management Case”). In addition, Morgan Stanley worked with the Company’s senior management to prepare extrapolations of the May Management Case for fiscal years 2031 through 2035 (the “May Extrapolations”), which, together with the May Management Case, we refer to as the “May Projections.” The May Management Case was reviewed and discussed with the Company Board in May 2026 and approved by the Company Board for use by Morgan Stanley, and the May Extrapolations were reviewed and discussed with the Company’s senior management in July 2026 and approved by the Company’s senior management for use by Morgan Stanley, and the May Management Case was shared with GTCR on June 19, 2026 and with Elliott on July 7, 2026. Subsequently, in September 2026 the Company’s senior management updated the May Projections for fiscal year 2026 to reflect the Company’s actual results for the second quarter of its fiscal year 2026 and senior management’s then-current estimates of the Company’s expected results for the third and fourth quarters of its fiscal year 2026 (the “September Management Case”). Morgan Stanley prepared updated extrapolations of the September Management Case based on assumptions consistent with the assumptions underlying the May Extrapolations (the “September Extrapolations”, which together with the September Management Case, we refer to as the “September Projections”). The September Projections were reviewed and discussed with the Company Board in September 2026 and approved by the Company Board for use by Morgan Stanley, and the September Management Case was shared with Parent on September 11, 2026. We refer to the May Projections and the September Projections, collectively, as the “Projections” and the May Extrapolations and September Extrapolations, collectively, as the “Extrapolations.” As directed by the Company Board, Morgan Stanley used the September Projections in connection with its opinion to the Company Board and financial analyses performed in preparing such opinion, as described under the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor.”
The Projections were prepared by the Company’s senior management on a stand-alone basis without giving effect to the Transactions or any changes to the Company’s operations, capital structure or strategy that may be implemented after the consummation of the Transactions or to any costs incurred in connection with the Transactions. Furthermore, the Projections do not take into account the effect of any failure of the Transactions (including the Merger) to be completed and should not be viewed as accurate or continuing in that context.
The tables below present summaries of the Projections prepared by the Company’s senior management and provided by senior management to the Company Board in advance of being used by Morgan Stanley and, other than the Extrapolations, being made available to Parent. The summary of the Projections is included in this proxy statement solely to give Company stockholders access to the Projections that were made available to the Company Board, and Morgan Stanley and, other than the Extrapolations, Parent and is not being included in this proxy statement to influence a Company stockholder’s decision whether to vote to adopt the Merger Agreement or for any other purpose. The inclusion of this information should not be regarded as an indication that the Company Board or the Company’s senior management or financial advisors, or any other person, considered, or now considers, such Projections to be material or to be necessarily predictive of actual future results, and these Projections should not be relied upon as such.
64

TABLE OF CONTENTS

May Projections
The May Projections (including the May Extrapolations) are summarized below:
 
 
 
 
Management Case
 
 
Extrapolations
($ in millions)
 
 
2026E
 
 
2027E
 
 
2028E
 
 
2029E
 
 
2030E
 
 
2031E
 
 
2032E
 
 
2033E
 
 
2034E
 
 
2035E
Total Revenue
 
 
$1,162
 
 
$1,295
 
 
$1,441
 
 
$1,604
 
 
$1,780
 
 
$1,947
 
 
$2,099
 
 
$2,229
 
 
$2,331
 
 
$2,401
Unburdened EBITDA(1)
 
 
$488
 
 
$564
 
 
$650
 
 
$748
 
 
$857
 
 
$945
 
 
$1,026
 
 
$1,098
 
 
$1,157
 
 
$1,201
Stock-Based Compensation
 
 
($139)
 
 
($117)
 
 
($130)
 
 
($144)
 
 
($160)
 
 
($163)
 
 
($166)
 
 
($169)
 
 
($172)
 
 
($175)
Burdened EBITDA(2)
 
 
$348
 
 
$448
 
 
$520
 
 
$603
 
 
$697
 
 
$782
 
 
$860
 
 
$929
 
 
$985
 
 
$1,026
Burdened EBIT(3)
 
 
$286
 
 
$375
 
 
$446
 
 
$529
 
 
$619
 
 
$696
 
 
$767
 
 
$830
 
 
$881
 
 
$918
Taxes
 
 
($74)
 
 
($97)
 
 
($116)
 
 
($137)
 
 
($161)
 
 
($181)
 
 
($199)
 
 
($216)
 
 
($229)
 
 
($239)
Depreciation and Amortization
 
 
$63
 
 
$73
 
 
$74
 
 
$75
 
 
$78
 
 
$86
 
 
$93
 
 
$99
 
 
$104
 
 
$108
Capital Expenditures (including Capitalized Software)
 
 
($73)
 
 
($75)
 
 
($76)
 
 
($77)
 
 
($80)
 
 
($87)
 
 
($94)
 
 
($100)
 
 
($105)
 
 
($108)
Change in Net Working Capital
 
 
($9)
 
 
($12)
 
 
($15)
 
 
($16)
 
 
($17)
 
 
($16)
 
 
($14)
 
 
($12)
 
 
($10)
 
 
($7)
Burdened Unlevered Free Cash Flow(4)
 
 
$191
 
 
$263
 
 
$313
 
 
$374
 
 
$439
 
 
$497
 
 
$552
 
 
$601
 
 
$642
 
 
$673
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
“Unburdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization.
(2)
“Burdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization, burdened by stock-based compensation.
(3)
“Burdened EBIT” is a non-GAAP measure calculated as earnings before interest and taxes, burdened by stock-based compensation.
(4)
“Burdened Unlevered Free Cash Flow” is a non-GAAP measure calculated as Burdened EBITDA minus taxes, minus capital expenditures (including capitalized software), and minus changes in net working capital.
September Projections
The September Projections (including the September Extrapolations) are summarized below:
 
 
 
 
Management Case
 
 
Extrapolations
($ in millions)
 
 
2026E
 
 
2027E
 
 
2028E
 
 
2029E
 
 
2030E
 
 
2031E
 
 
2032E
 
 
2033E
 
 
2034E
 
 
2035E
Total Revenue
 
 
$1,162
 
 
$1,295
 
 
$1,441
 
 
$1,604
 
 
$1,780
 
 
$1,947
 
 
$2,098
 
 
$2,228
 
 
$2,330
 
 
$2,400
Unburdened EBITDA(1)
 
 
$494
 
 
$564
 
 
$650
 
 
$748
 
 
$857
 
 
$944
 
 
$1,026
 
 
$1,097
 
 
$1,156
 
 
$1,200
Stock-Based Compensation
 
 
($131)
 
 
($117)
 
 
($130)
 
 
($144)
 
 
($160)
 
 
($163)
 
 
($166)
 
 
($169)
 
 
($172)
 
 
($175)
Burdened EBITDA(2)
 
 
$363
 
 
$448
 
 
$520
 
 
$604
 
 
$697
 
 
$781
 
 
$860
 
 
$928
 
 
$984
 
 
$1,025
Burdened EBIT(3)
 
 
$302
 
 
$375
 
 
$446
 
 
$529
 
 
$619
 
 
$696
 
 
$767
 
 
$829
 
 
$880
 
 
$917
Taxes
 
 
($79)
 
 
($97)
 
 
($116)
 
 
($138)
 
 
($161)
 
 
($181)
 
 
($199)
 
 
($216)
 
 
($229)
 
 
($238)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
65

TABLE OF CONTENTS

 
 
 
 
Management Case
 
 
Extrapolations
($ in millions)
 
 
2026E
 
 
2027E
 
 
2028E
 
 
2029E
 
 
2030E
 
 
2031E
 
 
2032E
 
 
2033E
 
 
2034E
 
 
2035E
Depreciation and Amortization
 
 
$61
 
 
$73
 
 
$74
 
 
$75
 
 
$78
 
 
$86
 
 
$93
 
 
$99
 
 
$104
 
 
$108
Capital Expenditures (including Capitalized Software)
 
 
($75)
 
 
($75)
 
 
($76)
 
 
($77)
 
 
($80)
 
 
($87)
 
 
($94)
 
 
($100)
 
 
($105)
 
 
($108)
Change in Net Working Capital
 
 
($9)
 
 
($12)
 
 
($15)
 
 
($16)
 
 
($17)
 
 
($16)
 
 
($14)
 
 
($12)
 
 
($10)
 
 
($7)
Burdened Unlevered Free Cash Flow(4)
 
 
$200
 
 
$263
 
 
$313
 
 
$374
 
 
$439
 
 
$497
 
 
$552
 
 
$600
 
 
$641
 
 
$672
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
“Unburdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization.
(2)
“Burdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization, burdened by stock-based compensation.
(3)
“Burdened EBIT” is a non-GAAP measure calculated as earnings before interest and taxes, burdened by stock-based compensation.
(4)
“Burdened Unlevered Free Cash Flow” is a non-GAAP measure calculated as Burdened EBITDA minus taxes, minus capital expenditures (including capitalized software), and minus changes in net working capital.
Additional Information About the Projections
The Projections were generated solely for internal use and not developed with a view toward public disclosure or with a view toward complying with the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial data or published guidelines of the SEC regarding forward-looking statements or U.S. generally accepted accounting principles (“GAAP”). The Projections are forward-looking statements.
The Projections were prepared by the Company’s senior management based on estimates they reasonably believed to be achievable. However, the information set forth in the Projections is not factual and should not be relied upon as being necessarily indicative of actual future results. The assumptions and estimates underlying the Projections, all of which are difficult to predict and many of which are beyond the control of the Company, may not be realized. There can be no assurance that the forecasted results or underlying assumptions will be realized, and actual results likely will differ, and may differ materially, from those reflected in the Projections, whether or not the Merger is completed. In addition, the Projections may be affected by the Company’s ability to achieve strategic goals, objectives and targets over the applicable period. Neither the Company nor any of its affiliates assumes any responsibility to Company stockholders for the accuracy of this information.
The Projections are subject to estimates and assumptions in many respects and, as a result, subject to interpretation. The Projections summarized in this section, while presented with numerical specificity, were based on numerous assumptions and estimates that necessarily involve judgments with respect to the Company’s business, financial condition and results of operations, industry performance, general business, economic, market and financial conditions and other matters, all of which are difficult or impossible to predict and many of which are beyond the Company’s control. Important factors that may affect actual results and the achievability of the Projections include, but are not limited to: general economic conditions and disruptions in the financial, debt, capital, credit or securities markets; industry and market dynamics; competition; fluctuations in currency exchange rates; changes in applicable laws; and those risks and uncertainties described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. See also the section of this proxy statement titled “Cautionary Statement Regarding Forward-Looking Statements.” The Projections also reflect assumptions as to certain business decisions that are subject to change. There can be no assurance that the Projections will be realized, and actual results will likely differ, and may differ materially, from those shown. Generally, the further out the period to which the Projections relate (including the periods covered by the Extrapolations), the less predictive the information becomes.
66

TABLE OF CONTENTS

In preparing and approving the Projections, the Company’s senior management utilized the following material assumptions. The Company’s senior management, using its business judgment, believed in good faith that these assumptions were reasonable:
•
Consolidated revenue growth at a compound annual growth rate of approximately 11% from fiscal year 2025 through fiscal year 2030, driven by (i) growth in the Company’s insurance business reflecting increased adoption of AI-enabled solutions among existing customers, including broader deployment of Intelligent Estimating, First Look and Intelligent Reinspection solutions, together with modest growth in core Auto Physical Damage solutions; (ii) additional insurance revenue growth from (a) the expansion of EvolutionIQ’s solutions through new customer additions and cross-selling opportunities within the Company’s existing insurance customer base; and (b) increased adoption of the Company’s casualty and subrogation solutions; and (iii) growth in the Company’s automotive business driven by new repair facility customers, increased upsell of packaged solutions and adoption of add-on solutions, and increased growth in the expansion of the supplier networks;
•
Gross profit and Burdened EBITDA margin expansion reflecting anticipated operating leverage as revenue grows, with operating expenses declining as a percentage of revenue while maintaining continued investment in product development;
•
Stock-based compensation expense declining as a percentage of revenue, reaching approximately $160 million in fiscal year 2030;
•
A tax rate of 26% (including federal, state and local taxes) throughout the periods covered by the Projections; and
•
Growth in Burdened Unlevered Free Cash Flow reflecting anticipated improvements in operating profitability.
The Projections contain non-GAAP financial measures including Unburdened EBITDA, Burdened EBITDA, Burdened EBIT and Burdened Unlevered Free Cash Flow. The Company’s senior management included such measures in the Projections because it believed that such measures may be useful in evaluating, on a prospective basis, the potential operating performance and cash flow of the Company. A material limitation associated with the use of the above non-GAAP financial measures is that they have no standardized measurement prescribed by GAAP and may not be comparable with similar non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in accordance with GAAP. Unburdened EBITDA, Burdened EBITDA, Burdened EBIT and Burdened Unlevered Free Cash Flow should not be considered as an alternative to operating income or net income as a measure of operating performance or operating cash flow or as a measure of liquidity. The SEC rules that would otherwise require a reconciliation of an adjusted financial measure to a GAAP financial measure do not apply to adjusted financial measures provided to a board of directors, senior management or a financial advisor in connection with a proposed business combination such as the Merger if the disclosure is included in a document such as this proxy statement. In addition, reconciliations of adjusted financial measures were not relied upon by the Company Board or the Company’s senior management or financial advisors in connection with their evaluation of the Merger. Accordingly, the Company has not provided a reconciliation of the adjusted financial measures included in the Projections to the relevant GAAP financial measures.
No independent registered public accounting firm provided any assistance in preparing the Projections. Accordingly, no independent registered public accounting firm has examined, compiled, or otherwise performed any procedures with respect to the Projections or expressed any opinion or given any other form of assurance with respect thereto, and they assume no responsibility for the information contained in the Projections. The Deloitte & Touche LLP reports included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, relate solely to the historical financial information of the Company and to an assessment of the Company’s internal controls over financial reporting. Such reports do not extend to the Projections and should not be read to do so.
The Projections summarized in this section were prepared prior to the execution of the Merger Agreement and have not been updated to reflect any changes after the date they were prepared. The Projections summarized in this section are based solely on information available to the Company’s senior management at the time of their preparation and have not been updated or revised to reflect information or results after the date they were prepared or as of the date of this proxy statement. The Company undertakes no obligation, except as required by law, to update or otherwise revise the
67

TABLE OF CONTENTS

Projections to reflect circumstances existing since their preparation or to reflect the occurrence of unanticipated events, even in the event that any or all of the underlying assumptions are shown to be in error or to not be appropriate, or to reflect changes in general economic or industry conditions.
By including the Projections in this proxy statement, neither the Company nor any of its affiliates, advisors, officers, directors, or representatives has made or makes any representation to any security holder (or any other person or entity) regarding the information included in the Projections or the ultimate performance of the Company, Parent, the surviving corporation or any of their affiliates compared to the information contained in the Projections. The Company has made no representation to Parent or Merger Sub, in the Merger Agreement or otherwise, concerning the Projections.
In light of the foregoing factors and the uncertainties inherent in the Projections, Company stockholders are cautioned not to place undue, if any, reliance on the Projections.
THE COMPANY DOES NOT INTEND TO UPDATE OR OTHERWISE REVISE THE ABOVE PROJECTIONS TO REFLECT CIRCUMSTANCES EXISTING AFTER THE DATE WHEN MADE OR TO REFLECT THE OCCURRENCE OF FUTURE EVENTS, EVEN IN THE EVENT THAT ANY OR ALL OF THE ASSUMPTIONS UNDERLYING SUCH PROJECTIONS ARE NO LONGER APPROPRIATE, EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.
Certain Effects of the Merger
If the Merger Proposal is approved and the other conditions to the Closing are either satisfied or waived, Merger Sub will be merged with and into the Company upon the terms set forth in the Merger Agreement. As the surviving corporation in the Merger, the Company will continue to exist following the Merger as a wholly owned subsidiary of Parent.
Following the Closing, all shares of Company Common Stock will be beneficially owned by Parent and except as otherwise expressly agreed to in writing prior to the Effective Time by Parent and a Company stockholder, none of the current Company stockholders will have any direct or indirect ownership interest in, or be a stockholder of, the Company, the surviving corporation or Parent after the Closing.
At the Effective Time, and without any action by any Company stockholder, each share of Company Common Stock (including, for the avoidance of doubt, the SPAC Merger Earnout Shares and the Sponsor Earnout Shares) that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company Shares, Dissenting Company Shares and Company RSAs) will be automatically cancelled, extinguished and converted into the right to receive the Per Share Price. See the section of this proxy statement titled “The Merger Agreement — Consideration to Be Received in the Merger.”
Company Options. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will, automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Per Share Price over the exercise price per share of such Company Option. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof.
Vested Company RSAs. At the Effective Time, each Vested Company RSA will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the Per Share Price.
Unvested Company RSAs. At the Effective Time, each Unvested Company RSA will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time, except as described below.
Vested Company RSUs. At the Effective Time, each Vested Company RSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to
68

TABLE OF CONTENTS

receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.
Unvested Company RSUs. At the Effective Time, each Unvested Company RSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company RSUs and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time, except as described below.
Vested Company PSUs. At the Effective Time, each Vested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU.
Unvested Company PSUs. At the Effective Time, each Unvested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (a) actual performance achieved through the Effective Time and (b) target-level performance, in accordance with the terms of such Unvested Company PSU, and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time, except as described below.
Restricted Cash Awards. All amounts payable in respect of the Restricted Cash Awards will be subject to any required withholding of taxes and will be paid, without interest, no later than the second regularly scheduled payroll date following the date on which the applicable portion of such award vests; provided that, if a holder of a Restricted Cash Award (i)(a) incurs a termination of employment or service without cause, (b) resigns for good reason, or (c) incurs a termination of employment or service due to death or disability, in each case, within 24 months following the Effective Time, or (ii) incurs a “good leaver” termination at any time following the Effective Time, any then-unvested portion of such Restricted Cash Award will vest in full upon such termination and will be paid within 60 days following the date of such termination, subject to any required withholding of taxes.
Effects on the Company if the Merger Is Not Completed
If the Merger Proposal is not approved by the Company stockholders, or if the Merger is not completed for any other reason, the Company stockholders will not receive any payment for their shares of Company Common Stock in connection with the Merger. Instead, the Company will remain an independent public company, Company Common Stock will continue to be registered under the Exchange Act and listed and traded on Nasdaq, and the Company will continue to file periodic and other reports with the SEC with respect to Company Common Stock. The Company stockholders will continue to own their shares and remain subject to the same general risks and opportunities as they currently are with respect to ownership of shares of Company Common Stock.
If the Merger is not completed, there is no assurance as to the effect of these risks and opportunities on the future value of your shares of Company Common Stock, including the risk that the market price of Company Common Stock may decline to the extent that the current market price of Company Common Stock reflects a market assumption that the Merger will be completed. If the Merger is not completed, there is no assurance that any other transaction acceptable to the Company will be offered or that the business, operations, financial condition, earnings or prospects of the Company will not be adversely affected. Pursuant to the Merger Agreement, under certain circumstances, the Company is permitted to terminate the Merger Agreement in order to enter into an alternative transaction and may be obligated to pay to Parent the Company Termination Fee. Further, under certain circumstances, Parent may be obligated to pay the Company the Parent Termination Fee. See the section of this proxy statement titled “The Merger Agreement — Termination of the Merger Agreement.”
69

TABLE OF CONTENTS

Financing of the Merger
Equity Financing
The Guarantors have committed, on a several and not joint basis, under executed equity commitment letters dated October 14, 2026 (in the case of that certain equity commitment letter delivered by the GTCR Funds, as amended on November 20, 2026) (the “Equity Commitment Letters”) to invest in Parent, directly or indirectly, up to an aggregate of $3,478,500,000 (referred to as “Equity Financing”), subject to the terms and conditions of those letters.
Funding of the Equity Financing is subject to the terms and conditions set forth in the applicable Equity Commitment Letters, including the satisfaction or waiver of the conditions to Parent’s and Merger Sub’s obligations to effect the Closing and concurrent funding arrangements described in those letters. The Merger is not subject to a financing condition.
The Equity Commitment Letters terminate in accordance with their terms, including upon the Closing or valid termination of the Merger Agreement, subject to certain express survival or enforcement provisions.
The Company is an express third-party beneficiary of the Equity Commitment Letters and is entitled to enforce specific provisions thereunder in accordance with the terms of such letters and the Company’s specific performance rights under the Merger Agreement.
Debt Financing
In connection with the execution of the Merger Agreement, Merger Sub entered into a debt commitment letter dated October 14, 2026, which was amended and restated by the Debt Commitment Letter dated as of October 28, 2026, with the Debt Financing Sources providing for commitments by such Debt Financing Sources, subject to the terms and conditions set forth in the Debt Commitment Letter, to provide, in connection with the Merger, (i) a senior secured first lien term loan facility in an aggregate principal amount of $1,750,000,000 (the “First Lien Term Facility”), (ii) a senior secured first lien revolving credit facility in an aggregate principal amount of $325,000,000 (the “Revolving Facility” and, together with the First Lien Term Facility, the “First Lien Facilities”) and (iii) a senior secured bridge facility in an aggregate principal amount of up to $1,100,000,000, on the terms and subject to the conditions set forth in the Debt Commitment Letter (the “Bridge Facility” and the Bridge Facility together with the First Lien Facilities, the “Debt Facilities”).
The borrower under the Debt Facilities will initially be Merger Sub and, immediately following the consummation of the Merger, the Company (collectively, in such capacities, the “Borrower”). On or prior to the Closing Date, the Borrower may issue Rule 144A-for-life senior secured notes generating up to $1.1 billion in gross proceeds (the “Notes”) in lieu of all or a portion of the Bridge Facility, and the amount of the Bridge Facility will be reduced by the gross proceeds of any Notes available on the Closing Date.
On the Closing Date, the proceeds of the First Lien Term Facility and the Bridge Facility (or the Notes issued in lieu thereof), together with the proceeds of any borrowings under the Revolving Facility funded on the Closing Date, the equity contribution and cash on hand, will be used to fund the Transactions, to repay in full the obligations outstanding under that certain Credit Agreement, dated as of September 21, 2021, by and among, inter alios, the Company, as borrower, Cypress Intermediate Holdings II, LLC, as holdings, Bank of America, N.A., as administrative agent, and the lenders from time to time party thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Existing Credit Agreement”), to pay fees, costs and expenses incurred in connection with the Transactions, and for working capital and general corporate purposes. On the Closing Date, borrowings under the Revolving Facility to pay Transaction costs may not exceed $50 million, with additional amounts available on the Closing Date to replace, backstop or cash collateralize existing letters of credit, for working capital and to fund any original issue discount or upfront fees resulting from the exercise of “market flex” provisions.
The availability of the Debt Facilities on the Closing Date is subject solely to the satisfaction (or waiver by the commitment parties party to the Debt Commitment Letter) of a limited number of conditions, including the following: (i) since the date of the Merger Agreement, no Company Material Adverse Effect shall have occurred, (ii) consummation of the Merger promptly following the initial borrowing under the Debt Facilities in all material respects in accordance with the Merger Agreement (subject to customary limitations on amendments, modifications or waivers of the Merger Agreement), (iii) the making of the equity contribution substantially concurrently with the initial funding of the Debt Facilities, (iv) the repayment in full of the Existing Credit Agreement, termination of all commitments thereunder and release of related liens and guarantees prior to or substantially concurrently with the Closing, (v) receipt of specified audited and unaudited financial statements of the Company and a pro forma balance
70

TABLE OF CONTENTS

sheet, (vi) solely with respect to the Bridge Facility, receipt by the investment banks engaged to place the Notes of a customary preliminary offering memorandum for the Notes and the expiration of a marketing period of at least 10 consecutive business days, (vii) execution and delivery of definitive loan documentation consistent with the Debt Commitment Letter and receipt of customary legal opinions, secretary’s certificates, evidence of authorization and a solvency certificate, (viii) execution and delivery of all documents required to create and perfect the security interests in the collateral, subject to certain limitations, (ix) delivery, at least three business days prior to the Closing Date, of documentation and other information required under applicable “know your customer,” anti-money laundering and beneficial ownership rules and regulations to the extent requested at least ten business days prior to the Closing Date, (x) payment of all fees and expenses required to be paid on the Closing Date pursuant to the Debt Commitment Letter and related fee letter and (xi) the accuracy in all material respects of certain specified representations set forth in the Merger Agreement, but only to the extent that the breach of such representations would give Merger Sub (or its affiliates) the right to terminate its obligations under the Merger Agreement or decline to consummate the Merger, and the accuracy in all material respects of certain specified representations to be set forth in the definitive loan documentation.
The commitments of the Debt Financing Sources under the Debt Commitment Letter will terminate on the earliest of (a) the date that is five (5) business days after the Termination Date, (b) (x) with respect to the First Lien Facilities, the initial funding under the First Lien Term Facility and (y) with respect to the Bridge Facility, the initial funding thereunder (or, to the extent of the gross proceeds thereof, the issuance of the Notes or certain demand securities), (c) the termination of the Merger Agreement by Merger Sub or with its written consent without the funding of the Debt Facilities and (d) the consummation of the Merger with or without the funding of the Debt Facilities.
The Company has agreed to provide, and to cause its subsidiaries and representatives to provide, certain customary cooperation in connection with the Debt Financing. For more information, see the section of this proxy statement titled “The Merger Agreement — Financing Cooperation.”
Guarantee
In connection with the execution of the Merger Agreement, each Guarantor delivered a limited guarantee dated October 14, 2026 (the “Limited Guarantees”) in favor of the Company. The Limited Guarantees cover, severally and not jointly and subject to their terms and applicable caps, Parent’s obligation to pay the Parent Termination Fee, specified reimbursement obligations and Enforcement Costs (the “Guaranteed Obligations”). The aggregate liability under the Limited Guarantee provided by the GTCR Funds is capped at $264,310,020 and the aggregate liability under the Limited Guarantee provided by the Elliott Funds is capped at $58,181,980. In addition, Enforcement Costs are capped at $7,500,000 in the aggregate.
Each Limited Guarantee is a payment guarantee and not a guarantee of collection, and is subject to the applicable cap and other limitations in the applicable Limited Guarantee and the Merger Agreement. Each Limited Guarantee will terminate upon the earliest to occur of (a) the consummation of the Closing in accordance with the terms of the Merger Agreement, (b) receipt by the Company of the indefeasible payment in full in cash of the Guaranteed Obligations payable under such Limited Guarantee (subject to the cap under such Limited Guarantee), (c) the valid termination of the Merger Agreement in accordance with its terms (if, and only if, at such time, Parent has no liability for any Guaranteed Obligation in accordance with the terms of the Merger Agreement), (d) the valid termination of the other Limited Guarantee in accordance with its terms and (e) the date that is ninety (90) days following the valid termination of the Merger Agreement in accordance with its terms in circumstances where Parent may have liability for the Guaranteed Obligations if the Company has not, prior to such date, asserted a claim for payment of any Guaranteed Obligation to Parent or the Guarantors, provided that if such claim for payment is brought prior to the date of valid termination of the Merger Agreement, such Limited Guarantee will not terminate until the earlier of (i) final resolution of such claim by a final non-appealable order of a court of competent jurisdiction and payment of the Guaranteed Obligations (subject to the cap under such Limited Guarantee), if applicable (or the date of such final resolution if the Guaranteed Obligations are determined by such court not to be payable), (ii) a written agreement signed by the parties thereto terminating such Limited Guarantee or (iii) payment in full of the Guaranteed Obligations due and owing (or alleged to be due and owing) by or on behalf of Parent or the Guarantors in cash.
Interests of the Company’s Directors and Executive Officers in the Merger
In considering the recommendations of the Company Board with respect to the Merger, Company stockholders should be aware that the Company’s directors and executive officers have certain interests, including financial interests, in the Merger that may be different from, or in addition to, the interests of Company stockholders generally. The
71

TABLE OF CONTENTS

Company Board and the Transaction Committee were aware of these interests and considered them, among other matters, in making their respective determinations: in the case of the Transaction Committee, to recommend the Merger to the Company Board, and in the case of the Company Board, to approve the Merger Agreement and to recommend that Company stockholders adopt the Merger Agreement. See the section of this proxy statement titled “— Background of the Merger” and the section of this proxy statement titled “— Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board.” These interests are described in more detail below, and certain of them are quantified in the narrative and the tables below.
The Company’s executive officers who are named executive officers for purposes of the discussion below are Githesh Ramamurthy (Chairman of the Board and Chief Executive Officer), Timothy A. Welsh (President and EVP of Customer Solutions & Operations), Brian Herb (Former Executive Vice President, Chief Financial and Administrative Officer), Mary Jo Prigge (Former EVP and Chief Service Delivery Officer) and John Goodson (Former EVP and Chief Product & Technology Officer). The Company’s executive officers who are not named executive officers for purposes of the discussion below are Joshua Valdez (Senior Vice President, Chief Product Officer and Interim Chief Technology Officer), Rodney Christo (Senior Vice President, Finance, Interim Chief Financial Officer and Chief Accounting Officer), and Marc Fredman (Former Senior Vice President, Chief Strategy Officer). In accordance with SEC rules, this discussion is required to cover former executive officers and directors of the Company who served as executive officers or directors of the Company at any time since January 1, 2025, which includes Mr. Herb, Ms. Prigge, Mr. Goodson and Mr. Fredman (each, a former executive officer) and Lauren Young (former director).
Treatment of the Company’s Equity Awards
Company Options. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will, automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Per Share Price over the exercise price per share of such Company Option. At the Effective Time, each Company Option that is outstanding as of immediately prior to the Effective Time with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof.
Vested Company RSAs. At the Effective Time, each Company RSA that vests in accordance with its terms as a result of the consummation of the Merger (each, a “Vested Company RSA”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the Per Share Price.
Unvested Company RSAs. At the Effective Time, each Unvested Company RSA will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSA Restricted Cash Award”), with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time, except as described below.
Vested Company RSUs. At the Effective Time, each Company RSU that is outstanding and vested as of immediately prior to the Effective Time or that vests in accordance with its terms as a result of the consummation of the Merger (each, a “Vested Company RSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.
Unvested Company RSUs. At the Effective Time, each Unvested Company RSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company RSUs and (ii) the Per Share Price,
72

TABLE OF CONTENTS

with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSU Restricted Cash Award”), with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time, except as described below.
Vested Company PSUs. At the Effective Time, each Company PSU for which the applicable performance conditions have been satisfied as of immediately prior to the Effective Time (a “Vested Company PSU”) will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest and subject to applicable withholding taxes, equal to the product of (i) the Per Share Price and (ii) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU.
Unvested Company PSUs. At the Effective Time, each Unvested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive a restricted cash award representing the right to receive an amount in cash equal to the product of (i) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (a) actual performance achieved through the Effective Time and (b) target-level performance, in accordance with the terms of such Unvested Company PSU and (ii) the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company PSU Restricted Cash Award” and, together with the Company RSA Restricted Cash Award and the Company RSU Restricted Cash Award, the “Restricted Cash Awards”), with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time, except as described below.
Restricted Cash Awards. All amounts payable in respect of the Company RSA Restricted Cash Awards, the Company RSU Restricted Cash Awards, and the Company PSU Restricted Cash Awards will be subject to any required withholding of taxes and will be paid, without interest, no later than the second regularly scheduled payroll date following the date on which the applicable portion of such award vests; provided that, if a holder of a Restricted Cash Award (i)(a) incurs a termination of employment or service without cause, (b) resigns for good reason, or (c) incurs a termination of employment or service due to death or disability, in each case, within 24 months following the Effective Time, or (ii) incurs a “good leaver” termination at any time following the Effective Time, any then-unvested portion of such Restricted Cash Award will vest in full upon such termination and will be paid within 60 days following the date of such termination, subject to any required withholding of taxes.
Quantification of Equity Award Payments. For an estimate of the amounts that would be payable to each of the Company’s named executive officers on settlement of their unvested Company equity awards, see the section of this proxy statement titled “— Quantification of Payments and Benefits” below. The estimated amount that would be payable to Messrs. Valdez, Christo and Fredman in settlement of their Unvested Company RSUs and Unvested Company PSUs if the Effective Time occurred on November 17, 2026 (the assumed date of the Effective Time solely for purposes of this disclosure) is $5,731,520 (assuming for this purpose that Unvested Company PSUs vest based on target level of performance). The estimated aggregate amount that would be payable to the seven non-employee directors of the Company for their Unvested Company RSUs if the Effective Time occurred on November 17, 2026 (the assumed date of the Effective Time solely for purposes of this disclosure) is $2,688,630.
SPAC Merger Earnout Shares
The Merger constitutes a “Change of Control” under the SPAC Merger Agreement. Immediately prior to the Effective Time, the Company will issue a number of shares of Company Common Stock comprising the maximum number of SPAC Merger Earnout Shares issuable in connection with the SPAC Merger Agreement to the persons entitled thereto, in accordance with the terms of the SPAC Merger Agreement. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder of shares thereof, all shares of Company Common Stock issued pursuant to the immediately preceding sentence will be cancelled and converted into the right to receive the Per Share Price in accordance with the Merger Agreement, without interest thereon and subject to any applicable tax withholdings. See the section of this proxy statement titled “The Merger Agreement — Consideration to Be Received in the Merger.” As of the date of this proxy statement, certain members of the Company Board and executive officers of the Company, and certain of their respective current and former affiliates,
73

TABLE OF CONTENTS

are entitled to receive SPAC Merger Earnout Shares pursuant to the SPAC Merger Agreement, and cash upon the conversion of such SPAC Merger Earnout Shares. The SPAC Merger Earnout Shares to be issued immediately prior to the consummation of the Merger are not outstanding as of the Record Date and therefore the holders of the SPAC Merger Earnout Shares will not be entitled to vote the SPAC Merger Earnout Shares on the proposals at the Special Meeting, including the Merger Proposal.
The following table sets forth the number of unissued SPAC Merger Earnout Shares to be issued to the Company’s directors, executive officers and their respective affiliates immediately prior to the consummation of the Merger and the aggregate Per Share Price to be received with respect thereto, in each case as if the Effective Time occurred on November 17, 2026:
 
 
 
 
 
 
 
 
 
 
SPAC Merger
Earnout Shares
 
 
Value of SPAC Merger
Earnout Shares ($)
Executive Officers
 
 
 
 
 
 
Githesh Ramamurthy
 
 
1,298,389
 
 
10,062,515
Tim Welsh
 
 
—
 
 
 
Rodney Christo
 
 
21,647
 
 
167,764
Joshua Valdez
 
 
—
 
 
—
Brian Herb
 
 
9,064
 
 
70,246
Mary Jo Prigge
 
 
22,707
 
 
175,979
John Goodson
 
 
—
 
 
—
Marc Fredman
 
 
75,404
 
 
584,381
Non-Employee Directors
 
 
 
 
 
 
Eric Wei(1)
 
 
9,919,012
 
 
76,872,343
William Ingram
 
 
7,698
 
 
59,660
Teri Williams
 
 
7,698
 
 
59,660
Eileen Schloss
 
 
7,698
 
 
59,660
Barak Eilam
 
 
—
 
 
—
John Schweitzer
 
 
—
 
 
—
Neil de Crescenzo
 
 
—
 
 
—
Lauren Young(1)(2)
 
 
9,919,012
 
 
76,872,343
 
 
 
 
 
 
 
(1)
The SPAC Merger Earnout Shares set forth in the table are held of record by Cypress Investor Holdings, L.P. (“Cypress Investor”), GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Advent International GPE VIII-C Limited Partnership (“Advent International VIII-C”). Based on the Company’s records and a Schedule 13D/A filed with the SEC on August 7, 2025, (a) Cypress Investment GP, LLC (“Cypress GP”) is the general partner of Cypress Investor, Advent International, L.P. (“Advent”) is the managing member of Cypress GP and Advent International GP, LLC (“Advent GP LLC”) is the general partner of Advent, (b) GPE VIII GP S.a.r.l (“Advent GP Luxembourg”) is the general partner of Advent International VIII-C, Advent International GPE VIII, LLC (“Advent VIII GP”) is the manager of Advent GP Luxembourg and Advent is the manager of Advent VIII GP and (c) GPE VIII GP Limited Partnership (“Advent GP Cayman”) is the general partner of GPE VIII CCC Co-Investment, Advent VIII GP is the general partner of Advent GP Cayman and Advent is the manager of Advent VIII GP. Mr. Wei is a Managing Partner of Advent and may have limited partner or other interests in one or more of the entities described herein. Ms. Young is a Managing Director of Advent and may have limited partner or other interests in one or more of the entities described herein.
(2)
The SPAC Merger Earnout Shares and related value reported for Ms. Young are the same SPAC Merger Earnout Shares and related value reported for Mr. Wei, which are held of record by the Advent entities described in footnote (1), and are not in addition to them.
2026 Annual Bonuses
Pursuant to the Merger Agreement, with respect to each annual cash incentive compensation plan or arrangement of the Company as in effect as of the date of the Merger Agreement and set forth in the confidential disclosure letter, Parent will, or will cause its affiliates (including the surviving corporation and any of its subsidiaries) to, for the 2026 calendar year, continue each such plan following the Closing in good faith and in the ordinary course of business substantially consistent with the Company’s or its applicable subsidiary’s past practice. Each individual who is an employee of the Company or any of its subsidiaries immediately prior to the Effective Time and continues to be an employee of Parent or one of its subsidiaries (including the surviving corporation) immediately following the Effective Time (each, a “Continuing Employee”) will be paid an annual bonus under such plans based on actual performance for the full 2026 calendar year, calculated in a manner consistent with the Company’s or its applicable subsidiary’s past practice prior to the Closing. Such annual bonuses will be paid at substantially the same time as annual bonuses have historically been paid by the Company or its applicable subsidiaries, but in no event later than March 15, 2027.
74

TABLE OF CONTENTS

Employment Agreements with Named Executive Officers
Each of Mr. Ramamurthy and Mr. Welsh is party to an employment agreement with the Company that provides for severance payments and benefits if the named executive officer’s employment is terminated by the Company without “cause” or by the named executive officer for “good reason” (each as defined in the applicable employment agreement), as summarized below. Brian Herb, Mary Jo Prigge and John Goodson were also each party to an employment agreement with the Company, but ceased to be employed by the Company on May 25, 2026, June 6, 2025 and October 10, 2025, respectively, and do not have any severance entitlements (outstanding or otherwise).
Githesh Ramamurthy. Under his employment agreement with the Company, dated April 27, 2017 (the “Ramamurthy Employment Agreement”), upon a qualifying termination, Mr. Ramamurthy is eligible to receive (i) 24 monthly cash severance payments, each equal to one-twelfth of the sum of his annual base salary and target annual cash bonus in effect at the time of his termination, (ii) a lump sum cash payment equal to a pro rata portion of the annual cash bonus, if any, that he would have earned for the year of termination had he remained employed through the bonus payment date, payable in accordance with the Company’s standard policies, and (iii) subsidized COBRA premiums for up to 24 months. These payments and benefits are subject to his timely execution and non-revocation of a general release of claims and continued compliance with his restrictive covenants, including 24-month post-employment noncompetition and employee and business non-solicitation covenants, a perpetual confidentiality covenant and an intellectual property assignment covenant. In addition, under his employment agreement with the Company, Mr. Ramamurthy is entitled to payment of his annual bonus with respect to any fiscal year of the Company, if any, subject only to his continued employment through the end of such fiscal year.
Timothy Welsh. Under his employment agreement with the Company, dated February 22, 2025, upon a qualifying termination, Mr. Welsh is eligible to receive (i) 12 monthly cash severance payments, each equal to one-twelfth of his annual base salary in effect at the time of his termination, (ii) a lump sum cash payment equal to the annual performance-based cash bonus, if any, that he would have earned for the year of termination based on actual performance had he remained employed through the bonus payment date, payable when annual bonuses are generally paid to similarly situated employees (but no later than March 15 of the following year), and (iii) subsidized COBRA premiums for up to 12 months. These payments and benefits are subject to his timely execution and non-revocation of a general release of claims and continued compliance with his restrictive covenants, including 12-month post-employment noncompetition and employee and business non-solicitation covenants, a perpetual confidentiality covenant and an intellectual property assignment covenant. In addition, under his employment agreement with the Company, Mr. Welsh is entitled to payment of his annual bonus with respect to any fiscal year of the Company, if any, subject only to his continued employment through the end of such fiscal year.
For an estimate of the value of the payments and benefits described above that would be payable to the Company’s named executive officers upon a qualifying termination, see “— Quantification of Payments and Benefits” below.
Arrangements with Parent
Except for the Rollover Agreements described in the section immediately below, as of the date of this proxy statement, none of the Company’s executive officers has had any discussions or negotiations, or entered into any agreement, with Parent or any of its affiliates regarding the potential terms of their individual employment arrangements or the right to purchase or participate in the equity of Parent or one or more of its affiliates following the Closing. Prior to or following the Closing, however, certain executive officers may have discussions, or may enter into agreements with, Parent, the Company, or their respective affiliates regarding employment with, or the right to purchase or participate in the equity of, Parent or one or more of its affiliates.
Rollover Agreements
Concurrently with the execution of the Merger Agreement, on October 14, 2026, Mr. Ramamurthy and Mr. Welsh (referred to as the “Rollover Investors”) each entered into a Rollover Agreement with Topco. Mr. Ramamurthy has agreed to roll over shares of Company Common Stock held by him (or his affiliate) that have an aggregate value equal to $75,000,000, and Mr. Welsh has agreed to roll over 50% of his pre-tax proceeds from the transaction. Each Rollover Investor, subject to the terms and conditions of the Rollover Agreements, will contribute such specified shares of Company Common Stock held by such Rollover Investor to Topco immediately prior to the Effective Time in exchange for equity interests of Topco. In addition, until the earliest of the termination of the Merger Agreement, the Effective Time or mutual written consent, each Rollover Investor has agreed to vote all shares of Company Common Stock held by such Rollover Investor in favor of the adoption of the Merger Agreement and against any Acquisition Proposal and
75

TABLE OF CONTENTS

certain other actions that would reasonably be expected to impede or delay the Merger. The Rollover Agreements will terminate automatically if the Merger Agreement is terminated.
Other Compensation Actions
In addition to the payments and benefits above, under the terms of the Merger Agreement, the Company may take certain compensation actions prior to the completion of the Merger that will affect the Company’s directors and executive officers, although determinations related to such actions have not been made as of the date of this proxy statement and the impact of such actions is not reflected in the amounts estimated below. Under the Merger Agreement, the Company may take certain actions before the Effective Time to mitigate the amount of potential “excess parachute payments” for “disqualified individuals” (each as defined in Section 280G of the Code), including the executive officers. As of the date of this proxy statement, the Company has not approved any specific actions to mitigate any impact of Section 280G of the Code on the Company or any disqualified individuals. In no event will any action include any obligation by the Company, Parent or any of their respective affiliates to indemnify any person against any taxes that may be imposed under Section 4999 of the Code.
Indemnification of Directors and Officers and Insurance
Pursuant to the terms of the Merger Agreement, the Company’s directors and executive officers will be entitled to certain ongoing indemnification and coverage under directors’ and officers’ liability insurance policies. See the section of this proxy statement titled “The Merger Agreement — Indemnification of Directors and Officers and Insurance.”
Quantification of Payments and Benefits
The table below sets forth the amount of payments and benefits that each of the Company’s named executive officers would receive in connection with the Merger, assuming the Merger were completed and each such named executive officer experienced a qualifying termination on November 17, 2026, which is the assumed date of the effective time of the Merger solely for purposes of the disclosure. The amounts below are determined using the Per Share Price of $7.75, and are based on multiple assumptions that may or may not actually occur or be accurate on the relevant date, including the assumptions described in the footnotes to the table and the assumptions that no named executive officer will receive any additional, or forfeit any, equity or equity-based awards prior to the Effective Time and the named executive officers’ base salaries and target annual bonus opportunities will remain unchanged from those in place as of November 17, 2026, the assumed date of the effective time of the Merger solely for purposes of the disclosure. Further, the table below assumes no reduction in payments or benefits for purposes of the excise tax under Section 4999 of the Code. As a result of the foregoing assumptions, the actual amounts, if any, to be received by a named executive officer may materially differ from the amounts set forth below.
 
 
 
 
 
 
 
 
 
 
Named Executive Officer
 
 
Cash
($)(1)
 
 
Equity
($)(2)
 
 
Total
($)
Githesh Ramamurthy
 
 
1,930,837
 
 
—
 
 
1,930,837
Timothy A. Welsh
 
 
1,043,498
 
 
9,026,487
 
 
10,069,985
Brian Herb
 
 
—
 
 
—
 
 
—
Mary Jo Prigge
 
 
—
 
 
490,513
 
 
490,513
John Goodson
 
 
—
 
 
—
 
 
—
 
 
 
 
 
 
 
 
 
 
(1)
Cash. For Mr. Ramamurthy, consists of (i) continued monthly payments, for 24 months, each equal to one-twelfth of the sum of his annual base salary and target annual bonus (which is currently 0% of his annual base salary); (ii) a lump sum cash payment equal to a pro rata portion of the annual performance-based cash bonus he would have earned for the year of termination, shown in the table above at target level; and (iii) a cash payment equal to the portion of the monthly COBRA premium for continued health coverage that the Company pays for active employees, for 24 months, regardless of whether Mr. Ramamurthy is legally entitled to COBRA benefits during such period. For Mr. Welsh, consists of (i) continued payment of his annual base salary for 12 months; (ii) a lump sum cash payment equal to the annual performance-based cash bonus, if any, that he would have earned for the year of termination based on actual performance had he remained employed through the bonus payment date, shown in the table above at target level; and (iii) a cash payment equal to the monthly COBRA premium for continued health coverage for 12 months, regardless of whether Mr. Welsh is legally entitled to COBRA benefits during such period. These severance payments are not “single-trigger” or “double-trigger” arrangements. They would be payable on a qualifying termination of employment whether or not in connection with the Merger. Brian Herb, Mary Jo Prigge and John Goodson were named executive officers for fiscal year 2025, but each ceased to be employed by the Company on May 25, 2026, June 6, 2025 and October 10, 2025, respectively, and thus no longer have any severance entitlements. Set forth below are the separate values of each of the severance payments.
76

TABLE OF CONTENTS

 
 
 
 
 
 
 
 
 
 
 
 
 
Named Executive Officer
 
 
Severance
($)
 
 
Prorated
Bonus
($)
 
 
COBRA
Payment
($)
 
 
Total
($)
Githesh Ramamurthy
 
 
1,900,000
 
 
—
 
 
30,837
 
 
1,930,837
Timothy A. Welsh
 
 
725,000
 
 
317,808
 
 
690
 
 
1,043,498
Brian Herb
 
 
—
 
 
—
 
 
—
 
 
—
Mary Jo Prigge
 
 
—
 
 
—
 
 
—
 
 
—
John Goodson
 
 
—
 
 
—
 
 
—
 
 
—
 
 
 
 
 
 
 
 
 
 
 
 
 
(2)
Equity. Consists of the value of the named executive officer’s Unvested Company RSUs and Unvested Company PSUs, which will be converted at the Effective Time into Company RSU Restricted Cash Awards and Company PSU Restricted Cash Awards, respectively, and which would vest on a qualifying termination of employment following the Effective Time. Amounts are calculated by multiplying the number of shares of Company Common Stock subject to each award by the Per Share Price of $7.75. For the Unvested Company PSUs, the number of shares is determined based on target performance. For Mr. Welsh, this accelerated vesting is a “double-trigger” benefit: it applies only if the named executive officer has a qualifying termination of employment following the Effective Time, as described under “— Treatment of the Company’s Equity Awards” above. Messrs. Ramamurthy, Herb, and Goodson do not hold any Unvested Company PSUs. In connection with Ms. Prigge’s termination of employment, her outstanding Unvested Company PSUs were amended to provide that, in consideration of her executing, and not revoking, a release of claims, the Unvested Company PSUs would remain outstanding and eligible to vest in accordance with the terms of the applicable agreement governing the Unvested Company PSUs, irrespective of her termination of employment. The table below excludes any amounts associated with Company RSUs or Company PSUs that are scheduled to vest in accordance with their terms on or prior to November 17, 2026, the assumed date of the effective time of the Merger solely for purposes of the disclosure, irrespective of the Merger. None of the Company Options held by any named executive officers are unvested as of the date of this proxy statement; accordingly, no amounts are reflected in the table below with respect to Company Options.
 
 
 
 
 
 
 
 
 
 
Named Executive Officer
 
 
Company RSUs
($)
 
 
Company PSUs
($)
 
 
Total
($)
Githesh Ramamurthy
 
 
—
 
 
—
 
 
—
Timothy A. Welsh
 
 
4,192,471
 
 
4,834,016
 
 
9,026,487
Brian Herb
 
 
—
 
 
—
 
 
—
Mary Jo Prigge
 
 
—
 
 
490,513
 
 
490,513
John Goodson
 
 
—
 
 
—
 
 
—
 
 
 
 
 
 
 
 
 
 
Material U.S. Federal Income Tax Considerations
The following discussion summarizes certain material U.S. federal income tax considerations applicable to Company stockholders who receive cash in exchange for shares of Company Common Stock pursuant to the Merger. This discussion is for general informational purposes only and does not purport to be a complete analysis of all potential tax consequences of the Merger. This discussion is based upon the provisions of the Code, the U.S. Treasury Regulations promulgated thereunder and judicial decisions and administrative rulings, all as in effect as of the date of this proxy statement and all of which are subject to change or varying interpretation, possibly with retroactive effect. Any such change or differing interpretation could affect the accuracy of the statements set forth herein. The U.S. federal income tax laws are complex and subject to varying interpretation. We have not sought, and do not intend to seek, any ruling from the IRS regarding any of the tax issues discussed herein. There can be no assurance that the IRS will not challenge one or more of the tax consequences of the Merger described in this proxy statement.
This discussion assumes that Company stockholders hold their shares as “capital assets” within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion is general in nature and does not address all aspects of U.S. federal income taxation that may be relevant to a particular holder of Company Common Stock in light of such holder’s individual circumstances, nor does it address U.S. state or local, non-U.S., or estate or gift taxes, the alternative minimum tax, the Medicare tax on net investment income or any other aspect of any U.S. federal tax other than U.S. federal income tax. This discussion also does not address tax considerations that may be relevant to Company stockholders subject to special treatment under the U.S. federal income tax laws, such as, but not limited to, banks or other financial institutions, brokers or dealers in securities or currencies, mutual funds, partnerships or other entities or arrangements classified as partnerships for U.S. federal income tax purposes or other pass-through entities and their partners or members, subchapter S corporations, tax-exempt organizations, any holder who actually or constructively owns more than 5% (by vote or value) of the outstanding Company Common Stock (other than as described herein), a holder who holds their shares of Company Common Stock as “qualified small business stock” for purposes of Sections 1045 and 1202 of the Code or as “Section 1244” stock within the meaning of Section 1244 of the Code, governmental organizations, retirement or other tax-deferred accounts, insurance companies, traders in securities who elect mark-to-market method of accounting, controlled foreign corporations, passive foreign investment companies, persons purchasing or selling Company Common Stock as part of a wash sale for tax purposes, corporations that accumulate earnings to avoid U.S. federal income tax, U.S. expatriates and former citizens or long-term residents of the United States, persons subject to base erosion and anti-abuse tax under Section 59A of the Code, holders who
77

TABLE OF CONTENTS

acquired their Company Common Stock through the exercise of Company Options or otherwise in connection with the performance of services, holders who hold their Company Common Stock as part of a hedge, straddle, constructive sale, conversion or other integrated transaction, U.S. holders (as defined below) whose functional currency is not the U.S. dollar, U.S. holders that hold Company Common Stock through non-U.S. brokers or other non-U.S. intermediaries, real estate investment trusts, regulated investment companies, entities subject to the U.S. anti-inversion rules, persons that are required to recognize income for tax purposes no later than the time when such income is taken into account in applicable financial statements (within the meaning of Section 451 of the Code), persons who own (directly, indirectly or constructively) an equity interest in Parent or the surviving corporation and holders who exercise appraisal rights in connection with the Merger under the DGCL.
If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Company Common Stock, the tax treatment of a partner in such partnership will generally depend on the status of the partner and activities of the partner and the partnership. If you are a partnership holding Company Common Stock or a partner of a partnership holding Company Common Stock, you are urged to consult your own tax advisor regarding the U.S. federal income tax consequences of the Merger relevant to you.
This discussion is for informational purposes only and is not tax advice. Company stockholders are urged to consult their tax advisors with respect to the U.S. federal income tax consequences of the Merger to them in light of their particular circumstances, as well as any tax consequences of the Merger arising under the U.S. federal tax laws other than those pertaining to income tax, including estate or gift tax laws, “golden parachute” rules, or under any state, local or non-U.S. tax laws or under any applicable income tax treaty.
U.S. Holders
For purposes of this discussion, the term “U.S. holder” means a beneficial owner of Company Common Stock that, for U.S. federal income tax purposes, is:
•
an individual who is a citizen or resident of the United States;
•
a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any State thereof or the District of Columbia;
•
a trust if (a) its administration is subject to the primary supervision of a court within the United States and one or more United States persons as described in Section 7701(a)(30) of the Code have the authority to control all substantial decisions of the trust or (b) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person (within the meaning of the Code); and
•
an estate, the income of which is subject to U.S. federal income tax regardless of its source.
The receipt of cash in exchange for shares of Company Common Stock pursuant to the Merger will generally be a taxable transaction for U.S. federal income tax purposes. A U.S. holder will generally recognize gain or loss for U.S. federal income tax purposes equal to the difference, if any, between the amount of cash received pursuant to the Merger (determined before the deduction of any applicable withholding taxes) and such U.S. holder’s adjusted tax basis in the shares of Company Common Stock exchanged for cash pursuant to the Merger. A U.S. holder’s adjusted tax basis in a share of Company Common Stock will generally be equal to the amount the U.S. holder paid for such share of Company Common Stock. Such gain or loss will generally be capital gain or loss and will be long-term capital gain or loss if the U.S. holder’s holding period for such shares of Company Common Stock exceeds one year as of the Closing Date. Long-term capital gains for certain non-corporate U.S. holders, including individuals, are generally eligible for a reduced rate of federal income taxation. Short-term capital gains are taxed at ordinary income rates. The deductibility of capital losses is subject to limitations. If a U.S. holder acquired different blocks of Company Common Stock (i.e., Company Common Stock not acquired at the same time and at the same price in a single transaction), such holder must determine its adjusted tax basis and holding period separately with respect to each block of Company Common Stock. U.S. holders who own separate blocks of Company Common Stock should consult their own tax advisors with respect to these rules.
A U.S. holder may, unless an exception applies, be subject to information reporting and backup withholding (currently at a rate of 24%) with respect to the cash received pursuant to the Merger. Backup withholding generally will not apply to a U.S. holder that provides its correct taxpayer identification number (referred to as the “TIN”) on IRS Form W-9 (or if appropriate, a substitute or successor form) and certifies under penalties of perjury that such U.S. holder is a United States person, that such TIN is correct and that such U.S. holder is not subject to backup withholding. Backup
78

TABLE OF CONTENTS

withholding is not an additional tax. Rather, any amounts withheld under the backup withholding rules may be refunded or credited against a U.S. holder’s U.S. federal income tax liability, if any, provided that such U.S. holder furnishes the required information to the IRS in a timely manner and other requirements are satisfied.
Non-U.S. Holders
For purposes of this discussion, a “non-U.S. holder” means a beneficial owner of Company Common Stock that is neither a U.S. holder nor an entity treated as a partnership for U.S. federal income tax purposes.
Any gain recognized on the receipt of cash pursuant to the Merger by a non-U.S. holder will generally not be subject to U.S. federal income tax unless:
•
the gain is effectively connected with the conduct of a U.S. trade or business of such non-U.S. holder (and, if required by an applicable income tax treaty, is also attributable to a permanent establishment or, in the case of an individual, a fixed base in the United States maintained by such non-U.S. holder), in which case the non-U.S. holder will generally be subject to tax on such gain in the same manner as a U.S. holder and, if the non-U.S. holder is a foreign corporation, such corporation may be subject to branch profits tax at the rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on earnings and profits (as determined for U.S. federal income tax purposes) effectively connected with a U.S. trade or business, subject to certain adjustments;
•
the non-U.S. holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of the Merger, and certain other conditions are met, in which case the non-U.S. holder will generally be subject to a 30% tax (or tax at such lower rate as may be specified under an applicable income tax treaty) on any gain realized, which may be offset by certain U.S.-source capital losses of the non-U.S. holder, if any, provided that such non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses; or
•
the Company is or has been a “United States real property holding corporation” for U.S. federal income tax purposes (a “USRPHC”) at any time during the shorter of (a) the five-year period ending on the date of the Merger and (b) the non-U.S. holder’s holding period in Company Common Stock (such period described in clause (a) and (b), the “Relevant Period”), and, if Company Common Stock is regularly traded on an established securities market (within the meaning of Section 897(c)(3) of the Code), the non-U.S. holder owned (directly, indirectly or constructively) more than 5% of the outstanding Company Common Stock at any time during such Relevant Period. Generally, a corporation is a USRPHC if the fair market value of its United States real property interests (as defined in the Code) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurances in this regard, the Company believes that it is not, and has not been, a USRPHC at any time during the five-year period ending on the date of the Merger. Non-U.S. holders should consult their own tax advisors regarding the possible consequences to them if the Company is a USRPHC.
A non-U.S. holder will be subject to information reporting and, in certain circumstances, backup withholding (currently at a rate of 24%) with respect to the cash received by such non-U.S. holder pursuant to the Merger. Non-U.S. holders generally may avoid information reporting and backup withholding by providing an applicable and properly executed IRS Form W-8BEN, IRS Form W-8BEN-E or other applicable IRS Form W-8 certifying under penalties of perjury the holder’s non-U.S. status (and the payor or applicable withholding agent does not have actual knowledge or reason to know that the non-U.S. holder is a United States person as defined under the Code) or otherwise establishes an exemption. Copies of information returns that are filed with the IRS may be made available under an applicable tax treaty or information exchange agreement to the taxing authorities of the country in which the non-U.S. holder resides or is established. Backup withholding is not an additional tax. Rather, any amounts withheld under the backup withholding rules may be refunded or credited against a non-U.S. holder’s U.S. federal income tax liability, if any, provided that the non-U.S. holder furnishes the required information to the IRS in a timely manner and other applicable requirements are satisfied. Non-U.S. holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them.
THE FOREGOING DISCUSSION IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL U.S. FEDERAL INCOME TAX CONSEQUENCES RELATING TO THE MERGER. THIS SUMMARY IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT
79

TABLE OF CONTENTS

TAX ADVICE. IN ADDITION, THIS DISCUSSION DOES NOT ADDRESS TAX CONSEQUENCES WHICH MAY VARY WITH, OR ARE CONTINGENT ON, A HOLDER’S INDIVIDUAL CIRCUMSTANCES. ACCORDINGLY, EACH HOLDER IS URGED TO CONSULT ITS OWN TAX ADVISOR REGARDING THE PARTICULAR TAX CONSEQUENCES OF THE MERGER TO SUCH HOLDER IN LIGHT OF SUCH HOLDER’S PARTICULAR CIRCUMSTANCES, INCLUDING THE TAX CONSEQUENCES WITH RESPECT TO ANY NON-INCOME TAX OR ANY STATE, LOCAL OR NON-U.S. TAX LAWS.
Regulatory Approvals Required for the Merger
General
Each party to the Merger Agreement will use its reasonable best efforts to (i) take (or cause to be taken) all actions; (ii) do (or cause to be done) all things; and (iii) assist and cooperate with the other parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable law or otherwise to consummate and make effective, as promptly as reasonably practicable, the Transactions, including by (A) causing the conditions precedent to the Merger to be satisfied; and (B)(I) obtaining all consents, waivers, approvals, orders and authorizations from governmental authorities; and (II) making all registrations, declarations and filings with governmental authorities, in each case that are necessary or advisable to consummate the Transactions.
Antitrust
Each of Parent and Merger Sub, on the one hand, and the Company, on the other hand, agreed to the extent required, within ten business days following the date of the Merger Agreement, to file with the FTC and the DOJ a notification and report form relating to the Merger as required by the HSR Act and to supply any additional information requested by those agencies. Pursuant to this, Parent and the Company filed their respective notification and report forms under the HSR Act on October 28, 2026. Parent will control strategy, communications and timing with respect to obtaining antitrust clearances, after considering in good faith all comments and advice of the Company, and Parent and Merger Sub are solely responsible for all HSR Act filing fees.
If and to the extent necessary to obtain clearances or waiting-period expirations or terminations under the HSR Act or other applicable antitrust laws, Parent and Merger Sub will take the actions required under the Merger Agreement so as to allow the Closing as soon as practicable and at least five business days prior to the Termination Date.
Notwithstanding the foregoing, nothing in the Merger Agreement requires Parent or any of its affiliates to, and the Company will not, without Parent’s prior written consent, take any action, including (i) any sale, divestiture, transfer, license, disposition or hold separate, (ii) any termination, modification or assignment of existing relationships, joint ventures, contracts or obligations, (iii) any modification of any course of conduct, (iv) any other restriction on activities regarding future operations, or (v) entering into any settlement, undertaking, consent decree, stipulation or agreement with or required by any governmental authority in connection with the Transactions, in each case with respect to Parent, Merger Sub or any of Parent’s affiliates (including GTCR, Elliott and their respective investment funds, investment vehicles and portfolio companies), other than the Company and its subsidiaries. In addition, no party is required to enter into any agreement or consent decree with the DOJ, the FTC or any other governmental authority, or take any other action, that is not conditioned on the Closing.
Parent will oppose any request for, or the entry of, and seek to have vacated or terminated, any order, judgment, decree, injunction or ruling of any governmental authority that could restrain, prevent or delay any clearance applicable to the Merger, including by defending through litigation any action asserted by any person and exhausting all avenues of appeal.
Legal Proceedings Regarding the Merger
As of the date of this proxy statement, the Company has received one demand letter on behalf of a purported stockholder of the Company pursuant to Section 220 of the DGCL, requesting access to certain books and records of the Company for the stated purposes of, among other things, investigating the events leading to the Merger Agreement, the independence and disinterestedness of certain members of the Company Board, and potential wrongdoing or mismanagement in connection with the Merger. The Company believes the claims asserted in the demand are without merit. As of the date of this proxy statement, there are no pending lawsuits challenging the Merger. However, potential plaintiffs may send additional demand letters or file lawsuits challenging the Merger. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could prevent or delay the Closing and result in substantial costs
80

TABLE OF CONTENTS

to the Company, including any costs associated with the indemnification of directors and officers. One of the conditions to the Closing is the absence of any law, injunction or order (whether temporary, preliminary or permanent) from any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger. Therefore, if a plaintiff were successful in obtaining an injunction prohibiting the consummation of the Merger on the agreed-upon terms, then such injunction may prevent the Merger from being consummated, or from being consummated within the expected time frame.
Delisting and Deregistration of Company Common Stock
If the Merger is completed, the shares of Company Common Stock will be delisted from Nasdaq and deregistered under the Exchange Act, and shares of Company Common Stock will no longer be publicly traded.
81

TABLE OF CONTENTS

THE MERGER AGREEMENT
This section describes the material terms and conditions of the Merger Agreement. The description in this section and elsewhere in this proxy statement is qualified in its entirety by reference to the complete text of the Merger Agreement and the first amendment to the Merger Agreement, copies of which are attached as Annex A-1 and Annex A-2, respectively, and are incorporated by reference into this proxy statement.
This summary does not purport to be complete and may not contain all of the information about the Merger Agreement that is important to you. We encourage you to read the Merger Agreement carefully and in its entirety. This section is not intended to provide you with factual information about the Company. Such information can be found elsewhere in this proxy statement and in the public filings the Company makes with the SEC, which may be obtained by following the instructions set forth in the section titled “Where You Can Find Additional Information.”
Explanatory Note Regarding the Merger Agreement
The Merger Agreement has been included to provide you with information regarding its terms. It is not intended to provide any other factual information about the Company, Parent, Merger Sub or any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger Agreement were made by the parties thereto only for the purposes of that agreement and as of specific dates; were made solely for the benefit of the parties to the Merger Agreement; may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures exchanged between the parties in connection with the execution of the Merger Agreement (such disclosures include information that has been included in the Company’s public disclosures, as well as additional nonpublic information); may have been made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to you. You should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Parent, Merger Sub or any of their respective subsidiaries or affiliates. Additionally, the representations, warranties, covenants, conditions and other terms of the Merger Agreement may be subject to subsequent waiver or modification. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures.
Structure of the Merger
Upon the terms and subject to the conditions set forth in the Merger Agreement and the applicable provisions of the DGCL, on the Closing Date, Merger Sub will be merged with and into the Company; the separate corporate existence of Merger Sub will thereupon cease; and the Company will continue as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent.
Consummation and Effectiveness of the Merger
Upon the terms and subject to the conditions set forth in the Merger Agreement, on the Closing Date, Parent, Merger Sub and the Company will cause the Merger to be consummated pursuant to the DGCL by filing a certificate of merger in customary form and substance with the Secretary of State of the State of Delaware in accordance with the applicable provisions of the DGCL (the time of such filing and acceptance for record by the Secretary of State of the State of Delaware, or such later time as may be agreed in writing by Parent, Merger Sub and the Company and specified in the certificate of merger, being the Effective Time).
The consummation of the Merger will take place at a closing to occur at (a) 9:00 a.m., New York City time, remotely by exchange of documents and signatures (or their electronic counterparts), on a date to be agreed upon by Parent, Merger Sub and the Company that is no later than the second business day after the satisfaction or waiver (to the extent permitted under the Merger Agreement) of the last to be satisfied or waived of the conditions set forth in the Merger Agreement (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted under the Merger Agreement) of such conditions); or (b) such other time, location and date as Parent, Merger Sub and the Company mutually agree in writing; provided that, if the Marketing Period (as defined in the Merger Agreement) has not ended at the time the Closing is otherwise required to be consummated pursuant to the Merger Agreement, then, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement at such time (other than those conditions that by their terms are to be satisfied at the Closing,
82

TABLE OF CONTENTS

but subject to the satisfaction or waiver (to the extent permitted under the Merger Agreement) of such conditions), the Closing will occur instead on the earlier of (x) the date that is two business days after the final day of the Marketing Period and (y) the date during the Marketing Period agreed to in writing by Parent and the Company.
Consideration to Be Received in the Merger
Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of any of the securities described in the Merger Agreement, (i) each share of common stock, par value $0.001 per share, of Merger Sub that is issued and outstanding as of immediately prior to the Effective Time will automatically be cancelled and converted into one validly issued, fully paid and nonassessable share of common stock of the surviving corporation; (ii) each share of Company Common Stock (including, for the avoidance of doubt, any SPAC Merger Earnout Shares issued pursuant to the terms of the Merger Agreement and any Sponsor Earnout Shares) that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company Shares, Dissenting Company Shares or Company RSAs) will be automatically cancelled, extinguished and converted into the right to receive cash in an amount equal to the Per Share Price, in accordance with the terms of the Merger Agreement (or in the case of a lost, stolen or destroyed certificate, upon delivery of an affidavit (and bond, if required) in accordance with the terms of the Merger Agreement); and (iii) each share of Company Common Stock that is (A) held by the Company as treasury stock or (B) owned by Parent or any of its subsidiaries (including Merger Sub), in each case as of immediately prior to the Effective Time, will automatically be cancelled and extinguished without any conversion thereof or consideration paid therefor.
The Per Share Price will be adjusted appropriately to reflect the effect of any stock split, reverse stock split, stock dividend (including any dividend or other distribution of securities convertible into or exchangeable or exercisable for Company Common Stock), reorganization, recapitalization, reclassification, subdivision, combination, exchange of shares or other similar change with respect to the Company Common Stock occurring on or after the date of the Merger Agreement and prior to the Effective Time.
Procedures for Receiving Per Share Price
Prior to the Closing, Parent will (i) select a nationally recognized bank or trust company reasonably acceptable to the Company to act as the payment agent for the Merger (the “Payment Agent”); and (ii) enter into a payment agent agreement, in form and substance reasonably acceptable to the Company, with such Payment Agent.
At or prior to the Closing, Parent will deposit (or cause to be deposited) with the Payment Agent, by wire transfer of immediately available funds, for payment to the holders of shares of Company Common Stock (other than to holders of Dissenting Company Shares and any amounts payable in respect of Company Equity Awards (as defined in the Merger Agreement)) pursuant to the terms of the Merger Agreement, an amount of cash equal to the aggregate consideration to which such holders of Company Common Stock become entitled pursuant to the terms of the Merger Agreement; provided, that the Company will, at the written request of Parent at least two business days prior to Closing, deposit with the Payment Agent at the Closing such portion of such aggregate consideration from the cash denominated in United States dollars and held in United States bank accounts of the Company or any of its subsidiaries as specified in such request. Until disbursed in accordance with the terms and conditions of the Merger Agreement, such cash may be invested by the Payment Agent, as reasonably directed by Parent or the surviving corporation, in (i) obligations of or fully guaranteed by the United States or any agency or instrumentality thereof and backed by the full faith and credit of the United States with a maturity of no more than thirty days; (ii) commercial paper obligations rated A-1 or P-1 or better by Moody’s Investors Service, Inc. or Standard & Poor’s Corporation, respectively; or (iii) certificates of deposit, bank repurchase agreements or banker’s acceptances of commercial banks with capital exceeding $1,000,000,000 (based on the most recent financial statements of such bank that are then publicly available) (such cash and any proceeds thereon, the “Payment Fund”). To the extent that (A) there are any losses with respect to any investments of the Payment Fund; (B) the Payment Fund diminishes for any reason below the level required for the Payment Agent to promptly pay the cash amounts contemplated by the terms of the Merger Agreement; or (C) all or any portion of the Payment Fund is unavailable for Parent (or the Payment Agent on behalf of Parent) to promptly pay the cash amounts contemplated by the terms of the Merger Agreement for any reason, Parent will, or will cause the surviving corporation to, promptly replace or restore the amount of cash in the Payment Fund so as to ensure that the Payment Fund is at all times fully available for distribution and maintained at a level sufficient for the Payment Agent to make the payments contemplated by the terms of the Merger Agreement. Any income from investment of the Payment Fund will be payable to Parent or the surviving corporation as Parent directs. The Payment Fund will not be used for any purpose other than the payment to holders of Company Common Stock as contemplated by the terms of the Merger Agreement.
83

TABLE OF CONTENTS

Promptly following the Effective Time (and in any event within three business days), Parent and the surviving corporation will cause the Payment Agent to mail to each holder of record as of immediately prior to the Effective Time (other than Owned Company Shares and Dissenting Company Shares, as applicable) of one or more certificates that immediately prior to the Effective Time represented issued and outstanding shares of Company Common Stock (other than Owned Company Shares and Dissenting Company Shares, as applicable) (the “Certificates”) (if any) (i) a letter of transmittal in customary form (which will specify that delivery will be effected, and risk of loss and title to the Certificates will pass, only upon delivery of the Certificates to the Payment Agent), and (ii) instructions for effecting the surrender of the Certificates in exchange for the Per Share Price payable with respect to the shares of Company Common Stock formerly represented thereby pursuant to the terms of the Merger Agreement. Upon surrender of Certificates for cancellation to the Payment Agent, together with such letter of transmittal, duly completed and validly executed in accordance with the instructions thereto, the holders of such Certificates will be entitled to receive in exchange therefor an amount in cash equal to the product obtained by multiplying (x) the aggregate number of shares of Company Common Stock represented by such Certificates by (y) the Per Share Price, and the Certificates so surrendered will forthwith be cancelled. Notwithstanding anything to the contrary in the Merger Agreement, no record holder of uncertificated shares of Company Common Stock (other than Owned Company Shares) (the “Uncertificated Shares”) will be required to deliver a Certificate or an executed letter of transmittal to the Payment Agent in order to receive the payment that such holder is entitled to receive pursuant to the terms of the Merger Agreement with respect to such Uncertificated Shares. In lieu thereof, upon receipt of an “agent’s message” by the Payment Agent or such other evidence of transfer as the Payment Agent may reasonably request in accordance with customary procedures of the Payment Agent, such record holder will be entitled to receive in exchange therefor an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares of Company Common Stock represented by such holder’s transferred Uncertificated Shares, by (2) the Per Share Price, and the transferred Uncertificated Shares will be cancelled. No interest will be paid or accrued for the benefit of holders of the Certificates or Uncertificated Shares on the Per Share Price payable upon the surrender of such Certificates and transfer of Uncertificated Shares pursuant to the terms of the Merger Agreement. Until so surrendered or transferred, outstanding Certificates and Uncertificated Shares will be deemed from and after the Effective Time to evidence only the right to receive the Per Share Price without interest thereon payable in respect thereof pursuant to the terms of the Merger Agreement.
Prior to the Effective Time, Parent and the Company will cooperate to establish procedures with the Payment Agent and the Depository Trust Company (“DTC”) with the objective that (i) if the Closing occurs at or prior to 11:30 a.m., Eastern Time, on the Closing Date, the Payment Agent will transmit to DTC or its nominees on the Closing Date an amount in cash, by wire transfer of immediately available funds, equal to (x) the number of shares of Company Common Stock (other than Owned Company Shares and Dissenting Company Shares) held of record by DTC or such nominee immediately prior to the Effective Time multiplied by (y) the Per Share Price (such amount, the “DTC Payment”), and (ii) if the Closing occurs after 11:30 a.m., Eastern Time, on the Closing Date, then the Payment Agent will transmit the DTC Payment to DTC or its nominees on the first business day after the Closing Date.
If payment of the Per Share Price is to be made to a person other than the person in whose name the surrendered Certificate or transferred Uncertificated Share in exchange therefor is registered, it will be a condition of payment that (i) the person requesting such exchange present proper evidence of transfer or otherwise be in proper form for transfer and (ii) the person requesting such payment have paid any transfer and other taxes required by reason of the payment of the Per Share Price to a person other than the registered holder of such Certificate or Uncertificated Share surrendered or have established to the reasonable satisfaction of the surviving corporation that such tax either has been paid or is not applicable.
Subject to applicable law and notwithstanding anything to the contrary in the Merger Agreement, none of the Payment Agent, Parent, the surviving corporation or any other party will be liable to a holder of shares of Company Common Stock for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar law.
Any portion of the Payment Fund that remains undistributed to the holders of the Certificates or Uncertificated Shares on the date that is one year after the Effective Time will be delivered to Parent (or the surviving corporation as directed by Parent) upon demand, and any holders of shares of Company Common Stock that were issued and outstanding immediately prior to the Merger who have not theretofore surrendered or transferred their Certificates or Uncertificated Shares representing such shares of Company Common Stock for exchange pursuant to the terms of the Merger Agreement will thereafter look for payment of the Per Share Price payable in respect of the shares of Company Common Stock represented by such Certificates or Uncertificated Shares solely to Parent (subject to abandoned
84

TABLE OF CONTENTS

property, escheat or similar law), as general creditors thereof, for any claim to the Per Share Price to which such holders may be entitled pursuant to the terms of the Merger Agreement. Any amounts remaining unclaimed by holders of any such Certificates or Uncertificated Shares five years after the Effective Time, or at such earlier date as is immediately prior to the time at which such amounts would otherwise escheat to, or become property of, any governmental authority, will, to the extent permitted by applicable law, become the property of the surviving corporation free and clear of any claims or interest of any such holders (and their successors, assigns or personal representatives) previously entitled thereto.
From and after the Effective Time, there will be no further registration of transfers on the records of the surviving corporation of shares of Company Common Stock that were issued and outstanding immediately prior to the Effective Time, other than transfers to reflect, in accordance with customary settlement procedures, trades effected prior to the Effective Time. If, after the Effective Time, Certificates or Uncertificated Shares are presented to the surviving corporation for any reason, they will (subject to compliance with the exchange procedures of the Merger Agreement) be cancelled and exchanged as provided in the Merger Agreement.
In the event that any Certificates have been lost, stolen or destroyed, the Payment Agent will issue in exchange therefor, upon the making of an affidavit of that fact by the holder thereof, the Per Share Price payable in respect thereof pursuant to the terms of the Merger Agreement. Parent or the Payment Agent may, in its reasonable discretion and as a condition precedent to the payment of such Per Share Price, require the owners of such lost, stolen or destroyed Certificates to deliver a bond in such reasonable amount as it may direct as indemnity against any claim that may be made against Parent, the surviving corporation or the Payment Agent with respect to the Certificates alleged to have been lost, stolen or destroyed.
Each of the Payment Agent, Parent, the Company and the surviving corporation (without duplication), including their respective affiliates and agents, will be entitled to deduct and withhold (or cause to be deducted and withheld) from any amount payable pursuant to the Merger Agreement to any person such amounts as are required to be deducted or withheld therefrom pursuant to any law in respect of applicable taxes. To the extent that such amounts are so deducted or withheld and paid over to the appropriate governmental authority, such amounts will be treated for all purposes of the Merger Agreement as having been paid to the person in respect of which such deduction and withholding was made.
Treatment of Company Equity Awards in the Merger
At the Effective Time, each Company Option outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Per Share Price over the exercise price per share of such Company Option. At the Effective Time, each Company Option with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof.
At the Effective Time, each Vested Company RSA outstanding and unsettled as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding taxes, equal to the Per Share Price.
At the Effective Time, each Unvested Company RSA outstanding as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company RSAs will become entitled to receive, in consideration of the cancellation of such Unvested Company RSAs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions (including, except as otherwise described below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time.
At the Effective Time, each Vested Company RSU outstanding and unsettled as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder
85

TABLE OF CONTENTS

thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding taxes, equal to the product of (x) the Per Share Price and (y) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time.
At the Effective Time, each Unvested Company RSU outstanding as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company RSUs will become entitled to receive, in consideration of the cancellation of such Unvested Company RSUs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the product of (A) the number of shares of Company Common Stock subject to such Unvested Company RSUs multiplied by (B) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions (including, except as otherwise described below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time.
At the Effective Time, each Vested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest thereon and subject to applicable withholding taxes, equal to the product of (x) the Per Share Price and (y) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU (such amount, together with the amounts payable in respect of Company Options, Vested Company RSAs and Vested Company RSUs described above, the “Closing Equity Award Consideration”).
At the Effective Time, each Unvested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company PSUs will become entitled to receive, in consideration of the cancellation of such Unvested Company PSUs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the product of (A) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (x) actual performance achieved through the Effective Time and (y) target-level performance, in accordance with the terms of such Unvested Company PSU, multiplied by (B) the Per Share Price, with such resulting amount rounded down to the nearest whole cent, with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions (including, except as otherwise described below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time.
As soon as practicable following the date of the Merger Agreement, the Company will take all actions with respect to the Company ESPP that are necessary to provide that with respect to the offering period under the Company ESPP in effect as of the date of the Merger Agreement, if any (the “ESPP Offering Period”), (i) no individual who was not a participant in the Company ESPP as of the date of the Merger Agreement may enroll in the Company ESPP, (ii) no participant may increase the percentage amount of their payroll deduction election from that in effect on the date of the Merger Agreement or make separate non-payroll contributions to the Company ESPP, (iii) no new offering period will be commenced under the Company ESPP prior to the Effective Time, (iv) the final exercise date for the ESPP Offering Period will be the earlier of the regularly scheduled final exercise date for such ESPP Offering Period and a date that is no later than ten calendar days prior to the Effective Time (the “Final Exercise Date”), (v) each Company ESPP participant’s accumulated contributions under the Company ESPP will be used to purchase shares of Company Common Stock in accordance with the terms of the Company ESPP as of the Final Exercise Date, and (vi) immediately prior to the Effective Time, the Company ESPP will terminate.
At or prior to the Closing, Parent will deposit (or cause to be deposited) with the Company, by wire transfer of immediately available funds, (i) Closing Equity Award Consideration owed to all holders of vested Company Options, Vested Company RSAs, Vested Company RSUs and Vested Company PSUs (collectively, the “Equity Award Holders”), solely to the extent that such Closing Equity Award Consideration is due and payable to the applicable Equity Award Holder on the Closing Date, and (ii) an amount in cash equal to the product obtained by multiplying (x) the aggregate number of SPAC Merger Earnout Shares issuable to all holders of Company Options pursuant to the terms of the Merger Agreement, by (y) the Per Share Price. As promptly as reasonably practicable, but in any event no later than five business days following the Closing Date, the Equity Award Holders will be paid by the Company or the surviving corporation, through its or its applicable subsidiary’s payroll system or payroll provider, to the extent such
86

TABLE OF CONTENTS

amount is due as of such date and solely with respect to such amount as is then due and payable, (A) such portion of the amount required to be paid to such holder in respect of the Closing Equity Award Consideration as of such date pursuant to the terms of the Merger Agreement and (B) all amounts required to be paid to the holders of Company Options in respect of the SPAC Merger Earnout Shares issuable to such holders pursuant to the terms of the Merger Agreement, in each case, less any required withholding pursuant to the terms of the Merger Agreement; provided, that to the extent that payments (x) in respect of the Closing Equity Award Consideration are owed to non-employee directors of the Company, such amounts will be paid by Parent, by wire transfer of immediately available funds, as promptly as reasonably practicable, but in any event no later than five business days, after the Closing or (y) in respect of any Company RSA Restricted Cash Award, Company RSU Restricted Cash Award or Company PSU Restricted Cash Award are owed to non-employee directors of the Company, such amounts will be paid by the Company or the surviving corporation, by wire transfer of immediately available funds, as promptly as reasonably practicable, but in any event no later than five business days after the applicable vesting date. Notwithstanding anything to the contrary contained in the Merger Agreement, to the extent that any Company Option, Company RSA, Company RSU or Company PSU constitutes nonqualified deferred compensation subject to Section 409A of the Code, any payment made in respect thereof pursuant to the terms of the Merger Agreement will be paid on the applicable settlement or payment date for such Company Option, Company RSA, Company RSU or Company PSU, as applicable, if required to comply with Section 409A of the Code.
All amounts payable in respect of the Restricted Cash Awards will be subject to any required withholding of taxes and will be paid, without interest, no later than the second regularly scheduled payroll date following the date on which the applicable portion of such award vests; provided that, if a holder of a Restricted Cash Award (i)(A) incurs a termination of employment or service without Cause (as defined in such holder’s applicable award agreement or employment agreement), (B) resigns for Good Reason (as defined in the Company Disclosure Letter), or (C) incurs a termination of employment or service due to death or Disability (with “Disability” meaning a disability that qualifies such holder for disability benefits under the Company’s long-term disability plan or applicable Social Security law), in each case, within 24 months following the Effective Time, or (ii) incurs a Good Leaver Termination (as defined in the Company Disclosure Letter) at any time following the Effective Time, any then-unvested portion of such Restricted Cash Award will vest in full upon such termination and will be paid within 60 days following the date of such termination, subject to any required withholding of taxes.
Effect on Other Company Securities; Company Earnout Shares.
Immediately prior to the Effective Time, all Sponsor Earnout Shares will vest in full and be released to Dragoneer Growth Opportunities Holdings in accordance with the SPAC Merger Agreement. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or Dragoneer Growth Opportunities Holdings, all Sponsor Earnout Shares shall be canceled and converted into the right to receive the Per Share Price in accordance with the Merger Agreement.
Immediately prior to the Effective Time, the Company shall issue a number of shares of Company Common Stock comprising the maximum number of SPAC Merger Earnout Shares issuable in connection with the SPAC Merger Agreement to the persons entitled thereto, in accordance with the terms of the SPAC Merger Agreement. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder of shares thereof, all shares of Company Common Stock issued pursuant to the immediately preceding sentence shall be canceled and converted into the right to receive the Per Share Price in accordance with the Merger Agreement.
Dissenting Company Shares
Notwithstanding anything to the contrary set forth in the Merger Agreement, if required by the DGCL (but only to the extent required thereby), any share of Company Common Stock that is issued and outstanding immediately prior to the Effective Time (other than the Owned Company Shares) and that is held by a holder of such share of Company Common Stock who has not voted in favor of the adoption of the Merger Agreement or consented thereto in writing and who has (or for which the “beneficial owner” (as defined in Section 262(a) of the DGCL) has) properly exercised appraisal rights with respect thereto in accordance with, and who has (and, to the extent applicable, for which the applicable beneficial owner has) complied with, Section 262 of the DGCL with respect to such share of Company Common Stock will not be converted into the right to receive the Per Share Price pursuant to the terms of the Merger Agreement, and holders and beneficial owners of such Dissenting Company Shares will be entitled to receive payment of the fair value of such Dissenting Company Shares in accordance with the provisions of Section 262 of the DGCL
87

TABLE OF CONTENTS

unless and until any such holder (or, to the extent applicable, such beneficial owner) fails to perfect or effectively withdraws or loses their rights to appraisal and payment under the DGCL. If, after the Effective Time, any such holder (or, to the extent applicable, such beneficial owner) fails to perfect or effectively withdraws or loses such rights with respect to any Dissenting Company Shares, such Dissenting Company Shares will thereupon be treated as if they had been converted into, at the Effective Time, the right to receive the Per Share Price without interest thereon and the surviving corporation will remain liable for payment of the Per Share Price without interest thereon for such Dissenting Company Shares in accordance with the Merger Agreement. At the Effective Time, any holder or beneficial owner of Dissenting Company Shares will cease to have any rights with respect thereto, except the rights provided in Section 262 of the DGCL and as provided in the previous sentence. The Company will give Parent (i) reasonably prompt (and in any event within three business days) notice of any demands received by the Company for appraisal of Company Common Stock, withdrawals of such demands and any other instruments served pursuant to the DGCL or other communications, in each case, received by the Company in respect of the Dissenting Company Shares and (ii) the opportunity to direct all negotiations and proceedings with respect to such demands. The Company will not, except with the prior written consent of Parent, make any payment with respect to any demands for appraisal or settle or offer to settle any such demands or waive any failure to timely deliver a written demand for appraisal or to timely take any other action to exercise appraisal rights or propose or agree to do any of the foregoing. Parent will not, except with the prior written consent of the Company, require the Company to make any payment with respect to any demands for appraisal or settle any such demands prior to the Closing.
Effects of the Merger; Certificate of Incorporation; Bylaws; Directors and Officers
At the Effective Time, the effect of the Merger will be as provided in the Merger Agreement and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time all (a) of the property, rights, privileges, powers and franchises of the Company and Merger Sub will vest in the surviving corporation; and (b) debts, liabilities and duties of the Company and Merger Sub will become the debts, liabilities and duties of the surviving corporation. At the Effective Time, (i) the certificate of incorporation of the Company will be amended and restated in its entirety to read as set forth in the Merger Agreement and, as so amended and restated, will be the certificate of incorporation of the surviving corporation until thereafter amended as provided by the DGCL and such certificate of incorporation and (ii) the bylaws of Merger Sub as in effect immediately prior to the Effective Time will become the bylaws of the surviving corporation, except that all references to Merger Sub will be automatically amended and will become references to the surviving corporation, until thereafter amended as provided by the DGCL, the certificate of incorporation and such bylaws.
In addition, the parties will take all actions necessary so that the directors of Merger Sub immediately prior to the Effective Time will be the directors of the surviving corporation immediately following the Effective Time, and the officers of the Company immediately prior to the Effective Time will be the officers of the surviving corporation immediately following the Effective Time, in each case, until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal, in each case as provided in the organizational documents of the surviving corporation and by applicable law.
Representations and Warranties
The Company, Parent and Merger Sub made representations and warranties in the Merger Agreement regarding themselves and, as applicable, their respective subsidiaries that are subject, in some cases, to specified exceptions and qualifications contained in the Merger Agreement (including “knowledge” and materiality qualifications and qualifications referring to dollar thresholds).
With respect to the representations and warranties of the Company, except (a) as disclosed in the reports, statements, schedules and other documents filed or furnished by the Company with the SEC on or since January 1, 2024 and at any time prior to 48 hours in advance of the execution and delivery of the Merger Agreement (the “Company SEC Documents”) (other than any disclosures contained (i) solely in the risk factors sections of such Company SEC Documents, except to the extent such information consists of factual or historical statements, and (ii) in the “Forward-Looking Statements” section in such Company SEC Documents), it being understood that any matter disclosed in such Company SEC Documents will not be deemed disclosed for purposes of certain representations and warranties of the Company; or (b) subject to the terms of the Merger Agreement, as set forth in the Company Disclosure Letter, the Company represented and warranted to Parent and Merger Sub.
88

TABLE OF CONTENTS

The Company’s representations and warranties to Parent and Merger Sub in the Merger Agreement relate to, among other things:
•
due organization, valid existence, good standing and authority and qualification to conduct business with respect to the Company and each of its subsidiaries;
•
the Company’s corporate power and authority to enter into and perform its obligations under the Merger Agreement and the enforceability of the Merger Agreement;
•
the necessary approval of the Company Board, receipt of a fairness opinion from Morgan Stanley and the inapplicability to the Merger of Section 203 of the DGCL, Article XII, Section 2 of the certificate of incorporation of the Company and any other similar anti-takeover statutes, regulations or provisions;
•
required consents, approvals and regulatory filings in connection with the Merger Agreement and performance of the Company’s obligations thereunder;
•
the absence of conflicts with laws, organizational documents and material contracts of the Company and its subsidiaries;
•
the capital structure of the Company and its subsidiaries;
•
compliance with SEC rules regarding filings and financial statements;
•
disclosure controls and procedures;
•
internal accounting controls and procedures;
•
the absence of specified undisclosed liabilities;
•
absence of certain changes;
•
the existence and enforceability of specified categories of the Company’s and its subsidiaries’ material contracts, any notices with respect to termination or non-renewal, or disputes with respect to, such material contracts, and the performance by the Company and its subsidiaries in all material respects of their respective obligations under such material contracts;
•
certain stockholder and management arrangements;
•
real property owned or leased by the Company and its subsidiaries;
•
environmental matters;
•
intellectual property matters;
•
data protection matters;
•
tax matters;
•
employee benefit plans;
•
labor matters;
•
compliance with laws;
•
the absence of pending and threatened litigation and orders;
•
insurance matters;
•
anti-corruption, anti-money laundering and sanctions compliance;
•
the absence of any investment banker, broker, finder or other financial intermediary, other than Morgan Stanley, that has been retained by or is authorized to act on behalf of the Company or any of its subsidiaries who will be entitled to any fee or commission from the Company or any of its subsidiaries in connection with the Transactions;
•
accuracy of information provided in this proxy statement;
•
related party transactions;
89

TABLE OF CONTENTS

•
government contracts;
•
customer contracts;
•
vendor contracts; and
•
the exclusivity and terms of the representations and warranties made by the Company, Parent and Merger Sub.
Parent and Merger Sub have jointly and severally made representations and warranties to the Company in the Merger Agreement, relating to, among other things:
•
due organization, valid existence, good standing and authority and qualification to conduct business with respect to Parent and Merger Sub;
•
Parent’s and Merger Sub’s corporate power and authority to enter into and perform their respective obligations under the Merger Agreement and the enforceability of the Merger Agreement;
•
the necessary approval of the board of directors or similar governing body of each of Parent and Merger Sub;
•
the absence of conflicts with laws, organizational documents and material contracts;
•
required consents, approvals and regulatory filings in connection with the Merger Agreement and the performance by Parent and Merger Sub of their respective obligations thereunder;
•
the absence of pending and threatened litigation and orders;
•
ownership of Company Common Stock;
•
the absence of any investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of Parent or any of its subsidiaries who will be entitled to any fee or commission from the Company in connection with the transactions contemplated by the Merger Agreement;
•
operations of Parent and Merger Sub;
•
the absence of a requirement for a vote or approval of the stockholders of Parent;
•
delivery and enforceability of the Limited Guarantees;
•
delivery, validity and sufficiency of the Financing Letters (as defined in the Merger Agreement), including the Equity Commitment Letters and the Debt Commitment Letter (as well as any fee letters related thereto);
•
solvency of the surviving corporation and its subsidiaries;
•
accuracy of information provided in this proxy statement; and
•
the exclusivity and terms of the representations and warranties made by the Company, Parent and Merger Sub.
Some of the representations and warranties in the Merger Agreement made by the Company are qualified as to “materiality” or “Company Material Adverse Effect.” For purposes of the Merger Agreement, “Company Material Adverse Effect” means any change, event, effect, development or occurrence that, individually or in the aggregate, has had, or would reasonably be expected to have, a material adverse effect on the business, properties, condition (financial or otherwise), assets, liabilities or results of operations of the Company and its subsidiaries, taken as a whole; provided that none of the following, and no changes, events, effects, developments, or occurrences to the extent arising out of, relating to or resulting from the following (in each case, by itself or when aggregated) will be deemed to be or constitute a Company Material Adverse Effect or will be taken into account when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur (subject to the limitations set forth below):
(i)
any general economic conditions, or conditions in the global, international or regional economy generally;
(ii)
any conditions in the equity, credit, debt, financial, banking, currency or capital markets, including (A) changes in interest rates or credit ratings; (B) changes in exchange rates for the currencies of any country; or (C) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market;
90

TABLE OF CONTENTS

(iii)
any general conditions in the industries in which the Company and its subsidiaries conduct business or in any jurisdiction or geographical area in which the Company and its subsidiaries conduct business, or changes therein;
(iv)
any political or geopolitical conditions, outbreak of hostilities, armed conflicts, acts of war (whether or not declared), rebellion, insurrection, sabotage, cyberattack, cyberterrorism, terrorism or military actions, including any escalation or worsening of, or any law or sanction, mandate, directive or pronouncement issued by a governmental authority after the date of the Merger Agreement in response to, the foregoing or any threats thereof, in each case, in the United States or any other country or region in the world;
(v)
any earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wildfires, nuclear incidents, foreign or domestic social protest or social unrest (whether or not violent) or other natural or man-made disasters, weather conditions, power outages or electrical black-outs, and other force majeure events, including any escalation or worsening of, or any law or sanction, mandate, directive, pronouncement, guideline or recommendation issued by a governmental authority in response to, any of the foregoing, in each case, in the United States or any other country or region in the world;
(vi)
the negotiation, execution, delivery or performance of the Merger Agreement or the announcement of the Merger Agreement or the pendency of the Merger or the other Transactions, including the impact thereof on the relationships, contractual or otherwise, of the Company and its subsidiaries with customers, suppliers, lenders, lessors, business or joint venture partners, officers, employees (including any employee departure or attrition), regulators, governmental authorities, vendors or any other third person (it being understood that this clause (vi) will not apply with respect to any representation, warranty or condition to Closing that is intended to address the consequences of the execution and delivery of the Merger Agreement);
(vii)
the compliance by any party with the express terms of the Merger Agreement, including any action taken or refrained from being taken pursuant to or in accordance with the express terms of the Merger Agreement or any action taken or refrained from being taken to which Parent has expressly approved or consented to in writing (including by email) following the date of the Merger Agreement;
(viii)
changes or proposed changes in GAAP or other accounting standards, or in any applicable laws (or the enforcement or interpretation of any of the foregoing) or in any regulatory or legislative conditions, including the adoption, implementation, repeal, modification, reinterpretation or proposal of any law, regulation or policy (or the enforcement or interpretation thereof) by any governmental authority, or any panel or advisory body empowered or appointed thereby, in each case, after the date of the Merger Agreement;
(ix)
any epidemics, pandemics, plagues, other outbreaks of illness or public health events (including quarantine restrictions mandated or recommended by any governmental authority in response to any of the foregoing), including any escalation or worsening of any of the foregoing, in each case, in the United States or any other country or region in the world;
(x)
any anti-dumping actions, international tariffs, sanctions, trade policies or disputes or any “trade war” in the United States or in any country or region in the world in which the Company and its subsidiaries conduct business;
(xi)
any changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded under the Merger Agreement);
(xii)
any failure by the Company and its subsidiaries to meet (A) any internal or public estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period; or (B) any budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that, in the case of each of the foregoing clauses (A) and (B), the underlying cause of any such failure may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded under the Merger Agreement);
(xiii)
the availability or cost of equity, debt or other financing to Parent or Merger Sub;
91

TABLE OF CONTENTS

(xiv)
any transaction litigation or any demand or legal proceeding for appraisal of the fair value of any shares of Company Common Stock pursuant to the DGCL in connection with the Merger Agreement;
(xv)
the identity of Parent, Merger Sub, or their respective affiliates as the acquiror of the Company; and
(xvi)
any breach by Parent or Merger Sub of the Merger Agreement,
except, in each case of clauses (i), (ii), (iii), (iv), (v), (viii), (ix) and (x), to the extent that such changes, events, effects, developments or occurrences have had a disproportionate adverse effect on the Company and its subsidiaries, taken as a whole, relative to other companies operating in the industries in which the Company and its subsidiaries conduct business, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur.
Certain of Parent’s and Merger Sub’s representations and warranties in the Merger Agreement are qualified by a “Parent Material Adverse Effect” standard (that is, they will not be deemed to be untrue and incorrect unless their failure to be true and correct would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect). For purposes of the Merger Agreement, a Parent Material Adverse Effect means a failure of any such representations and warranties of Parent and Merger Sub to be true and correct that would, individually or in the aggregate, reasonably be expected to prevent, materially delay, or have a material adverse effect on the ability of Parent or Merger Sub to perform its obligations under the Merger Agreement or to consummate the Transactions.
Conduct of Business by the Company Prior to Consummation of the Merger
The Merger Agreement provides that, except (a) as expressly contemplated by the Merger Agreement, (b) as set forth in the Company Disclosure Letter, (c) as required by applicable law, or (d) as approved by Parent in writing (which approval will not be unreasonably withheld, conditioned or delayed and will be deemed given if Parent provides no written response within five business days after a written request by the Company for such consent), during the period from the execution and delivery of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement pursuant to the terms of the Merger Agreement and the Effective Time, the Company will, and will cause each of its subsidiaries to, use its commercially reasonable efforts to (i) conduct its business in all material respects in the ordinary course of business, (ii) preserve intact in all material respects its business organizations and operations, and (iii) preserve intact in all material respects its significant commercial relationships with customers, vendors, employees, governmental authorities and other third parties; provided that no action or omission by the Company or its subsidiaries with respect to matters specifically addressed by the restrictions described below will be deemed a breach of this sentence unless such action or omission would constitute a breach of such relevant restriction.
In addition, the Company has agreed that, except (w) as expressly contemplated by the Merger Agreement, (x) as set forth in the Company Disclosure Letter, (y) as required by applicable law or (z) as approved by Parent in writing (which approval will not be unreasonably withheld, conditioned or delayed and will be deemed given if Parent provides no written response within five business days after a written request by the Company for such consent), during the period from the execution and delivery of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement pursuant to the terms of the Merger Agreement and the Effective Time, the Company will not, and will not permit any of its subsidiaries to (whether directly or indirectly and whether by merger, consolidation, division, conversion, operation of law or otherwise), among other things:
•
amend or repeal the organizational documents of the Company or any of its subsidiaries or adopt any such new organizational documents or provision thereof (other than immaterial amendments to the organizational documents of any subsidiary of the Company);
•
propose or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, conversion, division, restructuring, recapitalization or other reorganization;
•
issue, sell, deliver or agree or commit to issue, sell, deliver or authorize the issuance of any Company Securities (as defined in the Merger Agreement), except (i) in accordance with the terms of any award agreement under the Company Equity Plan (as defined in the Merger Agreement) or otherwise with respect to, and upon the vesting, exercise or settlement of, Company Options, Company RSAs, Company RSUs or Company PSUs, in each case, outstanding on the date of the Merger Agreement or granted after the date of the Merger Agreement in compliance with the Merger Agreement or (ii) for the issuance of SPAC Merger Earnout Shares in accordance with the Merger Agreement or the SPAC Merger Agreement;
92

TABLE OF CONTENTS

•
except for transactions solely among the Company and its subsidiaries or solely among the subsidiaries of the Company, adjust, reclassify, split, combine, subdivide or redeem, repurchase, purchase or otherwise acquire or amend the terms of, directly or indirectly, any of its capital stock or other equity or voting interest of the Company, other than (i) the acquisitions of shares of Company Common Stock in connection with the surrender of shares of Company Common Stock by holders of Company Options to pay the exercise price of such Company Options, (ii) the withholding of shares of Company Common Stock to satisfy tax obligations incurred in connection with the exercise of Company Options or the vesting or settlement of Company RSAs, Company RSUs and Company PSUs, and (iii) the acquisition by the Company of Company Options, Company RSUs, Company PSUs and Company RSAs in connection with the forfeiture of such awards, in each case of clauses (i), (ii) and (iii), in accordance with their terms;
•
(i) declare, set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any shares of capital stock or other equity or voting interest, except for dividends or other distributions made by any direct or indirect wholly owned subsidiary of the Company to the Company or one of its other wholly owned subsidiaries, (ii) modify the terms of any shares of its capital stock or other equity or voting interest or (iii) pledge or encumber any shares of its capital stock or other equity or voting interest;
•
(A) incur, assume, endorse, guarantee, or otherwise become liable for any indebtedness, except (i) borrowings in the ordinary course of business under the Company’s credit facilities as in effect on the date of the Merger Agreement or under facilities that replace, renew, extend, refinance or refund such existing credit facilities (including indebtedness incurred to repay or refinance related fees and expenses); provided that any such new facilities (x) are on terms not materially less favorable to the Company and its subsidiaries, (y) are not in an aggregate principal amount or, in the case of any revolving facility, an aggregate committed amount, in excess of the outstanding aggregate principal amount or aggregate committed amount, as applicable, of the facilities being so replaced, renewed, extended, refinanced or refunded, plus defeasance costs, original issue discount, upfront fees and other similar and customary fees, commissions, costs and expenses incurred in connection with such replacement, renewal, extension, refinancing or refunding and (z) will be repaid in full at or prior to the Effective Time, (ii) guarantees or credit support provided by the Company or any of its subsidiaries of the obligations of the Company or any of its subsidiaries to the extent such indebtedness is in existence on the date of the Merger Agreement or incurred in compliance with this covenant, (iii) letters of credit, bank guarantees, performance bonds and surety bonds entered into in the ordinary course of business and (iv) any intercompany indebtedness between the Company and its wholly owned subsidiaries or among the Company’s wholly owned subsidiaries or (B) settle, waive, or forgive any indebtedness owed to the Company or any of its subsidiaries;
•
(A) purchase any real property; (B) enter into any new lease agreement with respect to real property that is not leased by the Company or one of its subsidiaries as of the date of the Merger Agreement, other than any such lease providing for aggregate payments by the Company and its subsidiaries of less than $1,000,000 over the initial term thereof; or (C) with respect to any Lease (as defined in the Merger Agreement) for real property in effect on the date of the Merger Agreement, (1) waive, release, assign, or sublease any material rights or claims thereunder, (2) materially amend or modify the terms thereof, (3) except in the ordinary course of business, terminate such Lease for real property (other than as a result of expiration of the then-existing term), (4) except in the ordinary course of business, extend the term thereof, as in effect on the date of the Merger Agreement, or (5) grant any material waiver or give any consent thereunder;
•
except as required by any Employee Plan (as defined in the Merger Agreement) set forth in the Company Disclosure Letter: (i) establish, enter into, adopt, materially amend or modify, or terminate any Employee Plan (or any plan, policy, agreement or arrangement that would constitute a material Employee Plan if in effect on the date of the Merger Agreement), other than in conjunction with annual renewals of group welfare benefits in the ordinary course of business; or (ii) increase, modify or amend (including to accelerate the time of payment, vesting or funding of, or provide for the payment of amounts not otherwise due with respect to) the salaries, wages, benefits, bonuses or other compensation or other benefits payable or provided to any current or former director, officer, employee or individual service provider, except in the ordinary course of business; (iii) enter into or grant any change in control, severance, transaction, retention or similar agreement with any current or former employees, officers, directors or individual service providers of the Company or
93

TABLE OF CONTENTS

any of its subsidiaries; (iv) hire, engage, promote or terminate (other than for cause) any employee, officer, director or individual service provider of the Company or any of its subsidiaries whose annual base salary or wage rate exceeds $300,000; or (v) modify or amend any Company Equity Awards;
•
commence, settle, release, waive or compromise any pending or threatened legal proceeding (x) that involves any admission of liability or any injunctive or equitable relief or (y) for an amount in excess of $1,000,000 individually or $5,000,000 in the aggregate, other than any settlement of any legal proceeding or investigation (i) where the amount paid or to be paid by the Company or any of its subsidiaries is covered by insurance coverage maintained by the Company or any of its subsidiaries, (ii) for an amount not in excess of the amount, if any, reflected or reserved in the balance sheet (or the notes thereto) of the Company, (iii) in compliance with the terms of the Merger Agreement or (iv) involving any dispute between one or more of Parent or Merger Sub, on the one hand, and the Company, on the other hand, relating to the Merger Agreement or the transactions contemplated in the Merger Agreement;
•
materially change the Company’s or its subsidiaries’ methods, principles or practices of financial accounting or annual accounting period, except as required by GAAP, Regulation S-X promulgated under the Securities Act of 1933 (or any interpretation thereof), or by any governmental authority;
•
incur or commit to incur any capital expenditures other than (i) as set forth in the Company Disclosure Letter (the “Capex Budget”), or (ii) capital expenditures that do not exceed the Capex Budget by more than $15,000,000 in the aggregate;
•
enter into, modify in any material respect, amend in any material respect (including granting any material refunds, credits, rebates, allowances to customers thereunder) or terminate (other than any material contract that has expired in accordance with its terms) any material contract except, in each case, in the ordinary course of business; provided that material contracts relating to acquisitions and dispositions, indebtedness and leases will be exclusively governed by the corresponding restrictions described in this section;
•
(i) make (except in a manner consistent with past practice), change or revoke any material tax election, (ii) make any material change to any method of tax accounting, (iii) amend any material tax return, (iv) settle or compromise any material tax action, claim or assessment, (v) consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of material taxes, (vi) enter into any closing agreement with respect to a material amount of taxes, (vii) surrender any right to claim a material refund of taxes or (viii) initiate or enter into any voluntary disclosure agreement with a governmental authority with respect to a material amount of taxes;
•
acquire any division, assets, properties, businesses or equity securities or otherwise make any investment in any person (including by merger, consolidation or acquisition of stock or assets) for consideration in excess of $10,000,000 in the aggregate, other than (i) in or from any wholly owned subsidiary of the Company, or (ii) assets in the ordinary course of business;
•
sell, license, pledge, abandon, assign, transfer, or otherwise dispose of, any of the Company’s or its subsidiaries’ material assets (other than intellectual property, which is the subject of the following bullet), other than such sales, assignments, transfers or other dispositions that (i) are in the ordinary course of business or (ii) do not have a purchase price that exceeds $10,000,000 in the aggregate;
•
sell, assign, transfer, license, abandon, cancel, permit to lapse, pledge, encumber or otherwise dispose of any material Company Intellectual Property (as defined in the Merger Agreement), other than (i) the grant of non-exclusive licenses in the ordinary course of business and in a manner not inconsistent with past practices, (ii) the expiration of Registered Intellectual Property (as defined in the Merger Agreement) at the end of their statutory term, or (iii) pledges or encumbrances under the Existing Credit Agreement as in effect on the date of the Merger Agreement or any Permitted Lien (as defined in the Merger Agreement);
•
engage in any transaction with, or enter into any agreement, arrangement or understanding with, any affiliate of the Company or other person covered by Item 404 of Regulation S-K promulgated by the SEC that would be required to be disclosed pursuant to Item 404;
•
effectuate or announce any plant closing, mass employee layoff, furlough or any other action that would trigger the notice requirements of WARN (as defined in the Merger Agreement);
•
enter into, amend, or terminate any collective bargaining agreement;
94

TABLE OF CONTENTS

•
make any loans, advances or capital contributions to, any other person, except for (i) extensions of credit to customers in the ordinary course of business, (ii) advances to directors, officers and other employees for travel and other business-related expenses, in each case, in the ordinary course of business and in compliance in all material respects with the Company’s or its subsidiaries’ policies related thereto, and (iii) loans, advances or capital contributions to, any direct or indirect wholly owned subsidiaries of the Company; or
•
agree, resolve or commit to take any of the actions prohibited by the Merger Agreement.
Regulatory Filings; Efforts
Upon the terms and subject to the conditions set forth in the Merger Agreement and subject to any different standard set forth in the Merger Agreement with respect to any covenant or obligation, Parent and Merger Sub will, on the one hand, and the Company will, on the other hand, use their respective reasonable best efforts to (i) take (or cause to be taken) all actions; (ii) do (or cause to be done) all things; and (iii) assist and cooperate with the other parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable law or otherwise to consummate and make effective, as promptly as reasonably practicable, the Merger and the Transactions, including by (A) causing the conditions to the Merger set forth in the Merger Agreement to be satisfied and (B) (I) obtaining all consents, waivers, approvals, orders and authorizations from governmental authorities; and (II) making all registrations, declarations and filings with governmental authorities, in each case that are necessary or advisable to consummate the Transactions. The foregoing obligations will not apply to filings under antitrust laws, which will be governed by the obligations set forth in the Merger Agreement described below.
Notwithstanding anything to the contrary set forth in the Merger Agreement, none of Parent, Merger Sub, the Company nor any of their respective subsidiaries will be required to agree (or, in the case of the Company or its subsidiaries, will agree without Parent’s consent) to (i) the payment of a consent fee, “profit sharing” payment or other consideration (including increased or accelerated payments) or (ii) the provision of additional security (including a guaranty), in each case, in connection with the Merger, including in connection with obtaining any consent pursuant to any material contract.
Each of Parent and Merger Sub, on the one hand, and the Company (and its subsidiaries, if applicable), on the other hand, will, to the extent required, within ten business days following the date of the Merger Agreement file with the FTC and the DOJ a Notification and Report Form relating to the Merger Agreement and the Merger as required by the HSR Act. Each of Parent and the Company will (A) cooperate and coordinate with the other (or cause such cooperation or coordination) in the making of such filings; (B) supply the other (or cause the other to be supplied) with any information that may be required in order to make such filings; (C) subject to the terms of the Merger Agreement, supply (or cause to be supplied) any additional information that may be required or requested by the FTC, the DOJ or the governmental authorities of any other applicable jurisdiction in which any such filing is made; and (D) take, or cause to be taken, all actions necessary, proper or advisable, with respect to Parent, Merger Sub and their respective subsidiaries, if applicable, and of the Company and its subsidiaries, to (1) cause the expiration or termination of the applicable waiting periods pursuant to the HSR Act and any other antitrust laws applicable to the Merger Agreement or the Merger; and (2) obtain all clearances, consents, approvals, waivers, actions, non-actions and other authorizations pursuant to any antitrust laws applicable to the Merger Agreement or the Merger, in each case as promptly as practicable and in any event at least five business days prior to the Termination Date. Each of Parent and Merger Sub, on the one hand, and the Company (and its subsidiaries), on the other hand, will promptly inform the other (or cause the other to be informed) of any material communication from any governmental authority regarding the Merger in connection with such filings. If a party or any of its affiliates receives any comments or a request for additional information or documentary material from any governmental authority with respect to the Merger pursuant to the HSR Act or any other antitrust laws applicable to the Merger, then such party will make (or cause to be made), as promptly as practicable and after consultation with the other parties, an appropriate response to such request; provided that no party may extend any waiting period or enter into any agreement or understanding with any governmental authority without the permission of the other parties, which will not be unreasonably withheld, conditioned or delayed. Parent will control strategy, communications, and timing with respect to the parties’ efforts to obtain any necessary or advisable clearances, approvals, waivers, actions, non-actions, authorizations, consents, orders or declarations of any governmental authority or the expiration or termination of any applicable waiting period necessary to consummate the Transactions, including the Merger, after considering in good faith all comments and advice of the Company. Parent and Merger Sub will be solely responsible for payment of all filing fees in connection with filings made under the HSR Act and any other antitrust laws. Parent will prepare and make (or cause to be prepared and made) all filings, notifications, registrations, submissions of information and other documentation required or advisable under the HSR Act, supply (or cause to be
95

TABLE OF CONTENTS

supplied) any additional information requested by any governmental authority, and comply (or cause such compliance) with the notification, consultation and “outside counsel only” obligations set forth in the Merger Agreement.
In furtherance and not in limitation of the other covenants in the Merger Agreement, if and to the extent necessary to obtain clearances, consents, approvals, waivers, actions, expirations or terminations of any waiting period, non-actions or other authorizations pursuant to the HSR Act or any other antitrust laws applicable to the Merger, and to avoid or eliminate each and every impediment under any antitrust law and any other laws applicable to the Merger as promptly as practicable and in any event at least five business days prior to the Termination Date, each of Parent and Merger Sub will undertake (or cause to be undertaken, as applicable) to offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, and take (or cause to be taken) all actions with respect to Parent, Merger Sub, the Company and each of their respective subsidiaries necessary to avoid or eliminate each and every impediment and obtain all clearances, consents, approvals, waivers, actions, expirations or terminations of any waiting period, non-actions or other authorizations under the HSR Act and any other laws including (i) the sale, divestiture, transfer, license, disposition, or hold separate (through the establishment of a trust or otherwise), of any and all of the capital stock or other equity or voting interest, assets (whether tangible or intangible), rights, properties, products or businesses of the Company and its subsidiaries; (ii) the termination, modification, or assignment of existing relationships, joint ventures, contracts, or obligations of the Company and its subsidiaries; (iii) the modification of any course of conduct regarding future operations of the Company and its subsidiaries; and (iv) any other restrictions on the activities of the Company and its subsidiaries, including the freedom of action of the Company and its subsidiaries with respect to, or their ability to retain, one or more of their respective operations, divisions, businesses, product lines, customers, assets or rights or interests of the Company and its subsidiaries (each of the foregoing described in clauses (i) through (iv), together with entering into any settlement, undertaking, consent decree, stipulation or agreement with or required by any governmental authority in connection with the Transactions, a “Regulatory Concession”); in each case, so as to allow the consummation of the Merger as soon as practicable and, in any event, at least five business days prior to the Termination Date; provided that, notwithstanding anything in the Merger Agreement to the contrary, nothing in the Merger Agreement will require or obligate Parent or any of its affiliates to, and the Company will not, without the prior written consent of Parent, agree or otherwise be permitted to, take any action, including any Regulatory Concession, with respect to Parent, Merger Sub, or any of Parent’s affiliates (including (A)(x) GTCR LLC, and any investment funds or investment vehicles affiliated with, or managed or advised by GTCR, and (y) any portfolio company (as such term is commonly understood in the private equity industry) or investment of GTCR or of any such investment fund or investment vehicle, or any interest therein, or (B)(x) Elliott, and any investment funds or investment vehicles affiliated with, or managed or advised by Elliott, and (y) any portfolio company (as such term is commonly understood in the private equity industry) or investment of Elliott or of any such investment fund or investment vehicle), or any interest therein, in each case, other than the Company and its subsidiaries.
Parent will oppose (or cause to be opposed) any request for or the entry of, and seek (or cause to be sought) to have vacated or terminated, any order, judgment, decree, injunction or ruling of any governmental authority that could restrain, prevent or delay any required consents, clearances, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations applicable to the Merger, including by defending through litigation, any action asserted by any person in any court or before any governmental authority and by exhausting all avenues of appeal, including appealing properly any adverse decision or order by any governmental authority.
Notwithstanding the foregoing, nothing in the Merger Agreement will require Parent, Merger Sub, the Company or their respective subsidiaries to enter into any agreement or consent decree with the DOJ, FTC or any other governmental authority or take, or agree to take, any other action that is not conditioned on the Closing.
Parent and Merger Sub will not, and will cause the persons listed in the disclosure letter delivered by Parent and Merger Sub to the Company on the date of the Merger Agreement not to (i) acquire (by stock purchase, merger, consolidation, purchase of assets, license or otherwise), or (ii) enter into or agree to enter into, any contracts or arrangements, including for an acquisition (by stock purchase, merger, consolidation, purchase of assets, license or otherwise) of, any ownership interest, equity interests, assets or rights in or of any person that would reasonably be expected to, individually or in the aggregate, (A) prevent, materially delay or materially impede the obtaining of any clearances, approvals, waivers, actions, non-actions, authorizations, consents, orders or declarations of any governmental authority or the expiration or termination of any applicable waiting period necessary to consummate the Transactions, including the Merger, or (B) materially increase the risk of any governmental authority entering an order, ruling, judgment or injunction prohibiting the consummation of the Transactions, including the Merger.
96

TABLE OF CONTENTS

In furtherance and not in limitation of the foregoing, the Company, Parent and Merger Sub will, subject to any restrictions under applicable laws, undertake (or cause to be undertaken, as applicable) to (i) promptly notify the other parties of, and, if in writing, furnish the others with copies of (or, in the case of oral communications, advise the others of the contents of) any material communication received by such person from a governmental authority in connection with the Merger and provide the other parties a reasonable amount of time to review and discuss in advance (and to consider in good faith any comments made by the other parties in relation to) any proposed draft notifications, formal notifications, filing, submission or other written or oral communication (and any analyses, memoranda, white papers, presentations, correspondence or other documents submitted therewith) made in connection with the Merger to a governmental authority; (ii) keep the other parties informed (on a prompt basis) with respect to the status of any such submissions and filings to any governmental authority in connection with the Merger and any developments, meetings or discussions with any governmental authority in respect thereof, including with respect to (A) the receipt of any non-action, action, clearance, consent, approval, waiver or other authorizations, (B) the expiration or termination of any waiting period, (C) the commencement or proposed or threatened commencement of any investigation, litigation or administrative or judicial action or proceeding under applicable laws, including any proceeding initiated by a private party, and (D) the nature and status of any objections raised or proposed or threatened to be raised by any governmental authority with respect to the Merger; and (iii) not independently participate in any meeting, hearing, proceeding or substantive discussions (whether in person, by telephone, by video or otherwise) with or before any governmental authority in respect of the Merger without giving the other parties reasonable prior notice of such meeting or substantive discussions and, unless prohibited by such governmental authority, the opportunity to attend or participate. However, each of the Company, Parent and Merger Sub may reasonably designate any competitively sensitive information provided to any governmental authority as restricted to “outside counsel only” and any such information will not be shared with employees, officers or directors or their equivalents of the other party without approval of the party providing the commercially sensitive information; provided that each of the Company, Parent and Merger Sub may redact any valuation and related information before sharing any information provided to any governmental authority with another party on an “outside counsel only” basis, and that the Company, Parent and Merger Sub will not in any event be required to share information that benefits from legal privilege with the other parties, even on an “outside counsel only” basis, where this would, in the reasonable judgment of the Company’s counsel, cause such information to cease to benefit from legal privilege.
No Solicitation of Other Offers
From the date of the Merger Agreement until the earlier of the Effective Time and termination of the Merger Agreement, the Company is generally prohibited from soliciting Acquisition Proposals, providing non-public information to third parties in connection with an Acquisition Proposal or engaging in discussions or negotiations regarding an Acquisition Proposal, subject to the exceptions and requirements described below.
For purposes of the Merger Agreement:
•
“Acceptable Confidentiality Agreement” means any confidentiality agreement (x) in effect as of the date of the Merger Agreement or (y) executed, delivered and effective after the date of the Merger Agreement and containing terms that are not less favorable in any material respect to the Company than those contained in the Confidentiality Agreement (as defined in the Merger Agreement), except that such confidentiality agreement need not contain any “standstill” or similar provision or otherwise prohibit the making of any Acquisition Proposal.
•
“Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent or Merger Sub) to engage in an Acquisition Transaction.
•
“Acquisition Transaction” means any transaction or series of related transactions (other than the Merger) involving: (i) any direct or indirect purchase or other acquisition by any person or group, or equityholders of any such person or group, whether from the Company or any other person(s), of shares of Company Common Stock representing more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such purchase or other acquisition, including pursuant to a tender offer or exchange offer by any person or group that, if consummated in accordance with its terms, would result in such person or group beneficially owning more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such tender or exchange offer; (ii) any direct or indirect purchase or other acquisition by any person or group of more than 20% of the consolidated assets, net revenue or net income of the Company and its subsidiaries taken as a whole (measured by the fair market value thereof as determined in good faith by the
97

TABLE OF CONTENTS

Company Board) including the capital stock or other equity or voting interests in any of the Company’s subsidiaries; (iii) any merger, consolidation, business combination, share exchange, recapitalization, reorganization, liquidation, dissolution or other transaction involving the Company or any of its subsidiaries pursuant to which any person or group, or stockholders of any such person or group, would hold, directly or indirectly, more than 20% of the equity interests of the Company or the surviving or resulting entity of such transaction after giving effect to the consummation of such transaction; or (iv) any combination of the foregoing.
•
“Superior Proposal” means any unsolicited and bona fide written Acquisition Proposal for an Acquisition Transaction that did not result from a material breach of the non-solicitation terms of the Merger Agreement and that is on terms that the Company Board (or a committee thereof) has determined in good faith (after consultation with its financial advisors and outside legal counsel) would be more favorable to the Company stockholders from a financial point of view than the Merger (taking into account (i) any changes to the terms of the Merger Agreement offered by Parent in writing in response to such Superior Proposal in accordance with the Merger Agreement and (ii) all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the person making the proposal, and other aspects of such proposal that the Company Board (or a committee thereof) considers in good faith to be relevant) and (iii) is reasonably likely to be completed on the terms proposed (taking into account all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the person making the proposal and other aspects of such proposal that the Company Board (or a committee thereof) considers in good faith to be relevant). For purposes of the reference to an “Acquisition Proposal” in this definition, all references to “20%” in the definition of “Acquisition Transaction” will be deemed to be references to “50%.”
Subject to the exceptions described below, from the date of the Merger Agreement until the earlier to occur of the valid termination of the Merger Agreement and the Effective Time, the Company and its subsidiaries will not, and will not authorize or permit any of their respective representatives to, directly or indirectly:
•
solicit, initiate, propose or knowingly induce the making, submission or announcement of, or knowingly encourage, facilitate or assist, any inquiry, proposal or offer with respect to, that constitutes or could reasonably be expected to lead to, an Acquisition Proposal;
•
furnish or otherwise provide to any person (other than Parent, Merger Sub or any designees of Parent or Merger Sub) any non-public information relating to the Company or any of its subsidiaries or afford to any person access to the business, properties, assets, books, records or personnel, of the Company or any of its subsidiaries, in any such case with the intent to knowingly induce the making, submission or announcement of, or to knowingly encourage or knowingly facilitate, any proposal or offer with respect to, that constitutes or would reasonably be expected to lead to an Acquisition Proposal;
•
participate or otherwise engage in, enter into, continue or otherwise participate in, discussions or negotiations with any person (or its representatives, including potential financing sources of such person) with respect to an Acquisition Proposal (or inquiry, proposal, offer or any other effort or attempt that could reasonably be expected to lead to an Acquisition Proposal), in each case, other than informing such persons of the existence of the non-solicitation terms of the Merger Agreement or contacting such person solely in order to clarify (but not to negotiate) the terms and conditions of any Acquisition Proposal;
•
otherwise cooperate with or knowingly assist or participate in or knowingly facilitate the making of any Acquisition Proposal, including granting a waiver, amendment or release under any pre-existing standstill or similar provision to the extent necessary to allow for an Acquisition Proposal, or amendment to an Acquisition Proposal to be made to the Company or the Company Board;
•
approve, endorse or recommend an Acquisition Proposal; or
•
approve, endorse, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract relating to an Acquisition Transaction (including any “clean team” or similar arrangement), other than an Acceptable Confidentiality Agreement (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract relating to an Acquisition Transaction, an “Alternative Acquisition Agreement”).
98

TABLE OF CONTENTS

Notwithstanding these restrictions, from the date of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement and the Company’s receipt of the Requisite Stockholder Approval, the Company and the Company Board (or a committee thereof) may, directly or indirectly through one or more of their representatives, participate or engage in discussions or negotiations with, furnish any non-public information relating to the Company or any of its subsidiaries to, or afford access to the business, properties, assets, books, records or personnel, of the Company or any of its subsidiaries pursuant to an Acceptable Confidentiality Agreement to any person or such person’s representatives that has made, renewed or delivered to the Company an Acquisition Proposal after the date of the Merger Agreement, and otherwise facilitate such Acquisition Proposal or assist such person (and such person’s representatives and financing sources) with such Acquisition Proposal if requested by such person, in each case, with respect to an Acquisition Proposal that the Company Board (or a committee thereof) has determined in good faith (i) after consultation with its financial advisors and outside legal counsel, either constitutes a Superior Proposal or could reasonably be expected to lead to a Superior Proposal, and (ii) after consultation with its outside legal counsel, that the failure to do so would reasonably be likely to be inconsistent with its fiduciary duties under applicable law; provided that, subject to applicable law and any applicable “clean team” or similar arrangement, the Company will provide to Parent and Merger Sub any non-public information or data that is provided to any person given such access that was not previously made available to Parent or Merger Sub prior to or promptly (and in any event within 24 hours) following the time it is provided to such person.
From the date of the Merger Agreement until the earlier to occur of the termination of the Merger Agreement and the Effective Time, the Company will as promptly as reasonably practicable (and, in any event, within 48 hours) notify Parent if any Acquisition Proposal or any offers or proposals that would reasonably be expected to lead to an Acquisition Proposal are received by the Company or any of its representatives. Such notice must include (i) the identity of the person or group making such Acquisition Proposal or such offers or proposals; and (ii) a summary of the material terms and conditions of any such Acquisition Proposal or such offers or proposals and copies of any proposed material written agreements or material correspondence exchanged between the person (or its representatives) making such Acquisition Proposal and the Company (or its representatives). Thereafter, the Company must keep Parent reasonably informed, on a prompt basis, of the status and material terms of any such Acquisition Proposal or such offers or proposals (including any material amendments, revisions or other changes thereto) and the status of any related discussions or negotiations.
Nothing contained in the Merger Agreement will prohibit the Company or the Company Board (or a committee thereof) (i) from taking and disclosing to the Company stockholders a position contemplated by Rule 14d-9 or Rule 14e-2(a) promulgated under the Exchange Act or making a customary “stop-look-and-listen” communication to the Company stockholders pursuant to Rule 14d-9(f) under the Exchange Act or (ii) from making disclosures to the Company stockholders to the extent required under applicable securities laws with respect to the Transactions or an Acquisition Proposal, so long as, in each case, any such disclosure does not include any statement that constitutes, and does not otherwise constitute, a Company Board Recommendation Change (it being understood that neither (x) a customary “stop-look-and-listen” communication to the Company stockholders pursuant to Rule 14d-9(f) under the Exchange Act nor (y) a statement that the Company Board is evaluating a tender offer or exchange offer, in each case of clauses (x) and (y), made prior to the expiration of the period specified in clause (E) of the definition of Company Board Recommendation Change described below, will constitute a Company Board Recommendation Change); provided that the foregoing will in no way override the Company’s obligations under the Merger Agreement and no such communication or disclosure by the Company or the Company Board in accordance with and to the extent expressly permitted by the Merger Agreement will be deemed to be a Company Board Recommendation Change.
Prior to effecting a Company Board Recommendation Change in response to an Acquisition Proposal, the Company Board must have considered in good faith any proposals for amendments committed to by Parent in writing and have determined in good faith (after consultation with its financial advisors and outside legal counsel), that (x) such Acquisition Proposal continues to constitute a Superior Proposal and (y) the failure to take such action would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable Law if such changes proposed by Parent were to be given effect.
Financing Cooperation
Prior to the earlier of the Effective Time and the valid termination of the Merger Agreement, the Company has agreed to use, and to cause its subsidiaries and to use its reasonable best efforts to cause its and their respective representatives to use, reasonable best efforts to provide Parent and Merger Sub with all cooperation reasonably requested by Parent in connection with the Debt Financing, including using reasonable best efforts with respect to: (i) causing senior management of the Company and advisors to participate in a reasonable number of virtual or telephonic
99

TABLE OF CONTENTS

customary meetings, presentations, road shows, due diligence sessions (including with the Company’s accountants and auditors), drafting sessions and sessions with prospective lenders and rating agencies, at times and locations to be mutually agreed, (ii) providing customary assistance with the preparation of rating agency presentations, offering documents, private placement memoranda, bank information memoranda (including a version that does not include material non-public information), lender and investor presentations and other syndication materials, and customary authorization letters executed by a senior officer of the Company, (iii) assisting in the negotiation and preparation of, and executing and delivering, definitive financing agreements, corporate authorizations and other certificates (including a solvency certificate of the Company’s chief financial officer), and facilitating the pledging of, and perfection of security interests in, collateral, it being understood that such documents will not take effect until the Effective Time, (iv) furnishing Parent with the Required Financing Information (as defined in the Merger Agreement), including but not limited to, the Company’s audited and unaudited reviewed financial statements for specified periods, together with related management’s discussion and analysis, other historical financial and business information reasonably necessary to prepare pro forma financial statements and offering materials customary for a Rule 144A offering of secured high yield debt securities, and drafts of customary auditor comfort letters, subject to certain exclusions, (v) assisting in obtaining corporate and facility credit ratings, (vi) obtaining customary payoff letters and lien releases with respect to existing indebtedness of the Company and its subsidiaries and, at least four business days prior to the Closing Date, furnishing all documentation and other information required under applicable “know your customer,” anti-money laundering and beneficial ownership rules and regulations that any financing source has reasonably requested at least nine business days prior to the Closing Date (which obligation is not qualified by the reasonable best efforts standard), (vii) causing the Company’s independent auditors to provide customary assistance, including consents and customary “comfort letters” for a Rule 144A placement of securities, (viii) assisting in the taking of corporate and other actions, subject to the occurrence of the Closing, reasonably necessary to permit the consummation of the Debt Financing on the Closing Date, it being understood that no such action will take effect prior to the Closing, (ix) assisting Parent and Merger Sub in satisfying conditions precedent in the definitive financing documents to the extent such conditions require the cooperation of, or are within the control of, the Company or its subsidiaries and (x) providing customary authorization letters to the financing sources.
No such requested cooperation will require the Company or any of its subsidiaries to, among other things, (i) waive or amend any terms of the Merger Agreement or, to the extent not indemnified or reimbursed, pay any fees or reimburse any expenses prior to the Effective Time, (ii) enter into any definitive agreement the effectiveness of which is not conditioned upon the Closing (other than customary authorization letters, rating agency engagement letters and CFO certificates or other “management comfort”), (iii) to the extent not indemnified or reimbursed, give any indemnities that are effective prior to the Effective Time, (iv) take any action that would unreasonably and materially interfere with the conduct of the business of the Company and its subsidiaries or create a material risk of damage or destruction to any material property or assets of the Company or any of its subsidiaries, (v) cause any material representation, warranty or covenant in the Merger Agreement to be breached or any closing condition to fail to be satisfied, (vi) violate or waive any attorney-client or other legal privilege or materially breach applicable law, (vii) disclose trade secrets, customer-specific data or competitively sensitive information or violate any confidentiality obligation, (viii) provide information not reasonably obtainable from its books and records without undue effort or expense or (ix) deliver certain other excluded information. In addition, the Company will not be deemed to have breached its financing cooperation obligations unless (a) it has materially breached such obligations, (b) such breach was a proximate cause of the failure to obtain the Financing (as defined in the Merger Agreement), (c) Parent has notified the Company of such breach in writing and (d) the Company has not cured such breach within the earlier of ten business days following receipt of such notice (subject to extension under certain circumstances in the reasonable discretion of Parent) and the Termination Date. Parent has agreed to reimburse the Company for its reasonable and documented out-of-pocket costs and expenses incurred in connection with such cooperation, and Parent and Merger Sub have agreed to indemnify the Company, its subsidiaries and their respective representatives for liabilities incurred in connection with such cooperation, subject to certain exceptions.
Payoff of Existing Indebtedness
The Merger Agreement provides that, at least three business days prior to the Effective Time, with respect to the indebtedness under the Existing Credit Agreement to be repaid at the Effective Time, the Company will deliver (A) to Parent draft payoff letters in customary form from the lenders (or their applicable representative) with respect to the Existing Credit Agreement (i) setting forth the amounts required to pay off in full on the Closing Date such indebtedness and all other obligations owing to such holder of such indebtedness (including all principal, accrued and unpaid interest, fees and other amounts outstanding under the Existing Credit Agreement on the Closing Date) (other than any
100

TABLE OF CONTENTS

contingent reimbursement and indemnity obligations that expressly survive termination of the Existing Credit Agreement), after taking into account any required credit support and any existing letters of credit and required credit support contemplated by the applicable payoff letter to remain in effect or outstanding following the release of the liens described in clause (iii) below, (ii) confirming the termination of all commitments to extend credit under the Existing Credit Agreement upon payment of such indebtedness and the provision of any required credit support and (iii) providing that upon payment of the required amounts in respect of such indebtedness described in clause (i) and the provision of any required credit support, the termination and/or release of any related liens or other security interests and guarantees in connection with the Existing Credit Agreement (other than the required credit support) (the “Payoff Letters”) and (B) to the agent or lenders under the Existing Credit Agreement, any notices as may be required pursuant to the Existing Credit Agreement (including conditional notices of prepayment and redemption). At or prior to the Effective Time, Parent will provide (or cause to be provided) the funds necessary to repay and discharge in full such indebtedness, either to the Company or directly, on behalf of the Company, to the applicable agent or lenders, in each case in accordance with the Payoff Letters, and in accordance with such Payoff Letters, such indebtedness will be repaid and discharged substantially concurrently with the Effective Time.
Indemnification of Directors and Officers and Insurance
During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the surviving corporation and its subsidiaries will (and Parent will cause the surviving corporation and its subsidiaries to) honor and fulfill, in all respects, the obligations of the Company and its subsidiaries pursuant to any indemnification agreements in effect on the date of the Merger Agreement between the Company and any of its subsidiaries or affiliates, on the one hand, and any of their respective current or former directors, officers, managers or partners (and any person who becomes a director, officer, manager or partner of the Company or any of its subsidiaries prior to the Effective Time), on the other hand (each, together with such person’s heirs, executors and administrators, an “Indemnified Person” and, collectively, the “Indemnified Persons”). In addition, during the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the surviving corporation and its subsidiaries will (and Parent will cause the surviving corporation and its subsidiaries to) cause the organizational documents of the surviving corporation and its subsidiaries to contain provisions with respect to indemnification, exculpation and the advancement of expenses that are at least as favorable as the indemnification, exculpation and advancement of expenses provisions set forth in the organizational documents of the Company and its subsidiaries, as of the date of the Merger Agreement. During such six-year period, such provisions may not be repealed, amended or otherwise modified in any adverse manner except as required by applicable law.
Without limiting the generality of the foregoing, during the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the surviving corporation will (and Parent will cause the surviving corporation to) indemnify and hold harmless, to the fullest extent permitted by applicable law, and any of its subsidiaries in effect on the date of the Merger Agreement will, indemnify and hold harmless each Indemnified Person from and against any (x) reasonable and documented costs, fees and expenses (including reasonable attorneys’ fees and investigation expenses), and (y) judgments, fines, penalties, losses, claims, damages, liabilities and amounts paid in settlement or compromise in connection with any legal proceeding, whether civil, criminal, administrative or investigative, whenever asserted, to the extent that such legal proceeding arises, directly or indirectly, out of or pertains, directly or indirectly, to (i) the fact that an Indemnified Person is or was a director, officer, employee or agent of the Company or such subsidiary; (ii) any action or omission, or alleged action or omission, in such Indemnified Person’s capacity as a director, officer, employee or agent of the Company or any of its subsidiaries, or taken at the request of the Company or such subsidiary (including in connection with serving at the request of the Company or such subsidiary as a director, officer, employee, agent, trustee or fiduciary of another person (including any employee benefit plan), regardless of whether such action or omission, or alleged action or omission, occurred prior to, at or after the Effective Time); and (iii) the Merger, as well as any actions taken by the Company, Parent or Merger Sub with respect thereto (including any disposition of assets of the surviving corporation or any of its subsidiaries that is alleged to have rendered the surviving corporation or any of its subsidiaries insolvent), except that if, at any time prior to the sixth anniversary of the Effective Time, any Indemnified Person delivers to Parent a written notice asserting a claim for indemnification pursuant to the terms of the Merger Agreement, then the claim asserted in such notice will survive the sixth anniversary of the Effective Time until such claim is fully and finally resolved. In the event of any such legal proceeding, upon receipt of an undertaking by or on behalf of such Indemnified Person to repay any amount if it is ultimately determined by a court of competent jurisdiction in a final and non-appealable judgment that such Indemnified Person is not entitled to indemnification, the surviving corporation will advance all fees and expenses (including fees and expenses of any counsel) as incurred by an Indemnified Person in the defense of such legal proceeding, it being understood that such
101

TABLE OF CONTENTS

undertaking will be made without regard to such Indemnified Person’s ultimate entitlement to indemnification or ability to repay such advances, will not include the posting of any collateral and no other form of undertaking will be required. Notwithstanding anything to the contrary in the Merger Agreement, none of Parent, the surviving corporation nor any of their respective subsidiaries will settle or otherwise compromise or consent to the entry of any judgment with respect to, or otherwise seek the termination of, any legal proceeding for which indemnification may be sought by an Indemnified Person pursuant to the Merger Agreement unless such settlement, compromise, consent or termination includes an unconditional release of all Indemnified Persons from all liability arising out of, or relating to, such legal proceeding. Any determination required to be made with respect to whether the conduct of any Indemnified Person complies or complied with any applicable standard will be made by independent legal counsel selected by the surviving corporation (which counsel will be reasonably acceptable to such Indemnified Person), the fees and expenses of which will be paid by the surviving corporation.
During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the surviving corporation will (and Parent will cause the surviving corporation to) maintain in effect the Company’s current directors’ and officers’ liability insurance (“D&O insurance”) in respect of acts or omissions occurring at or prior to the Effective Time on terms (including with respect to coverage, conditions, retentions, limits and amounts) that are equivalent to those of the D&O insurance in effect as of immediately prior to the Effective Time. In satisfying its obligations pursuant to the terms of the Merger Agreement, the surviving corporation will not be obligated to pay annual premiums in excess of 300% of the amount paid by the Company for coverage for its last full fiscal year (such 300% amount, the “maximum annual premium”). If the annual premiums of such insurance coverage exceed the maximum annual premium, then the surviving corporation will be obligated to obtain a policy with the greatest coverage available for a cost not exceeding the maximum annual premium from an insurance carrier with the same or better credit rating as the Company’s current directors’ and officers’ liability insurance carrier. In satisfaction of the foregoing obligations, prior to the Effective Time the Company may (and at Parent’s request, the Company will) purchase a prepaid “tail” policy with respect to the D&O insurance so long as the aggregate cost for such “tail” policy does not exceed the aggregate maximum annual premium. If the Company elects to purchase such a “tail” policy prior to the Effective Time, the surviving corporation will (and Parent will cause the surviving corporation to) maintain such “tail” policy in full force and effect for a period of no less than six years after the Effective Time and continue to honor its obligations thereunder. If the Company is unable to obtain the “tail” policy and Parent or the surviving corporation is unable to obtain the insurance described above for an annual cost less than or equal to the maximum annual premium, Parent will cause the surviving corporation to instead obtain as much comparable insurance as possible for an aggregate annual premium equal to the maximum annual premium.
The foregoing obligations may not be terminated, amended or otherwise modified in any manner that adversely affects any Indemnified Person (or any other person who is a beneficiary pursuant to the D&O insurance or the “tail” policy referred to above (and their heirs and representatives), the “Other Indemnified Persons”) without the prior written consent of such affected Indemnified Person or Other Indemnified Person. Each of the Indemnified Persons or Other Indemnified Persons are intended to be third party beneficiaries of the provisions of the Merger Agreement described in this section, with full rights of enforcement as if a party. The rights of the Indemnified Persons and Other Indemnified Persons pursuant to such provisions will be in addition to, and not in substitution for, any other rights that such persons may have pursuant to (i) the Company’s Charter and bylaws; (ii) the organizational documents of the Company’s subsidiaries; (iii) any and all indemnification agreements entered into with the Company or any of its subsidiaries; or (iv) applicable law (whether at law or in equity).
If Parent, the surviving corporation or any of their respective successors or assigns (i) consolidates with or merges into any other person and is not the continuing or surviving corporation or entity in such consolidation or merger; or (ii) transfers or conveys all or substantially all of its properties and assets to any person, then proper provisions will be made to the extent such obligations are not otherwise assumed by operation of law so that the successors and assigns of Parent, the surviving corporation or any of their respective successors or assigns will assume all of the obligations of Parent and the surviving corporation described in this section.
Employee Matters
Pursuant to the Merger Agreement:
For a period of one year following the Effective Time or, if shorter, the period of employment, the surviving corporation and its subsidiaries will (and Parent will cause the surviving corporation and its subsidiaries to) maintain for the benefit of each employee of the Company or any of its subsidiaries prior to the Effective Time who continues to be an employee of Parent or one of its subsidiaries (including the surviving corporation) immediately after the Effective
102

TABLE OF CONTENTS

Time (each, a “Continuing Employee”) (i) a base salary or wage rate, as applicable, target annual (or shorter-term) cash incentive compensation opportunities (including bonus and commission, but excluding retention, long-term incentive, change in control or transaction compensation or equity or equity-based incentive opportunities) that are, in each case, no less than those in effect for such Continuing Employee immediately before the Effective Time; (ii) severance and termination benefits that are no less favorable than those applicable to such Continuing Employee immediately before the Effective Time; and (iii) all other benefit or compensation plans, programs, policies, agreements or arrangements of the surviving corporation or any of its subsidiaries (excluding any retention, long-term incentive, change in control or transaction compensation, equity or equity-based incentives, defined benefit pension plan, retiree health or retiree life insurance benefits or nonqualified deferred compensation benefits) at levels that are substantially similar in the aggregate to those in effect for such Continuing Employee under the Employee Plans as of immediately prior to the Effective Time.
With respect to each benefit or compensation plan, program, policy, arrangement or agreement that is made available to any Continuing Employee at or after the Effective Time (each such plan, a “New Plan”), the surviving corporation and its subsidiaries will (and Parent will cause the surviving corporation and its subsidiaries to) cause to be granted to such Continuing Employee credit for all service with the Company and its subsidiaries prior to the Effective Time for purposes of eligibility to participate and vesting and, with respect to vacation and severance benefits, entitlement to benefits, in each case, where length of service is relevant, and to the same extent that such service was recognized prior to the Effective Time under the corresponding Employee Plan (such plans, the “Old Plans”), except (i) to the extent that it would result in retroactive contributions or duplication of coverage or benefits for the same period of service or (ii) with respect to any defined benefit pension plan. In addition, and without limiting the generality of the foregoing, Parent will, or will cause its subsidiaries (including the surviving corporation) to take commercially reasonable efforts (i) to provide that each Continuing Employee will be immediately eligible to participate, without any waiting period, in any and all New Plans to the extent that coverage pursuant to any such New Plan replaces coverage pursuant to a corresponding Old Plan; (ii) for purposes of each New Plan providing life insurance, medical, dental, pharmaceutical, vision or disability benefits, to cause all waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work requirements of such New Plan to be waived for the Continuing Employees and their covered dependents; and (iii) for purposes of each New Plan providing medical, dental, pharmaceutical, or vision benefits, to cause any eligible expenses incurred by the Continuing Employees and their covered dependents during the portion of the plan year of the Old Plan ending on the date that Continuing Employees’ participation in the corresponding New Plan begins to be given full credit pursuant to such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such Continuing Employees and their covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan.
Any vacation or paid time off accrued but unused by a Continuing Employee as of immediately prior to the Effective Time will be credited to such Continuing Employee following the Effective Time in accordance with the applicable vacation or paid time off policy of the surviving corporation.
Parent will, or will cause its affiliates (including the surviving corporation and any of its respective subsidiaries) to, continue each annual cash incentive compensation plan or arrangement set forth on the Company Disclosure Letter, for the 2026 calendar year, following the Closing in good faith and in the ordinary course of business substantially consistent with the Company’s or its applicable subsidiary’s past practice. Each Continuing Employee will be paid an amount based on actual performance for the full 2026 calendar year, which amount will be paid at substantially the same time as annual bonuses have historically been paid by the Company or its applicable subsidiaries (but in no event later than the 15th day of the third month following the 2026 calendar year). The manner of calculating actual performance for such full 2026 calendar year will be consistent with the Company’s or its applicable subsidiary’s past practice prior to the Closing.
Nothing in the Merger Agreement will be deemed to: (i) guarantee employment or service for any period of time for, or preclude the ability of Parent, the surviving corporation or any of their respective subsidiaries to terminate any Continuing Employee or the employment or service of any other person; (ii) constitute the establishment or adoption of or amendment to any Employee Plan, New Plan or other benefit plan; (iii) create any third party beneficiary rights in any Continuing Employee (or beneficiary or dependent thereof); (iv) interfere with the right or limit the ability of Parent and its subsidiaries to create, amend, modify or terminate any Employee Plan, New Plan or other benefit plan.
103

TABLE OF CONTENTS

Other Covenants and Agreements
The Merger Agreement contains other covenants and agreements, including a covenant in which the initial press release with respect to the execution of the Merger Agreement will be a joint press release in the form reasonably agreed to by the parties. Following such initial press release, the Company and Parent will consult with each other before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Merger and will not issue any such press release or make any such public statement without the prior written consent of the other party except as otherwise provided in the Merger Agreement.
In addition, the Company will, prior to the Effective Time:
•
provide Parent with prompt notice of all transaction litigation against the Company and its subsidiaries and its and their directors and executive officers (including by providing copies of all pleadings with respect thereto) and keep Parent reasonably informed with respect to the status thereof; give Parent the opportunity to participate in (but not control) the defense, settlement or prosecution of such transaction litigation, including by giving Parent the opportunity to review and comment on all filings and responses to be made by the Company in connection with any transaction litigation; and consult with Parent with respect to the defense, settlement and prosecution of such transaction litigation. The Company may not compromise or settle or enter into any agreement, or consent to the entry of, any order or judgment with respect to such transaction litigation unless Parent has consented thereto in writing (which consent will not be unreasonably withheld, conditioned or delayed);
•
cooperate with Parent and use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things reasonably necessary, proper or advisable on its part pursuant to applicable laws and the rules and regulations of Nasdaq to cause the delisting by the Company of the Company Common Stock from Nasdaq as promptly as practicable after the Effective Time and the deregistration of the Company Common Stock pursuant to the Exchange Act as promptly as practicable after such delisting;
•
be permitted to take all such actions as may be reasonably necessary or advisable to cause the Merger, and any dispositions of equity securities of the Company (including derivative securities) (including the disposition, cancellation, or deemed disposition and cancellation of Company Common Stock, SPAC Merger Earnout Shares, Sponsor Earnout Shares, Company Options, Company RSUs, Company PSUs or Company RSAs) in connection with the Merger by each individual who is a director or executive officer of the Company, to be exempt under Rule 16b-3 promulgated under the Exchange Act;
•
as promptly as reasonably practicable following the date of the Merger Agreement (but in any event within 25 business days), the Company (with the assistance and cooperation of Parent and Merger Sub as reasonably requested by the Company) will prepare and file with the SEC a preliminary proxy statement relating to the Special Meeting. Subject to the terms of the Merger Agreement, the Company will include the Company Board Recommendation (as defined in the Merger Agreement) in the proxy statement. Subject to applicable law, the Company will use its reasonable best efforts to cause the proxy statement to be disseminated to the Company stockholders as promptly as reasonably practicable, and in no event more than five business days, following the filing thereof with the SEC and confirmation from the SEC that it will not review, or that it has completed its review of, the proxy statement, which confirmation will be deemed to have occurred if the SEC has not affirmatively notified the Company by 11:59 p.m., New York City time, on the tenth calendar day following such filing with the SEC that the SEC will or will not be reviewing the proxy statement; and
•
at or prior to the Closing, the Company will cause the termination, effective as of the Closing, of each affiliate agreement, other than certain affiliate contracts or other contracts set forth in the Company Disclosure Letter, in its entirety without any further liability or obligation of the Company or any of its subsidiaries from and after the Closing.
Conditions to Consummation of the Merger
The respective obligations of each party to consummate the Merger are subject to the satisfaction (or waiver by Parent and the Company where permissible pursuant to applicable law) at or prior to the Effective Time of each of the following conditions:
•
the Company’s receipt of the Requisite Stockholder Approval at the Special Meeting;
104

TABLE OF CONTENTS

•
the waiting periods (and any extensions thereof, including any agreement with any governmental authority to delay the Closing entered into in connection therewith) applicable to the Transactions pursuant to the HSR Act will have expired or otherwise been terminated; and
•
no law, injunction or order (whether temporary, preliminary or permanent) by any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger will have been enacted, entered or promulgated and be continuing in effect.
In addition, the obligations of Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or waiver by Parent where permissible pursuant to applicable law) at or prior to the Effective Time of each of the following further conditions:
•
the representations and warranties of the Company relating to organization and good standing, corporate power and enforceability, Company Board approval, certain aspects of the Company’s capitalization and brokers will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all material respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct in all material respects only as of such specified date);
•
the representations and warranties of the Company relating to certain other aspects of the Company’s capitalization will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct in all respects only as of such specified date), except for de minimis inaccuracies;
•
the representations and warranties of the Company relating to the absence of certain changes will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date;
•
the other representations and warranties of the Company will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) on the date of the Merger Agreement and on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct only as of such specified date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, have a Company Material Adverse Effect;
•
the Company will have complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by it at or prior to the Closing;
•
since the date of the Merger Agreement, there will not have occurred a Company Material Adverse Effect;
•
Parent and Merger Sub will have received a certificate of the Company, validly executed for and on behalf of the Company and in its name by a duly authorized executive officer thereof, certifying that the conditions set forth in the immediately preceding six bullets have been satisfied; and
•
at or prior to the Closing, the Company will have delivered to Parent, in a form reasonably satisfactory to Parent, a certificate complying with Treasury Regulation Section 1.1445-2(c)(3), certifying that the Company is not, and has not been during the applicable period described in Section 897(c)(1)(A)(ii) of the Code, a “United States real property holding corporation” within the meaning of Section 897(c) of the Code, together with a copy of the notice to the IRS provided in accordance with Treasury Regulation Section 1.897-2(h)(2).
In addition, the obligations of the Company to consummate the Merger are subject to the satisfaction (or waiver by the Company where permissible pursuant to applicable law) at or prior to the Effective Time of each of the following further conditions:
•
the representations and warranties of Parent and Merger Sub set forth in the Merger Agreement will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Parent Material Adverse Effect” or words of similar import) as of the Closing Date as if made on and as of such date (except to the
105

TABLE OF CONTENTS

extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct only as of such specified date), except where the failure of any such representations and warranties to be so true and correct, individually or in the aggregate, would not reasonably be expected to prevent, materially delay, or have a material adverse effect on the ability of Parent or Merger Sub to perform its obligations under the Merger Agreement or to consummate the Transactions;
•
Parent and Merger Sub will have complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by Parent and Merger Sub at or prior to the Closing; and
•
the Company will have received a certificate of Parent and Merger Sub, validly executed for and on behalf of Parent and Merger Sub and in their respective names by a duly authorized officer thereof, certifying that the conditions set forth in the immediately preceding two bullets have been satisfied.
Termination of the Merger Agreement
The Merger Agreement may be validly terminated only as follows (and may not be terminated for any other reason or on any other basis):
•
At any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), by mutual written agreement of Parent and the Company.
•
By either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), if (i) any permanent injunction or other final and non-appealable judgment or order issued by any court or other governmental authority of competent jurisdiction preventing the consummation of the Merger is in effect that, in each case, prohibits, makes illegal or enjoins the consummation of the Merger and has become final and non-appealable or (ii) any statute, rule or regulation has been enacted, entered or enforced that prohibits, makes illegal or enjoins the consummation of the Merger (a “Legal Restraint”); provided that this right to terminate will not be available to a party if the issuance of such Legal Restraint was primarily due to the failure of such party (treating Parent and Merger Sub as one party for this purpose) to perform any of its obligations under the Merger Agreement or if such party (treating Parent and Merger Sub as one party for this purpose) has failed to comply with its antitrust and regulatory obligations under the Merger Agreement.
•
By either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), if the Effective Time has not occurred by the Termination Date; provided that this right to terminate will not be available to a party (treating Parent and Merger Sub as one party for this purpose) if the failure of the Merger to be consummated prior to the Termination Date was primarily due to the failure of such party to perform any of its obligations under the Merger Agreement (it being understood that Parent’s failure to consummate the Closing due to the unavailability of the Debt Financing will not in itself be deemed to be an action or failure to act solely for purposes of this termination right).
•
By either Parent or the Company, at any time prior to the Effective Time, if the Company fails to obtain the Requisite Stockholder Approval at the Special Meeting (or any adjournment or postponement thereof) at which a vote is taken on the Merger.
•
By Parent, if the Company has breached or failed to perform any of its representations, warranties, covenants or other agreements contained in the Merger Agreement, which breach or failure to perform would result in a failure of a condition relating to the accuracy of the Company’s representations and warranties or the performance of the Company’s covenants, except that if such breach is capable of being cured prior to the Termination Date, Parent will not be entitled to terminate the Merger Agreement prior to the delivery by Parent to the Company of written notice of such breach, delivered at least forty-five days prior to such termination, stating Parent’s intention to terminate the Merger Agreement and the basis for such termination, it being understood that Parent will not be entitled to terminate the Merger Agreement if such breach has been cured prior to termination; provided that Parent will not have the right to terminate the Merger Agreement if it or Merger Sub is then in material breach of any representations, warranties, covenants or other agreements contained in the Merger Agreement that would result in a failure of a condition relating to the accuracy of Parent’s and Merger Sub’s representations and warranties or the performance of their covenants.
106

TABLE OF CONTENTS

•
By Parent, if at any time prior to the Company’s receipt of the Requisite Stockholder Approval, the Company Board has effected a Company Board Recommendation Change.
•
By the Company, if Parent or Merger Sub has breached or failed to perform any of its respective representations, warranties, covenants or other agreements contained in the Merger Agreement, which breach or failure to perform would result in a failure of a condition relating to the accuracy of Parent’s and Merger Sub’s representations and warranties or the performance of their covenants, except that if such breach is capable of being cured prior to the Termination Date, the Company will not be entitled to terminate the Merger Agreement prior to the delivery by the Company to Parent of written notice of such breach, delivered at least forty-five days prior to such termination, stating the Company’s intention to terminate the Merger Agreement and the basis for such termination, it being understood that the Company will not be entitled to terminate the Merger Agreement if such breach has been cured prior to termination; provided that the Company will not have the right to terminate the Merger Agreement if it is then in material breach of any representations, warranties, covenants or other agreements contained in the Merger Agreement that would result in a failure of a condition relating to the accuracy of the Company’s representations and warranties or the performance of the Company’s covenants.
•
By the Company, at any time prior to receiving the Requisite Stockholder Approval, in order to substantially concurrently enter into an Alternative Acquisition Agreement providing for a Superior Proposal received after the date of the Merger Agreement, if the Company (A) has complied in all material respects with the non-solicitation terms of the Merger Agreement in connection with such Superior Proposal and (B) pays to Parent in immediately available funds the Company Termination Fee substantially concurrently with such termination.
•
By the Company, if (i) all of the mutual conditions and the conditions to the obligations of Parent and Merger Sub to consummate the Merger are satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied), (ii) the Company has irrevocably confirmed to Parent in writing that it is prepared to consummate the Closing and (iii) Parent fails to consummate the Transactions by the date that is three business days after the later of (x) the first date on which Parent is required to consummate the Closing pursuant to the Merger Agreement and (y) the date of such notice.
Any valid termination of the Merger Agreement will be effective immediately upon the delivery of written notice by the terminating party to the other parties (or as specified in the mutual written agreement of Parent and the Company). In the event of the valid termination of the Merger Agreement, the Merger Agreement will be of no further force or effect without liability of any party (or any partner, member, stockholder, director, officer, employee, affiliate or representative of such party) to the other parties, except that certain provisions will survive termination, including the provisions relating to reimbursement and indemnification in connection with financing cooperation, public statements and disclosure, the manner, notice and effect of termination, fees and expenses (including termination fees) and certain general provisions. Notwithstanding the foregoing, but subject to the limitations on remedies described in the section of this proxy statement titled “— Termination Fees,” no termination of the Merger Agreement will relieve any party from any liability for fraud by such party or any Willful and Material Breach (as defined in the Merger Agreement) of the Merger Agreement by such party prior to termination. In addition, no termination of the Merger Agreement will affect the rights or obligations of any party pursuant to the Confidentiality Agreement.
Termination Fees
Company Termination Fee. The Company will be required to pay the Company Termination Fee to Parent in the following circumstances:
•
Tail-Fee Scenario. If (A) the Merger Agreement is validly terminated pursuant to (x) the Termination Date termination right (provided that at the Termination Date, all of the mutual conditions (other than the receipt of the Requisite Stockholder Approval) and all of the conditions to the Company’s obligations have been satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied as if such time were the Closing)), (y) the failure to obtain the Requisite Stockholder Approval termination right or (z) the Company Breach termination right; (B) following the execution and delivery of the Merger Agreement and prior to such termination, any person has publicly announced or provided to the Company Board or management of the Company an Acquisition Proposal and not publicly (in the case of an Acquisition Proposal that has been
107

TABLE OF CONTENTS

publicly announced) withdrawn such Acquisition Proposal at least five business days prior to the Special Meeting or prior to the date of termination in the case of a termination pursuant to the Termination Date or Company Breach termination rights; and (C) within twelve months following such termination, either an Acquisition Transaction is consummated or the Company enters into a definitive agreement providing for the consummation of an Acquisition Transaction, then the Company must promptly (and in any event within three business days) upon the earlier of entry into such definitive agreement or the consummation of such Acquisition Transaction pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent. For purposes of this bullet, all references to “20%” in the definition of “Acquisition Transaction” will be deemed to be references to “50%”;
•
Company Board Recommendation Change. If the Merger Agreement is validly terminated pursuant to the Company Board Recommendation Change termination right, then the Company must promptly (and in any event within three business days) following such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent; and
•
Superior Proposal. If the Merger Agreement is validly terminated pursuant to the Superior Proposal termination right, then the Company must substantially concurrently with such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent.
In no event will the Company or any of its subsidiaries have liability for monetary damages (including monetary damages in lieu of specific performance) in the aggregate in excess of the amount of the Company Termination Fee, including for Willful and Material Breach. Notwithstanding the foregoing, nothing in the Merger Agreement will relieve the Company from any liability for fraud prior to termination.
If the Merger Agreement is validly terminated (i) by the Company pursuant to the Parent or Merger Sub Breach termination right or the Parent Failure to Close termination right or (ii) by the Company or Parent pursuant to the Termination Date termination right (at a time at which the Company had, or would have had upon completion of the applicable notice and waiting periods, the right to terminate the Merger Agreement pursuant to the Parent or Merger Sub Breach termination right or the Parent Failure to Close termination right), then Parent will promptly (and in any event within three business days) pay the Company the Parent Termination Fee of $313,992,000 by wire transfer of immediately available funds to an account or accounts designated in writing by the Company. If the Parent Termination Fee is due and Parent fails to pay such amount to the Company (or its designee) in accordance with the Merger Agreement, then Parent will also be liable for any reasonable and documented out-of-pocket costs and expenses (including attorneys’ fees) incurred by the Company and its affiliates in connection with any legal proceeding or other action or proceeding to enforce the Company’s rights with respect to the Parent Termination Fee, together with interest on the Parent Termination Fee or any unpaid portion thereof at the prime rate, as published in The Wall Street Journal in effect on the date that such payment or portion thereof was required (such costs, expenses and interest, as applicable, the “Enforcement Costs”); provided, that such Enforcement Costs shall not, in the aggregate, exceed $7,500,000. In no event will Parent, Merger Sub or the Guarantors have liability for monetary damages of any kind (including monetary damages in lieu of specific performance, the Parent Termination Fee and/or damages for Willful and Material Breach) in the aggregate in excess of the amount of the Parent Termination Fee, the Enforcement Costs plus any reimbursement obligations of Parent under the Merger Agreement. Notwithstanding the foregoing, nothing in the Merger Agreement will relieve Parent from any liability for fraud prior to termination.
In no event will the Company be required to pay the Company Termination Fee or Parent be required to pay the Parent Termination Fee (and the Enforcement Costs, if any) on more than one occasion, whether or not the Company Termination Fee or the Parent Termination Fee, as applicable, may be payable pursuant to more than one provision of the Merger Agreement at the same or at different times and upon the occurrence of different events.
Superior Proposal and Change of Recommendation
Except as described below, the Company Board will not (i) (A) withhold, withdraw, amend or modify, or publicly propose to withhold, withdraw, amend or modify, the Company Board Recommendation; (B) adopt, approve, recommend or endorse or otherwise declare advisable, or publicly propose to adopt, approve or recommend to the Company stockholders, an Acquisition Proposal; (C) fail to include the Company Board Recommendation in this proxy statement; (D) fail to publicly reaffirm the Company Board Recommendation within ten business days after Parent so
108

TABLE OF CONTENTS

requests in writing following the public disclosure of an Acquisition Proposal (other than of the type referred to in the following clause (E)) with any person other than Parent and Merger Sub (provided that if the Special Meeting is scheduled to be held within ten business days from the date of such written request, promptly and in any event prior to the date which is two business days before the date on which the Special Meeting is scheduled to be held if at least two business days from the date of such written request); (E) fail to recommend, in a Solicitation/Recommendation Statement on Schedule 14D-9 under the Exchange Act, against any Acquisition Proposal that is a tender offer or exchange offer subject to Regulation 14D promulgated under the Exchange Act within ten business days after the commencement (within the meaning of Rule 14d-2 under the Exchange Act) of such tender offer or exchange offer (or if the Special Meeting is scheduled to be held within ten business days from the date of such commencement, promptly and in any event prior to the date which is two business days before the date on which the Special Meeting is scheduled to be held); or (F) resolve, agree or publicly propose to do any of the foregoing (any action described in clauses (A) through (F), a “Company Board Recommendation Change”) or (ii) cause or permit the Company or any of its subsidiaries to enter into an Alternative Acquisition Agreement. None of (1) the factually accurate disclosure by the Company of the receipt of an Acquisition Proposal, (2) the determination by the Company Board (or a committee thereof) that an Acquisition Proposal constitutes a Superior Proposal or (3) the delivery by the Company to Parent of any notice contemplated by the provisions described below will constitute a Company Board Recommendation Change.
Notwithstanding the restrictions described above, until the earlier to occur of the termination of the Merger Agreement and the Company’s receipt of the Requisite Stockholder Approval:
•
the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event (as defined below) if the Company Board (or a committee thereof) determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; provided that the Company Board (or a committee thereof) will not effect such a Company Board Recommendation Change unless (1) the Company has provided prior written notice to Parent at least four business days in advance (the “Intervening Event Notice Period”) to the effect that the Company Board (or a committee thereof) intends to effect a Company Board Recommendation Change, which notice will specify the basis for such Company Board Recommendation Change; (2) prior to effecting such Company Board Recommendation Change, the Company and its representatives, during the Intervening Event Notice Period, negotiate with Parent and its representatives in good faith (to the extent that Parent desires to so negotiate) to enable Parent to make such adjustments to the terms and conditions of the Merger Agreement and the Financing Letters in such a manner that would obviate the need to effect a Company Board Recommendation Change (and, in the event the Intervening Event thereafter changes in any material respect, the Company will be required to deliver a new written notice to Parent and to comply with such requirements with respect to such new written notice, with the Intervening Event Notice Period in respect of such new written notice being three business days); and (3) at the end of the Intervening Event Notice Period and prior to taking any such action, the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing to make revisions to the terms of the Merger Agreement and the Financing Letters, and has determined in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to effect a Company Board Recommendation Change would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable law if such changes proposed by Parent were to be given effect; or
•
if the Company has received an unsolicited and bona fide Acquisition Proposal that did not result from a material breach of the non-solicitation terms of the Merger Agreement and that the Company Board has determined in good faith (after consultation with its financial advisors and outside legal counsel) constitutes a Superior Proposal, then the Company Board may (A) effect a Company Board Recommendation Change with respect to such Acquisition Proposal or (B) cause the Company to terminate the Merger Agreement in order to substantially concurrently enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal; provided that the Company Board (or a committee thereof) will not take any action described in the foregoing clauses (A) and (B) unless (1) the Company Board determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; (2) (i) the Company has provided prior written notice to Parent at least four business days in advance (such notice period, including any extension thereto, the “Acquisition Proposal Notice Period”) to the effect that the Company Board (or a committee thereof) intends to take the actions described in clauses (A) or (B) above, including the identity of the person
109

TABLE OF CONTENTS

or group making such Acquisition Proposal, the material terms thereof and copies of all material relevant agreements (including any Alternative Acquisition Agreement) relating to such Acquisition Proposal, and (ii) prior to effecting such Company Board Recommendation Change or termination, the Company and its representatives, during the Acquisition Proposal Notice Period, negotiate with Parent and its representatives in good faith (to the extent that Parent desires to so negotiate) to enable Parent to make such adjustments to the terms and conditions of the Merger Agreement and the Financing Letters in such a manner that would obviate the need to effect a Company Board Recommendation Change or termination; provided that, in the event of any material modifications to such Acquisition Proposal (it being understood that any change to the financial terms (including the form, amount and timing of payment of consideration) or other material terms of such proposal will be deemed a material modification), the Company will be required to deliver a new written notice to Parent and to comply with the foregoing requirements with respect to such new written notice, it being understood that the Acquisition Proposal Notice Period in respect of such new written notice will be three business days; and (3) at the end of the Acquisition Proposal Notice Period and prior to taking any such action, the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing to make revisions to the terms of the Merger Agreement and the Financing Letters, and has determined in good faith (after consultation with its financial advisors and outside legal counsel), that (x) such Acquisition Proposal continues to constitute a Superior Proposal and (y) the failure to take such action would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable law if such changes proposed by Parent were to be given effect.
For purposes of the Merger Agreement, “Intervening Event” means any positive change, event, effect, development or circumstance occurring after the date of the Merger Agreement that (i) was not known or reasonably foreseeable to the Company Board on the date of the Merger Agreement (or, if known by the Company Board, the consequences of which were not known or reasonably foreseeable by the Company Board as of the date of the Merger Agreement) and (ii) does not relate to (A) any Acquisition Proposal or any matter relating thereto, (B) any change, in and of itself, in the stock price or trading volume of the Company Common Stock, (C) any breach by the Company of the Merger Agreement or (D) the mere fact, in and of itself, that the Company meets or exceeds any internal or published projections, forecasts, estimates or predictions of revenue, earnings or other financial or operating metrics for any period ending on or after the date of the Merger Agreement.
Amendment and Waiver
Subject to applicable law and subject to the other provisions of the Merger Agreement, the Merger Agreement may be amended by the parties at any time by execution of an instrument in writing signed on behalf of each of Parent, Merger Sub and the Company (pursuant to authorized action by the Company Board), except that in the event that the Company has received the Requisite Stockholder Approval, no amendment may be made to the Merger Agreement that requires the approval of the Company stockholders pursuant to the DGCL without such approval. Notwithstanding anything to the contrary contained in the Merger Agreement, certain provisions of the Merger Agreement for the benefit of the Debt Financing Sources, and the definition of “Debt Financing Sources” (and any other provision or definition of the Merger Agreement to the extent a modification, waiver or termination of such provision would modify the substance of any of the foregoing provisions) may not be amended, supplemented, waived or otherwise modified in any manner that is materially adverse to the Debt Financing Sources without the prior written consent of such Debt Financing Sources (such consent not to be unreasonably withheld, conditioned or delayed).
At any time and from time to time prior to the Effective Time, Parent and the Company may, to the extent legally allowed and except as otherwise set forth in the Merger Agreement, (x) extend the time for the performance of any of the obligations or other acts of the other party, as applicable; (y) waive any inaccuracies in the representations and warranties of the other party contained in the Merger Agreement or in any document delivered pursuant thereto; and (z) subject to the requirements of applicable law, waive compliance by the other party with any of the agreements or conditions contained in the Merger Agreement applicable to such party (with Parent and Merger Sub deemed a single party for this purpose). Any agreement on the part of a party to any such extension or waiver will be valid only if set forth in an instrument in writing signed by such party, and any delay in exercising any right pursuant to the Merger Agreement will not constitute a waiver of such right.
Governing Law; Jurisdiction and Waiver of Jury Trial
Except with respect to certain claims against the Debt Financing Sources described below, the Merger Agreement and all actions, proceedings, causes of action, claims or counterclaims (whether based on contract, tort, statute or otherwise) based upon, arising out of or relating to the Merger Agreement or the actions of Parent, Merger Sub or the
110

TABLE OF CONTENTS

Company in the negotiation, administration, performance and enforcement thereof (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in connection with the Merger Agreement or as an inducement to enter into the Merger Agreement), will be governed by, and construed in accordance with, the internal laws of the State of Delaware, including its statutes of limitations, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws, including any statutes of limitations, of any jurisdiction other than the State of Delaware.
Each of the parties has (a) irrevocably consented to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any legal proceeding relating to the Merger or the Limited Guarantees, for and on behalf of itself or any of its properties or assets, in accordance with the terms of the Merger Agreement or in such other manner as may be permitted by applicable law, and nothing in the Merger Agreement will affect the right of any party to serve legal process in any other manner permitted by applicable law; (b) irrevocably and unconditionally consented and submitted itself and its properties and assets in any legal proceeding to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any other state or federal court within the State of Delaware) (the “Chosen Courts”) in the event that any dispute or controversy arises out of the Merger Agreement, the Limited Guarantees or the transactions contemplated thereby; (c) agreed that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (d) agreed that any legal proceeding arising in connection with the Merger Agreement, the Limited Guarantees or the transactions contemplated thereby will be brought, tried and determined only in the Chosen Courts; (e) waived any objection that it may now or hereafter have to the venue of any such legal proceeding in the Chosen Courts or that such legal proceeding was brought in an inconvenient court and agreed not to plead or claim the same; and (f) agreed that it will not bring any legal proceeding relating to the Merger Agreement, the Limited Guarantees or the transactions contemplated thereby in any court other than the Chosen Courts. Each of Parent, Merger Sub and the Company has agreed that a final judgment in any legal proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable law.
Notwithstanding anything to the contrary contained in the Merger Agreement, all disputes, actions, causes of action, claims, cross-claims or third-party claims of any kind or description against any of the Debt Financing Sources under or in respect of any Debt Financing, the Debt Commitment Letter and the Fee Letters and the transactions and performance contemplated thereby related to the Merger Agreement and the Transactions or the facts and circumstances leading to its execution, whether in law or in equity and whether in contract, tort or otherwise (including any dispute, action, cause of action, claim, cross-claim or third-party claim of any kind or description arising out of or relating in any way to any Debt Financing), will be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts executed in and to be performed entirely within such State, without regard to conflict of law principles that would result in the application of any law other than the law of the State of New York, except as expressly set forth in the Debt Commitment Letter, and each of the parties agrees that it will not bring or support any such action against the Debt Financing Sources in any forum other than any New York state or federal court located in the Borough of Manhattan in the City of New York.
Specific Performance
In the Merger Agreement, the parties have acknowledged and agreed that irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the event that the parties do not perform the provisions of the Merger Agreement (including any party failing to take such actions as are required of it under the Merger Agreement in order to consummate the transactions contemplated by the Merger Agreement) in accordance with its specified terms or otherwise breach such provisions. Accordingly, subject to the limitations described below, the parties will be entitled, in addition to any other remedy to which they are entitled at law or in equity, to an injunction, specific performance and other equitable relief to prevent breaches (or threatened breaches) of the Merger Agreement and to enforce specifically the terms and provisions of the Merger Agreement, and the right of specific enforcement is an integral part of the Merger and, without that right, neither the Company nor Parent would have entered into the Merger Agreement. Subject to the limitations described below, the parties have agreed not to raise any objections to the granting of an injunction, specific performance or other equitable relief to prevent or restrain breaches or threatened breaches of the Merger Agreement by the Company, on the one hand, or Parent and Merger Sub, on the other hand, or to the specific performance of the terms and provisions of the Merger Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants, obligations and agreements of Parent and Merger Sub under
111

TABLE OF CONTENTS

the Merger Agreement. Any party seeking an injunction to prevent breaches of the Merger Agreement and to enforce specifically its terms and provisions will not be required to provide any bond or other security in connection with such injunction or enforcement, and each party has irrevocably waived any right that it may have to require the obtaining, furnishing or posting of any such bond or other security. The parties have further agreed that, subject to the limitations set forth in the Merger Agreement, by seeking specific performance, a party will not in any respect waive its right to seek any other form of relief that may be available to a party under the Merger Agreement, and nothing in the Merger Agreement will require any party to institute any legal proceeding for (or limit any party’s right to institute any legal proceeding for) specific performance under the Merger Agreement prior to, or as a condition to, exercising any termination right under the Merger Agreement (and pursuing damages after such termination), nor will the commencement of any legal proceeding for specific performance restrict or limit any party’s right to terminate the Merger Agreement in accordance with its terms or pursue any other remedies under the Merger Agreement that may be available then or thereafter.
Notwithstanding the foregoing, the parties have acknowledged and agreed that the Company will be entitled to an injunction, specific performance or other equitable remedies to enforce Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing, in accordance with and subject to the terms, conditions and limitations set forth in the Equity Commitment Letters, if, and only if, (i) all of the conditions to Parent’s and Merger Sub’s obligations to consummate the Merger have been and continue to be satisfied (other than those conditions that by their terms are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing), (ii) Parent and Merger Sub fail to consummate the Merger on the date required under the Merger Agreement, (iii) the Debt Financing has been funded in full in accordance with their terms and conditions or will be funded in full at the Closing in accordance with their terms and conditions (and, for the avoidance of doubt, if the Debt Financing has not been funded and will not be funded at the Closing for any reason, the Company will not be entitled to enforce Parent’s and Merger Sub’s obligation to consummate the transactions contemplated by the Merger Agreement and the Guarantors’ obligation to fund the Equity Financing under the terms of the Merger Agreement) and (iv) the Company has irrevocably confirmed in writing that (x) all conditions to the Company’s obligation to consummate the Merger have been satisfied (other than those that, by their nature, are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing) and (y) if specific performance is granted and the Equity Financing and the Debt Financing are funded, the Company is ready, willing and able to consummate the Merger.
112

TABLE OF CONTENTS

MARKET INFORMATION AND DIVIDENDS
The Company Common Stock is listed and traded on Nasdaq under the trading symbol “CCC.” On October 14, 2026, the last trading day prior to the public announcement of the execution of the Merger Agreement, the closing price of Company Common Stock on Nasdaq was $7.64 per share. On July 9, 2026, the last trading day prior to media speculation regarding a potential sale of the Company, the closing price of Company Common Stock on Nasdaq was $5.38 per share. On [•], 2026, the most recent practicable date before the filing of this proxy statement, the closing price of Company Common Stock on Nasdaq was $[•] per share.
The Per Share Price of $7.75 per share represents a premium of approximately 44% over the unaffected closing price of Company Common Stock on July 9, 2026. You are encouraged to obtain current market quotations for Company Common Stock in connection with voting your shares.
As of the close of business on the Record Date, there were [•] shares of Company Common Stock issued and outstanding and entitled to vote, held by [•] holders of record. The number of holders of record is based upon the actual number of holders registered in our records at such date and does not include holders of shares in “street name” or persons, partnerships, associations, corporations or other entities identified in security position listings maintained by depository trust companies.
The Company has no current plans to pay cash dividends. The declaration, amount and payment of any future dividends will be at the sole discretion of the Company Board, which may take into account general and economic conditions, the Company’s financial condition and results of operations, available cash and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and other factors that the Company Board may deem relevant, and subject to Parent’s consent. The Company’s ability to pay dividends is also limited by the Existing Credit Agreement. In addition, under the Merger Agreement, the Company has agreed not to declare, set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any shares of capital stock or other equity or voting interest prior to the Effective Time without Parent’s consent, other than dividends or other distributions made by any direct or indirect wholly owned subsidiary of the Company to the Company or one of its other wholly owned subsidiaries.
113

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth information about the beneficial ownership of the shares of Company Common Stock as of November 17, 2026, for:
•
each person or group known to us who beneficially owns more than 5% of shares of the Company Common Stock;
•
each of our directors;
•
each of our named executive officers; and
•
all of our directors and executive officers as a group.
Each stockholder’s percentage ownership is based on 591,324,835 shares of Company Common Stock outstanding as of November 17, 2026. Beneficial ownership for the purposes of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof or has the right to acquire such powers within 60 days. Company Common Stock subject to Company Options, Company RSAs, Company RSUs or Company PSUs that are currently exercisable or will vest within 60 days of November 17, 2026, are deemed to be outstanding and beneficially owned by the person holding the Company Options, Company RSAs, Company RSUs and Company PSUs. These shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as disclosed in the footnotes to this table and subject to applicable community property laws, we believe that each stockholder identified in the table possesses sole voting and investment power over all shares of Company Common Stock shown as beneficially owned by the stockholder.
 
 
 
 
 
 
 
Name and Address of Beneficial Owner1
 
 
Number of
Shares of
Company
Common
Stock
 
 
Percent of
Company
Common
Stock
Githesh Ramamurthy2
 
 
36,568,913
 
 
6.05%
Tim Welsh3
 
 
362,641
 
 
*
Brian Herb4
 
 
413,175
 
 
*
Mary Jo Prigge5
 
 
769,085
 
 
*
John Goodson
 
 
—
 
 
*
Neil de Crescenzo6
 
 
241,839
 
 
*
Barak Eilam7
 
 
22,013
 
 
*
William Ingram8
 
 
279,137
 
 
*
Eileen Schloss9
 
 
98,412
 
 
*
John Schweitzer10
 
 
11,625
 
 
*
Teri Williams11
 
 
206,243
 
 
*
Eric Wei
 
 
—
 
 
*
All directors and executive officers as a group (11 individuals)12
 
 
38,096,815
 
 
6.30%
Five Percent Holders:
 
 
 
 
 
 
T. Rowe Price Associates, Inc.13
 
 
43,837,469
 
 
7.41%
Vanguard Portfolio Management14
 
 
35,747,819
 
 
6.05%
Akre Capital Management, LLC15
 
 
30,313,000
 
 
5.13%
 
 
 
 
 
 
 
*
Means less than 1%.
(1)
Unless otherwise noted, the business address of each of the directors and officers is 167 N. Green Street, 9th Floor, Chicago, Illinois 60607. The table excludes (i) the contingent right of Mr. Ramamurthy, Mr. Herb, Ms. Prigge, Ms. Schloss, Ms. Williams and Mr. Ingram to receive, subject to adjustment, 1,298,389, 9,064, 22,707, 7,698, 7,698 and 7,698 shares, respectively, based on the Company achieving certain trading price targets for its common stock or undergoing a change of control and (ii) shares of common stock underlying Company PSUs, which represent a contingent right to receive a number of shares of common stock, cash or a combination thereof based on total shareholder return realized by stockholders over a specified period.
(2)
Includes (i) 23,896,593 shares of the Company Common Stock and (ii) 12,672,320 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. As a result of Mr. Ramamurthy’s commitment to exercise such options solely through ‘cashless’ means, he does not have a right to acquire the gross number of shares underlying such stock options pursuant to Rule 13d-3(d)(1) within 60 days of November 17, 2026.
114

TABLE OF CONTENTS

(3)
Includes 362,641 shares of the Company Common Stock.
(4)
Includes 413,175 shares of the Company Common Stock.
(5)
Includes 769,085 shares of the Company Common Stock.
(6)
Includes 241,839 shares of the Company Common Stock.
(7)
Includes 22,013 shares of the Company Common Stock.
(8)
Includes (i) 108,862 shares of the Company Common Stock and (ii) 170,275 shares of the Company Common Stock underlying stock options that are currently vested and exercisable.
(9)
Includes (i) 81,384 shares of the Company Common Stock and (ii) 17,028 shares of the Company Common Stock underlying stock options that are currently vested and exercisable.
(10)
Includes 11,625 shares of the Company Common Stock.
(11)
Includes (i) 35,968 shares of the Company Common Stock and (ii) 170,275 shares of the Company Common Stock underlying stock options that are currently vested and exercisable.
(12)
Includes (i) 24,998,707 shares of the Company Common Stock and (ii) 13,098,558 shares of the Company Common Stock underlying stock options that are currently vested and exercisable.
(13)
Based on Schedule 13G filed by T. Rowe Price Associates, Inc. with the SEC on August 14, 2026.
(14)
Based on Schedule 13G filed by Vanguard Portfolio Management with the SEC on April 29, 2026.
(15)
Based on Schedule 13G filed by Akre Capital Management, LLC with the SEC on May 15, 2026.
115

TABLE OF CONTENTS

APPRAISAL RIGHTS
General
If the Merger is consummated, Company stockholders that are holders of record and beneficial owners who do not vote (whether in person or by proxy) in favor of the Merger Proposal, and who are entitled to have their shares appraised by the Delaware Court of Chancery, may receive payment in cash for the “fair value” of their shares of Company Common Stock, as determined by the Delaware Court of Chancery, together with interest, if any, as determined by the Court, in lieu of the Per Share Price that the holders of record or beneficial owners of Company Common Stock would otherwise be entitled to pursuant to the Merger Agreement, subject to the requirements and limitations set forth in Section 262 of the DGCL described herein. These rights are known as appraisal rights. Company stockholders and beneficial owners electing to exercise appraisal rights must comply with the provisions of Section 262 of the DGCL in order to perfect their rights. Strict compliance with the statutory procedures is required to perfect appraisal rights under Delaware law.
This section is intended as a brief summary of the material provisions of Delaware law, including the DGCL pertaining to appraisal rights. The following discussion, however, is not a complete statement of the law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section 262 of the DGCL that is accessible at the following publicly available website: https://delcode.delaware.gov/title8/c001/sc09/index.html#262 and any amendments thereto after the date of this proxy statement and incorporated by reference herein. All references in Section 262 of the DGCL and in this summary to “stockholder” (and all references in this summary to “holder”) are to the holder of record of the shares of Company Common Stock immediately prior to the Effective Time as to which appraisal rights are asserted. All references within Section 262 of the DGCL and this summary to “beneficial owner” mean the beneficial owner of shares of Company Common Stock held either in voting trust or by a nominee on behalf of such person. Failure to comply strictly with the procedures set forth in Section 262 of the DGCL will result in the loss of appraisal rights. The following discussion does not constitute any legal or other advice, nor does it constitute a recommendation as to whether or not a Company stockholder or beneficial owner should exercise its right to seek appraisal under Section 262 of the DGCL. In view of the complexity of the provisions of Section 262 of the DGCL, stockholders and beneficial owners wishing to exercise appraisal rights are urged to consult their legal and financial advisors before attempting to exercise such rights.
Subject to certain exceptions specified in Section 262 of the DGCL and summarized below, holders and beneficial owners of shares of Company Common Stock who: (a) submit a proper written demand for appraisal of such shares to the Company prior to the vote on the adoption of the Merger Agreement; (b) do not vote such shares (and ensure that such shares are not voted) in favor of the adoption of the Merger Agreement or do not otherwise withdraw, lose or waive his, her or its appraisal rights; (c) continuously are the holders of record or beneficial owners, as the case may be, of such shares through the Effective Time; (d) strictly comply with the applicable procedures and requirements set forth in Section 262 of the DGCL; and (e) do not thereafter withdraw his, her or its demand for appraisal of such shares or otherwise lose his, her or its rights to seek appraisal will be entitled to have their shares appraised by the Delaware Court of Chancery and receive payment in cash of the “fair value” of such shares (as determined by the Delaware Court of Chancery, exclusive of any element of value arising from the accomplishment or expectation of the Merger) as of the completion of the Merger instead of the Per Share Price. Any such Company stockholder or beneficial owner awarded “fair value” for the holder’s shares by the Delaware Court of Chancery would receive payment of that fair value in cash, together with interest, if any, in lieu of the right to receive the Per Share Price. It is possible that any such “fair value” as determined by the Delaware Court of Chancery may be more or less than, or the same as, that which Company stockholders will receive pursuant to the Merger Agreement.
Section 262 of the DGCL requires that stockholders as of the record date for notice of the Special Meeting to vote on the adoption of the Merger Agreement for whom appraisal rights are available be notified not less than 20 days before the Special Meeting. A copy of Section 262 of the DGCL or information directing the stockholders to a publicly available electronic resource at which Section 262 of the DGCL may be accessed without subscription or cost must be included with such notice.
This proxy statement constitutes our notice to the Company stockholders of the availability of appraisal rights in connection with the Merger in compliance with the requirements of Section 262 of the DGCL and a copy of the applicable statutory provisions is accessible at the following publicly available website without subscription or cost: https://delcode.delaware.gov/title8/c001/sc09/index.html#262.
116

TABLE OF CONTENTS

Company stockholders or beneficial owners who wish to exercise appraisal rights or who wish to preserve the right to do so should review the following summary and the applicable statutory provisions carefully. Failure to comply with the procedures of Section 262 of the DGCL in a timely and proper manner will result in the loss of appraisal rights. In addition, the Delaware Court of Chancery will dismiss appraisal proceedings in respect of the Company unless certain stock ownership conditions are satisfied by the Company stockholders and beneficial owners seeking appraisal. Because of the complexity of the procedures for exercising the right to seek appraisal, stockholders and beneficial owners who wish to exercise appraisal rights are urged to consult with their own legal and financial advisors in connection with compliance under Section 262 of the DGCL. A Company stockholder who loses his, her, their or its appraisal rights will be entitled to receive the Per Share Price.
How to Exercise and Perfect Your Appraisal Rights
If you are a Company stockholder or beneficial owner and wish to exercise the right to seek an appraisal of your shares of Company Common Stock, you must satisfy all of the following conditions:
•
you must deliver to the Company a written demand for appraisal before the vote on the Merger Agreement at the Special Meeting. This written demand for appraisal must be in addition to and separate from any proxy or vote abstaining from, voting against or otherwise failing to vote for the Merger Proposal. Voting against or failing to vote for the Merger Proposal by itself does not constitute a demand for appraisal within the meaning of Section 262 of the DGCL. The demand must reasonably inform us of the identity of the holder of record holding the shares for which appraisal is demanded, the intention of the person to demand appraisal of his, her or its shares and, in case of a demand made by a beneficial owner, must be accompanied by documentary evidence of such beneficial owner’s beneficial ownership of the shares and a statement that such documentary evidence is a true and correct copy of what it purports to be and must provide an address at which such beneficial owner consents to receive notices given by the surviving corporation under Section 262 of the DGCL and to be set forth on the verified list required by Section 262(f) of the DGCL. A stockholder’s and beneficial owner’s failure to make a written demand for appraisal before the vote with respect to the Merger Proposal is taken will constitute a waiver of appraisal rights;
•
you must not vote in favor of, or consent in writing to, the Merger Proposal with respect to such shares. A vote in favor of the Merger Proposal, whether by proxy submitted by mail, over the Internet or by telephone or at the Special Meeting, will constitute a waiver of your appraisal rights in respect of the shares so voted and will nullify any previously filed written demands for appraisal. A proxy which does not contain voting instructions will, unless revoked, be voted in favor of the Merger Proposal. Therefore, a stockholder who submits a proxy and who wishes to exercise appraisal rights must effectively revoke that proxy pursuant to one of the means described in this proxy statement;
•
you must continuously hold (in the case of a stockholder demanding appraisal) or beneficially own (in the case of a beneficial owner demanding appraisal) your shares of Company Common Stock from the date of making the demand through the Effective Time. You will lose your appraisal rights if you are a holder of record and transfer the shares, or if you are a beneficial owner and cease to beneficially own such shares, before the Effective Time;
•
you or the surviving corporation must file a petition in the Delaware Court of Chancery requesting a determination of the fair value of the shares within 120 days after the Effective Time. The surviving corporation is under no obligation to file any petition and has no present intention of doing so; and
•
you must otherwise comply with the applicable procedures and requirements set forth in Section 262 of the DGCL.
If you fail to comply with any of these conditions and the Merger is completed, you will be entitled to receive the Per Share Price, but you will have no appraisal rights with respect to your shares of Company Common Stock.
In addition, because the Company Common Stock is listed on a national securities exchange and is expected to continue to be listed on such exchange immediately prior to the Closing, the Delaware Court of Chancery will dismiss appraisal proceedings as to all holders and beneficial owners of shares of Company Common Stock who are otherwise entitled to appraisal rights, unless (a) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of Company Common Stock eligible for appraisal, (b) the value of the consideration provided in the Merger for
117

TABLE OF CONTENTS

such total number of shares entitled to appraisal exceeds $1 million or (c) the Merger was approved pursuant to Sections 253 or 267 of the DGCL. We refer to these conditions (a) to (c) as the “ownership thresholds.” At least one of the ownership thresholds must be met in order for the Company stockholders to be entitled to seek appraisal with respect to such shares of Company Common Stock.
Voting, via the Internet during the Special Meeting or by proxy, against, abstaining from voting on or failing to vote on the Merger Proposal will not constitute a written demand for appraisal as required by Section 262 of the DGCL. The written demand for appraisal is in addition to and separate from any proxy or vote. However, you must not vote your shares via the Internet during the Special Meeting or by proxy in favor of the Merger Proposal in order to exercise your appraisal rights with respect to such shares.
Who May Exercise Appraisal Rights
Only a holder of record or beneficial owner of shares of Company Common Stock may assert appraisal rights for the shares of Company Common Stock registered in that holder’s name. A demand for appraisal must be executed by or on behalf of the holder of record or beneficial owner of the shares. The demand should set forth, fully and correctly, the name of the Company stockholder holding the shares in record name as it appears on the stock certificates (or in the stock ledger).
A holder of record of shares of Company Common Stock is entitled to demand appraisal of the shares registered in that holder’s name. A demand for appraisal in respect of shares of Company Common Stock by a holder of record must reasonably inform the Company of the identity of the Company stockholder and that the stockholder intends thereby to demand an appraisal of such stockholder’s shares.
In addition, a beneficial owner may, in such person’s name, demand in writing appraisal of such beneficial owner’s shares of Company Common Stock. A demand for appraisal in respect of such shares of Company Common Stock should be executed by or on behalf of the beneficial owner and must reasonably inform the Company of the identity of the beneficial owner and that the beneficial owner intends thereby to demand an appraisal of such owner’s shares. The demand made by such beneficial owner must also (a) reasonably identify the holder of record of the shares for which the demand is made, (b) provide documentary evidence of such beneficial owner’s beneficial ownership and a statement that such documentary evidence is a true and correct copy of what it purports to be and (c) provide an address at which such beneficial owner consents to receive notices given by the surviving corporation under Section 262 of the DGCL and to be set forth on the verified list required by Section 262(f) of the DGCL. If the shares with respect to which a demand is made are owned of record or beneficially owned in a fiduciary capacity, such as by a trustee, guardian, or custodian, such demand should be executed by or on behalf of the record owner or beneficial owner in such capacity.
A holder of record, such as a bank, broker or other nominee, who holds shares of Company Common Stock as a nominee or intermediary for others, may exercise his, her or its right of appraisal with respect to the shares of Company Common Stock held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares of Company Common Stock as to which appraisal is sought. Where no number of shares of Company Common Stock is expressly mentioned, the demand will be presumed to cover all shares of Company Common Stock held in the name of the holder of record or beneficially owned by the beneficial owner.
If you own shares of Company Common Stock jointly with one or more other persons, as in a joint tenancy or tenancy in common, demand for appraisal should be executed by or for you and all other joint owners. An authorized agent, including an agent for two or more joint owners, may execute the demand for appraisal for a holder of record; however, the agent must identify the holder or holders of record and expressly disclose the fact that, in exercising the demand, such person is acting as an agent.
Company stockholders who hold their shares in brokerage or bank accounts or other nominee forms, and who wish to exercise appraisal rights, should consult with their brokers, banks and other nominees, as applicable, to determine the appropriate procedure for the broker, bank or other nominee holder to make a demand for appraisal of those shares. A person having a beneficial interest in shares held of record in the name of another person, such as a broker, bank or other nominee, must act promptly to cause the holder of record to follow properly and in a timely manner the steps necessary to perfect appraisal rights.
118

TABLE OF CONTENTS

If you elect to exercise appraisal rights under Section 262 of the DGCL, all written demands for appraisal pursuant to Section 262 should be mailed or delivered to:
CCC Intelligent Solutions Holdings Inc.
167 N. Green Street, 9th Floor
Chicago, Illinois 60607
Attention: Chief Legal Officer
Surviving Corporation’s Actions After Completion of the Merger
If the Merger is consummated, the surviving corporation will give written notice of the Effective Time within ten days after the Effective Time to the Company stockholders and beneficial owners who did not vote in favor of the adoption of the Merger Agreement and who made a written demand for appraisal in accordance with Section 262 of the DGCL and otherwise complied with Section 262 of the DGCL. At any time within 60 days after the Effective Time, any person entitled to appraisal who did not commence an appraisal proceeding or join in such a proceeding as a named party will have the right to withdraw the demand and to accept the Per Share Price in accordance with the Merger Agreement for his, her or its shares of Company Common Stock. In addition, no appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder or beneficial owner without the approval of the Delaware Court of Chancery, which approval may be conditioned on the terms the Delaware Court of Chancery deems just (including without limitation, a reservation of jurisdiction for any application to the Delaware Court of Chancery made with respect to the allocation of the expenses of the proceeding); provided, however, that this provision will not affect the right of any Company stockholder or beneficial owner that has made an appraisal demand but who has not commenced an appraisal proceeding or joined such proceeding as a named party to withdraw such stockholder’s or beneficial owner’s demand for appraisal and to accept the terms and the Per Share Price offered in the Merger within 60 days after the Effective Time. Any withdrawal of a demand for appraisal made more than 60 days after the Effective Time may only be made with the written approval of the surviving corporation. Within 120 days after the Effective Time, either a holder of record or a beneficial owner of Company Common Stock, provided such person has complied with the requirements of Section 262 of the DGCL and is otherwise entitled to appraisal rights, or the surviving corporation must commence an appraisal proceeding by filing a petition in the Delaware Court of Chancery, with a copy served on the surviving corporation in the case of a petition filed by a stockholder or beneficial owner, demanding an appraisal of the value of the shares of Company Common Stock held by all persons who have properly demanded appraisal. The surviving corporation is under no obligation to file an appraisal petition and has no present intention of doing so. If you desire to have your shares appraised, you should initiate any petitions necessary for the perfection of your appraisal rights within the time periods and in the manner prescribed in Section 262 of the DGCL. If, within 120 days after the Effective Time, no petition has been filed as provided in Section 262 of the DGCL, all rights to appraisal will cease and any person who previously demanded appraisal will become entitled only to the Per Share Price, in accordance with and pursuant to the terms of the Merger Agreement. Any failure to file such a petition within the period specified in Section 262 could nullify a previous written demand for appraisal.
Within 120 days after the Effective Time, any stockholder or beneficial owner who has complied with the provisions of Section 262 of the DGCL will be entitled to receive from the surviving corporation, upon written request, a statement setting forth the aggregate number of shares of Company Common Stock not voted in favor of the adoption of the Merger Agreement and with respect to which the Company has received demands for appraisal, and the aggregate number of holders or beneficial owners holding or owning those shares (for which purpose the holder of record of shares held by a beneficial owner who has made a demand for appraisal shall not be considered a separate stockholder holding such shares). The surviving corporation must give this statement to you within the later of (a) ten days after receipt by the surviving corporation of the request therefor or (b) ten days after expiration of the period for delivery of demands for appraisal.
If a petition for appraisal is duly filed by you or another holder of record or beneficial owner of Company Common Stock who has properly exercised his, her or its appraisal rights in accordance with the provisions of Section 262 of the DGCL, and a copy of the petition is delivered to the surviving corporation, the surviving corporation will then be obligated, within 20 days after receiving service of a copy of the petition, to file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all holders and beneficial owners who have demanded an appraisal of their shares and with whom agreements as to the value of their shares have not been reached by the surviving corporation. Upon the filing of any such petition, the Delaware Court of Chancery may order that notice of the time and place fixed for the hearing on the petition be mailed, by registered or certified mail, to the surviving corporation and all persons shown on the verified list at the addresses stated therein. The costs of these
119

TABLE OF CONTENTS

notices are borne by the surviving corporation. After notice to persons who demanded appraisal of their shares of Company Common Stock as may be required by the court, the Delaware Court of Chancery is empowered to conduct a hearing on the petition to determine those persons who have complied with Section 262 and who have become entitled to appraisal thereunder. The Delaware Court of Chancery will then determine which stockholders and beneficial owners are entitled to appraisal rights and may require the persons demanding appraisal for their shares represented by certificates to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings, and the Delaware Court of Chancery may dismiss the proceedings as to any such person who fails to comply with this direction. The Delaware Court of Chancery will also dismiss proceedings as to all Company stockholders and beneficial owners if none of the ownership thresholds described above is met. Where proceedings are not dismissed or the demand for appraisal is not successfully withdrawn, the appraisal proceeding will be conducted as to the shares of Company Common Stock for which the applicable stockholders and beneficial owners thereof are entitled to appraisal, in accordance with the rules of the Delaware Court of Chancery, including any rules specifically governing appraisal proceedings. The Delaware Court of Chancery will thereafter determine the fair value of such shares of Company Common Stock at the Effective Time, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid upon the amount determined to be fair value. Unless the Delaware Court of Chancery in its discretion determines otherwise for good cause shown, interest from the Effective Time through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the Effective Time and the date of payment of the judgment. However, the surviving corporation has the right, at any point prior to the Delaware Court of Chancery’s entry of judgment in the proceedings, to make a voluntary cash payment to each person entitled to appraisal. Notwithstanding the foregoing or anything herein to the contrary, if the surviving corporation makes a voluntary cash payment at any time before the entry of judgment in the appraisal proceeding pursuant to subsection (h) of Section 262 of the DGCL, interest will accrue thereafter only on the sum of (a) the difference, if any, between the amount paid by the surviving corporation in such voluntary cash payment and the fair value of the shares as determined by the Delaware Court of Chancery and (b) interest accrued on the amount of the voluntary cash payment before such payment was made, unless such interest was paid at the time the voluntary cash payment is made. Upon application by the surviving corporation or by any person entitled to participate in the appraisal proceeding, the Delaware Court of Chancery may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the persons entitled to an appraisal. Any person whose name appears on the verified list may participate fully in all proceedings until it is finally determined that such person is not entitled to appraisal rights. When the value is determined, the Delaware Court of Chancery will direct the payment of such value, less any amounts already paid in a voluntary cash payment, with interest thereon, if any, to the persons entitled to receive the same. Payment shall be so made to each such person upon such terms and conditions as the Delaware Court of Chancery may order.
After the Delaware Court of Chancery determines the stockholder is entitled to appraisal, and that at least one of the ownership thresholds above has been satisfied, then the appraisal proceeding will be conducted in accordance with the rules of the Delaware Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceedings, the Delaware Court of Chancery will determine the “fair value” of the shares of Company Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining the fair value of the shares of Company Common Stock, the Delaware Court of Chancery is required to take into account all relevant factors. In Weinberger v. UOP, Inc., the Delaware Supreme Court discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that “proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court” should be considered and that “[f]air price obviously requires consideration of all relevant factors involving the value of a company.”
The Delaware Supreme Court has stated that, in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other factors which were known, or which could be ascertained as of the date of the Merger which throw any light on future prospects of the merged corporation. The Delaware Supreme Court has recently indicated that transaction price is one of the relevant factors the Delaware Court of Chancery may consider in determining fair value and that absent deficiencies in the sale process the transaction price may be given “considerable weight.” Section 262 of the DGCL provides that fair value is to be “exclusive of any element of value arising from the accomplishment or expectation of the merger.” In Cede & Co. v. Technicolor, Inc., the Delaware Supreme Court stated that such exclusion is a “narrow exclusion [that] does not encompass known elements of value,” but which rather applies only to the speculative elements of value arising from
120

TABLE OF CONTENTS

such accomplishment or expectation. In Weinberger, the Delaware Supreme Court construed Section 262 of the DGCL to mean that “elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.”
You should be aware that the fair value of your shares of Company Common Stock as determined under Section 262 of the DGCL could be more than, the same as, or less than the value that you are entitled to receive under the terms of the Merger Agreement and that an opinion of any investment banking firm as to the fairness from a financial point of view of the consideration payable in a merger is not an opinion as to, and does not in any manner address, fair value under Section 262 of the DGCL.
Moreover, neither the Company nor Parent anticipates offering more than the Per Share Price to any Company stockholder or beneficial owner exercising appraisal rights and reserves the right to make a voluntary cash payment pursuant to subsection (h) of Section 262 of the DGCL and to assert, in any appraisal proceeding, that, for purposes of Section 262, the “fair value” of a share of Company Common Stock is less than the Per Share Price. No representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of Chancery.
If any stockholder who demands appraisal of his, her, or its shares of Company Common Stock under Section 262 fails to perfect, or loses or successfully withdraws, such holder’s right to appraisal, the stockholder’s shares of Company Common Stock will be deemed to have been converted at the Effective Time into the right to receive the Per Share Price less applicable withholding taxes. If no party files a petition for appraisal within 120 days after the Effective Time or if none of the ownership thresholds above has been satisfied in respect of such shares, then all of the Company stockholders and beneficial owners will lose the right to an appraisal and will instead receive the Per Share Price described in the Merger Agreement, without interest thereon.
The Delaware Court of Chancery may determine the costs of the appraisal proceeding and may tax those costs to the parties as the Delaware Court of Chancery determines to be equitable under the circumstances. Upon application of any person whose name appears on the verified list filed by the surviving corporation who participated in the proceeding and incurred expenses in connection therewith, the Delaware Court of Chancery may order all or a portion of such expenses, including, without limitation, reasonable attorneys’ fees and the fees and expenses of experts, to be charged pro rata against the value of all shares of Company Common Stock entitled to appraisal not dismissed pursuant to Section 262(k) of the DGCL or subject to such an award pursuant to a reservation of jurisdiction under Section 262(k) of the DGCL. In the absence of such an order, each party to the appraisal proceeding bears its own expenses of its attorneys and experts.
If you have duly demanded an appraisal in compliance with Section 262 of the DGCL you may not, on or after the Effective Time, vote the shares subject to the demand for any purpose or receive any dividends or other distributions on those shares, except dividends or other distributions payable to holders of record of Company Common Stock as of a record date prior to the Effective Time.
If you have not commenced an appraisal proceeding or joined such a proceeding as a named party you may withdraw a demand for appraisal and accept the Per Share Price by delivering a written withdrawal of the demand for appraisal and an acceptance of the Per Share Price to the surviving corporation within 60 days after the Effective Time or thereafter with the written approval of the surviving corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder or beneficial owner without the approval of the Delaware Court of Chancery, which may be conditioned on the terms the Delaware Court of Chancery deems just (including without limitation, a reservation of jurisdiction for any application to the Delaware Court of Chancery made with respect to the allocation of the expenses of the proceeding); provided, however, that this provision will not affect the right of any Company stockholder or beneficial owner that has made an appraisal demand but who has not commenced an appraisal proceeding or joined such proceeding as a named party to withdraw such stockholder’s or beneficial owner’s demand for appraisal and to accept the terms and the Per Share Price offered in the Merger within 60 days after the Effective Time or thereafter with the written approval of the surviving corporation. If you fail to perfect, successfully withdraw your demand for appraisal, or lose the appraisal right, your shares of Company Common Stock will be converted into the right to receive the Per Share Price, without interest thereon.
Failure to follow the steps required by Section 262 of the DGCL for perfecting appraisal rights will result in the loss of your appraisal rights. In that event, you will be entitled to receive the Per Share Price for your shares of Company Common Stock in accordance with the Merger Agreement without interest. In view of the complexity of the provisions of Section 262 of the DGCL, if you are a Company stockholder or beneficial owner and are considering exercising your appraisal rights under the DGCL, you are urged to consult your own legal and financial advisors.
121

TABLE OF CONTENTS

Holders and beneficial owners of Company Common Stock considering seeking to exercise their appraisal rights should be aware that the fair value of their shares of Company Common Stock as determined under Section 262 could be more than, the same as or less than the Per Share Price that they would otherwise be entitled to receive if they did not seek appraisal of their shares of Company Common Stock. Failure to comply strictly with all of the procedures set forth in Section 262 will result in a loss of statutory appraisal rights. The process of demanding and exercising appraisal rights requires compliance with the prerequisites of Section 262 of the DGCL. Consequently, and in view of the complexity of the provisions of Section 262, if you wish to exercise your appraisal rights, you are urged to consult with your own legal and financial advisors in connection with compliance under Section 262 of the DGCL. To the extent there are any inconsistencies between the foregoing summary and Section 262 of the DGCL, the DGCL will govern.
122

TABLE OF CONTENTS

HOUSEHOLDING
The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for companies. The Company and some brokers household proxy materials, delivering a single proxy statement to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker or us that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, please notify your broker if your shares are held in a brokerage account or us if your shares are registered in your name. You can notify us by contacting Broadridge Financial Solutions, Inc. at 1-866-540-7095 or in writing at Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York 11717, or by contacting our Investor Relations department at CCC Intelligent Solutions Holdings Inc., 167 N. Green Street, 9th Floor, Chicago, Illinois 60607, (312) 229-2355. Upon written or oral request, we will promptly deliver a separate copy of this proxy statement to a stockholder at a shared address to which a single copy of the proxy statement was delivered.
123

TABLE OF CONTENTS

FUTURE STOCKHOLDER PROPOSALS
If the Merger is completed, we will not have public stockholders and there will be no public participation in any future stockholder meetings. If the Merger is not completed, you will continue to be entitled to attend and participate in our stockholder meetings, including our annual meetings of stockholders.
The Company held its 2026 annual meeting of stockholders on May 21, 2026. If the Merger is completed, the Company does not expect to hold a 2027 annual meeting of stockholders. If the Merger is not completed, the Company expects to hold a 2027 annual meeting of stockholders.
As described in the Company’s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC on April 7, 2026, stockholder proposals submitted pursuant to SEC Rule 14a-8 for inclusion in the Company’s proxy statement and form of proxy for the 2027 annual meeting of stockholders must be received by the Company at its principal executive offices at 167 N. Green Street, 9th Floor, Chicago, Illinois 60607 on or before December 8, 2026, and must otherwise comply with the SEC’s rules.
Stockholders wishing to nominate a director or bring a proposal before the 2027 annual meeting of stockholders (other than pursuant to Rule 14a-8) must provide written notice to the Secretary at the Company’s principal executive offices not earlier than the close of business on January 21, 2027 and not later than February 20, 2027, assuming the Company does not change the date of the 2027 annual meeting by more than 30 days before or more than 60 days after the anniversary of the 2026 annual meeting. If the date is so changed, the Company will release an updated time frame. Any such nomination or proposal must comply with the other provisions of the Company’s Bylaws.
In addition to satisfying the requirements of the Bylaws, to comply with the universal proxy rules under Rule 14a-19 of the Exchange Act, stockholders who intend to solicit proxies in support of director nominees other than the Company Board’s nominees must also provide written notice to the Secretary that sets forth all the information required by Rule 14a-19 of the Exchange Act. Such notice must be postmarked or transmitted electronically to the Company at its principal executive offices no later than the advance notice deadline described above.
124

TABLE OF CONTENTS

WHERE YOU CAN FIND ADDITIONAL INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public on the SEC’s website at www.sec.gov. Copies of certain information filed by us with the SEC are also available on our investor relations website at https://ir.cccis.com. Our website is not part of this proxy statement and is not incorporated by reference into this proxy statement.
The SEC allows us to “incorporate by reference” information into this proxy statement, which means that we can disclose important information to you by referring to other documents filed separately with the SEC. The information incorporated by reference is deemed to be part of this proxy statement, except for any information superseded by information in this proxy statement or incorporated by reference subsequent to the date of this proxy statement. This proxy statement incorporates by reference the documents set forth below that we have previously filed with the SEC. These documents contain important information about us and our financial condition and are incorporated by reference into this proxy statement.
The following Company filings with the SEC are incorporated by reference (in each case excluding any information furnished and not filed):
•
the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 24, 2026, including the portions of the Company’s definitive proxy statement on Schedule 14A for its 2026 annual meeting of stockholders, filed with the SEC on April 7, 2026, that are incorporated by reference into Part III thereof;
•
the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2026, June 30, 2026, and September 30, 2026 filed with the SEC on April 30, 2026, July 30, 2026 and October 29, 2026, respectively; and
•
the Company’s Current Reports on Form 8-K or 8-K/A, filed with the SEC on March 2, 2026, April 30, 2026 (with respect to Item 5.02 only), May 22, 2026, May 29, 2026 and October 15, 2026.
Notwithstanding the foregoing, information furnished under Item 2.02 or Item 7.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated by reference into this proxy statement, unless expressly stated otherwise therein. In addition, we incorporate by reference any future filings made by the Company with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this proxy statement and before the date of the Special Meeting (excluding any current reports on Form 8-K to the extent disclosure is furnished and not filed).
We will provide, without charge, to each person to whom a proxy statement is delivered, upon written or oral request of such person and by first class mail or other equally prompt means within one business day of receipt of such request, a copy of any and all of the information that has been incorporated by reference in the proxy statement (not including exhibits to the information that is incorporated by reference unless such exhibits are specifically incorporated by reference into the information that the proxy statement incorporates).
You may request copies of these filings at no cost to you by writing or telephoning the Company as follows:
CCC Intelligent Solutions Holdings Inc.
167 N. Green Street, 9th Floor
Chicago, Illinois 60607
Attn: Investor Relations
Telephone No. (312) 229-2355; Email: IR@cccis.com
Statements contained in this proxy statement regarding the contents of any contract or other document are not necessarily complete and each such statement is qualified in its entirety by reference to that contract or other document filed as an exhibit with the SEC.
The information contained in this proxy statement speaks only as of the date indicated on the cover of this proxy statement unless the information specifically indicates that another date applies. You should not assume that the information contained in this proxy statement is accurate as of any date other than those dates, and the mailing of this proxy statement to stockholders does not create any implication to the contrary.
This proxy statement does not constitute the solicitation of a proxy in any jurisdiction to or from any person to whom or from whom it is unlawful to make such proxy solicitation in that jurisdiction. We have not authorized anyone to give you any information or to make any representation about the proposed Merger or the Company that is different from or adds to the information contained in this proxy statement or in the documents we have publicly filed with the SEC. Therefore, if anyone does give you any different or additional information, you should not rely on it.
125

TABLE OF CONTENTS

Annex A-1
AGREEMENT AND PLAN OF MERGER
 
by and among
 
MOZART PARENT, LLC,
 
MOZART MERGER SUB (DE), INC.
 
and
 
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
 
Dated as of October 14, 2026

TABLE OF CONTENTS

TABLE OF CONTENTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page
ARTICLE I DEFINITIONS & INTERPRETATIONS
 
 
A-2
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1
 
 
Certain Definitions
 
 
A-2
 
 
 
1.2
 
 
Index of Defined Terms
 
 
A-15
 
 
 
1.3
 
 
Certain Interpretations
 
 
A-16
 
 
 
 
 
 
 
 
 
 
ARTICLE II THE MERGER
 
 
A-18
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1
 
 
The Merger
 
 
A-18
 
 
 
2.2
 
 
The Effective Time
 
 
A-18
 
 
 
2.3
 
 
The Closing
 
 
A-18
 
 
 
2.4
 
 
Effect of the Merger
 
 
A-18
 
 
 
2.5
 
 
Certificate of Incorporation and Bylaws
 
 
A-18
 
 
 
2.6
 
 
Directors and Officers
 
 
A-18
 
 
 
2.7
 
 
Effect on Capital Stock
 
 
A-19
 
 
 
2.8
 
 
Treatment of Equity Awards
 
 
A-20
 
 
 
2.9
 
 
Effect on Other Company Securities; Company Earnout Shares
 
 
A-22
 
 
 
2.10
 
 
Exchange of Certificates
 
 
A-22
 
 
 
2.11
 
 
No Further Ownership Rights in Company Common Stock
 
 
A-24
 
 
 
2.12
 
 
Lost, Stolen or Destroyed Certificates
 
 
A-24
 
 
 
2.13
 
 
Required Withholding
 
 
A-24
 
 
 
 
 
 
 
 
 
 
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY
 
 
A-24
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1
 
 
Organization; Good Standing
 
 
A-25
 
 
 
3.2
 
 
Corporate Power; Enforceability
 
 
A-25
 
 
 
3.3
 
 
Company Board Approval; Fairness Opinion; Anti-Takeover Laws
 
 
A-25
 
 
 
3.4
 
 
Requisite Stockholder Approval
 
 
A-26
 
 
 
3.5
 
 
Non-Contravention
 
 
A-26
 
 
 
3.6
 
 
Requisite Governmental Approvals
 
 
A-26
 
 
 
3.7
 
 
Company Capitalization
 
 
A-26
 
 
 
3.8
 
 
Subsidiaries
 
 
A-27
 
 
 
3.9
 
 
Company SEC Documents
 
 
A-28
 
 
 
3.10
 
 
Company Financial Statements; Internal Controls; Indebtedness
 
 
A-28
 
 
 
3.11
 
 
No Undisclosed Liabilities
 
 
A-29
 
 
 
3.12
 
 
Absence of Certain Changes
 
 
A-29
 
 
 
3.13
 
 
Material Contracts
 
 
A-29
 
 
 
3.14
 
 
Real Property
 
 
A-30
 
 
 
3.15
 
 
Environmental Matters
 
 
A-30
 
 
 
3.16
 
 
Intellectual Property
 
 
A-30
 
 
 
3.17
 
 
Tax Matters
 
 
A-31
 
 
 
3.18
 
 
Employee Benefits
 
 
A-32
 
 
 
3.19
 
 
Labor Matters
 
 
A-34
 
 
 
3.20
 
 
Compliance with Laws
 
 
A-34
 
 
 
3.21
 
 
Data Privacy; IT Systems
 
 
A-35
 
 
 
3.22
 
 
Legal Proceedings; Orders
 
 
A-35
 
 
 
3.23
 
 
Insurance
 
 
A-35
 
 
 
3.24
 
 
Anti-Corruption; Anti-Money Laundering; Sanctions Compliance
 
 
A-35
 
 
 
3.25
 
 
Brokers
 
 
A-36
 
 
 
 
 
 
 
 
 
 
A-i

TABLE OF CONTENTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page
 
 
 
3.26
 
 
Company Information
 
 
A-36
 
 
 
3.27
 
 
Related Party Transactions
 
 
A-36
 
 
 
3.28
 
 
Government Contracts
 
 
A-36
 
 
 
3.29
 
 
Customer Contracts
 
 
A-36
 
 
 
3.30
 
 
Vendor Contracts
 
 
A-36
 
 
 
3.31
 
 
No Other Representations or Warranties
 
 
A-37
 
 
 
 
 
 
 
 
 
 
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
 
 
A-37
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1
 
 
Organization; Good Standing
 
 
A-37
 
 
 
4.2
 
 
Corporate Power; Enforceability
 
 
A-37
 
 
 
4.3
 
 
Non-Contravention
 
 
A-37
 
 
 
4.4
 
 
Requisite Governmental Approvals
 
 
A-38
 
 
 
4.5
 
 
[Reserved]
 
 
A-38
 
 
 
4.6
 
 
Legal Proceedings; Orders
 
 
A-38
 
 
 
4.7
 
 
Ownership of Company Common Stock
 
 
A-38
 
 
 
4.8
 
 
Brokers
 
 
A-38
 
 
 
4.9
 
 
Operations of Parent and Merger Sub
 
 
A-38
 
 
 
4.10
 
 
No Parent Vote or Approval Required
 
 
A-38
 
 
 
4.11
 
 
Guarantee
 
 
A-38
 
 
 
4.12
 
 
Financing
 
 
A-38
 
 
 
4.13
 
 
Stockholder and Management Arrangements
 
 
A-40
 
 
 
4.14
 
 
Solvency
 
 
A-40
 
 
 
4.15
 
 
Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans
 
 
A-40
 
 
 
4.16
 
 
Parent and Merger Sub Information
 
 
A-41
 
 
 
4.17
 
 
No Other Representations or Warranties
 
 
A-41
 
 
 
 
 
 
 
 
 
 
ARTICLE V INTERIM OPERATIONS OF THE COMPANY
 
 
A-41
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1
 
 
Affirmative Obligations
 
 
A-41
 
 
 
5.2
 
 
Forbearance Covenants
 
 
A-41
 
 
 
5.3
 
 
No Solicitation
 
 
A-44
 
 
 
5.4
 
 
No Control of the Other Party’s Business
 
 
A-48
 
 
 
 
 
 
 
 
 
 
ARTICLE VI ADDITIONAL COVENANTS
 
 
A-48
 
 
 
 
 
 
 
 
 
 
 
 
 
6.1
 
 
Required Action and Forbearance; Efforts
 
 
A-48
 
 
 
6.2
 
 
Antitrust and Regulatory Matters
 
 
A-48
 
 
 
6.3
 
 
Proxy Statement
 
 
A-50
 
 
 
6.4
 
 
Company Stockholder Meeting
 
 
A-51
 
 
 
6.5
 
 
Financing
 
 
A-52
 
 
 
6.6
 
 
Financing Cooperation
 
 
A-56
 
 
 
6.7
 
 
Anti-Takeover Laws
 
 
A-59
 
 
 
6.8
 
 
Access
 
 
A-60
 
 
 
6.9
 
 
Section 16(b) Exemption
 
 
A-60
 
 
 
6.10
 
 
Directors’ and Officers’ Exculpation, Indemnification and Insurance
 
 
A-60
 
 
 
6.11
 
 
Employee Matters
 
 
A-62
 
 
 
6.12
 
 
Obligations of Merger Sub
 
 
A-64
 
 
 
6.13
 
 
Notification of Certain Matters
 
 
A-64
 
 
 
 
 
 
 
 
 
 
A-ii

TABLE OF CONTENTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page
 
 
 
6.14
 
 
Public Statements and Disclosure
 
 
A-64
 
 
 
6.15
 
 
Transaction Litigation
 
 
A-64
 
 
 
6.16
 
 
Stock Exchange Delisting; Deregistration
 
 
A-64
 
 
 
6.17
 
 
Additional Agreements
 
 
A-65
 
 
 
6.18
 
 
Parent Vote
 
 
A-65
 
 
 
6.19
 
 
Certain Arrangements
 
 
A-65
 
 
 
6.20
 
 
Termination of Agreements
 
 
A-65
 
 
 
 
 
 
 
 
 
 
ARTICLE VII CONDITIONS TO THE MERGER
 
 
A-65
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1
 
 
Conditions to Each Party’s Obligations to Effect the Merger
 
 
A-65
 
 
 
7.2
 
 
Conditions to the Obligations of Parent and Merger Sub
 
 
A-65
 
 
 
7.3
 
 
Conditions to the Company’s Obligations to Effect the Merger
 
 
A-66
 
 
 
 
 
 
 
 
 
 
ARTICLE VIII TERMINATION, AMENDMENT AND WAIVER
 
 
A-66
 
 
 
 
 
 
 
 
 
 
 
 
 
8.1
 
 
Termination
 
 
A-66
 
 
 
8.2
 
 
Manner and Notice of Termination; Effect of Termination
 
 
A-68
 
 
 
8.3
 
 
Fees and Expenses
 
 
A-68
 
 
 
8.4
 
 
Amendment
 
 
A-71
 
 
 
8.5
 
 
Extension; Waiver
 
 
A-71
 
 
 
 
 
 
 
 
 
 
ARTICLE IX GENERAL PROVISIONS
 
 
A-71
 
 
 
 
 
 
 
 
 
 
 
 
 
9.1
 
 
Survival of Representations, Warranties and Covenants
 
 
A-71
 
 
 
9.2
 
 
Notices
 
 
A-71
 
 
 
9.3
 
 
Assignment
 
 
A-72
 
 
 
9.4
 
 
Confidentiality
 
 
A-73
 
 
 
9.5
 
 
Entire Agreement
 
 
A-73
 
 
 
9.6
 
 
Third Party Beneficiaries
 
 
A-73
 
 
 
9.7
 
 
Severability
 
 
A-73
 
 
 
9.8
 
 
Remedies
 
 
A-73
 
 
 
9.9
 
 
Governing Law
 
 
A-75
 
 
 
9.10
 
 
Consent to Jurisdiction
 
 
A-75
 
 
 
9.11
 
 
WAIVER OF JURY TRIAL
 
 
A-75
 
 
 
9.12
 
 
No Recourse
 
 
A-76
 
 
 
9.13
 
 
Company Disclosure Letter References
 
 
A-76
 
 
 
9.14
 
 
Counterparts
 
 
A-76
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBITS
 
 
 
Exhibit A
 
 
Certificate of Incorporation of the Surviving Corporation
 
 
 
 
A-iii

TABLE OF CONTENTS

AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of October 14, 2026, by and among Mozart Parent, LLC, a Delaware limited liability company (“Parent”), Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company”). Each of Parent, Merger Sub and the Company are sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.” All capitalized terms that are used in this Agreement have the respective meanings given to them in this Agreement.
RECITALS
A. The Company Board has unanimously (with respect to all directors present) (i) determined that it is in the best interests of the Company and its stockholders, and declared it advisable, to enter into this Agreement providing for the merger of Merger Sub with and into the Company (the “Merger”), with the Company being the surviving corporation in the Merger, in accordance with the General Corporation Law of the State of Delaware (the “DGCL”) upon the terms and subject to the conditions set forth herein; (ii) approved the execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and other obligations hereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth herein; (iii) resolved to recommend that the Company Stockholders adopt this Agreement in accordance with the DGCL; and (iv) directed that the adoption of this Agreement be submitted for consideration by the Company Stockholders at a meeting thereof.
B. (i) Each of the sole member of Parent and the board of directors of Merger Sub have (A) declared it advisable to enter into this Agreement; and (B) approved the execution and delivery of this Agreement, the performance of their respective covenants and other obligations hereunder, and the consummation of the Merger upon the terms and subject to the conditions set forth herein; and (ii) Parent, in its capacity as the sole stockholder of Merger Sub, will adopt this Agreement by written consent promptly following its execution.
C. Concurrently with the execution and delivery of this Agreement, and as a condition and inducement to the Company’s willingness to enter into this Agreement, Parent and Merger Sub have delivered limited guarantees (the “Guarantees”) from each of GTCR Fund XIV/A LP, GTCR Fund XIV/C LP, GTCR Co-Invest XIV/A LP, GTCR Co-Invest XIV/B LP, Elliott Associates, L.P. and Elliott International, L.P. (each, a “Guarantor” and collectively, the “Guarantors”), in favor of the Company and pursuant to which, subject to the terms and conditions contained therein, the Guarantors are guaranteeing certain obligations of Parent and Merger Sub contained in this Agreement.
D. Parent, Merger Sub and the Company desire to (i) make certain representations, warranties, covenants and agreements in connection with this Agreement and the Merger; and (ii) prescribe certain conditions with respect to the consummation of the Merger.
A-1

TABLE OF CONTENTS

AGREEMENT
NOW, THEREFORE, in consideration of the foregoing premises and the representations, warranties, covenants and agreements set forth herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound hereby, Parent, Merger Sub and the Company agree as follows:
ARTICLE I
DEFINITIONS & INTERPRETATIONS
1.1 Certain Definitions. For all purposes of and pursuant to this Agreement, the following capitalized terms have the following respective meanings:
(a) “Acceptable Confidentiality Agreement” means any confidentiality agreement (x) in effect as of the date of this Agreement or (y) executed, delivered and effective after the date of this Agreement and containing terms that are not less favorable in any material respect to the Company than those contained in the Confidentiality Agreement, except that such confidentiality agreement need not contain any “standstill” or similar provision or otherwise prohibit the making of any Acquisition Proposal.
(b) “Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent or Merger Sub) to engage in an Acquisition Transaction.
(c) “Acquisition Transaction” means any transaction or series of related transactions (other than the Merger) involving:
(i) any direct or indirect purchase or other acquisition by any Person or Group, or equityholders of any such Person or Group, whether from the Company or any other Person(s), of shares of Company Common Stock representing more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such purchase or other acquisition, including pursuant to a tender offer or exchange offer by any Person or Group that, if consummated in accordance with its terms, would result in such Person or Group beneficially owning more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such tender or exchange offer;
(ii) any direct or indirect purchase or other acquisition by any Person or Group of more than 20% of the consolidated assets, net revenue or net income of the Company and its Subsidiaries taken as a whole (measured by the fair market value thereof as determined in good faith by the Company Board) including the capital stock or other equity or voting interests in any of the Company’s Subsidiaries;
(iii) any merger, consolidation, business combination, share exchange, recapitalization, reorganization, liquidation, dissolution or other transaction involving the Company or any of its Subsidiaries pursuant to which any Person or Group, or stockholders of any such Person or Group, would hold, directly or indirectly, more than 20% of the equity interests of the Company or the surviving or resulting entity of such transaction after giving effect to the consummation of such transaction; or
(iv) any combination of the foregoing.
(d) “Affiliate” means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control with such Person. For purposes of this definition, the term “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the ownership of voting securities or partnership or other ownership interests, by contract or otherwise. For the avoidance of doubt, with respect to Parent, the term “Affiliate” shall not include any investment fund, investment vehicle or client sponsored or advised by GTCR LLC (“GTCR”), Elliott Investment Management L.P. (“Elliott”), or any Guarantor or any of their respective Affiliates or any of the portfolio companies (as such term is commonly understood in the private equity industry) or other investments of any such investment fund, investment vehicle or client; provided that this limitation shall not apply with respect to the definition of “Parent Related Parties” or the definition of “Transaction Litigation”, or pursuant to Section 6.6(e) (Confidentiality), Section 6.14 (Public Statements and Disclosure) or Section 9.3 (Assignment).
(e) “AI Technologies” means any artificial intelligence, deep learning or machine learning technology or system or other technology or system that, in each case, infers, from the input it receives, how to generate
A-2

TABLE OF CONTENTS

outputs such as predictions, content, recommendations or decisions, including any: (i) learning and predictive analysis, (ii) algorithmic, rule-based expressions, (iii) generative artificial intelligence and (iv) software, algorithms, models, hardware or other equipment used as a component in the foregoing.
(f) “Anti-Corruption Laws” means Laws related to bribery, corruption, kickbacks, racketeering, or other improper payments, including without limitation the U.S. Foreign Corrupt Practices Act of 1977, as amended, the UK Bribery Act of 2010, and Laws implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, 1997.
(g) “Anti-Money Laundering Laws” means Laws related to money laundering, anti-terrorism, proceeds of crime, or financial recordkeeping, including without limitation the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act).
(h) “Antitrust Laws” means the Sherman Antitrust Act of 1890, the Clayton Antitrust Act of 1914, the HSR Act, the Federal Trade Commission Act of 1914, and all other Laws, in any jurisdiction, whether domestic or foreign, in each case that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or significant impediments or lessening of competition or the creation or strengthening of a dominant position through merger or acquisition, in any case that are applicable to the Merger.
(i) “Audited Company Balance Sheet” means the consolidated balance sheet (and the notes thereto) of the Company and its consolidated Subsidiaries as of December 31, 2025 set forth in the Company’s Form 10-K filed by the Company with the SEC on February 24, 2026.
(j) “Business Day” means any day other than Saturday or Sunday or a day on which commercial banks are authorized or required by Law to be closed in New York, New York.
(k) “Bylaws” means the By-Laws of the Company.
(l) “Charter” means the Certificate of Incorporation of the Company, dated as of July 30, 2021.
(m) “Code” means the U.S. Internal Revenue Code of 1986.
(n) “Company Board” means the Board of Directors of the Company.
(o) “Company Common Stock” means the common stock, par value $0.0001 per share, of the Company.
(p) “Company Credit Agreement” means the Credit Agreement, dated as of September 21, 2021, among, inter alios, the Company, Cypress Intermediate Holdings II, LLC, the lenders and issuing banks from time to time party thereto, the joint lead arrangers and joint bookrunners party thereto and Bank of America, N.A., as administrative agent and swingline lender, and all pledge, security and other agreements and documents related thereto.
(q) “Company Earnout Shares” means, collectively, the SPAC Merger Earnout Shares and the Sponsor Earnout Shares.
(r) “Company Equity Plan” means the CCC Intelligent Solutions Holdings Inc. 2021 Incentive Equity Plan.
(s) “Company ESPP” means the CCC Intelligent Solutions Holdings Inc. 2021 Employee Stock Purchase Plan.
(t) “Company Indebtedness” means all debt outstanding under the Company Credit Agreement.
(u) “Company Intellectual Property” means any Intellectual Property that is owned or purported to be owned by the Company or any of its Subsidiaries.
(v) “Company Material Adverse Effect” means any change, event, effect, development or occurrence that, individually or in the aggregate, has had, or would reasonably be expected to have, a material adverse effect on the business, properties, condition (financial or otherwise), assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided that none of the following, and no changes, events, effects, developments, or occurrences to the extent arising out of, relating to or resulting from the
A-3

TABLE OF CONTENTS

following (in each case, by itself or when aggregated) will be deemed to be or constitute a Company Material Adverse Effect or will be taken into account when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur (subject to the limitations set forth below):
(i) any general economic conditions, or conditions in the global, international or regional economy generally;
(ii) any conditions in the equity, credit, debt, financial, banking, currency or capital markets, including (A) changes in interest rates or credit ratings; (B) changes in exchange rates for the currencies of any country; or (C) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market;
(iii) any general conditions in the industries in which the Company and its Subsidiaries conduct business or in any jurisdiction or geographical area in which the Company and its Subsidiaries conduct business, or changes therein;
(iv) any political or geopolitical conditions, outbreak of hostilities, armed conflicts, acts of war (whether or not declared), rebellion, insurrection, sabotage, cyberattack, cyberterrorism, terrorism or military actions, including any escalation or worsening of, or any Law or sanction, mandate, directive or pronouncement issued by a Governmental Authority after the date hereof in response to, the foregoing or any threats thereof, in each case, in the United States or any other country or region in the world;
(v) any earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wild fires, nuclear incidents, foreign or domestic social protest or social unrest (whether or not violent) or other natural or man-made disasters, weather conditions, power outages or electrical black-outs, and other force majeure events, including any escalation or worsening of, or any Law or sanction, mandate, directive, pronouncement, guideline or recommendation issued by a Governmental Authority in response to, any of the foregoing, in each case, in the United States or any other country or region in the world;
(vi) the negotiation, execution, delivery or performance of this Agreement or the announcement of this Agreement or the pendency of the Merger or the other Transactions, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with customers, suppliers, lenders, lessors, business or joint venture partners, officers, employees (including any employee departure or attrition), regulators, Governmental Authorities, vendors or any other third Person (it being understood that this clause (vi) shall not apply with respect to any representation, warranty or condition to Closing that is intended to address the consequences of the execution and delivery of this Agreement);
(vii) the compliance by any Party with the express terms of this Agreement, including any action taken or refrained from being taken pursuant to or in accordance with the express terms of this Agreement or any action taken or refrained from being taken to which Parent has expressly approved or consented to in writing (including by email) following the date of this Agreement;
(viii) changes or proposed changes in GAAP or other accounting standards, or in any applicable Laws (or the enforcement or interpretation of any of the foregoing) or in any regulatory or legislative conditions, including the adoption, implementation, repeal, modification, reinterpretation or proposal of any Law, regulation or policy (or the enforcement or interpretation thereof) by any Governmental Authority, or any panel or advisory body empowered or appointed thereby, in each case, after the date hereof;
(ix) any epidemics, pandemics, plagues, other outbreaks of illness or public health events (including quarantine restrictions mandated or recommended by any Governmental Authority in response to any of the foregoing), including any escalation or worsening of any of the foregoing, in each case, in the United States or any other country or region in the world;
(x) any anti-dumping actions, international tariffs, sanctions, trade policies or disputes or any “trade war” in the United States or in any country or region in the world in which the Company and its Subsidiaries conduct business;
(xi) any changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded hereunder);
A-4

TABLE OF CONTENTS

(xii) any failure by the Company and its Subsidiaries to meet (A) any internal or public estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period; or (B) any budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that, in the case of each of foregoing clauses (A) and (B), the underlying cause of any such failure may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded hereunder);
(xiii) the availability or cost of equity, debt or other financing to Parent or Merger Sub;
(xiv) any Transaction Litigation or any demand or Legal Proceeding for appraisal of the fair value of any shares of Company Common Stock pursuant to the DGCL in connection herewith;
(xv) the identity of Parent, Merger Sub, or the respective Affiliates as the acquiror of the Company; and
(xvi) any breach by Parent or Merger Sub of this Agreement,
except, in each case of clauses (i), (ii), (iii), (iv), (v), (viii), (ix) and (x), to the extent that such changes, events, effects, developments or occurrences have had a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the industries in which the Company and its Subsidiaries conduct business, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur.
(w) “Company Options” means any options to purchase shares of Company Common Stock, granted pursuant to the Company Equity Plan.
(x) “Company Preferred Stock” means the preferred stock, par value $0.0001 per share, of the Company.
(y) “Company PSUs” means awards of performance-based restricted stock units of the Company, granted pursuant to the Company Equity Plan.
(z) “Company Registered Intellectual Property” means all of the Registered Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries.
(aa) “Company RSAs” means unvested shares of restricted Company Common Stock granted pursuant to the Company Equity Plan.
(bb) “Company RSUs” means awards of time-based restricted stock units of the Company, granted pursuant to the Company Equity Plan.
(cc) “Company Stockholders” means the holders of shares of Company Common Stock.
(dd) “Company Termination Fee” means an amount equal to $149,520,000.
(ee) “Compliant” means, with respect to the Required Financing Information, that (i) the financial statements included in the Required Financing Information that are available to Parent on the first day of, and on each day during, any such thirteen consecutive Business Day period comprising the Marketing Period (A) comply in all material respects with all applicable requirements of Regulation S-X under the Securities Act for a registered public offering of secured high yield non-convertible debt securities on a registration statement on Form S-1 that would be applicable to such Required Financing Information (other than requirements that would require or relate to any Excluded Information or in respect of which compliance is not customary in a Rule 144A offering of secured high yield non-convertible debt securities), (B) would not be deemed stale under customary practices for offerings and private placements of secured high yield non-convertible debt securities under Rule 144A and (C) are in a form such that the Company’s independent auditors would reasonably be expected to be able to issue to the Financing Sources (subject to completion of its normal practices and procedures) a customary “comfort letter” (including customary “negative assurance” and change period comfort) with respect to such financial statements on the last day of the thirteen consecutive Business Day period and (ii) such Required Financing Information, when taken as a whole, does not contain any untrue
A-5

TABLE OF CONTENTS

statement of a material fact regarding the Company and its Subsidiaries or omit to state any material fact regarding the Company and its Subsidiaries necessary in order to make the statements contained in such Required Financing Information, when taken as a whole in light of the circumstances under which they were made, not misleading.
(ff) “Confidentiality Agreement” means the agreement listed in Section 9.4 of the Company Disclosure Letter.
(gg) “Continuing Employees” means each individual who is an employee of the Company or any of its Subsidiaries immediately prior to the Effective Time (including those on vacation, sick leave, maternity leave, military service, lay-off, disability or other paid time off or leave of absence) and continues to be an employee of Parent or one of its Subsidiaries (including the Surviving Corporation) immediately following the Effective Time.
(hh) “Contract” means any agreement, contract, subcontract, note, bond, mortgage, indenture, lease, license or sublicense.
(ii) “Debt Financing Sources” means (i) the Persons that have committed to provide and/or arrange, or otherwise enter into agreements in connection with, the Debt Financing, including such Persons that are parties to the Debt Commitment Letters and any joinder agreements, indentures, note purchase agreements, credit agreements or similar documentation entered into pursuant thereto or relating thereto, together with each other Person that commits to provide or otherwise provides and/or arrange, or otherwise enters into agreements in connection with, any Alternate Debt Financing in accordance with this Agreement, in each case, together with their Affiliates, (ii) the respective partners (general or limited), controlling parties, principals, officers, directors, members, stockholders, managers, employees, attorneys, advisors, agents, accountants, consultants and other authorized representatives of the Persons described in the foregoing clause (i) and (iii) the successors and assigns of the Persons described in the foregoing clauses (i) and (ii).
(jj) “DOJ” means the U.S. Department of Justice or any successor thereto.
(kk) “Employee Plan” means each “employee benefit plan” (as defined in Section 3(3) of ERISA, whether or not subject to ERISA) and each other bonus, commission, stock option, stock appreciation right, restricted stock, restricted stock unit, performance stock unit, stock purchase, phantom stock or other equity-based, employment, independent contractor, incentive compensation, profit sharing, savings, retirement, disability, vacation, deferred compensation, severance, separation, termination, retention, change of control, stay bonus, time-off, and other similar material plan, program, agreement or arrangement, whether or not funded, that is maintained or contributed to (or required to be contributed to) by the Company or any of its Subsidiaries for the benefit of any current or former employee, officer, director or individual service provider of the Company or any of its Subsidiaries or with respect to which the Company or any of its Subsidiaries has any actual or contingent liability, other than any such plan, scheme or arrangement that is sponsored by a Governmental Authority, or any Multiemployer Plan.
(ll) “Environmental Law” means any Law relating to public or worker health or safety (to the extent relating to Hazardous Substances), the protection of the environment (including ambient air, surface water, groundwater or land) or pollution.
(mm) “ERISA” means the Employee Retirement Income Security Act of 1974.
(nn) “Exchange Act” means the Securities Exchange Act of 1934.
(oo) “Financing Sources” means, collectively, the Debt Financing Sources and the Preferred Equity Financing Sources.
(pp) “Fraud” means actual and intentional fraud under the common law of Delaware with respect to the making of an express representation or warranty set forth in this Agreement or in any certificate delivered pursuant hereto (and shall exclude any claim based on equitable fraud, constructive knowledge, reckless or negligent misrepresentation or any similar theory).
(qq) “FTC” means the U.S. Federal Trade Commission or any successor thereto.
(rr) “GAAP” means generally accepted accounting principles in the United States, as in effect from time to time.
A-6

TABLE OF CONTENTS

(ss) “Government Contract” means any prime Contract, subcontract, task order or delivery order that is (i) between the Company or any of its Subsidiaries, on the one hand, and a Governmental Authority, on the other hand, or (ii) is entered into by the Company or any of its Subsidiaries as a subcontractor (at any tier) to provide products or services in connection with a Contract between another entity and a Governmental Authority.
(tt) “Governmental Authority” means any government, political subdivision, governmental, administrative, self-regulatory or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental entity, including any state insurance department, and any court, tribunal, judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational.
(uu) “Governmental Authorization” means any authorizations, approvals, licenses, franchises, clearances, permits, certificates, waivers, consents, exemptions, variances, expirations and terminations of any waiting period requirements issued by or obtained from, and any notices, filings, registrations, qualifications, declarations and designations with, a Governmental Authority.
(vv) “Group” has the meaning as used in Section 13(d) of the Exchange Act.
(ww) “Hazardous Substance” means any toxic or hazardous material, substance or waste, including any which is defined or regulated under Environmental Laws due to its hazardous or dangerous properties or characteristics.
(xx) “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
(yy) “Indebtedness” means, with respect to any Person, without duplication, as of the date of determination: (i) all obligations of such Person for borrowed money, (ii) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (iii) all lease obligations of such Person that have been classified as capital or finance leases in the consolidated financial statements or which are required to be classified as capital or finance leases in accordance with GAAP, (iv) with respect to interest rate or currency swap, hedging, futures, forward contracts or other similar transactions or arrangements of such Person, the net termination or close-out amount that would be payable by such Person to the counterparty thereunder if such transaction or arrangement were terminated on the date of determination (after giving effect to any netting or set-off provisions thereof), (v) all indebtedness of others secured by a lien on property or assets owned or acquired by such Person, whether or not the indebtedness secured thereby have been assumed, (vi) all letters of credit, performance bonds, surety bonds or bankers’ acceptances issued for the account of such Person, to the extent drawn upon, and (vii) all guarantees of such Person of any Indebtedness of any other Person other than a wholly owned subsidiary of such Person; provided that Indebtedness shall not include liabilities or obligations solely between the Company and any wholly-owned Subsidiary or solely between any wholly-owned Subsidiaries. For the avoidance of doubt, no amount shall be included more than once in determining Indebtedness, including where an amount would otherwise be captured by more than one of the foregoing clauses.
(zz) “Intellectual Property” means all intellectual and industrial property rights, whether registered or unregistered, in any jurisdiction including such rights in and to: (i) all patents and applications therefor, including all reissues, reexaminations, divisionals, renewals, extensions, provisionals, continuations and continuations-in-part thereof (“Patents”); (ii) all copyrights, copyright registrations and applications therefor (“Copyrights”); (iii) trademarks, service marks, trade dress rights and similar designation of origin and rights therein, and registrations and applications for registration thereof, together with all of the goodwill associated with any of the foregoing (“Marks”); (iv) Internet domain names, social and mobile media identifiers and URLs; (v) data and databases; and (vi) rights in inventions, trade secrets, proprietary information, and confidential information (“Trade Secrets”).
(aaa) “Intervening Event” means any positive change, event, effect, development or circumstance occurring after the date of this Agreement that (i) was not known or reasonably foreseeable to the Company Board on the date of this Agreement (or, if known by the Company Board, the consequences of which were not known or reasonably foreseeable by the Company Board as of the date of this Agreement) and (ii) does not relate to (A) any Acquisition Proposal or any matter relating thereto, (B) any change, in and of itself, in the
A-7

TABLE OF CONTENTS

stock price or trading volume of the Company Common Stock, (C) any breach by the Company of this Agreement or (D) the mere fact, in and of itself, that the Company meets or exceeds any internal or published projections, forecasts, estimates or predictions of revenue, earnings or other financial or operating metrics for any period ending on or after the date hereof.
(bbb) “IRS” means the U.S. Internal Revenue Service.
(ccc) “IT Assets” means computer and information technology systems, equipment, and services, including all software, computer hardware, networks, data processing centers, and platforms.
(ddd) “Knowledge” of the Company, with respect to any matter in question, means the actual knowledge of the Company’s (i) Chief Executive Officer, (ii) Senior Vice President, Finance & Chief Accounting Officer and Interim Chief Financial Officer, and (iii) the Vice President of Finance, in each case after reasonable inquiry of such individual’s direct reports.
(eee) “Law” means any federal, national, state, county, municipal, provincial, local, foreign or multinational statute, constitution, common law, ordinance, code, decree, Order, judgment, rule or regulation, issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Authority and any award, order or decision of an arbitrator or arbitration panel with jurisdiction over the parties and subject matter of the dispute or proceeding.
(fff) “Legal Proceeding” means any claim, action, charge, lawsuit, litigation, investigation, audit, inquiry, arbitration or other similar legal proceeding brought by or pending before any Governmental Authority, arbitrator, mediator or other tribunal.
(ggg) “Marketing Period” means the first period of thirteen consecutive Business Days commencing on or after the date of this Agreement throughout which (A) Parent has received the Required Financing Information and such Required Financing Information remains Compliant throughout such period (it being understood and agreed that if the Required Financing Information is not Compliant at any time during such thirteen consecutive Business Day period, such thirteen consecutive Business Day period shall terminate and restart when such Required Financing Information is Compliant) and (B) the conditions set forth in Sections 7.1 and 7.2 are and shall be satisfied assuming that the Closing Date were to be scheduled for any time during such thirteen consecutive Business Day period (other than those conditions that by their nature are to be satisfied at the Closing, but provided that throughout such period such conditions are and remain capable of being satisfied); provided, that (x) the Marketing Period shall be deemed to have been completed and automatically end on any earlier date on which the Debt Financing is consummated and Parent or any of its Affiliates shall have obtained the net proceeds contemplated thereby (including as a result of the issuance of indebtedness into escrow), (y) November 27, 2026 shall not constitute a Business Day for purposes of such thirteen consecutive Business Day period (provided, that, for the avoidance of doubt, such exclusions shall not restart such period) and (z) at all times from and after March 17, 2027, clause (B) above shall apply other than with respect to the condition set forth in Section 7.1(a), which condition shall not be required to be satisfied, or capable of being satisfied, at the commencement of or during such thirteen consecutive Business Day period (it being understood that this clause (z) shall not constitute a waiver of any such condition for purposes of Article VII); provided, further, that if such thirteen consecutive Business Day period has not been completed on or prior to December 18, 2026, then such period shall be deemed to have not commenced prior to January 4, 2027; provided, however, that if the Company shall in good faith believe that it has provided the Required Financing Information that is Compliant to Parent and that the Marketing Period has commenced, the Company may deliver to Parent a written notice to that effect (stating the date on which it believes it completed such delivery (such date, the “Indicated Date”)), in which case the Marketing Period will be deemed to have commenced on the Indicated Date, unless Parent in good faith reasonably believes either (i) that the Marketing Period has commenced on a date later than that specified in the Company’s notice or (ii) that the Company has not completed the delivery of Required Financing Information or such Required Financing Information is not Compliant and, within three Business Days after the delivery of such notice by the Company, delivers a written notice to the Company to that effect (stating with reasonable specificity either the date on which the Required Financing Information was delivered or, if applicable, why Parent believes the Marketing Period has not commenced and any elements of noncompliance); provided that (A) notwithstanding anything to the contrary, the delivery of the Required Financing Information shall be satisfied at any time which (and so long as) Parent shall have actually received the Required Financing Information, regardless of whether or when any such
A-8

TABLE OF CONTENTS

notice is delivered by the Company and (B) it is understood that the delivery of such written notice from Parent to the Company will not prejudice the Company’s right to assert that the Required Financing Information has in fact been delivered and that the Marketing Period has commenced. Notwithstanding anything in this definition to the contrary, the Marketing Period shall be deemed not to have commenced if, after the date hereof and prior to the completion of such thirteen consecutive Business Day period, (I) the Required Financing Information ceases to be Compliant for any reason, in which case the Marketing Period shall be deemed not to commence unless and until Parent has received all of the Required Financing Information and all of such Required Financing Information is and remains Compliant throughout the Marketing Period, (II) the independent auditors of the Company shall have withdrawn their audit opinion with respect to any audited financial statements of the Company and its Subsidiaries included in the Required Financing Information, in which case the Marketing Period shall be deemed not to have commenced unless and until such independent auditors or another nationally recognized independent accounting firm reasonably acceptable to Parent have issued an unqualified audit opinion with respect to such financial statements, or (III) the Company or the independent auditors of the Company shall have determined or publicly announced that a restatement of any financial statements of the Company and its Subsidiaries included in the Required Financing Information is required, in which case the Marketing Period shall be deemed not to commence unless and until such restatement has been completed and the Required Financing Information has subsequently been amended and delivered to the Parent or the Company or its independent auditors, respectively, has determined in writing or publicly announced, as applicable, that no such restatement shall be required. For the avoidance of doubt, there will be only one full Marketing Period and if a Marketing Period is completed prior to the Closing Date, there will be no requirement for a subsequent Marketing Period to run.
(hhh) “Material Contract” means any of the following Contracts (other than Employee Plans) by which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or their respective assets, rights, property or business are bound or subject to:
(i) any “material contract” (as defined in Item 601(b)(10) of Regulation S-K promulgated by the SEC, other than those agreements and arrangements described in Item 601(b)(10)(iii) of Regulation S-K) with respect to the Company and its Subsidiaries, taken as a whole;
(ii) any Contract (A) relating to the disposition or acquisition of equity or real or tangible assets by the Company or any of its Subsidiaries or (B) pursuant to which the Company or any of its Subsidiaries will acquire any material ownership interest in any other Person or other business enterprise (other than any Subsidiary of the Company), in each case, outside of the ordinary course of business pursuant to which the Company or its Subsidiaries have material continuing obligations;
(iii) any Contract with any customer of the Company or any of its Subsidiaries who, in either case in the year ended December 31, 2025 or as of the six month period ended June 30, 2026, was one of the (A) fifteen (15) largest sources of revenues for the “Insurer Solutions Group” business line of the Company and its Subsidiaries, and (B) ten (10) largest sources of revenues for the Company and its Subsidiaries in their “Auto Solutions Group” business line (each such customer, a “Material Customer”), in each case, based on amounts paid or payable (excluding any purchase orders entered into in the ordinary course of business);
(iv) any Contract with any vendor of the Company or any of its Subsidiaries who, in either case in the year ended December 31, 2025 or as of the six month period ended June 30, 2026, was one of the fifteen (15) largest sources of payment obligations for the Company and its Subsidiaries (each such vendor, a “Material Supplier”), taken as a whole, based on amounts paid or payable (excluding any purchase orders entered into in the ordinary course of business);
(v) any Contract that provides for payment obligations by the Company or any of its Subsidiaries in any twelve-month period of $5,000,000 or more in any individual case that may not be cancelled without any material penalty, liability or obligation (including any material ongoing liability or obligation) to the Company or its Subsidiaries that are party thereto upon notice of ninety days or less and that is not disclosed pursuant to clause (iv) above;
(vi) any Contract relating to or evidencing Indebtedness of the Company or any Subsidiary of the Company in excess of $20,000,000 (excluding intercompany loans between the Company and any of its wholly-owned Subsidiaries or between any wholly-owned Subsidiaries of the Company);
A-9

TABLE OF CONTENTS

(vii) any Contract containing any (A) “most favored nation” or similar provisions, (B) exclusivity provisions, (C) rights of first refusal or first offer provisions, or (D) any covenant or other provision (x) limiting the right of the Company or any of its Subsidiaries to engage in any line of business or compete with any Person or in any geographic region, or (y) prohibiting or restricting the Company or any of its Subsidiaries from engaging in any business with any Person or levying a fine, charge or other payment for doing so;
(viii) any Contract that involves a (A) revenue or profit sharing or similar agreement under which the Company or any of its Subsidiaries has outstanding commitments or (B) “minimum purchase” requirement, “take or pay,” “ship or pay” or similar obligations, in each case with outstanding commitments in an amount in excess of $5,000,000, in any calendar year;
(ix) any Contract providing for the payment, increase or vesting of any material benefits or compensation in connection with the Merger or the Transactions (other than Contracts evidencing Company Options, Company RSUs, Company PSUs or Company RSAs);
(x) any Contract providing for indemnification of any officer, director, employee, consultant or independent contractor by the Company or any of its Subsidiaries;
(xi) any Contract that is a settlement or similar agreement that imposes material obligations on the Company or any of its Subsidiaries after the date of this Agreement;
(xii) any Contract under which the Company or its Subsidiaries have continuing payment obligations after the date of this Agreement in excess of $5,000,000, with respect to an “earnout” or other contingent payment obligations;
(xiii) any Contract that grants any right of first refusal or right of first offer or similar right that limits or purports to limit the ability of the Company or any of its Subsidiaries to sell, transfer, pledge or otherwise dispose of any material amount of its assets or its business that may not be cancelled upon notice of ninety days or less without any material penalty, liability or obligation to the Company or its Subsidiaries;
(xiv) any Contract pursuant to which the Company or any of its Subsidiaries (A) has granted any third party a license or other right in or to material Company Intellectual Property or (B) received a license or other right in or to material Intellectual Property (excluding, in each case, non-exclusive licenses (i) for non-customized, commercially available, “off-the-shelf” software licensed to the Company or any of its Subsidiaries for payments that do not exceed $1,000,000 in any one-year period, (ii) granted to customers, vendors, and service providers in the ordinary course of business) or (iii) for commercially-available data for payments that do not exceed $1,000,000 in any one-year period;
(xv) any Contract that limits the right of the Company or any of its Subsidiaries from using, enforcing, registering, licensing or otherwise exploiting any material Company Intellectual Property, such as settlement agreements, co-existence agreements, and covenants not to sue;
(xvi) any Lease relating to the Leased Real Property, in each case, requiring by its terms aggregate payments by the Company or in excess of $1,000,000 during the year ended December 31, 2025, or reasonably expected to be in excess of such threshold in the year ended December 31, 2026;
(xvii) any Contract that is with an affiliate or other Person that would be required to be disclosed under Item 404 of Regulation S-K promulgated under the Exchange Act (each such Contract, an “Affiliate Agreement”);
(xviii) any Contract with any Governmental Authority;
(xix) any Collective Bargaining Agreement; and
(xx) any Contract that involves a joint venture, partnership, profit sharing, or similar agreement from which the Company or any of its Subsidiaries recognized revenues in excess of $5,000,000 during the year ended December 31, 2025.
(iii) “Nasdaq” means the Nasdaq Global Market and any successor stock exchange or inter-dealer quotation system operated by The Nasdaq Stock Market LLC or any successor thereto.
A-10

TABLE OF CONTENTS

(jjj) “Order” means any order, verdict, decision, writ, judgment, injunction, decree (including any consent decree or similar order or judgment), ruling, stipulation, determination or award, whether civil, criminal or administrative, made, issued, rendered or entered by or with any Governmental Authority against or otherwise applicable to any Person or its property or assets (whether temporary, preliminary or permanent).
(kkk) “Organizational Documents” means the certificate of incorporation, bylaws, certificate of formation, partnership agreement, limited liability company agreement and all other similar documents, instruments or certificates executed, adopted or filed in connection with the creation, formation or organization of a legal entity.
(lll) “Permitted Liens” means any of the following: (i) liens for Taxes, assessments and governmental charges or levies either not yet due or payable or that are being contested in good faith and by appropriate proceedings and for which appropriate reserves have been established in accordance with GAAP; (ii) mechanics’, carriers’, workmen’s, warehouseman’s, repairmen’s, materialmen’s or other liens or security interests arising in the ordinary course of business for amounts that are not yet due or payable, or that are being contested in good faith and by appropriate proceedings; (iii) liens imposed by applicable Law (other than Laws in respect of Tax); (iv) pledges or deposits to secure obligations pursuant to workers’ compensation Law or similar legislation or to secure public or statutory obligations; (v) pledges and deposits to secure the performance of bids, trade contracts, leases, surety and appeal bonds, performance bonds and other obligations of a similar nature, in each case in the ordinary course of business; (vi) defects, imperfections or irregularities in title, charges, easements, covenants and rights of way (of record) and other similar liens, and zoning, building and other similar codes or restrictions generally applicable to the district in which the Real Property is located, in each case that do not adversely affect in any material respect the current occupancy, use of or access to the applicable property; (vii) any non-exclusive license or sublicense of Intellectual Property entered into in the ordinary course; (viii) liens pursuant to any Company Indebtedness (and any refinancing, extension, renewal or replacement thereof) that will be extinguished at Closing; (ix) statutory, common Law or contractual liens securing payments not yet due or payable, including liens of landlords pursuant to the terms of any lease or liens against the interests of the landlord or owner of any Leased Real Property under Leases for which there exist no default unless caused by the Company or any of its Subsidiaries; (x) matters that would be disclosed by an accurate survey or inspection of the Real Property; or (xi) non-monetary liens (or other encumbrances) that do not materially and adversely affect the current use, occupancy or operation of, or access to, the property or other assets subject thereto.
(mmm) “Person” means any individual, corporation (including any non-profit corporation), limited liability company, joint stock company, general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, firm, Governmental Authority or other enterprise, association, organization or entity.
(nnn) “Personal Information” means information that is defined as “personal data,” “personally identifiable information,” “individually identifiable health information,” “protected health information”, “personal information” or any other similar term under any applicable Law.
(ooo) “Preferred Equity Financing Sources” means (i) the Persons, solely in their respective capacities as such, that have committed to provide or otherwise entered or will enter into agreements in connection with all or any part of the Preferred Equity Financing (including the parties to the Preferred Equity Commitment Letters and any agreements or any joinder agreements entered into in connection therewith), together with their respective Affiliates and their respective successors and assigns, (ii) the respective partners (general or limited), controlling parties, principals, officers, directors, members, stockholders, managers, employees, attorneys, advisors, agents, accountants, consultants and other authorized representatives of the Persons described in the foregoing clause (i) and (iii) the successors and assigns of the Persons described in the foregoing clauses (i) and (ii), in the case of each of clauses (i), (ii) and (iii), solely in their respective capacities as providers of, or as having committed to provide, the Preferred Equity Financing.
(ppp) “Registered Intellectual Property” means all U.S., international and foreign (i) Patents and Patent applications (including provisional applications); (ii) registered Marks and applications to register Marks (including intent-to-use applications, or other registrations or applications related to Marks); (iii) registered Copyrights and applications for Copyright registration; and (iv) domain names.
(qqq) “Reimbursement Obligations” means Parent’s obligations pursuant to Section 6.6(f) and Section 6.6(g).
A-11

TABLE OF CONTENTS

(rrr) “Representatives” means, with respect to any Person, such Person’s controlled Affiliates and its and their respective directors, officers, employees, accountants, consultants, legal counsel, financial advisors, financing sources, insurance providers, and agents and other advisors and representatives.
(sss) “Required Financing Information” means the following financial statements, business and other financial data and other pertinent and customary information, in each case, regarding the Company and its Subsidiaries, and in each case, to the extent reasonably and timely requested by Parent in order to consummate the Debt Financing:
(i) the audited consolidated financial statements of the Company consisting of balance sheets as of the last date of each of the two fiscal years of the Company ended at least sixty days prior to the Closing Date, consolidated statements of operations and comprehensive income, cash flows and stockholders’ equity for each of the three fiscal years of the Company ended at least sixty days prior to the Closing Date and the unqualified audit report of the Company’s independent auditors related thereto, prepared in accordance with GAAP and a management’s discussion and analysis of financial condition and results of operations with respect to such financial statements;
(ii) the unaudited consolidated financial statements of the Company consisting of balance sheets and statements of operations and comprehensive income, cash flows and stockholders’ equity as of the last day of and for each completed fiscal quarter or interim period following the most recently completed financial statements delivered pursuant to clause (i) (and for the corresponding fiscal quarter or interim period for the prior fiscal year) and ended at least forty-five days before the Closing Date, other than with respect to any quarter end that is also a fiscal year end, prepared in accordance with GAAP (including footnotes thereto), which unaudited financial statements have been reviewed by the Company’s independent auditors in accordance with AU-C 930, and a management’s discussion and analysis of financial condition and results of operations with respect to such financial statements;
(iii) to the extent reasonably available to the Company from its historical books and records (A) such other historical financial and business information of the Company of the type and form customarily included in offering memoranda for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A and (B) such other historical financial information regarding the Company reasonably necessary to permit Parent to prepare pro forma financial statements customarily included in offering memoranda for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A; and
(iv) drafts of “comfort” letters in form and substance (including as to “negative assurance” and change period comfort) customary for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A relating to the financial statements and financial information delivered pursuant to the foregoing clauses (i), (ii) and (iii), which the Company’s independent auditors would be prepared to issue upon completion of customary procedures;
provided that notwithstanding anything to the contrary in this definition or otherwise, nothing in this Agreement shall require the Company or its Affiliates to provide (or be deemed to require the Company or its Affiliates to prepare) any (A) description of all or any portion of the Debt Financing, including any “description of notes”, “plan of distribution” and information customarily provided by investment banks or their counsel or advisors in the preparation of an offering memorandum for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A, (B) risk factors relating to, or any description of, all or any component of the financing contemplated thereby, (C) historical financial statements or other information required by Rule 3-16, Rule 3-10, Rule 13-01 (but other than financial data regarding the Company and its Subsidiaries sufficient to enable Parent to include disclosure regarding guarantor and non-guarantor information customarily included in offering memoranda for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A), or Rule 13-02 of Regulation S-X under the Securities Act, (D) any compensation discussion and analysis or other information required by Item 10, Item 402 and Item 601 of Regulation S-K under the Securities Act, XBRL exhibits or any information regarding executive compensation or related persons related to SEC Release Nos. 33-8732A, 34-54302A and IC-27444A, (E) other information customarily excluded from an offering memorandum for private placements of secured high yield non-convertible debt securities issued pursuant to Rule 144A in a “Rule 144A-for-life” offering, (F) pro forma financial information, (G) projections or
A-12

TABLE OF CONTENTS

(H) information regarding any post-Closing or pro forma cost savings, synergies, capitalization, ownership or other post-Closing pro forma adjustments desired to be incorporated into any information used in connection with the Debt Financing. The information described in clauses (A)-(H) of this definition is collectively referred to as the “Excluded Information”.
(ttt) “Sanctioned Country” means at any time, any country, region, or territory which is, or has been since April 24, 2019, itself the subject or target of any comprehensive Sanctions (currently, the Crimea, Kherson, so-called Donetsk People’s Republic, so-called Luhansk People’s Republic, and Zaporizhzhia regions of Ukraine, Cuba, Iran, and North Korea).
(uuu) “Sanctioned Person” means any Person that is (i) listed on any Sanctions-related list administered or enforced by any Sanctions authority; (ii) organized, resident, or located in a Sanctioned Country; (iii) 50% or more owned or controlled by any such Person or Persons described in the foregoing clauses (i) or (ii); or (iv) otherwise a subject or target of any Sanctions.
(vvv) “Sanctions” means economic or financial sanctions or trade embargoes imposed, administered, or enforced from time to time by any Sanctions Authority.
(www) “Sanctions Authority” means the U.S. government, including the Office of Foreign Assets Control of the U.S. Department of the Treasury, U.S. Department of Commerce, or the U.S. Department of State, the United Nations, the European Union, any EU Member State, and the United Kingdom.
(xxx) “Sarbanes-Oxley Act” means the Sarbanes-Oxley Act of 2002.
(yyy) “SEC” means the U.S. Securities and Exchange Commission or any successor thereto.
(zzz) “Securities Act” means the Securities Act of 1933.
(aaaa) “SPAC Merger Agreement” means that certain Business Combination Agreement, dated as of February 2, 2021, by and among Dragoneer Growth Opportunities Corp., a Cayman Islands exempted company, Chariot Opportunity Merger Sub, Inc., a Delaware corporation, and Cypress Holdings, Inc., a Delaware corporation.
(bbbb) “SPAC Merger Earnout Shares” means the shares of Company Common Stock issuable in accordance with the SPAC Merger Agreement upon the occurrence of certain triggering events as set forth in and pursuant to Section 2.7(a) of the SPAC Merger Agreement.
(cccc) “Sponsor” means Dragoneer Growth Opportunities Holdings, a Cayman Islands limited liability company.
(dddd) “Sponsor Earnout Shares” means the shares of Company Common Stock issued to the Sponsor and subject to forfeiture based on the occurrence of certain triggering events as provided in Section 2.8 of the SPAC Merger Agreement.
(eeee) “Subsidiary” means, with respect to any Person, any other Person (other than a natural Person) of which securities or other ownership interests (i) having ordinary voting power to elect a majority of the board of directors, managers or trustees, or other Persons performing similar functions or (ii) representing more than 50% of such securities or ownership interests, in each case, are at the time directly or indirectly owned or controlled by such first Person.
(ffff) “Superior Proposal” means any unsolicited and bona fide written Acquisition Proposal for an Acquisition Transaction that did not result from a material breach of Section 5.3 and that is on terms that the Company Board (or a committee thereof) has determined in good faith (after consultation with its financial advisors and outside legal counsel) would be more favorable to the Company Stockholders from a financial point of view than the Merger (taking into account (i) any changes to the terms of this Agreement offered by Parent in writing in response to such Superior Proposal in accordance with Section 5.3(c) and (ii) all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the Person making the proposal, and other aspects of such proposal that the Company Board (or a committee thereof) considers in good faith to be relevant) and (iii) is reasonably likely to be completed on the terms proposed (taking into account all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the Person making the proposal and other aspects of such
A-13

TABLE OF CONTENTS

proposal that the Company Board (or a committee thereof) considers in good faith to be relevant). For purposes of the reference to an “Acquisition Proposal” in this definition, all references to “20%” in the definition of “Acquisition Transaction” shall be deemed to be references to “50%.”
(gggg) “Tax” means any U.S. federal, state and local and non-U.S. taxes, assessments, duties and similar governmental charges and impositions (including taxes based upon or measured by gross receipts, income, profits, sales, use, or occupation, and value added, ad valorem, transfer, franchise, withholding, payroll, employment, excise and property taxes) imposed by any Governmental Authority, together with any interest, penalties and additions to tax imposed thereon.
(hhhh) “Tax Return” means any return, declaration, report, statement, or information return filed or required to be filed with a Governmental Authority with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof.
(iiii) “Transaction Litigation” means any Legal Proceeding (including derivative claims) commenced or threatened in writing against a Party or any of its Subsidiaries or Affiliates (and/or their respective directors and/or executive officers) or otherwise relating to, involving or affecting such Party or any of its Subsidiaries or Affiliates, in each case in connection with, arising from or otherwise relating to this Agreement or the Transactions, other than any Legal Proceedings among the Parties related to this Agreement or the Financing Letters.
(jjjj) “Transactions” means the Merger and the other transactions contemplated by this Agreement.
(kkkk) “Treasury Regulation” means the U.S. Treasury Regulations promulgated under the Code, and any reference to any particular Treasury Regulation Section will be interpreted to include any final or temporary revision of or successor to that Section regardless of how numbered or classified.
(llll) “Unvested Company PSU” means each outstanding Company PSU as of immediately prior to the Effective Time that is not a Vested Company PSU.
(mmmm) “Unvested Company RSA” means each outstanding Company RSA as of immediately prior to the Effective Time that is not a Vested Company RSA.
(nnnn) “Unvested Company RSU” means each outstanding Company RSU as of immediately prior to the Effective Time that is not a Vested Company RSU.
(oooo) “Vested Company PSU” means each Company PSU that is unexpired and outstanding as of immediately prior to the Effective Time and for which the applicable performance conditions have been satisfied as of immediately prior to the Effective Time.
(pppp) “Vested Company RSA” means a Company RSA that vests in accordance with its terms, as in effect on the date hereof, as a result of the consummation of the Merger.
(qqqq) “Vested Company RSU” means a Company RSU that is unexpired, outstanding, and vested as of immediately prior to the Effective Time or that vests in accordance with its terms, as in effect on the date hereof, as a result of the consummation of the Merger.
(rrrr) “WARN” means the U.S. Worker Adjustment and Retraining Notification Act of 1988 or any similar state, local or foreign Law.
(ssss) “Willful and Material Breach” means a breach that is a consequence of an act or omission undertaken by the breaching party with the actual knowledge that the taking of, or failure to take, such act would cause or constitute a material breach of this Agreement.
A-14

TABLE OF CONTENTS

1.2 Index of Defined Terms. The following capitalized terms have the respective meanings given to them in the respective Sections of this Agreement set forth opposite each of the capitalized terms below:
 
 
 
 
Term
 
 
Section Reference
Agreement
 
 
Preamble
Acquisition Proposal Notice Period
 
 
5.3(c)(ii)(1)
Alternative Acquisition Agreement
 
 
5.3(a)
Alternative Financing
 
 
6.5(d)
Capex Budget
 
 
5.2(k)
Capitalization Date
 
 
3.7(a)
Certificate of Merger
 
 
2.2
Certificates
 
 
2.10(c)
Chosen Courts
 
 
9.10(a)
Closing
 
 
2.3
Closing Date
 
 
2.3
Closing Equity Award Consideration
 
 
2.8(f)
Closing Option Consideration
 
 
2.8(a)
Closing PSU Consideration
 
 
2.8(f)
Closing RSA Consideration
 
 
2.8(d)
Closing RSU Consideration
 
 
2.8(f)
Company
 
 
Preamble
Company Board Recommendation
 
 
3.3(a)
Company Board Recommendation Change
 
 
5.3(d)(i)
Company Disclosure Letter
 
 
Article III
Company PSU Restricted Cash Award
 
 
2.8(h)
Company IT Assets
 
 
3.21
Company Related Parties
 
 
8.3(e)(i)
Company RSA Restricted Cash Award
 
 
2.8(c)
Company RSU Restricted Cash Award
 
 
2.8(e)
Company SEC Documents
 
 
Article III
Company Securities
 
 
3.7(c)
Company Stockholder Meeting
 
 
6.4(a)
Company Subsidiary Securities
 
 
3.8(c)
Continuation Period
 
 
6.11(a)
Copyrights
 
 
1.1(bbb)
D&O Insurance
 
 
6.10(c)
Debt Commitment Letters
 
 
6.6(a)
Debt Financing
 
 
6.6(a)
DGCL
 
 
Recitals
Dissenting Company Shares
 
 
2.7(c)
DTC
 
 
2.10(d)
DTC Payment
 
 
2.10(d)
Effective Time
 
 
2.2
Electronic Delivery
 
 
9.14
Enforceability Exceptions
 
 
3.2
Equity Award Holders
 
 
2.8(i)
Equity Commitment Letters
 
 
4.12(a)
Equity Financing
 
 
4.12(a)
Equity Providers
 
 
6.6(e)
ESPP Offering Period
 
 
2.8(d)
Fee Letter
 
 
4.12(a)
Financing
 
 
4.12(a)
 
 
 
 
A-15

TABLE OF CONTENTS

 
 
 
 
Term
 
 
Section Reference
Financing Letters
 
 
4.12(a)
Guarantee
 
 
Recitals
Guarantor
 
 
Recitals
Indemnified Persons
 
 
6.10(a)
Intervening Event Notice Period
 
 
5.3(c)(i)(1)
Lease
 
 
3.14
Leased Real Property
 
 
3.14
Legal Restraint
 
 
8.1(b)
Marks
 
 
1.1(bbb)
Material Customer
 
 
1.1(jjj)(iii)
Master Supplier
 
 
1.1(jjj)(iv)
Maximum Annual Premium
 
 
6.10(c)
Merger
 
 
Recitals
Merger Sub
 
 
Preamble
Multiemployer Plan
 
 
3.18(c)
New Commitment Letters
 
 
6.5(d)
New Plan
 
 
6.11(b)
Old Plans
 
 
6.11(b)
Other Indemnified Persons
 
 
6.10(e)
Other Required Company Filing
 
 
6.3(b)
Owned Company Shares
 
 
2.7(a)(iii)
Owned Real Property
 
 
3.14
Parent
 
 
Preamble
Parent Disclosure Letter
 
 
4.13
Parent Material Adverse Effect
 
 
7.3(a)
Parent Related Parties
 
 
8.3(e)(i)
Parent Termination Fee
 
 
8.3(c)
Party
 
 
Preamble
Patents
 
 
1.1(bbb)
Payment Agent
 
 
2.10(a)
Payment Fund
 
 
2.10(b)
Per Share Price
 
 
2.7(a)(ii)
Preferred Equity Financing Letters
 
 
4.12(a)
Proxy Statement
 
 
6.3(a)
Real Property
 
 
3.14
Regulatory Concession
 
 
6.2(b)
Representative
 
 
5.3(a)
Requisite Stockholder Approval
 
 
3.4
Restricted Cash Awards
 
 
2.8(h)
Restricted Cash Award Holders
 
 
2.8(j)
Surviving Corporation
 
 
2.1
Termination Date
 
 
8.1(c)
Uncertificated Shares
 
 
2.10(c)
 
 
 
 
1.3 Certain Interpretations.
(a) When a reference is made in this Agreement to an Article or a Section, such reference is to an Article or a Section of this Agreement unless otherwise indicated and references to “paragraphs” or “clauses” are to separate paragraphs or clauses of the Section or subsection in which the reference occurs. When a reference is made in this Agreement to a Schedule or Exhibit, such reference is to a Schedule or Exhibit to this Agreement, as applicable, unless otherwise indicated.
A-16

TABLE OF CONTENTS

(b) When used herein, (i) the words “hereof,” “hereunder,” “herein” and “herewith” and words of similar import will, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; and (ii) the words “include,” “includes” and “including” will be deemed in each case to be followed by the words “without limitation.”
(c) Unless the context otherwise requires, “neither,” “nor,” “any,” “either” and “or” are not exclusive.
(d) The word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and does not simply mean “if.”
(e) When used in this Agreement, references to “$” or “Dollars” are references to U.S. dollars.
(f) The meaning assigned to each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural forms of such term, and words denoting any gender include all genders. Where a word or phrase is defined in this Agreement, each of its other grammatical forms has a corresponding meaning.
(g) When reference is made to any party to this Agreement or any other agreement or document, such reference includes such Party’s successors and permitted assigns. References to any Person include the successors and permitted assigns of that Person.
(h) Unless the context otherwise requires, all references in this Agreement to the Subsidiaries of a Person will be deemed to include all direct and indirect Subsidiaries of such Person.
(i) Unless the context otherwise requires, any definition of or reference to any Law or any provision of any Law herein shall be construed as referring to such Law as from time to time amended, supplemented or modified, including by succession of comparable successor Laws and references to the rules and regulations promulgated thereunder or pursuant thereto.
(j) References to any agreement or Contract are to that agreement or Contract as amended, modified or supplemented (including by waiver or consent) from time to time.
(k) All accounting terms used herein will be interpreted in accordance with GAAP.
(l) The table of contents and headings set forth in this Agreement are for convenience of reference purposes only and will not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or any term or provision hereof.
(m) The measure of a period of one month or year for purposes of this Agreement will be the date of the following month or year corresponding to the starting date. If no corresponding date exists, then the end date of such period being measured will be the next actual date of the following month or year (for example, one month following February 18 is March 18 and one month following March 31 is May 1). References to “from” or “through” any date mean, unless otherwise specified, from and including or through and including such date, respectively.
(n) The Parties agree that they have been represented by legal counsel during the negotiation, execution and delivery of this Agreement and therefore waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.
(o) Documents or other information or materials will be deemed to have been “made available” by the Company if such documents, information or materials have been (i) posted to a virtual data room titled “Project Mozart” managed by the Company at www.datasite.com; or (ii) delivered or provided to Parent or its Affiliates or its or their respective Representatives, in each case at any time prior to 48 hours in advance of the execution and delivery of this Agreement.
(p) All references to time shall refer to New York City time unless otherwise specified. If any time period for giving notice or taking action hereunder expires on a day which is not a Business Day, the time period shall be automatically extended to the immediately following Business Day.
(q) All references to “ordinary course of business” shall mean ordinary course of business consistent with past practice.
A-17

TABLE OF CONTENTS

ARTICLE II
THE MERGER
2.1 The Merger. Upon the terms and subject to the conditions set forth in this Agreement and the applicable provisions of the DGCL, on the Closing Date, (a) Merger Sub will be merged with and into the Company; (b) the separate corporate existence of Merger Sub will thereupon cease; and (c) the Company will continue as the surviving corporation of the Merger and as a wholly-owned Subsidiary of Parent. The Company, as the surviving corporation of the Merger, is sometimes referred to herein as the “Surviving Corporation.”
2.2 The Effective Time. Upon the terms and subject to the conditions set forth in this Agreement, on the Closing Date, Parent, Merger Sub and the Company shall cause the Merger to be consummated pursuant to the DGCL by filing a certificate of merger in customary form and substance (the “Certificate of Merger”) with the Secretary of State of the State of Delaware in accordance with the applicable provisions of the DGCL (the time of such filing and acceptance for record by the Secretary of State of the State of Delaware, or such later time as may be agreed in writing by Parent, Merger Sub and the Company and specified in the Certificate of Merger, being referred to herein as the “Effective Time”).
2.3 The Closing. The consummation of the Merger will take place at a closing (the “Closing”) to occur at (a) 9:00 a.m., New York City time, remotely by exchange of documents and signatures (or their electronic counterparts), on a date to be agreed upon by Parent, Merger Sub and the Company that is no later than the second Business Day after the satisfaction or waiver (to the extent permitted hereunder) of the last to be satisfied or waived of the conditions set forth in Article VII (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted hereunder) of such conditions); or (b) such other time, location and date as Parent, Merger Sub and the Company mutually agree in writing; provided that, if the Marketing Period has not ended at the time the Closing is otherwise required to be consummated pursuant to this Section 2.3, then, subject to the satisfaction or waiver of the conditions set forth in Article VII at such time (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted hereunder) of such conditions), the Closing shall occur instead on the earlier of (x) the date that is two (2) Business Days after the final day of the Marketing Period and (y) the date during the Marketing Period agreed to in writing by Parent and the Company. The date on which the Closing occurs is referred to as the “Closing Date.”
2.4 Effect of the Merger. At the Effective Time, the effect of the Merger will be as provided in this Agreement and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time all (a) of the property, rights, privileges, powers and franchises of the Company and Merger Sub will vest in the Surviving Corporation; and (b) debts, liabilities and duties of the Company and Merger Sub will become the debts, liabilities and duties of the Surviving Corporation.
2.5 Certificate of Incorporation and Bylaws.
(a) Certificate of Incorporation. At the Effective Time, the certificate of incorporation of the Company shall be amended and restated in its entirety to read as set forth in Exhibit A attached hereto and, as so amended and restated, shall be the certificate of incorporation of the Surviving Corporation until thereafter amended as provided by the DGCL and such certificate of incorporation (subject to Section 6.10(a)).
(b) Bylaws. At the Effective Time, the bylaws of Merger Sub as in effect immediately prior to the Effective Time shall become the bylaws of the Surviving Corporation, except that all references to Merger Sub shall be automatically amended and shall become references to the Surviving Corporation, until thereafter amended as provided by the DGCL, the certificate of incorporation and such bylaws (subject to Section 6.10(a)).
2.6 Directors and Officers. The Parties shall take all actions necessary so that the directors of Merger Sub immediately prior to the Effective Time will be the directors of the Surviving Corporation immediately following the Effective Time, and the officers of the Company immediately prior to the Effective Time will be the officers of the Surviving Corporation immediately following the Effective Time, in each case, until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal, in each case as provided in the Organizational Documents of the Surviving Corporation and by applicable Law.
A-18

TABLE OF CONTENTS

2.7 Effect on Capital Stock.
(a) Capital Stock. Upon the terms and subject to the conditions set forth in this Agreement, at the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of any of the securities described in this Section 2.7, the following will occur:
(i) each share of common stock, par value $0.001 per share, of Merger Sub that is issued and outstanding as of immediately prior to the Effective Time will automatically be canceled and converted into one validly issued, fully paid and nonassessable share of common stock of the Surviving Corporation;
(ii) each share of Company Common Stock (including, for the avoidance of doubt, any SPAC Merger Earnout Shares issued pursuant to Section 2.9(b) and any Sponsor Earnout Shares) that is issued and outstanding as of immediately prior to the Effective Time (other than Owned Company Shares, Dissenting Company Shares or Company RSAs) will be automatically cancelled, extinguished and converted into the right to receive cash in an amount equal to $7.75, without interest thereon (the “Per Share Price”), in accordance with the provisions of Section 2.10 (or in the case of a lost, stolen or destroyed certificate, upon delivery of an affidavit (and bond, if required) in accordance with the provisions of Section 2.12); and
(iii) each share of Company Common Stock that is (A) held by the Company as treasury stock or (B) owned by Parent or any of its Subsidiaries (including Merger Sub), in each case as of immediately prior to the Effective Time (collectively, the “Owned Company Shares”) will automatically be cancelled and extinguished without any conversion thereof or consideration paid therefor.
(b) Adjustment to the Per Share Price. The Per Share Price will be adjusted appropriately to reflect the effect of any stock split, reverse stock split, stock dividend (including any dividend or other distribution of securities convertible into or exchangeable or exercisable for Company Common Stock), reorganization, recapitalization, reclassification, subdivision, combination, exchange of shares or other similar change with respect to the Company Common Stock occurring on or after the date of this Agreement and prior to the Effective Time.
(c) Statutory Rights of Appraisal. Notwithstanding anything to the contrary set forth in this Agreement, if required by the DGCL (but only to the extent required thereby), any share of Company Common Stock that is issued and outstanding immediately prior to the Effective Time (other than the Owned Company Shares) and that is held by a holder of such share of Company Common Stock who has not voted in favor of the adoption of this Agreement or consented thereto in writing and who has (or for which the “beneficial owner” (as defined, solely for purposes of this Section 2.7, in Section 262(a) of the DGCL) has) properly exercised appraisal rights with respect thereto in accordance with, and who has (and, to the extent applicable, for which the applicable beneficial owner has) complied with, Section 262 of the DGCL with respect to such share of Company Common Stock (collectively, the “Dissenting Company Shares”) will not be converted into the right to receive the Per Share Price pursuant to this Section 2.7, and holders and beneficial owners of such Dissenting Company Shares will be entitled to receive payment of the fair value of such Dissenting Company Shares in accordance with the provisions of Section 262 of the DGCL unless and until any such holder (or, to the extent applicable, such beneficial owner) fails to perfect or effectively withdraws or loses their rights to appraisal and payment under the DGCL. If, after the Effective Time, any such holder (or, to the extent applicable, such beneficial owner) fails to perfect or effectively withdraws or loses such rights with respect to any Dissenting Company Shares, such Dissenting Company Shares will thereupon be treated as if they had been converted into, at the Effective Time, the right to receive the Per Share Price without interest thereon and the Surviving Corporation shall remain liable for payment of the Per Share Price without interest thereon for such Dissenting Company Shares in accordance with this Agreement. At the Effective Time, any holder or beneficial owner of Dissenting Company Shares will cease to have any rights with respect thereto, except the rights provided in Section 262 of the DGCL and as provided in the previous sentence. The Company shall give Parent (i) reasonably prompt (and in any event within three (3) Business Days) notice of any demands received by the Company for appraisal of Company Common Stock, withdrawals of such demands and any other instruments served pursuant to the DGCL or other communications, in each case, received by the Company in respect of the Dissenting Company Shares and (ii) the opportunity to direct all negotiations and proceedings with respect to such demands. The Company shall not, except with the prior written consent of Parent, make any payment with respect to any demands for appraisal or settle or offer to settle any such demands or waive any failure to timely deliver a written demand for
A-19

TABLE OF CONTENTS

appraisal or to timely take any other action to exercise appraisal rights or propose or agree to do any of the foregoing. Parent shall not, except with the prior written consent of the Company, require the Company to make any payment with respect to any demands for appraisal or settle any such demands prior to the Closing.
2.8 Treatment of Equity Awards.
(a) Company Options. At the Effective Time, each Company Option outstanding as of immediately prior to the Effective Time with an exercise price per share less than the Per Share Price, whether vested or unvested, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding Taxes, equal to the product of (i) the number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Per Share Price over the exercise price per share of such Company Option (the “Closing Option Consideration”). At the Effective Time, each Company Option with an exercise price per share equal to or greater than the Per Share Price will be cancelled without any action on the part of the holder thereof and without any cash payment being made in respect thereof.
(b) Vested Company RSAs. At the Effective Time, each Vested Company RSA outstanding and unsettled as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding Taxes, equal to the Per Share Price (the “Closing RSA Consideration”).
(c) Unvested Company RSAs. At the Effective Time, each Unvested Company RSA outstanding as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company RSAs shall become entitled to receive, in consideration of the cancellation of such Unvested Company RSAs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSA Restricted Cash Award”), with payment of such Company RSA Restricted Cash Award subject to the same terms and conditions (including, except as otherwise provided in Section 2.8(j) below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company RSAs as of immediately prior to the Effective Time.
(d) Vested Company RSUs. At the Effective Time, each Vested Company RSU outstanding and unsettled as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into and will become the right to receive an amount in cash, without interest thereon and subject to applicable withholding Taxes, equal to the product of (x) the Per Share Price and (y) the total number of shares of Company Common Stock subject to such Vested Company RSU as of immediately prior to the Effective Time (the “Closing RSU Consideration”).
(e) Unvested Company RSUs. At the Effective Time, each Unvested Company RSU outstanding as of immediately prior to the Effective Time, will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company RSUs shall become entitled to receive, in consideration of the cancellation of such Unvested Company RSUs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the product of (A) the number of shares of Company Common Stock subject to such Unvested Company RSUs multiplied by (B) the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company RSU Restricted Cash Award”), with payment of such Company RSU Restricted Cash Award subject to the same terms and conditions (including, except as otherwise provided in Section 2.8(j) below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company RSUs as of immediately prior to the Effective Time.
(f) Vested Company PSUs. At the Effective Time, each Vested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and converted into the right to receive an amount in cash, without interest thereon and subject to applicable withholding Taxes, equal to the product of (x) the Per Share Price and (y) the total number of shares of Company Common Stock subject to such Vested Company PSU as of immediately prior to the Effective Time, calculated based on
A-20

TABLE OF CONTENTS

actual performance achieved through the end of the applicable performance period in accordance with the terms of such Vested Company PSU (the “Closing PSU Consideration”, and together with the Closing Option Consideration, the Closing RSA Consideration and the Closing RSU Consideration, the “Closing Equity Award Consideration”).
(g) Unvested Company PSUs. At the Effective Time, each Unvested Company PSU will automatically, without any action on the part of Parent, Merger Sub, the Company or the holder thereof, be cancelled and each holder of any such cancelled Unvested Company PSUs shall become entitled to receive, in consideration of the cancellation of such Unvested Company PSUs and in settlement therefor, a restricted cash award representing the right to receive an amount in cash equal to the product of (A) the number of shares of Company Common Stock subject to such Unvested Company PSUs that are calculated and deemed to have satisfied the performance-based vesting condition based on the greater of (x) actual performance achieved through the Effective Time and (y) target-level performance, in accordance with the terms of such Unvested Company PSU, multiplied by (B) the Per Share Price, with such resulting amount rounded down to the nearest whole cent (such restricted cash award, the “Company PSU Restricted Cash Award,” and together with the Company RSU Restricted Cash Award and Company RSA Restricted Cash Award, the “Restricted Cash Awards”), with payment of such Company PSU Restricted Cash Award subject to the same terms and conditions (including, except as otherwise provided in Section 2.8(j) below, as to vesting, forfeiture, acceleration, settlement and payment) as applied to the corresponding cancelled Unvested Company PSUs as of immediately prior to the Effective Time.
(h) Company ESPP. As soon as practicable following the date of this Agreement, the Company shall take all actions with respect to the Company ESPP that are necessary to provide that with respect to the offering period under the Company ESPP in effect as of the date of this Agreement, if any (the “ESPP Offering Period”), (i) no individual who was not a participant in the Company ESPP as of the date of this Agreement may enroll in the Company ESPP, (ii) no participant may increase the percentage amount of their payroll deduction election from that in effect on the date of this Agreement or make separate non-payroll contributions to the Company ESPP, (iii) no new offering period shall be commenced under the Company ESPP prior to the Effective Time, (iv) the final exercise date for the ESPP Offering Period shall be the earlier of the regularly scheduled final exercise date for such ESPP Offering Period and a date that is no later than ten (10) calendar days prior to the Effective Time (the “Final Exercise Date”), (v) each Company ESPP participant’s accumulated contributions under the Company ESPP shall be used to purchase shares of Company Common Stock in accordance with the terms of the Company ESPP as of the Final Exercise Date, and (vi) immediately prior to the Effective Time, the Company ESPP shall terminate.
(i) Payment Procedures. At or prior to the Closing, Parent shall deposit (or cause to be deposited) with the Company, by wire transfer of immediately available funds, (i) Closing Equity Award Consideration owed to all holders of vested Company Options, Vested Company RSAs, Vested Company RSUs and Vested Company PSUs (collectively, the “Equity Award Holders”), solely to the extent that such Closing Equity Award Consideration is due and payable to the applicable Equity Award Holder on the Closing Date, and (ii) an amount in cash equal to the product obtained by multiplying (x) the aggregate number of SPAC Merger Earnout Shares issuable to all holders of Company Options pursuant to Section 2.9(b), by (y) the Per Share Price. As promptly as reasonably practicable, but in any event no later than five Business Days following the Closing Date, the Equity Award Holders will be paid by the Company or the Surviving Corporation, through its or its applicable Subsidiary’s payroll system or payroll provider, to the extent such amount is due as of such date and solely with respect to such amount as is then due and payable, (A) such portion of the amount required to be paid to such holder in respect of the Closing Equity Award Consideration as of such date pursuant to this Section 2.8 and (B) all amounts required to be paid to the holders of Company Options in respect of the SPAC Merger Earnout Shares issuable to such holders pursuant to Section 2.9(b), in each case, less any required withholding pursuant to Section 2.13; provided, that to the extent that payments (x) in respect of the Closing Equity Award Consideration are owed to non-employee directors of the Company, such amounts shall be paid by Parent, by wire transfer of immediately available funds, as promptly as reasonably practicable, but in any event no later than five Business Days, after the Closing or (y) in respect of any Company RSA Restricted Cash Award, Company RSU Restricted Cash Award or Company PSU Restricted Cash Award are owed to non-employee directors of the Company, such amounts shall be paid by the Company or the Surviving Corporation, by wire transfer of immediately available funds, as promptly as reasonably practicable, but in any event no later than five Business Days after the applicable vesting date. Notwithstanding anything to the
A-21

TABLE OF CONTENTS

contrary contained in this Agreement, to the extent that any Company Option, Company RSA, Company RSU or Company PSU constitutes nonqualified deferred compensation subject to Code Section 409A, any payment made in respect thereof pursuant to this Section 2.8 shall be paid on the applicable settlement or payment date for such Company Option, Company RSA, Company RSU or Company PSU, as applicable, if required to comply with Code Section 409A.
(j) Restricted Cash Awards. All amounts payable in respect of the Restricted Cash Awards shall be subject to any required withholding of Taxes and shall be paid, without interest, no later than the second regularly scheduled payroll date following the date on which the applicable portion of such award vests; provided that, if a holder of a Restricted Cash Award (a “Restricted Cash Award Holder”) (i)(A) incurs a termination of employment or service without Cause (as defined in such Restricted Cash Award Holder’s applicable award agreement or employment agreement), (B) resigns for Good Reason (as defined on Section 2.8(j) of the Company Disclosure Letter), or (C) incurs a termination of employment or service due to death or Disability (with “Disability” meaning a disability that qualifies such Restricted Cash Award Holder for disability benefits under the Company’s long-term disability plan or applicable Social Security law), in each case, within 24 months following the Effective Time, or (ii) incurs a Good Leaver Termination (as defined on Section 2.8(j) of the Company Disclosure Letter) at any time following the Effective Time, any then-unvested portion of such Restricted Cash Award shall vest in full upon such termination and shall be paid within 60 days following the date of such termination, subject to any required withholding of Taxes.
2.9 Effect on Other Company Securities; Company Earnout Shares. The Parties acknowledge and agree that the Transactions constitute a “Change in Control” for all purposes of Sections 2.7(a) and 2.8 of the SPAC Merger Agreement, and in connection therewith, all Company Earnout Shares shall be treated as set forth in this Section 2.9.
(a) Sponsor Earnout Shares. Immediately prior to the Effective Time, all Sponsor Earnout Shares shall vest in full and be released to the Sponsor in accordance with Section 2.8 of the SPAC Merger Agreement. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or the Sponsor, all Sponsor Earnout Shares shall be canceled and converted into the right to receive the Per Share Price in accordance with Section 2.7(a)(ii) and subject to Section 2.10.
(b) SPAC Merger Earnout Shares. Immediately prior to the Effective Time, the Company shall issue a number of shares of Company Common Stock comprising the maximum number of SPAC Merger Earnout Shares issuable in connection with Section 2.7(a) of the SPAC Merger Agreement to the Persons entitled thereto, in accordance with the terms of the SPAC Merger Agreement. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder of shares thereof, all shares of Company Common Stock issued pursuant to the immediately preceding sentence shall be canceled and converted into the right to receive the Per Share Price in accordance with Section 2.7(a)(ii) and subject to Section 2.8(i) and Section 2.10.
2.10 Exchange of Certificates.
(a) Payment Agent. Prior to the Closing, Parent shall (i) select a nationally recognized bank or trust company reasonably acceptable to the Company to act as the payment agent for the Merger (the “Payment Agent”); and (ii) enter into a payment agent agreement, in form and substance reasonably acceptable to the Company, with such Payment Agent.
(b) Payment Fund. At or prior to the Closing, Parent shall deposit (or cause to be deposited) with the Payment Agent, by wire transfer of immediately available funds, for payment to the holders of shares of Company Common Stock (other than to holders of Dissenting Company Shares and any amounts payable pursuant to Section 2.8(i)) pursuant to Section 2.7, an amount of cash equal to the aggregate consideration to which such holders of Company Common Stock become entitled pursuant to Section 2.7; provided, that the Company shall, at the written request of Parent at least 2 Business Days prior to Closing, deposit with the Payment Agent at the Closing such portion of such aggregate consideration from the cash denominated in United States dollars and held in United States bank accounts of the Company or any of its Subsidiaries as specified in such request. Until disbursed in accordance with the terms and conditions of this Agreement, such cash may be invested by the Payment Agent, as reasonably directed by Parent or the Surviving Corporation, in (i) obligations of or fully guaranteed by the United States or any agency or instrumentality thereof and backed by the full faith and credit of the United States with a maturity of no more than thirty days; (ii) commercial paper obligations rated A-1 or P-1 or better by Moody’s Investors Service, Inc. or Standard & Poor’s
A-22

TABLE OF CONTENTS

Corporation, respectively; or (iii) certificates of deposit, bank repurchase agreements or banker’s acceptances of commercial banks with capital exceeding $1,000,000,000 (based on the most recent financial statements of such bank that are then publicly available) (such cash and any proceeds thereon, the “Payment Fund”). To the extent that (A) there are any losses with respect to any investments of the Payment Fund; (B) the Payment Fund diminishes for any reason below the level required for the Payment Agent to promptly pay the cash amounts contemplated by Section 2.7; or (C) all or any portion of the Payment Fund is unavailable for Parent (or the Payment Agent on behalf of Parent) to promptly pay the cash amounts contemplated by Section 2.7 for any reason, Parent shall, or shall cause the Surviving Corporation to, promptly replace or restore the amount of cash in the Payment Fund so as to ensure that the Payment Fund is at all times fully available for distribution and maintained at a level sufficient for the Payment Agent to make the payments contemplated by Section 2.7. Any income from investment of the Payment Fund shall be payable to Parent or the Surviving Corporation as Parent directs. The Payment Fund shall not be used for any purpose other than the payment to holders of Company Common Stock as contemplated by Section 2.7.
(c) Payment Procedures. Promptly following the Effective Time (and in any event within three Business Days), Parent and the Surviving Corporation shall cause the Payment Agent to mail to each holder of record as of immediately prior to the Effective Time (other than Owned Company Shares and Dissenting Company Shares, as applicable) of one or more certificates that immediately prior to the Effective Time represented issued and outstanding shares of Company Common Stock (other than Owned Company Shares and Dissenting Company Shares, as applicable) (the “Certificates”) (if any) (i) a letter of transmittal in customary form (which shall specify that delivery will be effected, and risk of loss and title to the Certificates will pass, only upon delivery of the Certificates to the Payment Agent), and (ii) instructions for effecting the surrender of the Certificates in exchange for the Per Share Price payable with respect to the shares of Company Common Stock formerly represented thereby pursuant to Section 2.7. Upon surrender of Certificates for cancellation to the Payment Agent, together with such letter of transmittal, duly completed and validly executed in accordance with the instructions thereto, the holders of such Certificates will be entitled to receive in exchange therefor an amount in cash equal to the product obtained by multiplying (x) the aggregate number of shares of Company Common Stock represented by such Certificates by (y) the Per Share Price, and the Certificates so surrendered will forthwith be cancelled. Notwithstanding anything to the contrary in this Agreement, no record holder of uncertificated shares of Company Common Stock (other than Owned Company Shares) (the “Uncertificated Shares”) shall be required to deliver a Certificate or an executed letter of transmittal to the Payment Agent in order to receive the payment that such holder is entitled to receive pursuant to Section 2.7 with respect to such Uncertificated Shares. In lieu thereof, upon receipt of an “agent’s message” by the Payment Agent or such other evidence of transfer as the Payment Agent may reasonably request in accordance with customary procedures of the Payment Agent, such record holder will be entitled to receive in exchange therefor an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares of Company Common Stock represented by such holder’s transferred Uncertificated Shares, by (2) the Per Share Price, and the transferred Uncertificated Shares shall be cancelled. No interest shall be paid or accrued for the benefit of holders of the Certificates or Uncertificated Shares on the Per Share Price payable upon the surrender of such Certificates and transfer of Uncertificated Shares pursuant to this Section 2.10(c). Until so surrendered or transferred, outstanding Certificates and Uncertificated Shares shall be deemed from and after the Effective Time to evidence only the right to receive the Per Share Price without interest thereon payable in respect thereof pursuant to Section 2.7.
(d) DTC Payment. Prior to the Effective Time, Parent and the Company shall cooperate to establish procedures with the Payment Agent and the Depository Trust Company (“DTC”) with the objective that (i) if the Closing occurs at or prior to 11:30 a.m., Eastern time, on the Closing Date, the Payment Agent shall transmit to DTC or its nominees on the Closing Date an amount in cash, by wire transfer of immediately available funds, equal to (x) the number of shares of Company Common Stock (other than Owned Company Shares and Dissenting Company Shares) held of record by DTC or such nominee immediately prior to the Effective Time multiplied by (y) the Per Share Price (such amount, the “DTC Payment”), and (ii) if the Closing occurs after 11:30 a.m., Eastern time, on the Closing Date, then the Payment Agent will transmit the DTC Payment to DTC or its nominees on the first Business Day after the Closing Date.
(e) Transfers of Ownership. If payment of the Per Share Price is to be made to a Person other than the Person in whose name the surrendered Certificate or transferred Uncertificated Share in exchange therefor is registered, it shall be a condition of payment that (i) the Person requesting such exchange present proper
A-23

TABLE OF CONTENTS

evidence of transfer or shall otherwise be in proper form for transfer and (ii) the Person requesting such payment shall have paid any transfer and other Taxes required by reason of the payment of the Per Share Price to a Person other than the registered holder of such Certificate or Uncertificated Share surrendered or shall have established to the reasonable satisfaction of the Surviving Corporation that such Tax either has been paid or is not applicable.
(f) No Liability. Subject to applicable Law and notwithstanding anything to the contrary in this Agreement, none of the Payment Agent, Parent, the Surviving Corporation or any other Party shall be liable to a holder of shares of Company Common Stock for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar Law.
(g) Distribution of Payment Fund to Parent. Any portion of the Payment Fund that remains undistributed to the holders of the Certificates or Uncertificated Shares on the date that is one year after the Effective Time shall be delivered to Parent (or the Surviving Corporation as directed by Parent) upon demand, and any holders of shares of Company Common Stock that were issued and outstanding immediately prior to the Merger who have not theretofore surrendered or transferred their Certificates or Uncertificated Shares representing such shares of Company Common Stock for exchange pursuant to this Section 2.10 shall thereafter look for payment of the Per Share Price payable in respect of the shares of Company Common Stock represented by such Certificates or Uncertificated Shares solely to Parent (subject to abandoned property, escheat or similar Law), as general creditors thereof, for any claim to the Per Share Price to which such holders may be entitled pursuant to Section 2.7. Any amounts remaining unclaimed by holders of any such Certificates or Uncertificated Shares five years after the Effective Time, or at such earlier date as is immediately prior to the time at which such amounts would otherwise escheat to, or become property of, any Governmental Authority, will, to the extent permitted by applicable Law, become the property of the Surviving Corporation free and clear of any claims or interest of any such holders (and their successors, assigns or personal representatives) previously entitled thereto.
2.11 No Further Ownership Rights in Company Common Stock. From and after the Effective Time, there shall be no further registration of transfers on the records of the Surviving Corporation of shares of Company Common Stock that were issued and outstanding immediately prior to the Effective Time, other than transfers to reflect, in accordance with customary settlement procedures, trades effected prior to the Effective Time. If, after the Effective Time, Certificates or Uncertificated Shares are presented to the Surviving Corporation for any reason, they shall (subject to compliance with the exchange procedures of Section 2.10(c)) be cancelled and exchanged as provided in this Article II.
2.12 Lost, Stolen or Destroyed Certificates. In the event that any Certificates have been lost, stolen or destroyed, the Payment Agent shall issue in exchange therefor, upon the making of an affidavit of that fact by the holder thereof, the Per Share Price payable in respect thereof pursuant to Section 2.7. Parent or the Payment Agent may, in its reasonable discretion and as a condition precedent to the payment of such Per Share Price, require the owners of such lost, stolen or destroyed Certificates to deliver a bond in such reasonable amount as it may direct as indemnity against any claim that may be made against Parent, the Surviving Corporation or the Payment Agent with respect to the Certificates alleged to have been lost, stolen or destroyed.
2.13 Required Withholding. Each of the Payment Agent, Parent, the Company and the Surviving Corporation (without duplication), including their respective Affiliates and agents, shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amount payable pursuant to this Agreement to any Person such amounts as are required to be deducted or withheld therefrom pursuant to any Law in respect of applicable Taxes. To the extent that such amounts are so deducted or withheld and paid over to the appropriate Governmental Authority, such amounts will be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
With respect to any Section of this Article III, except (a) as disclosed in the reports, statements, schedules and other documents filed or furnished by the Company with the SEC on or since January 1, 2024 and at any time prior to 48 hours in advance of the execution and delivery of this Agreement (the “Company SEC Documents”) (other than any disclosures contained (i) solely in the risk factors sections of such Company SEC Documents, except to the extent such information consists of factual or historical statements, and (ii) in the “Forward-Looking Statements”
A-24

TABLE OF CONTENTS

section in such Company SEC Documents), it being understood that any matter disclosed in such Company SEC Documents shall not be deemed disclosed for purposes of Sections 3.1, 3.2, 3.3, 3.4, 3.7 and 3.25; or (b) subject to the terms of Section 9.13, as set forth in the disclosure letter delivered by the Company to Parent and Merger Sub on the date of this Agreement (the “Company Disclosure Letter”), the Company hereby represents and warrants to Parent and Merger Sub as follows:
3.1 Organization; Good Standing. The Company is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware. The Company has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties, rights and assets, except where the failure to have such power or authority would not have, individually or in the aggregate, a Company Material Adverse Effect. The Company is duly qualified to do business and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except where the failure to be so qualified or in good standing would not have, individually or in the aggregate, a Company Material Adverse Effect. The Company is not in violation of its Organizational Documents in any material respect.
3.2 Corporate Power; Enforceability. The Company has the requisite corporate power and authority to (a) execute and deliver this Agreement; (b) perform its obligations hereunder; and (c) subject to receiving the Requisite Stockholder Approval, consummate the Transactions. This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Parent and Merger Sub, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that (i) such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws affecting or relating to creditors’ rights generally and (ii) equitable remedies of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (such exceptions in clauses (i) and (ii), the “Enforceability Exceptions”).
3.3 Company Board Approval; Fairness Opinion; Anti-Takeover Laws.
(a) Company Board Approval. The Company Board unanimously (with respect to all directors present) has (i) determined that it is in the best interests of the Company and its stockholders, and declared it advisable, to enter into this Agreement and consummate the Merger upon the terms and subject to the conditions set forth herein; (ii) approved the execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and other obligations hereunder, and the consummation of the Merger upon the terms and conditions set forth herein; (iii) resolved to recommend that the Company Stockholders adopt this Agreement in accordance with the DGCL; and (iv) directed that the adoption of this Agreement be submitted for consideration by the Company Stockholders at a meeting thereof (collectively, the “Company Board Recommendation”), which Company Board Recommendation has not been withdrawn, rescinded or modified in any way as of the date hereof.
(b) Fairness Opinion . The Company Board has received from Morgan Stanley & Co. LLC an opinion, dated on or about the date hereof, to the effect that, as of the date of such opinion, and based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations set forth in such opinion, the Per Share Price to be paid to the holders of shares of Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to this Agreement is fair from a financial point of view to such holders of shares of the Company Common Stock. A signed, correct and complete copy of such opinion will be promptly made available to Parent, for informational purposes only, following receipt thereof by the Company.
(c) Anti-Takeover Laws. Assuming the accuracy of the representations of Parent and Merger Sub set forth in Section 4.7, the Company Board has taken all necessary actions so that the restrictions on business combinations set forth in Section 203 of the DGCL and any other similar applicable “anti-takeover” Law (or similar provisions in the Charter and Bylaws (including, for the avoidance of doubt, Article XII, Section 2 of the Charter)) will not be applicable to the Merger.
A-25

TABLE OF CONTENTS

3.4 Requisite Stockholder Approval. The adoption of this Agreement by the affirmative vote (in person or by proxy) of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote at the Company Stockholder Meeting (the “Requisite Stockholder Approval”) is the only vote or approval of the holders of any of the Company’s capital stock necessary under applicable Law, the Charter or the Bylaws to adopt this Agreement and consummate the Transactions.
3.5 Non-Contravention. The execution and delivery of this Agreement by the Company, the performance by the Company of obligations hereunder, and the consummation of the Transactions (a) do not violate or conflict with any provision of the Charter or the Bylaws; (b) do not violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of time or both, would become a default) pursuant to, result in the termination of, accelerate the performance required by, or result in a right of termination or acceleration pursuant to, any Material Contract; (c) do not, assuming the Governmental Authorizations referred to in Section 3.6 are obtained and, in the case of the consummation of the Merger, subject to obtaining the Requisite Stockholder Approval, violate or conflict with any Law applicable to the Company or any of its Subsidiaries; and (d) will not result in the creation of any lien (other than Permitted Liens) upon any of the properties or assets of the Company or any of its Subsidiaries, except in the case of each of clauses (b), (c) and (d) for such violations, conflicts, breaches, defaults, terminations, accelerations or liens that would not (i) have, individually or in the aggregate, a Company Material Adverse Effect or (ii) prevent, materially delay or materially impair the ability of the Company to consummate the Transactions.
3.6 Requisite Governmental Approvals. No Governmental Authorization is required on the part of the Company or any of its Subsidiaries in connection with (a) the execution and delivery of this Agreement by the Company; (b) the performance by the Company of its covenants and other obligations pursuant to this Agreement; or (c) the consummation of the Transactions by the Company, except for (i) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and such filings with Governmental Authorities to satisfy the applicable Laws of states in which the Company and its Subsidiaries are qualified to do business; (ii) such filings and approvals as may be required by any applicable federal or state securities Laws, including the filing of the Proxy Statement with the SEC and compliance with any applicable requirements of the Exchange Act; (iii) compliance with any applicable requirements of Nasdaq; (iv) compliance with any applicable requirements of the HSR Act and any applicable foreign Antitrust Laws set forth on Section 3.6(c)(iv) of the Company Disclosure Letter; and (v) such other Governmental Authorizations the failure of which to obtain would not (A) have, individually or in the aggregate, a Company Material Adverse Effect or (B) prevent, materially delay or materially impair the ability of the Company to consummate the Transactions.
3.7 Company Capitalization.
(a) Capital Stock. The authorized capital stock of the Company consists of (i) 5,000,000,000 shares of Company Common Stock; and (ii) 100,000,000 shares of Company Preferred Stock. As of 11:59 p.m., New York City time, on October 9, 2026 (such time and date, the “Capitalization Date”), (A) 590,693,325 shares of Company Common Stock were issued and outstanding; (B) no shares of Company Preferred Stock were issued and outstanding; and (C) no shares of Company Common Stock (all of which are Company Common Stock) were held by the Company as treasury shares. All issued and outstanding shares of Company Common Stock are validly issued, fully paid, nonassessable and free of any preemptive rights.
(b) Stock Reservation and Awards. As of the Capitalization Date, the Company has reserved: (i) 104,462,447 shares of Company Common Stock for issuance pursuant to the Company Equity Plan and (ii) 8,918,021 shares of Company Common Stock for issuance under the Company ESPP. As of the Capitalization Date, there were: (A) 18,866,341 shares of Company Common Stock subject to outstanding Company Options; (B) 21,727,494 shares of Company Common Stock subject to outstanding Company RSUs; (C) 3,356,923 shares of Company Common Stock subject to outstanding Company PSUs (calculated based on deemed target-level performance achievement) and 7,593,715 shares of Company Common Stock subject to outstanding Company PSUs (calculated based on maximum performance achievement); (D) 26,058 Company RSAs; and (E) 15,000,000 shares of Company Common Stock issuable as SPAC Merger Earnout Shares pursuant to the SPAC Merger Agreement. From the Capitalization Date to the date of this Agreement, the Company has not issued or granted any shares of Company Common Stock, other than pursuant to the exercise of Company Options or the vesting or settlement of Company RSAs, Company RSUs or Company PSUs, in each case, which were granted prior to the date of this Agreement and has not issued any Company Preferred Stock.
A-26

TABLE OF CONTENTS

(c) Company Securities. Except as set forth in Sections 3.7(a) and (b), as of the date of this Agreement, there are (i) no issued and outstanding shares of capital stock of, or other equity or voting interest in, the Company other than those shares of Company Common Stock that were reserved for issuance as of the Capitalization Date as set forth in Section 3.7(b) and have become outstanding after the Capitalization Date and prior to the date hereof; (ii) no outstanding options, warrants, calls, convertible, exchangeable or exercisable securities or other rights or binding arrangements that obligate the Company or any of its Subsidiaries to (A) issue, transfer or sell any shares of capital stock of, or other equity or voting interest in, the Company or securities convertible into or exchangeable or exercisable for such shares or other equity or voting interests (in each case other than to the Company or a Subsidiary thereof); or (B) grant, extend or enter into any such subscription, option, warrant, call, convertible, exchangeable or exercisable security, or other similar right, agreement or commitment relating to any shares of capital stock of, or other equity or voting interest in, the Company; and (iii) no outstanding restricted shares, restricted share units, stock appreciation rights, performance shares, contingent value rights, “phantom” stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital stock of, or other equity or voting interest in, the Company (the items in clauses (i), (ii) and (iii), collectively, the “Company Securities”).
(d) Other Rights. There are no (i) voting trusts, proxies or similar arrangements or understandings to which the Company is a party or by which the Company is bound with respect to the voting of any shares of capital stock of, or other equity or voting interest in, the Company; (ii) bonds, debentures, notes or other Indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any matter which the holders of Company Common Stock have the right to vote; or (iii) obligations or binding commitments of any character to which the Company is a party or by which it is bound (A) restricting the transfer of any shares of capital stock of, or other equity or voting interest in, the Company or (B) to make payments based on the price or value of any Company Securities or (C) granting any preemptive rights, anti-dilutive rights or rights of first refusal or other similar rights with respect to any Company Securities. As of the date of this Agreement, the Company is not a party to any Contract that obligates it to repurchase, redeem or otherwise acquire any Company Securities. There are no accrued and unpaid dividends with respect to any outstanding shares of Company Common Stock.
3.8 Subsidiaries.
(a) Organization; Good Standing. Each of the Subsidiaries of the Company (i) is duly organized, validly existing and in good standing (with respect to jurisdictions that recognize the concept of good standing) under the Laws of the jurisdiction of its organization and (ii) has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease and operate its properties, rights and assets, except, in each case, as would not have, individually or in the aggregate, a Company Material Adverse Effect. Each of the Subsidiaries of the Company is duly qualified to do business and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except where the failure to be so qualified or in good standing would not have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Capitalization of Subsidiaries. All of the outstanding capital stock of, or other equity or voting interest in, each Subsidiary of the Company has been duly authorized, validly issued and is fully paid and nonassessable (where such concepts are recognized under applicable Law). The Company or a wholly-owned Subsidiary of the Company owns one hundred percent of the capital stock of, and any other equity or voting interest in, each direct or indirect Subsidiary of the Company, free and clear of all liens other than Permitted Liens and such transfer restrictions of general applicability as may be provided under the Securities Act or other applicable securities Laws, except for directors’ qualifying shares or similar interests required to be held by applicable Law. The Company does not own, directly or indirectly, any capital stock or other equity or voting interest of, or any other securities convertible into or exchangeable or exercisable for capital stock or other equity or voting interest of, any Person other than the Subsidiaries of the Company. No Subsidiary of the Company owns any shares of capital stock or other securities of the Company.
(c) Company Subsidiary Securities. Except as set forth in Section 3.8(b), there are (i) no issued and outstanding shares of capital stock of, or other equity or voting interest in, any Subsidiary of the Company; (ii) no outstanding options, warrants, calls, convertible, exchangeable or exercisable securities or other rights or
A-27

TABLE OF CONTENTS

binding arrangements (including with respect to any voting trusts, proxies or other similar arrangements or understandings or any bonds, debentures, notes or other Indebtedness having the right to vote, or convertible into, or exchangeable for, securities having the right to vote) that obligate any Subsidiary of the Company to (A) issue, transfer or sell any shares of capital stock of, or other equity or voting interest in, such Subsidiary or securities convertible into or exchangeable or exercisable for such shares or other equity or voting interests (in each case other than to the Company or a Subsidiary thereof); or (B) grant, extend or enter into any such subscription, option, warrant, call, convertible, exercisable or exchangeable security, or other similar right, agreement or commitment relating to any capital stock of, or other equity or voting interest in, any Subsidiary of the Company; and (iii) no outstanding restricted shares, restricted share units, stock appreciation rights, performance shares, contingent value rights, “phantom” stock or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital stock of, or other equity or voting interest in, any Subsidiary of the Company (the items in clauses (i), (ii) and (iii), collectively, the “Company Subsidiary Securities”).
3.9 Company SEC Documents. Since January 1, 2024, the Company has filed, or furnished, as applicable, on a timely basis all material Company SEC Documents that have been required to be filed or furnished by it pursuant to applicable Laws prior to the date of this Agreement. Each Company SEC Document complied, as of its filing or furnishing date (or, if amended or superseded by a filing or furnishing prior to the date of this Agreement, on the date of such amended or superseding filing or furnishing), in all material respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, each as in effect on the date that such Company SEC Document was filed or furnished (or, if amended or superseded by a filing or furnishing prior to the date of this Agreement, on the date of such amended or superseded filing or furnishing). As of its filing or furnishing date (or, if amended or superseded by a filing or furnishing prior to the date of this Agreement, on the date of such amended or superseding filing or furnishing), and, in the case of a registration statement or amendment thereto, as of the date such registration statement or amendment became effective, each Company SEC Document did not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. No Subsidiary of the Company is required to file any forms, reports, schedules, prospectuses, registration statements or documents with the SEC. There are no outstanding unresolved comments with respect to the Company or the Company SEC Documents noted in comment letters or other correspondence received by the Company or its attorneys from the SEC. To the Knowledge of the Company, there are no pending (i) formal or informal investigations of the Company by the SEC or (ii) inspections of an audit of the Company’s financial statements by the Public Company Accounting Oversight Board.
3.10 Company Financial Statements; Internal Controls; Indebtedness.
(a) Company Financial Statements. The consolidated financial statements (including any related notes and schedules) of the Company filed with the Company SEC Documents (i) were prepared in accordance with GAAP applied on a consistent basis; and (ii) fairly present, in all material respects, the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of operations and cash flows for the periods then ended (subject, in the case of the unaudited financial statements, to normal and recurring year-end adjustments, none of which, individually or in the aggregate, are material). Except as has been described in the Company SEC Documents, there are no unconsolidated Subsidiaries of the Company or any off-balance sheet arrangements of the type required to be disclosed pursuant to Item 303(a)(4) of Regulation S-K promulgated by the SEC.
(b) Disclosure Controls and Procedures. The Company has established and maintains “disclosure controls and procedures” and “internal control over financial reporting” (in each case as defined pursuant to Rule 13a-15 and Rule 15d-15 promulgated under the Exchange Act). The Company’s disclosure controls and procedures are reasonably designed to ensure that all (i) material information required to be disclosed by the Company in the reports and other documents that it files or furnishes pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC; and (ii) such material information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. The Company has established and maintained effective internal controls over financial reporting in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. No events, facts or circumstances have occurred such that the Company’s management
A-28

TABLE OF CONTENTS

would not be able to complete its assessment of the effectiveness of the Company’s internal control over financial reporting in compliance with the requirements of Section 404 of the Sarbanes-Oxley Act when next due, and conclude, after such assessment, that such system was effective. Since January 1, 2024, the principal executive officer and principal financial officer of the Company have made all certifications required by the Sarbanes-Oxley Act (including Sections 302 and 906 thereof). Neither the Company nor its principal executive officer or principal financial officer has received notice from any Governmental Authority challenging or questioning the accuracy, completeness, form or manner of filing of such certifications as of the date of this Agreement. There were no material weaknesses, or significant deficiencies that in the aggregate would amount to a material weakness, identified in the management of the Company’s assessment of internal controls as of and for the year ended December 31, 2023 (nor has any such material weakness been identified since such date through the date of this Agreement). Since January 1, 2024, neither the Company nor, to the Knowledge of the Company, the Company’s independent registered public accounting firm has identified or been made aware of (A) any significant deficiency or material weakness in the system of internal control over financial reporting utilized by the Company or any of its Subsidiaries that has not been subsequently remediated or (B) any fraud (whether or not material) that involves the Company’s management or other employees who have a role in the preparation of financial statements or the internal control over financial reporting utilized by the Company or any of its Subsidiaries.
3.11 No Undisclosed Liabilities. Neither the Company nor any of its Subsidiaries has any liabilities (whether accrued, absolute, determined, contingent or otherwise and whether due or to become due) that would be required to be reflected or reserved against on a balance sheet (or the notes thereto) prepared in accordance with GAAP, other than liabilities (a) reflected and adequately reserved against in the consolidated financial statements of the Company and its Subsidiaries as of June 30, 2026, included in the Company SEC Documents filed prior to the date of this Agreement; (b) arising pursuant to this Agreement or incurred in connection with the Transactions, in each case, in accordance with the terms of this Agreement; (c) incurred in the ordinary course of business since June 30, 2026 (none of which is a liability for breach of Contract, breach of warranty, tort, infringement or violation of Law); or (d) that would not have, individually or in the aggregate, a Company Material Adverse Effect.
3.12 Absence of Certain Changes.
(a) Since June 30, 2026, except in connection with the Transactions, the business of the Company and its Subsidiaries has been conducted, in all material respects, in the ordinary course of business.
(b) Since December 31, 2025 through the date of this Agreement, there has not been any change, event, development, effect or occurrence that has had, individually or in the aggregate, a Company Material Adverse Effect.
(c) Since June 30, 2026 through the date of this Agreement, there has not been any event, occurrence, or action that, if taken following the date of this Agreement and prior to the Closing Date, would require Parent’s consent pursuant to Section 5.2(a) (Forbearance Covenants; Organizational Documents), Section 5.2(c) (Forbearance Covenants; Company Securities), Section 5.2(f) (Forbearance Covenants; Indebtedness), Section 5.2(h) (Forbearance Covenants; Legal Proceedings), Section 5.2(i) (Forbearance Covenants; Accounting), Section 5.2(j) (Forbearance Covenants; Tax), Section 5.2(m) (Forbearance Covenants; Acquisitions), Section 5.2(n) (Forbearance Covenants; Dispositions) or Section 5.2(o) (Forbearance Covenants; Intellectual Property).
3.13 Material Contracts.
(a) List of Material Contracts. Section 3.13(a) of the Company Disclosure Letter contains a true, correct and complete list of all Material Contracts, as in effect as of the date of this Agreement, to which the Company or any of its Subsidiaries is a party.
(b) Validity. Each Material Contract (other than any Material Contract that has expired in accordance with its terms) is valid and binding on the Company or the applicable Subsidiary of the Company that is a party thereto and is in full force and effect, except where the failure to be valid and binding and in full force and effect would not have, individually or in the aggregate, a Company Material Adverse Effect. The Company and each of its Subsidiaries, and, to the Knowledge of the Company, any other party thereto, has performed all obligations required to be performed by it under each Material Contract, except where the failure to fully perform would not have, individually or in the aggregate, a Company Material Adverse Effect. No event has
A-29

TABLE OF CONTENTS

occurred that, with notice or lapse of time or both, would constitute such a breach or default pursuant to any Material Contract by the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any other party thereto, except for such breaches and defaults that would not have, individually or in the aggregate, a Company Material Adverse Effect. Since December 31, 2025 to the date hereof, the Company has not received any written, or, to the Knowledge of the Company, verbal notice from or on behalf of any party to a Material Contract indicating that such party intends to terminate, or not renew, any Material Contract with such party.
3.14 Real Property. Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, (a) the Company and its Subsidiaries have good and valid fee simple title to all of the real property owned by the Company and its Subsidiaries (the “Owned Real Property”), free and clear of liens and encumbrances, except Permitted Liens; (b) the Company and its Subsidiaries have a good and valid leasehold interest in all of its Leased Real Property, free and clear of all liens and encumbrances (except for Permitted Liens); (c) each lease, license, sublease and occupancy agreement (each, a “Lease”) with respect to real property leased, licensed, subleased or otherwise used by the Company or its Subsidiaries as lessee or sublessee (the “Leased Real Property,” together with the Owned Real Property, the “Real Property”), is valid and binding on the Company or its Subsidiaries and is in full force and effect and, to the Knowledge of the Company, valid and binding on, and enforceable against, the other parties thereto, subject to proper authorization and execution of such Lease by the other party thereto and the application of any Enforceability Exception; (d) neither the Company nor any of its Subsidiaries is in breach or default under any of the Leases, beyond any applicable grace periods, and no event has occurred which would result in a breach or violation of, or a default under, any Lease by the Company nor any of its Subsidiaries or, to the Knowledge of the Company, any other party thereto (in each case, with or without notice or lapse of time or both); and (e) neither the Company nor any of its Subsidiaries has received written notice of, and, to the Knowledge of the Company, there are no existing, pending or threatened condemnation, eminent domain or similar proceedings with respect to the Real Property or any material portion thereof. Section 3.14 of the Company Disclosure Letter sets forth a true and complete list of all Real Property as of the date of this Agreement. True and complete copies in all material respects of all Leases (including all amendments, modifications and supplements thereto) have been made available to Parent.
3.15 Environmental Matters. Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, (a) the Company and its Subsidiaries are and since January 1, 2024 have been in compliance with all applicable Environmental Laws and all Governmental Authorizations required thereunder, (b) no written notice, report or other information regarding any actual or alleged violation of, or liability arising under, any Environmental Law has been received by the Company or any of its Subsidiaries, the substance of which has not been resolved, (c) there is no Legal Proceeding pending and, to the Knowledge of the Company, there is no Legal Proceeding threatened in writing or investigation pending against the Company or any of its Subsidiaries under or relating to any Environmental Law, and (d) there has been no release or disposal of, contamination by, or exposure of any Person to any Hazardous Substances by or on behalf of the Company or any of its Subsidiaries or their predecessors or otherwise on Real Property operated by the Company or any of its Subsidiaries so as to give rise to any liability (contingent or otherwise) under any Environmental Law for the Company or any of its Subsidiaries.
3.16 Intellectual Property.
(a) Section 3.16(a) of the Company Disclosure Letter sets forth a true, correct and complete list of all Company Registered Intellectual Property as of the date of this Agreement and, except as would not have, individually or in the aggregate, a Company Material Adverse Effect, such Company Registered Intellectual Property is subsisting, valid, and enforceable. The Company has maintained all Company Registered Intellectual Property in the ordinary course of business consistent with reasonable business practices, except for any such failure to maintain that would not have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, the Company or one of its Subsidiaries, as applicable, exclusively own, free and clear of all security interests, encumbrances or liens (other than Permitted Liens), all of the Company Intellectual Property, and the Company or one of its Subsidiaries, as applicable, owns, or is licensed or otherwise possesses adequate rights to use, all other Intellectual Property used in their respective businesses as currently conducted; provided, however, that the representation and warranty in this Section 3.16(b) shall not constitute or be deemed or construed as any representation or warranty with respect to infringement, misappropriation or violation by the Company or any of its Subsidiaries of any Intellectual Property, which is addressed in Section 3.16(d) below.
A-30

TABLE OF CONTENTS

(c) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, since January 1, 2024, there have been no Legal Proceedings pending or, to the Knowledge of the Company, Legal Proceedings threatened in writing or investigations pending against the Company or any of its Subsidiaries alleging infringement, misappropriation or violation by the Company or any of its Subsidiaries of any Intellectual Property of such Person or challenging the ownership, validity or enforceability of any Company Intellectual Property.
(d) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, since January 1, 2024, (i) the conduct of the business of the Company and its Subsidiaries has not infringed, misappropriated or violated any Intellectual Property of any Person, and (ii) to the Knowledge of the Company, no Person is infringing, misappropriating or violating any Company Intellectual Property.
(e) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, no proprietary software of the Company or its Subsidiaries incorporates, is derived from or links to any open source software in a manner that would require the Company or one of its Subsidiaries to make its proprietary source code available to any Person, and no Person (other than employees, contractors, consultants or any other Persons, in each case, for the purpose of performing services for the Company and its Subsidiaries and subject to reasonable confidentiality obligations) has possession of, or any current or contingent right to possess, any proprietary source code of the Company or any of its Subsidiaries. All Persons who created or invented any material Company Intellectual Property have assigned in writing to the Company or any of its Subsidiaries all of their rights, to the extent permitted under applicable Law, in such material Company Intellectual Property that do not vest in the Company or one of its Subsidiaries by operation of Law. Neither the Company nor any of its Subsidiaries has used AI Technologies to develop any material Intellectual Property for which the ownership of such Intellectual Property by the Company or such Subsidiary thereof would reasonably be expected to be adversely affected in any material respect by such use of AI Technologies to develop such Intellectual Property.
3.17 Tax Matters.
(a) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect:
(i) Each of the Company and its Subsidiaries have timely filed (taking into account valid extensions) all Tax Returns required to be filed by it and all such Tax Returns are correct, complete and accurate in all material respects.
(ii) The Company and each of its Subsidiaries have timely paid all Taxes that are required to be paid by it.
(iii) Neither the Company nor any of its Subsidiaries has executed any waiver, except in connection with any ongoing Tax examination, of any statute of limitations on, or extended the period for the assessment or collection of, any Tax, in each case that will remain in effect after the Closing Date.
(iv) The Company and each of its Subsidiaries have timely paid or withheld with respect to their shareholders, creditors, employees, independent contractors, and other Persons all Taxes required to be paid or withheld and has, within the time and in the manner required by applicable Law, paid over such withheld amounts to the proper Governmental Authority.
(v) No audits, examinations, investigations, disputes, claims or other proceedings with any Governmental Authority with respect to Taxes of the Company or any of its Subsidiaries are presently in progress or have been threatened in writing. No deficiency with respect to Taxes has been assessed in writing against the Company or any of its Subsidiaries which has not been fully paid. No written claim has been made by a Governmental Authority in a jurisdiction where the Company or any of its Subsidiaries does not file a Tax Return that the Company or the applicable Subsidiary, as the case may be, is or may be subject to Tax in that jurisdiction, which claim is still outstanding.
(vi) Neither the Company nor any of its Subsidiaries (A) is a party to or bound by, or currently has any liability pursuant to, any Tax sharing, allocation or indemnification agreement, other than any customary commercial agreement entered into in the ordinary course of business the primary purpose of which is unrelated to Taxes; (B) has any liability for the Taxes of any Person, other than the Company and its Subsidiaries, pursuant to Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or non-U.S. Law) as a transferee or successor, by contract (other than any customary commercial
A-31

TABLE OF CONTENTS

agreement entered into in the ordinary course of business the primary purpose of which is unrelated to Taxes) or otherwise as a matter of law; or (C) has been included in any consolidated, unitary or combined Tax Return provided for under any federal, state, local or non-U.S. Tax Law (other than a group the common parent of which is or was the Company or a Subsidiary of the Company and which includes only the Company and any of its Subsidiaries).
(vii) Neither the Company nor any of its Subsidiaries has engaged in a “listed transaction” as defined in Code Section 6707A(c)(2) and Treasury Regulation Section 1.6011-4(b)(2).
(viii) The Company has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period described in Section 897(c)(1)(A)(ii) of the Code.
(ix) There are no liens for Taxes upon any of the assets of the Company or any of its Subsidiaries other than Permitted Liens.
(x) Neither the Company nor any of its Subsidiaries has in the last two years constituted a “distributing corporation” or a “controlled corporation” in a transaction involving the distribution of stock intended to qualify for tax free treatment pursuant to Section 355 of the Code.
(xi) Neither the Company nor any of its Subsidiaries will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any of the following: (i) any change in or incorrect method of accounting of the Company or any of its Subsidiaries for a taxable period ending on or prior to the Closing Date; (ii) any “closing agreement” as described in Section 7121 of the Code (or any similar provision of other applicable Law) executed by the Company or any of its Subsidiaries on or prior to the Closing Date; (iii) any installment sale or open transaction disposition made, or prepaid amount received or deferred revenue accrued, by the Company or any of its Subsidiaries on or prior to the Closing Date; (iv) any intercompany transactions or excess loss account described in Treasury Regulation under Section 1502 of the Code (or any corresponding or similar provision of state or local income Tax Law); or (v) any election under Section 965(h) of the Code.
(xii) Neither the Company nor any of its Subsidiaries is or has been subject to Tax in any country other than the country in which it is organized by virtue of having a permanent establishment (within the meaning of any applicable tax treaty) or other place of business or taxable presence in that country.
(xiii) Notwithstanding any other provision in this Agreement, no representation or warranty is made with respect to the existence, availability, usability or limitations (or lack thereof) after the Closing Date of any net operating loss, net operating loss carryforward, capital loss, capital loss carryforward or other Tax attribute (whether U.S. federal, state or local or non-U.S.) of the Company or any of its Subsidiaries.
3.18 Employee Benefits.
(a) Employee Plans. Section 3.18(a) of the Company Disclosure Letter sets forth a true, correct and complete list, as of the date of this Agreement, of all material Employee Plans. With respect to each material Employee Plan, the Company has made available to Parent a true and correct copy of, if applicable: (A) the current plan document and all amendments thereto (or, with respect to any such plan that is not in writing, a written description of the material terms thereof); (B) any related trust agreements or other funding arrangements; (C) the most recent summary plan description and all summaries of material modification thereto; (D) the most recent annual reports (Form 5500) filed with the U.S. Department of Labor; (E) the most recent determination or opinion letter issued by the Internal Revenue Service (“IRS”) with respect to any Employee Plan intended to be qualified under Code Section 401(a); (F) written compliance and nondiscrimination testing results for the most recently completed plan year; and (G) any non-routine correspondence or filings with any Governmental Authority during the past three years.
(b) The Company has made available to Parent accurate and complete copies of the Company Equity Plans, representative forms of award agreements evidencing the Company Options, Company RSUs, Company PSUs and Company RSAs (together, the “Company Equity Awards”) and copies of award agreements evidencing any Company Equity Award that varies in any material respect from the representative form. Section 3.18(b) of the Company Disclosure Letter sets forth the following information with respect to each
A-32

TABLE OF CONTENTS

Company Equity Award outstanding as of the date of this Agreement: (i) the name of the Company Equity Plan pursuant to which such award was granted; (ii) the name or employee identification number of the Equity Award Holder; (iii) the type of Company Equity Award (including, if such Company Equity Award is a Company Option, whether such Company Option is intended to constitute an “incentive stock option” (within the meaning of Section 422 of the Code)); (iv) the number of shares of Company Common Stock to be issued upon exercise or settlement, as applicable, of such Company Equity Award (assuming, in the case of Company PSUs, performance is satisfied at target and at maximum performance) or the number of Company RSAs, as applicable; (v) the exercise price of such Company Equity Award, if applicable; (vi) the date on which such Company Equity Award was granted; and (vii) the vesting schedule of such Company Equity Award (including accelerated vesting provisions). The exercise price of each Company Option was equal to or greater than the fair market value of a share of Company Common Stock as of the date of grant of such Company Option within the meaning of Section 409A of the Code.
(c) Absence of Certain Plans. No Employee Plan is, and at no time during the six-year period prior to the date of this Agreement has the Company or any of its Subsidiaries maintained, sponsored or participated in, or contributed to, or had any obligations or liabilities (whether contingent or otherwise) with respect to (i) a “multiemployer plan” (as defined in Section 3(37) of ERISA) (a “Multiemployer Plan”), (ii) a “multiple employer plan” (as defined in Section 4063 or Section 4064 of ERISA), (iii) a pension plan that is subject to the funding standards of Section 312 of ERISA or Code Section 412 or Title IV of ERISA, or (iv) a “multiple employer welfare arrangement” as defined in Section 3(40) of ERISA. Neither the Company nor any of its Subsidiaries has any liability or obligation with respect to any “employee benefit plan” (as defined in Section 3(3) of ERISA) as a consequence of at any time being considered a single employer under Section 414 of the Code with any other Person.
(d) Compliance. Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, each Employee Plan has been established, maintained, funded, operated and administered in accordance with its terms and with all applicable Law, including the applicable provisions of ERISA and the Code. Each Employee Plan that is intended to be a “qualified plan” within the meaning of Code Section 401(a) has received a favorable determination letter, or may rely on a favorable opinion letter, issued by the IRS, and, to the Knowledge of the Company, no events have occurred that would reasonably be expected to result in the revocation of the qualified status of any such Employee Plan.
(e) Employee Plan Legal Proceedings. Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, there are no Legal Proceedings pending and, to the Knowledge of the Company, there are no Legal Proceedings threatened or investigations pending on behalf of or against any Employee Plan, other than routine claims for benefits. No Employee Plan is under audit or is the subject of an audit or investigation by any Governmental Authority, nor, to the Knowledge of the Company, is any such audit or investigation threatened or anticipated with respect to any Employee Plan.
(f) No Welfare Benefit Plan. No Employee Plan that is a “welfare benefit plan” (as defined in Section 3(1) of ERISA) provides post-termination or retiree life insurance or health benefits to any Person, except as may be required by Code Section 4980B or any similar Law (the full cost of which is paid by the participant). The Company and its Subsidiaries have not incurred (whether or not assessed) any material penalty, Tax or assessable payment under Code Sections 4980B, 4980D, 4980H, 6721 or 6722.
(g) Acceleration; Section 280G. Except as provided in this Agreement or as set forth on Section 3.18(g) of the Company Disclosure Letter, none of the execution and delivery of this Agreement or the consummation of the Transactions (whether alone or in connection with any other event) could reasonably be expected to (i) result in any payment or compensation to any current or former employees, officers, directors or individual service providers of the Company or any of its Subsidiaries of any money or other property or accelerate or provide any other rights or benefits (including with respect to time of payment, funding or vesting) to such Person, (ii) require a contribution by the Company or any of its Subsidiaries, (iii) limit or restrict any rights of the Company or any of its Subsidiaries to amend or terminate any Employee Plan, or (iv) otherwise result in any payment (whether in cash, property or the vesting of property) or benefit made by the Company or any of its Subsidiaries that could, individually or in combination with any other payment or benefit, constitute an “excess parachute payment” within the meaning of Section 280G(b)(1) of the Code or impose an excise Tax under Section 4999 of the Code.
A-33

TABLE OF CONTENTS

(h) Section 409A. Each Employee Plan subject to Code Section 409A has been operated and maintained in all material respects in operational compliance with, and is in all material respects in documentary compliance with, Code Section 409A and applicable guidance thereunder. Neither the Company nor any of its Subsidiaries has any obligation to provide (and no Employee Plan or other Contract provides) any individual with the right to a gross-up, indemnification, reimbursement or other payment for any Taxes pursuant to Section 409A or 4999 of the Code or otherwise.
3.19 Labor Matters.
(a) Section 3.19(a) of the Company Disclosure Letter sets forth the collective bargaining agreements or similar Contracts with any labor union, works council or other labor organization representing any employees of the Company or any of its Subsidiaries (each a “Labor Union”) to which the Company or any of its Subsidiaries is a party as of the date of this Agreement (“Collective Bargaining Agreements”). To the Knowledge of the Company, as of the date of this Agreement, there are, and since January 1, 2024 there have been, no pending or threatened proceedings of any Labor Union to organize any employees of the Company or any of its Subsidiaries with regard to their employment with the Company or any of its Subsidiaries. As of the date of this Agreement, there is, and since January 1, 2024 there has been, no strike, lockout, concerted work stoppage or other material labor dispute against the Company or any of its Subsidiaries pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries.
(b) Since January 1, 2024, there has been no “mass layoff” or “plant closing” as defined by WARN related to the Company or any of its Subsidiaries, and the Company and its Subsidiaries have not incurred any outstanding liability under WARN.
(c) Since January 1, 2024, to the Knowledge of the Company, no employee of the Company or any of its Subsidiaries with a title above Senior Vice President has been accused of any sexual harassment, sexual assault or other similar misconduct or sexual discrimination in connection with his or her employment with the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries has entered into any settlement agreements related to such accusations.
(d) The Company and its Subsidiaries are, and since January 1, 2024 have been, in compliance in all material respects with all Laws relating to employment, labor and employment practices, including all such Laws relating to or respecting terms and conditions of employment, wages and hours, equal employment opportunity, discrimination, harassment, retaliation, occupational health and safety, classification of employees and independent contractors, immigration (including compliance with worker authorization requirements), pay equity, pay transparency, disability rights or benefits, labor relations, plant closures and layoffs (including WARN), employee leave issues, employee trainings and notices, affirmative action, unemployment insurance, workers’ compensation, automated employment decision tools and other artificial intelligence.
(e) To the Knowledge of the Company, as of the date of this Agreement, no employee of the Company or any of its Subsidiaries with a title above Senior Vice President has provided written notice to terminate his or her employment with the Company or its Subsidiaries prior to the one-year anniversary of the Closing Date.
3.20 Compliance with Laws.
(a) The Company and each of its Subsidiaries are, and since January 1, 2024 have been, in compliance with all Laws that are applicable to the Company and its Subsidiaries or to the conduct of the business or operations of the Company and its Subsidiaries, except for such noncompliance that would not have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, (i) the Company and its Subsidiaries have all Governmental Authorizations necessary for the ownership, conduct and operation of its business as presently conducted, and each such Governmental Authorization is in full force and effect, (ii) the Company and its Subsidiaries are, and since January 1, 2024 have been, duly licensed to the extent required by applicable Law (for the type of business written, sold, produced or managed) except as would not be material to the Company or its Subsidiaries, taken as a whole, and (iii) the Company and its Subsidiaries are in compliance with the terms and conditions of all Governmental Authorizations necessary for the ownership, conduct and operation of its businesses. Since January 1, 2024, neither the Company nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any conflict with or breach of any such Governmental Authorization, the substance of which has not been resolved. No loss,
A-34

TABLE OF CONTENTS

non-renewal, suspension, revocation, modification or expiration of, nor any noncompliance with, any Governmental Authorization is pending or, to the Knowledge of the Company, threatened. All fees and charges with respect to each material Governmental Authorization have been paid in full. The Company and its Subsidiaries are not under any agreement or understanding with a Governmental Authority which in any way restricts their authority to conduct business or requires them to take, or refrain from taking, any action relating to the conduct of the business not otherwise permitted by applicable Law.
3.21 Data Privacy; IT Systems.
(a) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, (i) the Company and its Subsidiaries take and since January 1, 2024 have taken measures that are commercially reasonable (as a whole) to protect (A) the security, integrity and continuous operation of the IT Assets used by or on behalf of the Company or any of its Subsidiaries in the operation of the Company’s or its Subsidiaries’ businesses (and the confidential information, including Personal Information, stored therein or processed thereby) (“Company IT Assets”) and (B) the confidentiality of the Trade Secrets and Personal Information of the Company or any of its Subsidiaries; (ii) the Company IT Assets are free of any material malware, viruses, worms, Trojan horses, bugs, or other similar disabling code or instructions that would prevent the Company IT Assets from functioning as necessary for the operation of the business of the Company and its Subsidiaries or otherwise cause material harm to the Company IT Assets; and (iii) since January 1, 2024, there have been no unauthorized disclosures of Personal Information processed by or on behalf of the Company or any of its Subsidiaries, or outages, failures or substandard performances, security breaches, or unauthorized access or use of the Company IT Assets (and data, including Personal Information, processed thereby), except for those that were resolved without material cost or liability or the duty under applicable Law to notify any Person of such event.
(b) Except as would not have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries comply and since January 1, 2024 have complied with all applicable Laws, binding industry standards, publicly posted privacy policies and legally and/or contractually binding obligations, in each case, regarding (i) the collection, use, storage, disclosure and other processing of Personal Information and (ii) use of AI Technologies (collectively, “Privacy Requirements”).
3.22 Legal Proceedings; Orders.
(a) No Legal Proceedings. Except as would not (i) have, individually or in the aggregate, a Company Material Adverse Effect or (ii) prevent, materially delay or materially impair the ability of the Company to consummate the Transactions, and other than any Transaction Litigation commenced or threatened after the date of this Agreement, since January 1, 2024 there are no Legal Proceedings pending and, to the Knowledge of the Company, there are no Legal Proceedings threatened or investigations pending against the Company or any of its Subsidiaries.
(b) No Orders . Except as (i) would not have, individually or in the aggregate, a Company Material Adverse Effect or (ii) would not prevent, materially delay or materially impair the ability of the Company to consummate the Transactions, since January 1, 2024 neither the Company nor any of its Subsidiaries is or has been subject to any Order.
3.23 Insurance. The Company and its Subsidiaries have all material policies of insurance covering the Company and its Subsidiaries and any of their respective employees, properties or assets, including policies of life, property, fire, workers’ compensation, products liability, directors’ and officers’ liability and other casualty and liability insurance, that are customarily carried by Persons conducting business similar to that of the Company and its Subsidiaries, except as would not have, individually or in the aggregate, a Company Material Adverse Effect. As of the date of this Agreement, all such insurance policies are in full force and effect, no notice of cancellation has been received and there is no existing default or event that, with notice or lapse of time or both, would constitute a default by any insured party thereunder, except for such defaults that would not have, individually or in the aggregate, a Company Material Adverse Effect.
3.24 Anti-Corruption; Anti-Money Laundering; Sanctions Compliance.
(a) None of the Company, any of its Subsidiaries, or any of their respective officers, directors, or employees, nor, to the Knowledge of the Company, any agents, or representatives, or other Persons acting on behalf of the Company or any of its Subsidiaries has, in each case in their roles as such, (i) in the last five years
A-35

TABLE OF CONTENTS

taken any action in furtherance of an offer, provision, payment, or promise to pay anything of value, directly or indirectly, to any Person to influence official action or secure an improper business advantage for any Company Entities in material violation of any Anti-Corruption Laws, or otherwise violated, in any material respect, any applicable Anti-Corruption Laws or, in any material respect, applicable Anti-Money Laundering Laws; nor (ii) since April 24, 2019 engaged in any transaction or dealing with or for the benefit of any Sanctioned Person or in any Sanctioned Country in material violation of applicable Sanctions, or otherwise violated, in any material respect any applicable Sanctions.
(b) None of the Company, any of its Subsidiaries, or any of their respective officers, directors, or employees, nor, to the Knowledge of the Company, any agents, or representatives, or other Persons acting on behalf of the Company or any of its Subsidiaries (i) is a Sanctioned Person.
(c) None of the Company nor any of its Subsidiaries is or has been, to the Knowledge of the Company, subject to any investigation or inquiry by, or has received any written communication from, any Governmental Authority related to any actual, potential, or alleged violation of any Anti-Corruption Laws, Anti-Money Laundering Laws, or Sanctions.
(d) The Company and its Subsidiaries have implemented and maintain in effect policies and procedures reasonably designed to promote compliance with applicable Anti-Corruption Laws, Anti-Money Laundering Laws, and Sanctions.
3.25 Brokers. Except for Morgan Stanley & Co. LLC, there is no financial advisor, investment banker, broker, finder or agent that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who is entitled to any financial advisor’s, investment banking, brokerage, finder’s or other similar fee or commission in connection with the Transactions.
3.26 Company Information. The information supplied or to be supplied by the Company for inclusion in the Proxy Statement will not, at the time the Proxy Statement is first disseminated to the Company Stockholders or at the time of the Company Stockholder Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, except that no representation or warranty is made by the Company with respect to statements made therein based on information supplied by Parent or Merger Sub for inclusion or incorporation by reference therein.
3.27 Related Party Transactions. Neither the Company nor any of its Subsidiaries is a party to any agreement, commitment or transaction with or for the benefit of any Person that is required to be disclosed under Item 404 of Regulation S-K promulgated under the Exchange Act and that is not so disclosed.
3.28 Government Contracts. The Company and its Subsidiaries have established and maintain customary internal controls for compliance with each of their Government Contracts and all invoices submitted in connection with any Government Contract were current, accurate and complete in all material respects upon submission. Neither the Company nor any of its Subsidiaries has (a) been suspended or debarred from government contracts by any Governmental Authority; (b) been audited or, to the knowledge of the Company, investigated by any Governmental Authority with respect to any Government Contract; (c) conducted or initiated any internal investigation or made a voluntary or mandatory disclosure to any Governmental Authority or other Person with respect to any alleged or potential irregularity, misstatement or omission arising under or relating to a Government Contract; (d) received from any Governmental Authority any notice of breach, cure, show cause or default with respect to any Government Contract; or (e) had any Government Contract terminated by any Governmental Authority for default or failure to perform.
3.29 Customer Contracts. Section 3.29 of the Company Disclosure Letter lists each Material Customer. Since December 31, 2025, until the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written (or, to the Company’s knowledge, oral) notice from any Material Customer to the effect that any such Material Customer will stop, or materially decrease the rate of, buying products of the Company or any of its Subsidiaries or otherwise terminate, not renew, materially adversely modify or materially reduce its business with the Company or any of its Subsidiaries (in each case, whether as a result of the consummation of the Transaction or otherwise).
3.30 Vendor Contracts. Section 3.30 of the Company Disclosure Letter lists each Material Supplier. Since December 31, 2025, until the date of this Agreement, neither the Company nor any of its Subsidiaries has
A-36

TABLE OF CONTENTS

received any written (or, to the Company’s knowledge, oral) notice from any Material Supplier to the effect that any such Material Supplier will stop, materially decrease the rate of, or materially increase the price of supplying materials, products or services to the Company or any of its Subsidiaries or otherwise terminate, not renew, materially adversely modify or materially reduce its business with the Company or any of its Subsidiaries (in each case, whether as a result of the consummation of the Transaction or otherwise).
3.31 No Other Representations or Warranties. Except for the representations and warranties expressly made by the Company in this Article III or in any certificate delivered pursuant to this Agreement, neither the Company nor any other Person makes or has made any representation or warranty of any kind whatsoever, express or implied, at Law or in equity, with respect to the Company or any of its Subsidiaries or their respective business, operations, assets, liabilities, condition (financial or otherwise) or prospects, notwithstanding the delivery or disclosure to the Parent and Merger Sub or any of their Affiliates or Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing. Without limiting the generality of the foregoing, neither the Company nor any other Person makes or has made any express or implied representation or warranty to Parent, Merger Sub or any of their respective Representatives with respect to (a) any financial projection, forecast, estimate, or budget relating to the Company, any of its Subsidiaries or their respective businesses or (b) except for the representations and warranties made by the Company in this Article III or in any certificate delivered pursuant to this Agreement, any oral or written information presented to Parent, Merger Sub or any of their respective Representatives in the course of their due diligence investigation of the Company, the negotiation of this Agreement or the course of the Transactions. Except for the representations and warranties expressly set forth in Article IV, the Company hereby acknowledges that neither Parent, Merger Sub, nor any other Person, makes or has made or is making any other express or implied representation or warranty with respect to Parent, Merger Sub, or any of their Subsidiaries or their respective business or operations, including with respect to any information provided or made available to the Company or any of its Representatives or any information developed by the Company or any of its Representatives.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
Parent and Merger Sub hereby jointly and severally represent and warrant to the Company as follows:
4.1 Organization; Good Standing. Parent (a) is duly organized, validly existing and in good standing pursuant to the Laws of its jurisdiction of organization; and (b) has the requisite power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties and assets. Merger Sub (i) is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware; and (ii) has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties and assets. Neither Parent nor Merger Sub is in violation of its Organizational Documents.
4.2 Corporate Power; Enforceability. Each of Parent and Merger Sub has the requisite corporate power and authority to (a) execute and deliver this Agreement; (b) perform its obligations hereunder; and (c) consummate the Transactions. This Agreement has been duly executed and delivered by each of Parent and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes a legal, valid and binding obligation of each of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its terms, subject to the Enforceability Exceptions.
4.3 Non-Contravention. The execution and delivery of this Agreement by each of Parent and Merger Sub, the performance by each of Parent and Merger Sub of their respective covenants and other obligations hereunder, and the consummation of the Transactions do not (a) violate or conflict with any provision of the Organizational Documents of Parent or Merger Sub; (b) violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of time or both, would become a default) pursuant to, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration pursuant to any of the terms, conditions or provisions of any Contract or other instrument or obligation to which Parent or Merger Sub is a party or by which Parent, Merger Sub or any of their properties or assets may be bound; (c) assuming the Governmental Authorizations referred to in Section 4.4 are obtained, violate or conflict with any Law applicable to Parent or Merger Sub; or (d) result in the creation of any lien (other than Permitted Liens) upon any of the properties or assets of Parent or Merger Sub, except in the case of each of clauses (b), (c) and (d) for such violations, conflicts, breaches, defaults, terminations, accelerations or liens that would not, individually or in the aggregate, have a Parent Material Adverse Effect.
A-37

TABLE OF CONTENTS

4.4 Requisite Governmental Approvals. No Governmental Authorization is required on the part of Parent, Merger Sub or any of their Affiliates in connection with (a) the execution and delivery of this Agreement by each of Parent and Merger Sub; (b) the performance by each of Parent and Merger Sub of their respective covenants and obligations pursuant to this Agreement; or (c) the consummation of the Transactions by Parent and Merger Sub, except (i) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware; (ii) such filings and approvals as may be required by any federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act; (iii) compliance with any applicable requirements of the HSR Act and any applicable foreign Antitrust Laws; and (iv) such other Governmental Authorizations the failure of which to obtain would not, individually or in the aggregate, have a Parent Material Adverse Effect.
4.5 [Reserved].
4.6 Legal Proceedings; Orders.
(a) No Legal Proceedings . Other than any Transaction Litigation brought after the date hereof, there are no Legal Proceedings pending and, to the knowledge of Parent or any of its Affiliates, there are no Legal Proceedings threatened in writing or investigations pending against Parent or Merger Sub that would, individually or in the aggregate, have a Parent Material Adverse Effect.
(b) No Orders. Neither Parent nor Merger Sub is subject to any order of any kind or nature that would prevent or materially delay the consummation of the Transactions or the ability of Parent and Merger Sub to fully perform their respective covenants and obligations pursuant to this Agreement.
4.7 Ownership of Company Common Stock. None of Parent, Merger Sub or any of their respective directors or officers (a) has directly owned any shares of Company Common Stock; or (b) is or has been an “interested stockholder” (as defined in Section 203 of the DGCL) of the Company, in each case during the three years prior to the date of this Agreement.
4.8 Brokers. There is no financial advisor, investment banker, broker, finder, agent or other Person that has been retained by or is authorized to act on behalf of Parent, Merger Sub or any of their Affiliates who is entitled to any financial advisor’s, investment banking, brokerage, finder’s or other similar fee or commission payable by the Company prior to Closing in connection with the Transactions.
4.9 Operations of Parent and Merger Sub. The authorized capital stock of Merger Sub consists solely of 1,000,000 shares of common stock, par value $0.001 per share, all of which are validly issued and outstanding. Each of Parent and Merger Sub has been formed solely for the purpose of engaging in the Merger, and, prior to the Effective Time, Parent and Merger Sub shall not have engaged in any other business activities and shall not have incurred liabilities or obligations other than as contemplated by the Financing Letters, the Guarantees and this Agreement. Parent owns beneficially and of record all of the outstanding capital stock and other equity and voting interest in Merger Sub, free and clear of all liens.
4.10 No Parent Vote or Approval Required. No vote or consent of the holders of any capital stock of, or other equity or voting interest in, Parent is necessary to approve this Agreement or consummate the Merger. The adoption of this Agreement by the affirmative vote or consent of Parent as the sole stockholder of Merger Sub is the only vote or consent of the holders of the capital stock of, or other equity interest in, Merger Sub necessary under applicable Law or its Organizational Documents to adopt this Agreement and consummate the Merger.
4.11 Guarantees. Concurrently with the execution of this Agreement, each Guarantor has delivered to the Company a true, correct and complete copy of such Guarantor’s Guarantee, duly executed by such Guarantor in favor of the Company. As of the date of this Agreement, each Guarantee is in full force and effect and constitutes a legal, valid and binding obligation of such Guarantor, enforceable against it in accordance with its terms. As of the date of this Agreement, no event has occurred that, with notice or lapse of time or both, would, or would reasonably be expected to, constitute a default or breach or failure to satisfy a condition on the part of any Guarantor under such Guarantor’s Guarantee.
4.12 Financing.
(a) Financing Letters . As of the date of this Agreement, Parent has delivered to the Company true, correct and complete copies of (i) duly executed equity commitment letter, dated as of the date of this Agreement, between Parent and each Guarantor (collectively, the “Equity Commitment Letters”) pursuant to which such Guarantor has committed, subject to the terms and conditions therein, to invest in Parent, directly or indirectly,
A-38

TABLE OF CONTENTS

the amounts set forth therein for the purpose of funding a portion of the transactions contemplated hereby and thereby (the “Equity Financing”); (ii) a duly executed preferred equity commitment letter, dated the date of this Agreement, among Parent, Mozart Holdings, LLC and the Preferred Equity Financing Sources party thereto (including all exhibits, schedules, term sheets, and annexes thereto, as may be amended or modified in accordance with the terms hereof, collectively the “Preferred Equity Commitment Letter”), pursuant to which the Preferred Equity Financing Sources provided commitments therein and have committed, subject to the terms and conditions therein, to purchase the preferred equity in the amounts set forth therein (together with any Alternate Preferred Financing, the “Preferred Equity Financing”) and (iii) a duly executed debt commitment letter, dated as of the date of this Agreement, among Merger Sub and the Debt Financing Sources party thereto (including all exhibits, schedules, term sheets, and annexes thereto, as may be amended or modified in accordance with the terms hereof, collectively the “Debt Commitment Letter” and, together with the Equity Commitment Letters, the Preferred Equity Commitment Letter and the Fee Letters referenced below, the “Financing Letters”), pursuant to which the Debt Financing Sources providing commitments therein have committed, subject to the terms and conditions therein, to lend the amounts set forth therein for the purposes set forth therein (including the funding of a portion of the transactions contemplated hereby and thereby (including the repayment, prepayment or discharge of the outstanding Company Indebtedness)) (together with any Alternate Debt Financing, the “Debt Financing” and, together with the Equity Financing and the Preferred Equity Financing, the “Financing”). Parent has also delivered to the Company a true, correct and complete copy of any executed fee letter (which may be redacted in a customary manner solely with respect to fees and other economic provisions (including customary “market flex” terms); provided that no such redaction shall cover any terms that would adversely affect the conditionality, enforceability, availability or termination of the Preferred Equity Financing or the Debt Financing) in connection with the Preferred Equity Commitment Letter or the Debt Commitment Letter (any such letter, a “Fee Letter”, and together with the Preferred Equity Commitment Letter and the Debt Commitment Letter, the “Preferred Equity Financing Letters” and the “Debt Financing Letters”, respectively). Each Equity Commitment Letter provides that the Company is an express third-party beneficiary thereof for purposes of specifically enforcing the applicable guarantor’s obligation to fund the Equity Financing in accordance with, and subject to, the terms and conditions thereof.
(b) No Amendments. As of the date of this Agreement, (i) the Financing Letters and the terms of the Financing have not been amended or modified; (ii) no such amendment or modification is contemplated, except with respect to any “market flex” terms contained in the Fee Letter and except for the addition as parties to the Debt Commitment Letter of lenders, lead arrangers, bookrunners, agents, managers or similar entities who have not executed the Debt Commitment Letter as of the date hereof and (iii) the respective commitments contained in the Financing Letters have not been withdrawn, terminated, replaced or rescinded in any respect. As of the date of this Agreement, other than the Financing Letters, and any customary engagement letters or customary fee letters, in each case, with respect to the Debt Financing or the Preferred Equity Financing (none of which adversely affect the conditionality, enforceability, availability or termination of the Debt Financing or the Preferred Equity Financing), there are no other Contracts or side letters to which Parent, Merger Sub or any of their respective Affiliates is a party relating to the funding or investing, as applicable, of the full amount of the Financing at Closing, other than as expressly set forth in the Financing Letters delivered to the Company prior to the date of this Agreement.
(c) Sufficiency of Financing. Assuming satisfaction of the conditions set forth in Section 7.1 and Section 7.2, the aggregate proceeds of the Financing (both before and after giving effect to the exercise of any or all “flex” or “securities demand” provisions related thereto) when funded in accordance with the Financing Letters is sufficient to (i) make all payments contemplated by this Agreement on the terms and conditions set forth herein in connection with the consummation of the Closing (including the payment of all amounts payable pursuant to Article II in connection with or as a result of the Merger); (ii) repay, prepay or discharge (substantially simultaneously with the Merger) the principal of and interest on, and all other indebtedness outstanding pursuant to the Company Indebtedness as contemplated by this Agreement; and (iii) pay all fees and expenses required to be paid at Closing by the Company, Parent or Merger Sub in connection with the Merger and the Financing.
(d) Validity. As of the date of this Agreement, the Financing Letters (in the forms delivered by Parent to the Company) are in full force and effect with respect to, and constitute the legal, valid and binding obligations of, Parent and, to the knowledge of Parent, the other parties thereto, as applicable, and assuming due and valid execution by each other party thereto, enforceable against Parent and, to the knowledge of Parent, the other
A-39

TABLE OF CONTENTS

parties thereto, as applicable, in accordance with their terms (except as limited by the Enforceability Exceptions). Other than as expressly set forth in the Debt Commitment Letter and the Equity Commitment Letters, as of the date of this Agreement, there are no conditions precedent, side letters or other contingencies or agreements related to the funding of the amount of the Financing required to consummate the transactions contemplated by this Agreement pursuant to any agreement relating to the Financing to which the Guarantors, Parent, Merger Sub or any of their respective Affiliates is a party. As of the date of this Agreement, assuming satisfaction of the conditions set forth in Section 7.1 and Section 7.2, each of Parent and Merger Sub has no reason to believe that it will be unable to satisfy on a timely basis any term or condition in the Financing Letters applicable to it. As of the date of this Agreement, no event has occurred that, with or without notice or lapse of time or both, would, or would reasonably be expected to constitute a default or breach on the part of Parent or, to the knowledge of Parent, any of the other parties thereto pursuant to the Financing Letters. As of the date of this Agreement, assuming satisfaction of the conditions set forth in Section 7.1 and Section 7.2, Parent has no reason to believe that the amount of the Financing required to consummate the transactions contemplated by this Agreement will not be made available to Merger Sub on or prior to the Closing Date. As of the date of this Agreement, Parent and Merger Sub have fully paid, or caused to be fully paid, all commitment or other fees and amounts that are due and payable on or prior to the date of this Agreement pursuant to the terms of the Financing Letters.
4.13 Stockholder and Management Arrangements. Except as set forth on Section 4.13 of the disclosure letter delivered by Parent and Merger Sub to the Company on the date of this Agreement (the “Parent Disclosure Letter”), as of the date of this Agreement, none of the Guarantors, Parent, Merger Sub or any of their respective Affiliates is a party to any Contract with any director, officer or employee of the Company or any of its Subsidiaries (a) relating to (i) this Agreement or the Merger; (ii) the compensation and retention of such Persons following the Effective Time or (iii) the Surviving Corporation or any of its Subsidiaries following the Effective Time, or (b) pursuant to which (i) any holder of Company Common Stock would be entitled to receive consideration of a different amount or nature than the Per Share Price in respect of such holder’s shares of Company Common Stock or (ii) any holder of Company Common Stock has agreed to approve this Agreement or vote against any Superior Proposal.
4.14 Solvency. As of the Effective Time, and assuming (i) the satisfaction or waiver of the conditions set forth in Section 7.1 and Section 7.2, (ii) that the representations and warranties of the Company contained in this Agreement are true and correct in all material respects and performance by the Company of its obligations hereunder in all material respects, and (iii) immediately after giving effect to the Merger (including the payment of all amounts payable pursuant to Article II in connection with or as a result of the Merger and all related fees and expenses of Parent, Merger Sub, the Company and their respective Subsidiaries in connection therewith), (a) the amount of the “fair saleable value” of the assets of the Surviving Corporation and its Subsidiaries (on a consolidated basis) will exceed (i) the value of all liabilities of the Surviving Corporation and such Subsidiaries (on a consolidated basis), including contingent and other liabilities; and (ii) the amount that will be required to pay the probable liabilities of the Surviving Corporation and its Subsidiaries (on a consolidated basis) on their existing debts (including contingent liabilities) as such debts become absolute and matured; (b) the Surviving Corporation and its Subsidiaries (on a consolidated basis) will not have an unreasonably small amount of capital for the operation of the businesses in which they are engaged or proposed to be engaged; and (c) the Surviving Corporation and its Subsidiaries (on a consolidated basis) will be able to pay their liabilities, including contingent and other liabilities, as they mature. No transfer of property is being made by Parent, Merger Sub, the Surviving Corporation or any their respective Affiliates (or is contemplated being made) and no obligation is being incurred (or is contemplated being incurred) by Parent, Merger Sub, the Surviving Corporation or any of their respective Affiliates in connection with the Transactions (or any series of related transactions or any other transactions in close proximity with the Transactions) (A) with the intent to hinder, delay or defraud either present or future creditors of the Surviving Corporation, Parent, Merger Sub, the Company or any of its Subsidiaries or any of their respective Affiliates, (B) that would reasonably be expected to render the Surviving Corporation, Parent, Merger Sub or any of their respective Affiliates insolvent or (C) that as of the date of this Agreement, is reasonably expected to have a material adverse effect on the long term financial sustainability of the Surviving Corporation, Parent, Merger Sub or any of their respective Affiliates.
4.15 Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans. In connection with the due diligence investigation of the Company by Parent and Merger Sub, Parent and Merger Sub have received and may continue to receive from the Company certain estimates, projections, forecasts, and other forward-looking information, as well as certain business and strategic plan information, regarding the
A-40

TABLE OF CONTENTS

Company and its Subsidiaries and their respective businesses and operations. Parent and Merger Sub hereby acknowledge that there are uncertainties inherent in attempting to make such estimates, projections, forecasts, and other forward-looking statements, as well as in such business and strategic plans, with which Parent and Merger Sub are familiar, that Parent and Merger Sub are taking full responsibility for making their own evaluation of the adequacy and accuracy of all estimates, projections, forecasts, and other forward-looking information, as well as such business plans, so furnished to them (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking information, or business plans), and that, except for the representations and warranties expressly set forth in Article III, Parent and Merger Sub have not relied on such information or on any other representation or warranty (express or implied), memorandum, presentation or other materials or information provided by or on behalf of the Company and will have no claim against the Company or any of its Subsidiaries, or any of their respective Representatives, with respect thereto or any rights hereunder with respect thereto, except pursuant to the express terms of this Agreement, including on account of a breach of any of the representations, warranties, covenants, or agreements set forth herein or against the Company in the case of Fraud. Without limiting the generality of the foregoing, Parent and Merger Sub each acknowledges and agrees that neither the Company nor any other Person makes or has made any representations or warranties with respect to any estimates, projections, forecasts, or other forward-looking information made available to Parent, Merger Sub or any of their respective Representatives (including in certain “data rooms,” “virtual data rooms,” management presentations or in any other form in expectation of, or in connection with, the Transactions).
4.16 Parent and Merger Sub Information. The information supplied or to be supplied by Parent or Merger Sub for inclusion in the Proxy Statement will not, at the time the Proxy Statement is first disseminated to the stockholders of the Company or at the time of the Company Stockholder Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading.
4.17 No Other Representations or Warranties. Except for the representations and warranties expressly made by Parent and Merger Sub in this Article IV or in any certificate delivered pursuant to this Agreement, none of Parent, Merger Sub or any other Person makes or has made any representation or warranty of any kind whatsoever, express or implied, at Law or in equity, with respect to Parent or Merger Sub or their Affiliates or their respective business, operations, assets, liabilities, condition (financial or otherwise), notwithstanding the delivery or disclosure to the Company or any of its Affiliates or Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing. Except for the representations and warranties expressly set forth in Article III, Parent and Merger Sub hereby acknowledge that neither the Company nor any of its Subsidiaries, nor any other Person, makes or has made or is making any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective business or operations, including with respect to any information provided or made available to Parent, Merger Sub or any of their respective Representatives or any information developed by Parent, Merger Sub or any of their respective Representatives.
ARTICLE V
INTERIM OPERATIONS OF THE COMPANY
5.1 Affirmative Obligations. Except (a) as expressly contemplated by this Agreement, (b) as set forth in Section 5.1 of the Company Disclosure Letter, (c) as required by applicable Law, or (d) as approved by Parent in writing (which approval shall not be unreasonably withheld, conditioned or delayed and shall be deemed given if Parent provides no written response within five Business Days after a written request by the Company for such consent), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall, and shall cause each of its Subsidiaries to, use its commercially reasonable efforts to (i) conduct its business in all material respects in the ordinary course of business, (ii) preserve intact in all material respects its business organizations and operations, and (iii) preserve intact in all material respects its significant commercial relationships with customers, vendors, employees, Governmental Authorities and other third parties; provided that no action or omission by the Company or its Subsidiaries with respect to matters specifically addressed by any provision of Section 5.2 shall be deemed a breach of this sentence unless such action or omission would constitute a breach of such relevant provision of Section 5.2.
5.2 Forbearance Covenants. Except (w) as expressly contemplated by this Agreement, (x) as set forth in Section 5.2 of the Company Disclosure Letter, (y) as required by applicable Law or (z) as approved by Parent in writing (which approval shall not be unreasonably withheld, conditioned or delayed and shall be deemed given if
A-41

TABLE OF CONTENTS

Parent provides no written response within five Business Days after a written request by the Company for such consent), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall not, and shall not permit any of its Subsidiaries, to (whether directly or indirectly and whether by merger, consolidation, division, conversion, operation of law or otherwise):
(a) amend or repeal the Organizational Documents of the Company or any of its Subsidiaries or adopt any such new Organizational Documents or provision thereof (other than immaterial amendments to the Organizational Documents of any Subsidiary of the Company);
(b) propose or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, conversion, division, restructuring, recapitalization or other reorganization;
(c) issue, sell, deliver or agree or commit to issue, sell, deliver or authorize the issuance of any Company Securities, except (i) in accordance with the terms of any award agreement under the Company Equity Plan or otherwise with respect to, and upon the vesting, exercise or settlement of, Company Options, Company RSAs, Company RSUs or Company PSUs, in each case, outstanding on the date of this Agreement or granted after the date of this Agreement in compliance with this Agreement or (ii) for the issuance of SPAC Merger Earnout Shares in accordance with this Agreement or the SPAC Merger Agreement;
(d) except for transactions solely among the Company and its Subsidiaries or solely among the Subsidiaries of the Company, adjust, reclassify, split, combine, subdivide or redeem, repurchase, purchase or otherwise acquire or amend the terms of, directly or indirectly, any of its capital stock or other equity or voting interest of the Company, other than (i) the acquisitions of shares of Company Common Stock in connection with the surrender of shares of Company Common Stock by holders of Company Options to pay the exercise price of such Company Options, (ii) the withholding of shares of Company Common Stock to satisfy Tax obligations incurred in connection with the exercise of Company Options or the vesting or settlement of Company RSAs, Company RSUs and Company PSUs, and (iii) the acquisition by the Company of Company Options, Company RSUs, Company PSUs and Company RSAs in connection with the forfeiture of such awards, in each case of clauses (i), (ii) and (iii), in accordance with their terms;
(e) (i) declare, set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any shares of capital stock or other equity or voting interest, except for dividends or other distributions made by any direct or indirect wholly owned Subsidiary of the Company to the Company or one of its other wholly-owned Subsidiaries, (ii) modify the terms of any shares of its capital stock or other equity or voting interest; or (iii) pledge or encumber any shares of its capital stock or other equity or voting interest;
(f) (A) incur, assume, endorse, guarantee, or otherwise become liable for any Indebtedness, except (i) borrowings in the ordinary course of business under the Company’s credit facilities as in effect on the date of this Agreement or under facilities that replace, renew, extend, refinance or refund such existing credit facilities (including indebtedness incurred to repay or refinance related fees and expenses); provided that any such new facilities (x) are on terms not materially less favorable to the Company and its Subsidiaries, (y) are not in an aggregate principal amount or, in the case of any revolving facility, an aggregate committed amount, in excess of the outstanding aggregate principal amount or aggregate committed amount, as applicable, of the facilities being so replaced, renewed, extended, refinanced or refunded, plus defeasance costs, original issue discount, upfront fees and other similar and customary fees, commissions, costs and expenses incurred in connection with such replacement, renewal, extension, refinancing or refunding and (z) will be repaid in full at or prior to the Effective Time, (ii) guarantees or credit support provided by the Company or any of its Subsidiaries of the obligations of the Company or any of its Subsidiaries to the extent such indebtedness is in existence on the date of this Agreement or incurred in compliance with this Section 5.2(f), (iii) letters of credit, bank guarantees, performance bonds and surety bonds entered into in the ordinary course of business and (iv) any intercompany indebtedness between the Company and its wholly owned Subsidiaries or among the Company’s wholly owned Subsidiaries or (B) settle, waive, or forgive any Indebtedness owed to the Company or any of its Subsidiaries;
(g) except as required by any Employee Plan set forth on Section 3.18(a) of the Company Disclosure Letter: (i) establish, enter into, adopt, materially amend or modify, or terminate any Employee Plan (or any plan, policy, agreement or arrangement that would constitute a material Employee Plan if in effect on the date
A-42

TABLE OF CONTENTS

of this Agreement), other than in conjunction with annual renewals of group welfare benefits in the ordinary course of business; or (ii) increase, modify or amend (including to accelerate the time of payment, vesting or funding of, or provide for the payment of amounts not otherwise due with respect to) the salaries, wages, benefits, bonuses or other compensation or other benefits payable or provided to any current or former director, officer, employee or individual service provider, except in the ordinary course of business; (iii) enter into or grant any change in control, severance, transaction, retention or similar agreement with any current or former employees, officers, directors or individual service providers of the Company or any of its Subsidiaries; (iv) hire, engage, promote or terminate (other than for cause) any employee, officer, director or individual service provider of the Company or any of its Subsidiaries whose annual base salary or wage rate exceeds $300,000; or (v) modify or amend any Company Equity Awards;
(h) commence, settle, release, waive or compromise any pending or threatened Legal Proceeding (x) that involves any admission of liability or any injunctive or equitable relief or (y) for an amount in excess of $1,000,000 individually or $5,000,000 in the aggregate, other than any settlement of any Legal Proceeding or investigation (i) where the amount paid or to be paid by the Company or any of its Subsidiaries is covered by insurance coverage maintained by the Company or any of its Subsidiaries, (ii) for an amount not in excess of the amount, if any, reflected or reserved in the balance sheet (or the notes thereto) of the Company, (iii) in compliance with Section 6.15 or (iv) involving any dispute between one or more of Parent or Merger Sub, on the one hand, and the Company, on the other hand, relating to this Agreement or the transactions contemplated herein;
(i) materially change the Company’s or its Subsidiaries’ methods, principles or practices of financial accounting or annual accounting period, except as required by GAAP, Regulation S-X promulgated under the Securities Act (or any interpretation thereof), or by any Governmental Authority;
(j) (i) make (except in a manner consistent with past practice), change or revoke any material Tax election, (ii) make any material change to any method of Tax accounting, (iii) amend any material Tax Return, (iv) settle or compromise any material Tax action, claim or assessment, (v) consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of material Taxes, (vi) enter into any closing agreement with respect to a material amount of Taxes, (vii) surrender any right to claim a material refund of Taxes or (viii) initiate or enter into any voluntary disclosure agreement with a Governmental Authority with respect to a material amount of Taxes;
(k) incur or commit to incur any capital expenditures other than (i) as set forth in Section 5.2(k) of the Company Disclosure Letter (the “Capex Budget”), or (ii) capital expenditures that do not exceed the Capex Budget by more than $15,000,000 in the aggregate;
(l) enter into, modify in any material respect, amend in any material respect (including granting any material refunds, credits, rebates, allowances to customers thereunder) or terminate (other than any Material Contract that has expired in accordance with its terms) any Material Contract except, in each case, in the ordinary course of business; provided that any Material Contract (x) described by the definition set forth in Section 1.1(hhh)(ii) (Material Contracts; Acquisitions and Dispositions) shall be exclusively governed by Section 5.2(m), (y) described by the definition set forth in Section 1.1(hhh)(vi) (Material Contracts; Indebtedness) shall be exclusively governed by Section 5.2(f) and (z) described by the definition set forth in Section 1.1(hhh)(xvi) (Material Contracts; Leases) shall be exclusively governed by Section 5.2(t);
(m) acquire any division, assets, properties, businesses or equity securities or otherwise make any investment in any Person (including by merger, consolidation or acquisition of stock or assets) for consideration in excess of $10,000,000 in the aggregate, other than (i) in or from any wholly owned Subsidiary of the Company, or (ii) assets in the ordinary course of business;
(n) sell, license, pledge, abandon, assign, transfer, or otherwise dispose of, any of the Company’s or its Subsidiaries’ material assets (other than Intellectual Property, which is the subject of clause (o)), other than such sales, assignments, transfers or other dispositions that (i) are in the ordinary course of business or (ii) do not have a purchase price that exceeds $10,000,000 in the aggregate;
(o) sell, assign, transfer, license, abandon, cancel, permit to lapse, pledge, encumber or otherwise dispose of any material Company Intellectual Property, other than (i) the grant of non-exclusive licenses in the ordinary
A-43

TABLE OF CONTENTS

course of business and in a manner not inconsistent with past practices, (ii) the expiration of Registered Intellectual Property at the end of their statutory term, or (iii) pledges or encumbrances under the Company Credit Agreement as in effect on the date of this Agreement or any Permitted Lien;
(p) engage in any transaction with, or enter into any agreement, arrangement or understanding with, any Affiliate of the Company or other Person covered by Item 404 of Regulation S-K promulgated by the SEC that would be required to be disclosed pursuant to Item 404;
(q) effectuate or announce any plant closing, mass employee layoff, furlough or any other action that would trigger the notice requirements of WARN;
(r) enter into, amend, or terminate any Collective Bargaining Agreement;
(s) (A) purchase any real property; (B) enter into any new lease agreement with respect to real property that is not leased by the Company or one of its Subsidiaries as of the date hereof, other than any such lease providing for aggregate payments by the Company and its Subsidiaries of less than $1,000,000 over the initial term thereof; or (C) with respect to any Lease for Real Property in effect on the date hereof, (1) waive, release, assign, or sublease any material rights or claims thereunder, (2) materially amend or modify the terms thereof, (3) except in the ordinary course of business, terminate such Lease for Real Property (other than as a result of expiration of the then-existing term), (4) except in the ordinary course of business, extend the term thereof, as in effect on the date hereof, or (5) grant any material waiver or give any consent thereunder;
(t) make any loans, advances or capital contributions to, any other Person, except for (i) extensions of credit to customers in the ordinary course of business, (ii) advances to directors, officers and other employees for travel and other business-related expenses, in each case, in the ordinary course of business and in compliance in all material respects with the Company’s or its Subsidiaries’ policies related thereto, and (iii) loans, advances or capital contributions to, any direct or indirect wholly owned Subsidiaries of the Company; or
(u) agree, resolve or commit to take any of the actions prohibited by this Section 5.2.
5.3 No Solicitation.
(a) No Solicitation or Negotiation. Subject to the terms of Section 5.3(b), from the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company and its Subsidiaries shall not, and shall not authorize or permit any of their respective Representatives to, directly or indirectly, (i) solicit, initiate, propose or knowingly induce the making, submission or announcement of, or knowingly encourage, facilitate or assist, any inquiry, proposal or offer with respect to, that constitutes or could reasonably be expected to lead to, an Acquisition Proposal; (ii) furnish or otherwise provide to any Person (other than Parent, Merger Sub or any designees of Parent or Merger Sub) any non-public information relating to the Company or any of its Subsidiaries or afford to any Person access to the business, properties, assets, books, records or personnel, of the Company or any of its Subsidiaries, in any such case with the intent to knowingly induce the making, submission or announcement of, or to knowingly encourage or knowingly facilitate, any proposal or offer with respect to, that constitutes or would reasonably be expected to lead to an Acquisition Proposal; (iii) participate or otherwise engage in, enter into, continue or otherwise participate in, discussions or negotiations with any Person (or its Representatives, including potential financing sources of such Person) with respect to an Acquisition Proposal (or inquiry, proposal, offer or any other effort or attempt that could reasonably be expected to lead to an Acquisition Proposal), in each case, other than informing such Persons of the existence of the provisions contained in this Section 5.3 or contacting such Person solely in order to clarify (but not to negotiate) the terms and conditions of any Acquisition Proposal; (iv) otherwise cooperate with or knowingly assist or participate in or knowingly facilitate the making of any Acquisition Proposal, including granting a waiver, amendment or release under any pre-existing standstill or similar provision to the extent necessary to allow for an Acquisition Proposal, or amendment to an Acquisition Proposal to be made to the Company or the Company Board; (v) approve, endorse or recommend an Acquisition Proposal; or (vi) approve, endorse, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other Contract relating to an Acquisition Transaction (including any “clean team” or similar arrangement), other than an Acceptable Confidentiality Agreement (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other Contract relating to an Acquisition Transaction, an “Alternative Acquisition Agreement”).
A-44

TABLE OF CONTENTS

Subject to the following two sentences of this Section 5.3(a), and subject to the terms of Section 5.3(b), promptly (and in any event within three (3) Business Days) following the execution of this Agreement, the Company shall request the return or destruction of all non-public information concerning the Company or its Subsidiaries theretofore furnished to any such Person (other than Parent, the Guarantors, the Financing Sources and their respective Representatives and Affiliates) with whom a confidentiality agreement was entered into at any time prior to the date hereof with respect to an Acquisition Proposal, and shall immediately cease and shall cause each of its Subsidiaries and use its reasonable best efforts to cause its and their respective Representatives to immediately (x) cease any discussions, communications or negotiations with any Person (other than the Parties and their respective Representatives) in connection with an Acquisition Proposal (or proposals or offers that could reasonably be expected to lead to an Acquisition Proposal) by such Person, in each case that exists as of the date of this Agreement and (y) shut off all access of any Person (other than the Parties and their respective Representatives) to any electronic data room maintained by the Company with respect to the Transactions. From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company will be required to enforce, and will not be permitted to waive, terminate or modify, any provision of any standstill or similar provision that prohibits or purports to prohibit a proposal being made to the Company Board (or any committee thereof) unless the Company Board (or any committee thereof) has determined in good faith, after consultation with its financial advisors and outside legal counsel, that failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law.
(b) Superior Proposals. Notwithstanding anything to the contrary set forth in this Agreement, from the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Company’s receipt of the Requisite Stockholder Approval, the Company and the Company Board (or a committee thereof) may, directly or indirectly through one or more of their Representatives, participate or engage in discussions or negotiations with, furnish any non-public information relating to the Company or any of its Subsidiaries to, or afford access to the business, properties, assets, books, records or personnel, of the Company or any of its Subsidiaries pursuant to an Acceptable Confidentiality Agreement to any Person or such Person’s Representatives that has made, renewed or delivered to the Company an Acquisition Proposal after the date of this Agreement, and otherwise facilitate such Acquisition Proposal or assist such Person (and such Person’s Representatives and financing sources) with such Acquisition Proposal if requested by such Person, in each case, with respect to an Acquisition Proposal that the Company Board (or a committee thereof) has determined in good faith (i) after consultation with its financial advisors and outside legal counsel, either constitutes a Superior Proposal or could reasonably be expected to lead to a Superior Proposal, and (ii) after consultation with its outside legal counsel, that the failure to do so would reasonably be likely to be inconsistent with its fiduciary duties under applicable Law; provided that, subject to applicable Law and any applicable “clean team” or similar arrangement, the Company shall provide to Parent and Merger Sub any non-public information or data that is provided to any Person given such access that was not previously made available to Parent or Merger Sub prior to or promptly (and in any event within 24 hours) following the time it is provided to such Person.
(c) Company Board Recommendation Change; Entry into Alternative Acquisition Agreement. Notwithstanding anything to the contrary set forth in this Agreement, until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Company’s receipt of the Requisite Stockholder Approval:
(i) the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event (within the meaning of clause (A) of the definition of “Company Board Recommendation Change”) if the Company Board (or a committee thereof) determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law; provided that the Company Board (or a committee thereof) shall not effect such a Company Board Recommendation Change unless:
(1) the Company has provided prior written notice to Parent at least four Business Days in advance (such notice period, including any extension thereto, in accordance with this Section 5.3(c)(i), the “Intervening Event Notice Period”) to the effect that the Company Board (or a committee thereof) intends to effect a Company Board Recommendation Change, which notice shall specify the basis for such Company Board Recommendation Change; and
A-45

TABLE OF CONTENTS

(2) prior to effecting such Company Board Recommendation Change, the Company and its Representatives, during the Intervening Event Notice Period, negotiate with Parent and its Representatives in good faith (to the extent that Parent desires to so negotiate) to enable Parent to make such adjustments to the terms and conditions of this Agreement and the Financing Letters in such a manner that would obviate the need to effect a Company Board Recommendation Change; provided that, in the event the Intervening Event to which this provision applies thereafter changes in any material respect, the Company will be required to deliver a new written notice to Parent and to comply with the requirements of this Section 5.3(c)(i) with respect to such new written notice, it being understood that the “Intervening Event Notice Period” in respect of such new written notice will be three (3) Business Days; and
(3) at the end of the Intervening Event Notice Period and prior to taking any such action, the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing to make revisions to the terms of this Agreement and the Financing Letters, and has determined in good faith (after consultation with its financial advisors and outside legal counsel), that the failure to effect a Company Board Recommendation Change would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable Law if such changes proposed by Parent were to be given effect; or
(ii) if the Company has received an unsolicited and bona fide Acquisition Proposal that did not result from a material breach of this Section 5.3 and that the Company Board has determined in good faith (after consultation with its financial advisors and outside legal counsel) constitutes a Superior Proposal, then the Company Board may (A) effect a Company Board Recommendation Change with respect to such Acquisition Proposal; or (B) cause the Company to terminate this Agreement pursuant to Section 8.1(h) in order to substantially concurrently enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal; provided that the Company Board (or a committee thereof) shall not take any action described in the foregoing clauses (A) and (B) unless:
(1) the Company Board determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law;
(2) (i) the Company has provided prior written notice to Parent at least four Business Days in advance (such notice period, including any extension thereto in accordance with this Section 5.3(c)(ii)(1), the “Acquisition Proposal Notice Period”) to the effect that the Company Board (or a committee thereof) intends to take the actions described in clauses (A) or (B) of Section 5.3(c)(ii), including the identity of the Person or Group making such Acquisition Proposal, the material terms thereof and copies of all material relevant agreements (including any Alternative Acquisition Agreement) relating to such Acquisition Proposal; and (ii) prior to effecting such Company Board Recommendation Change or termination, the Company and its Representatives, during the Acquisition Proposal Notice Period, negotiate with Parent and its Representatives in good faith (to the extent that Parent desires to so negotiate) to enable Parent to make such adjustments to the terms and conditions of this Agreement and the Financing Letters in such a manner that would obviate the need to effect a Company Board Recommendation Change or termination; provided that, in the event of any material modifications to such Acquisition Proposal (it being understood that any change to the financial terms (including the form, amount and timing of payment of consideration) or other material terms of such proposal shall be deemed a material modification), the Company will be required to deliver a new written notice to Parent and to comply with the requirements of this Section 5.3(c)(ii)(1) with respect to such new written notice, it being understood that the “Acquisition Proposal Notice Period” in respect of such new written notice will be three Business Days; and
(3) at the end of the Acquisition Proposal Notice Period and prior to taking any such action, the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing to make revisions to the terms of this Agreement and the Financing Letters, and has determined in good faith (after consultation with its financial advisors and outside legal counsel), that
A-46

TABLE OF CONTENTS

(x) such Acquisition Proposal continues to constitute a Superior Proposal and (y) the failure to take such action would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable Law if such changes proposed by Parent were to be given effect.
(d) No Change in Company Board Recommendation or Entry into an Alternative Acquisition Agreement. Except as permitted by Section 5.3(c) or Section 5.3(f), the Company Board shall not:
(i) (A) withhold, withdraw, amend or modify, or publicly propose to withhold, withdraw, amend or modify, the Company Board Recommendation; (B) adopt, approve, recommend or endorse or otherwise declare advisable, or publicly propose to adopt, approve or recommend to the Company Stockholders an Acquisition Proposal; (C) fail to include the Company Board Recommendation in the Proxy Statement; (D) fail to publicly reaffirm the Company Board Recommendation within ten Business Days after Parent so requests in writing following the public disclosure of an Acquisition Proposal (other than of the type referred to in the following clause (E)) with any Person other than Parent and Merger Sub (provided that if the Company Stockholder Meeting is scheduled to be held within ten Business Days from the date of such written request, promptly and in any event prior to the date which is two Business Days before the date on which the Company Stockholder Meeting is scheduled to be held if at least two Business Days from the date of such written request), (E) fail to recommend, in a Solicitation/Recommendation Statement on Schedule 14D-9 under the Exchange Act, against any Acquisition Proposal that is a tender offer or exchange offer subject to Regulation 14D promulgated under the Exchange Act within ten Business Days after the commencement (within the meaning of Rule 14d-2 under the Exchange Act) of such tender offer or exchange offer (or if the Company Stockholder Meeting is scheduled to be held within ten Business Days from the date of such commencement, promptly and in any event prior to the date which is two Business Days before the date on which the Company Stockholder Meeting is scheduled to be held) or (F) resolve, agree or publicly propose to do any of the foregoing (any action described in clauses (A) through (F), a “Company Board Recommendation Change”); provided that, for the avoidance of doubt, none of (1) the factually accurate disclosure by the Company of the receipt of an Acquisition Proposal, (2) the determination by the Company Board (or a committee thereof) that an Acquisition Proposal constitutes a Superior Proposal, or (3) the delivery by the Company to Parent of any notice contemplated by Section 5.3(c) will constitute a Company Board Recommendation Change; or
(ii) cause or permit the Company or any of its Subsidiaries to enter into an Alternative Acquisition Agreement.
(e) Notice. From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall as promptly as reasonably practicable (and, in any event, within 48 hours) notify Parent if any Acquisition Proposal or any offers or proposals that would reasonably be expected to lead to an Acquisition Proposal are received by the Company or any of its Representatives. Such notice must include (i) the identity of the Person or Group making such Acquisition Proposal or such offers or proposals; and (ii) a summary of the material terms and conditions of any such Acquisition Proposal or such offers or proposals and copies of any proposed material written agreements or material correspondence exchanged between the Person (or its Representatives) making such Acquisition Proposal and the Company (or its Representatives). Thereafter, the Company must keep Parent reasonably informed, on a prompt basis, of the status and material terms of any such Acquisition Proposal or such offers or proposals (including any material amendments, revisions or other changes thereto) and the status of any related discussions or negotiations.
(f) Certain Disclosures. Nothing contained in this Agreement will prohibit the Company or the Company Board (or a committee thereof) (i) from taking and disclosing to the Company Stockholders a position contemplated by Rule 14d-9 or Rule 14e-2(a) promulgated under the Exchange Act or making a customary “stop-look-and-listen” communication to the Company Stockholders pursuant to Rule 14d-9(f) under the Exchange Act or (ii) from making disclosures to the Company Stockholders to the extent required under applicable securities Laws with respect to the Transactions or an Acquisition Proposal, so long as, in each case, any such disclosure does not include any statement that constitutes, and does not otherwise constitute, a Company Board Recommendation Change (it being understood that neither (x) a customary “stop-look-and-listen” communication to the Company Stockholders pursuant to Rule 14d-9(f) under the Exchange Act nor (y) a statement that the Company Board is evaluating a tender offer or exchange offer, in each case of clauses (x) and (y), made prior to the expiration of the period specified in clause (E) of
A-47

TABLE OF CONTENTS

Section 5.3(d)(i), shall constitute a Company Board Recommendation Change); provided that the foregoing shall in no way override the Company’s obligations pursuant to Section 5.3(d) and no such communication or disclosure by the Company or the Company Board in accordance with and to the extent expressly permitted by this Section 5.3(f) shall be deemed to be a Company Board Recommendation Change.
5.4 No Control of the Other Party’s Business. The Parties acknowledge and agree that the restrictions set forth in this Agreement are not intended to give Parent or Merger Sub, on the one hand, or the Company, on the other hand, directly or indirectly, the right to control or direct the business or operations of the other at any time prior to the Effective Time. Prior to the Effective Time, each of Parent, Merger Sub and the Company shall exercise, consistent with the terms, conditions and restrictions of this Agreement, complete control and supervision over their own business and operations.
ARTICLE VI
ADDITIONAL COVENANTS
6.1 Required Action and Forbearance; Efforts.
(a) Reasonable Best Efforts. Upon the terms and subject to the conditions set forth in this Agreement (including this Section 6.1(a)) and subject to any different standard set forth herein with respect to any covenant or obligation (including Section 5.1, Section 5.3(c) and Section 6.2), Parent and Merger Sub shall, on the one hand, and the Company shall, on the other hand, use their respective reasonable best efforts to (i) take (or cause to be taken) all actions; (ii) do (or cause to be done) all things; and (iii) assist and cooperate with the other Parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable Law or otherwise to consummate and make effective, as promptly as reasonably practicable, the Merger and the Transactions, including by (A) causing the conditions to the Merger set forth in Article VII to be satisfied and (B) (I) obtaining all consents, waivers, approvals, orders and authorizations from Governmental Authorities; and (II) making all registrations, declarations and filings with Governmental Authorities, in each case that are necessary or advisable to consummate the Transactions.
(b) No Consent Fee. Notwithstanding anything to the contrary set forth in this Section 6.1 or elsewhere in this Agreement, none of Parent, Merger Sub, the Company nor any of their respective Subsidiaries will be required to agree (or, in the case of the Company or its Subsidiaries, will agree without Parent’s consent) to (i) the payment of a consent fee, “profit sharing” payment or other consideration (including increased or accelerated payments) or (ii) the provision of additional security (including a guaranty), in each case, in connection with the Merger, including in connection with obtaining any consent pursuant to any Material Contract.
(c) Limitations. Section 6.1(a) shall not apply to filings under Antitrust Laws, which shall be governed by the obligations set forth in Section 6.2 below.
6.2 Antitrust and Regulatory Matters.
(a) Filing Under Antitrust Laws. Each of Parent and Merger Sub shall, on the one hand, and the Company (and its Subsidiaries, if applicable), on the other hand, shall, to the extent required, within ten Business Days following the date of this Agreement file with the FTC and the Antitrust Division of the DOJ a Notification and Report Form relating to this Agreement and the Merger as required by the HSR Act. Each of Parent and the Company shall (A) cooperate and coordinate with the other (or cause such cooperation or coordination) in the making of such filings; (B) supply the other (or cause the other to be supplied) with any information that may be required in order to make such filings; (C) subject to Section 6.2(c), supply (or cause to be supplied) any additional information that may be required or requested by the FTC, the DOJ or the Governmental Authorities of any other applicable jurisdiction in which any such filing is made; and (D) take, or cause to be taken, all actions necessary, proper or advisable, with respect to Parent, Merger Sub and their respective Subsidiaries, if applicable, and of the Company and its Subsidiaries, to (1) cause the expiration or termination of the applicable waiting periods pursuant to the HSR Act and any other Antitrust Laws applicable to this Agreement or the Merger; and (2) obtain all clearances, consents, approvals, waivers, actions, non-actions and other authorizations pursuant to any Antitrust Laws applicable to this Agreement or the Merger, in each case as promptly as practicable and in any event at least five Business Days prior to the Termination Date. Each of Parent and Merger Sub shall, on the one hand, and the Company (and its Subsidiaries), on the other hand, shall promptly inform the other (or cause the other to be informed) of any material communication from any Governmental Authority regarding the Merger in connection with such filings. If a Party or any of its Affiliates
A-48

TABLE OF CONTENTS

receives any comments or a request for additional information or documentary material from any Governmental Authority with respect to the Merger pursuant to the HSR Act or any other Antitrust Laws applicable to the Merger, then such Party shall make (or cause to be made), as promptly as practicable and after consultation with the other Parties, an appropriate response to such request; provided that no Party may extend any waiting period or enter into any agreement or understanding with any Governmental Authority without the permission of the other Parties, which shall not be unreasonably withheld, conditioned or delayed. Parent shall control strategy, communications, and timing with respect to parties’ efforts to obtain any necessary or advisable clearances, approvals, waivers, actions, non-actions, authorizations, consents, Orders or declarations of any Governmental Authority or the expiration or termination of any applicable waiting period necessary to consummate the Transactions, including the Merger, after considering in good faith all comments and advice of the Company. Parent and Merger Sub shall be solely responsible for payment of all filing fees in connection with filings made under the HSR Act and any other Antitrust Laws. Parent shall prepare and make (or cause to be prepared and made) all filings, notifications, registrations, submissions of information and other documentation required or advisable under the HSR Act, supply (or cause to be supplied) any additional information requested by any Governmental Authority, and comply (or cause such compliance) with the notification, consultation and “outside counsel only” obligations set forth in Section 6.2(c).
(b) Avoidance of Impediments. In furtherance and not in limitation of the other covenants in this Section 6.2, if and to the extent necessary to obtain clearances, consents, approvals, waivers, actions, expirations or terminations of any waiting period, non-actions or other authorizations pursuant to the HSR Act or any other Antitrust Laws applicable to the Merger, and to avoid or eliminate each and every impediment under any Antitrust Law and any other Laws applicable to the Merger as promptly as practicable and in any event at least five Business Days prior to the Termination Date, each of Parent and Merger Sub shall undertake (or cause to be undertaken, as applicable) to offer, negotiate, commit to and effect, by consent decree, hold separate order or otherwise, and take (or cause to be taken) all actions with respect to Parent, Merger Sub, the Company and each of their respective Subsidiaries necessary to avoid or eliminate each and every impediment and obtain all clearances, consents, approvals, waivers, actions, expirations or terminations of any waiting period, non-actions or other authorizations under the HSR Act and any other Laws including (i) the sale, divestiture, transfer, license, disposition, or hold separate (through the establishment of a trust or otherwise), of any and all of the capital stock or other equity or voting interest, assets (whether tangible or intangible), rights, properties, products or businesses of the Company and its Subsidiaries; (ii) the termination, modification, or assignment of existing relationships, joint ventures, Contracts, or obligations of the Company and its Subsidiaries; (iii) the modification of any course of conduct regarding future operations of the Company and its Subsidiaries; and (iv) any other restrictions on the activities of the Company and its Subsidiaries, including the freedom of action of the Company and its Subsidiaries with respect to, or their ability to retain, one or more of their respective operations, divisions, businesses, product lines, customers, assets or rights or interests of the Company and its Subsidiaries (each of the foregoing described in clauses (i) through (iv) of this Section 6.2(b), together with entering into any settlement, undertaking, consent decree, stipulation or agreement with or required by any Governmental Authority in connection with the Transactions, a “Regulatory Concession”); in each case, so as to allow the consummation of the Merger as soon as practicable and, in any event, at least five Business Days prior to the Termination Date; provided that, notwithstanding anything in this Agreement to the contrary, nothing in this Section 6.2(b) or any other provision of this Agreement shall require or obligate Parent or any of its affiliates to, and the Company shall not, without the prior written consent of Parent, agree or otherwise be permitted to, take any action, including any Regulatory Concession, with respect to Parent, Merger Sub, or any of Parent’s affiliates (including (A)(x) GTCR LLC, and any investment funds or investment vehicles affiliated with, or managed or advised by GTCR, and (y) any portfolio company (as such term is commonly understood in the private equity industry) or investment of GTCR or of any such investment fund or investment vehicle, or any interest therein, or (B)(x) Elliott, and any investment funds or investment vehicles affiliated with, or managed or advised by Elliott, and (y) any portfolio company (as such term is commonly understood in the private equity industry) or investment of Elliott or of any such investment fund or investment vehicle), or any interest therein, in each case, other than the Company and its Subsidiaries. Parent shall oppose (or cause to be opposed) any request for or the entry of, and seek (or cause to be sought) to have vacated or terminated, any order, judgment, decree, injunction or ruling of any Governmental Authority that could restrain, prevent or delay any required consents, clearances, approvals, waivers, actions, waiting period expirations or terminations, non-actions or other authorizations applicable to the Merger, including by defending through litigation, any action asserted by any Person in any court or before any Governmental Authority and by
A-49

TABLE OF CONTENTS

exhausting all avenues of appeal, including appealing properly any adverse decision or order by any Governmental Authority. Notwithstanding the foregoing, nothing in this Agreement shall require the Parent, Merger Sub, the Company or their respective Subsidiaries to enter into any agreement or consent decree with the DOJ, FTC or any other Governmental Authority or take, or agree to take, any other action that is not conditioned on the Closing.
(c) Cooperation. In furtherance and not in limitation of the foregoing, the Company, Parent and Merger Sub shall, subject to any restrictions under applicable Laws, undertake (or cause to be undertaken, as applicable) to (i) promptly notify the other Parties of, and, if in writing, furnish the others with copies of (or, in the case of oral communications, advise the others of the contents of) any material communication received by such Person from a Governmental Authority in connection with the Merger and provide the other Parties a reasonable amount of time to review and discuss in advance (and to consider in good faith any comments made by the other Parties in relation to) any proposed draft notifications, formal notifications, filing, submission or other written or oral communication (and any analyses, memoranda, white papers, presentations, correspondence or other documents submitted therewith) made in connection with the Merger to a Governmental Authority; (ii) keep the other Parties informed (on a prompt basis) with respect to the status of any such submissions and filings to any Governmental Authority in connection with the Merger and any developments, meetings or discussions with any Governmental Authority in respect thereof, including with respect to (A) the receipt of any non-action, action, clearance, consent, approval, waiver or other authorizations, (B) the expiration or termination of any waiting period, (C) the commencement or proposed or threatened commencement of any investigation, litigation or administrative or judicial action or proceeding under applicable Laws, including any proceeding initiated by a private party, and (D) the nature and status of any objections raised or proposed or threatened to be raised by any Governmental Authority with respect to the Merger; and (iii) not independently participate in any meeting, hearing, proceeding or substantive discussions (whether in person, by telephone, by video or otherwise) with or before any Governmental Authority in respect of the Merger without giving the other Parties reasonable prior notice of such meeting or substantive discussions and, unless prohibited by such Governmental Authority, the opportunity to attend or participate. However, each of the Company, Parent and Merger Sub may reasonably designate any competitively sensitive information provided to any Governmental Authority as restricted to “outside counsel only” and any such information shall not be shared with employees, officers or directors or their equivalents of the other Party without approval of the Party providing the commercially sensitive information; provided that each of the Company, Parent and Merger Sub may redact any valuation and related information before sharing any information provided to any Governmental Authority with another Party on an “outside counsel only” basis, and that the Company, Parent and Merger Sub shall not in any event be required to share information that benefits from legal privilege with the other Parties, even on an “outside counsel only” basis, where this would, in the reasonable judgment of the Company’s counsel, cause such information to cease to benefit from legal privilege.
(d) Other Actions. Parent and Merger Sub shall not, and shall cause the Persons listed on Section 6.2(d) of the Parent Disclosure Letter not to (i) acquire (by stock purchase, merger, consolidation, purchase of assets, license or otherwise), or (ii) enter into or agree to enter into, any Contracts or arrangements, including for an acquisition (by stock purchase, merger, consolidation, purchase of assets, license or otherwise) of, any ownership interest, equity interests, assets or rights in or of any Person that would reasonably be expected to, individually or in the aggregate, (A) prevent, materially delay or materially impede the obtaining of any clearances, approvals, waivers, actions, non-actions, authorizations, consents, orders or declarations of any Governmental Authority or the expiration or termination of any applicable waiting period necessary to consummate the Transactions, including the Merger, or (B) materially increase the risk of any Governmental Authority entering an order, ruling, judgment or injunction prohibiting the consummation of the Transactions, including the Merger.
6.3 Proxy Statement.
(a) Proxy Statement. As promptly as reasonably practicable following the date of this Agreement (but in any event within 25 Business Days), the Company (with the assistance and cooperation of Parent and Merger
A-50

TABLE OF CONTENTS

Sub as reasonably requested by the Company) shall prepare and file with the SEC a preliminary proxy statement (as amended or supplemented, the “Proxy Statement”) relating to the Company Stockholder Meeting. Subject to Section 5.3, the Company shall include the Company Board Recommendation in the Proxy Statement.
(b) Other Required Company Filing. If the Company is required to file any document other than the Proxy Statement with the SEC in connection with the Merger pursuant to applicable Law (such document, as amended or supplemented, an “Other Required Company Filing”), then the Company (with the assistance and cooperation of Parent and Merger Sub as reasonably requested by the Company) shall promptly prepare and file such Other Required Company Filing with the SEC. The Company shall use its reasonable best efforts to cause the Proxy Statement and any Other Required Company Filing to comply as to form in all material respects with the applicable requirements of the Exchange Act and the rules of the SEC and Nasdaq. The Company may not file the Proxy Statement or any Other Required Company Filing with the SEC without providing Parent and its counsel, to the extent practicable, a reasonable opportunity to review and comment thereon and the Company shall give due consideration to all reasonable additions, deletions or changes suggested thereto by the other Parties or their respective counsel.
(c) Furnishing Information. Each of the Company, on the one hand, and Parent and Merger Sub, on the other hand, shall furnish all information concerning it and its Affiliates, if applicable, as the other Party may reasonably request in connection with the preparation and filing with the SEC of the Proxy Statement and any Other Required Company Filing. If at any time prior to the Company Stockholder Meeting any information relating to the Company, Parent, Merger Sub or any of their respective Affiliates should be discovered by the Company, on the one hand, or Parent or Merger Sub, on the other hand, that should be set forth in an amendment or supplement to the Proxy Statement or any Other Required Company Filing, as the case may be, so that such filing would not include any misstatement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, then the Party that discovers such information shall promptly notify the other, and an appropriate amendment or supplement to such filing describing such information shall be promptly prepared and filed with the SEC by the appropriate Party and, to the extent required by applicable law or the SEC or its staff, disseminated to the Company Stockholders.
(d) Consultation Prior to Certain Communications. The Company and its Affiliates, on the one hand, and Parent, Merger Sub and their respective Affiliates, on the other hand, shall provide the other Party a reasonable opportunity to review and comment on any written communication with the SEC or its staff with respect to the Proxy Statement or any Other Required Company Filing, as the case may be, and each Party shall give due consideration to all reasonable additions, deletions or changes suggested thereto by the other Parties or their respective counsel.
(e) Notices. The Company, on the one hand, and Parent and Merger Sub, on the other hand, shall advise the other, promptly after it receives notice thereof, of (i) any receipt of a request by the SEC or its staff for any amendment or revisions to the Proxy Statement or any Other Required Company Filing, as the case may be; (ii) any receipt of comments from the SEC or its staff on the Proxy Statement or any Other Required Company Filing, as the case may be; or (iii) any receipt of a request by the SEC or its staff for additional information (including any meetings with the SEC or its staff) in connection with the items covered in clauses (i) and (ii) above.
(f) Dissemination of Proxy Statement. Subject to applicable Law, the Company shall use its reasonable best efforts to cause the Proxy Statement to be disseminated to the Company Stockholders as promptly as reasonably practicable, and in no event more than five Business Days, following the filing thereof with the SEC and confirmation from the SEC that it will not review, or that it has completed its review of, the Proxy Statement, which confirmation will be deemed occurred if the SEC has not affirmatively notified the Company by 11:59 p.m., New York City time, on the tenth calendar day following such filing with the SEC that the SEC will or will not be reviewing the Proxy Statement.
6.4 Company Stockholder Meeting.
(a) Call of Company Stockholder Meeting. Subject to Section 5.3, following the clearance of the Proxy Statement by the SEC, the Company shall take all necessary actions, including in accordance with applicable Law, the Organizational Documents of the Company and the rules of the NASDAQ, to duly call and hold a meeting of its stockholders (the “Company Stockholder Meeting”) as promptly as reasonably practicable
A-51

TABLE OF CONTENTS

following the mailing of the Proxy Statement to the Company Stockholders for the purpose of obtaining the Requisite Stockholder Approval (with the record date and meeting date set in consultation with Parent); provided, however, that in no event shall the Company be required to hold the Company Stockholder Meeting prior to the twentieth Business Day following the mailing of the Proxy Statement.
(b) Adjournment of Company Stockholder Meeting. Notwithstanding anything to the contrary in this Agreement, nothing will prevent the Company from postponing or adjourning the Company Stockholder Meeting, in consultation with Parent, (i) to allow additional solicitation of votes in order to obtain the Requisite Stockholder Approval; (ii) if there are holders of an insufficient number of shares of the Company Common Stock present or represented by proxy at the Company Stockholder Meeting to constitute a quorum at the Company Stockholder Meeting (it being understood that the Company may not adjourn or postpone the Company Stockholder Meeting more than two times pursuant to this clause (ii) without Parent’s written consent (such consent not to be unreasonably withheld, conditioned or delayed)); (iii) if the Company is required to postpone or adjourn the Company Stockholder Meeting by applicable Law or a request from the SEC or its staff; or (iv) in order to give the Company Stockholders sufficient time to evaluate any information or disclosure that the Company has sent to the Company Stockholders or otherwise made available to the Company Stockholders if, in the good faith judgment of the Company Board (after consultation with outside legal counsel), the failure to do so would be reasonably likely to be inconsistent with its fiduciary obligations under applicable Law; provided, that in the case of the foregoing clause (iv), such postponement or adjournment shall not be for more than five Business Days and occur more than two times without Parent’s written consent (such consent not to be unreasonably withheld, conditioned or delayed); provided, further, that in no event (x) shall the Company Stockholder Meeting be postponed or adjourned beyond the date that is five Business Days prior to the Termination Date or (y) once it is fixed by the Company Board, shall the record date for the Company Stockholder Meeting change (whether or not in connection with any such postponement or adjournment), without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed). The Company shall, unless there has been a Company Board Recommendation Change in accordance with the terms of this Agreement or this Agreement has been terminated in accordance with Article VIII, use its reasonable best efforts to solicit from its stockholders proxies in favor of the adoption of this Agreement and take all other action necessary or advisable to secure the Requisite Stockholder Approval. The Company shall keep Parent reasonably informed with respect to proxy solicitation as reasonably requested by Parent and shall provide such information and reasonable cooperation as Parent may reasonably request in connection therewith, and providing a list of all stockholders of the Company entitled to vote at the Company Stockholder Meeting, the then current tally of proxies that have been granted and not withdrawn by stockholders of the Company and any other information reasonably requested by Parent in connection with Parent determining whether or not to consent to an adjournment of the Company Stockholder Meeting. In addition, the Company will consult with Parent with respect to strategy regarding securing the Requisite Stockholder Approval. Subject to the provisions of this Agreement, the Company will conduct a “broker search” in accordance with Rule 14a-13 of the Exchange Act, taking into account the interpretations and guidance issued by the SEC or its staff, in a manner to enable the record date for the Company Stockholder Meeting to be set so that the Company Stockholder Meeting can be held promptly following the effectiveness of the Proxy Statement.
6.5 Financing.
(a) No Amendments to Financing Letters . Prior to the Closing, each of Parent and Merger Sub shall not, without the prior written consent of the Company, agree to, or permit any withdrawal, rescindment, amendment or modification to be made to, or any waiver of any provision under, the Equity Commitment Letters if such amendment, modification, or waiver would (i) reduce the aggregate amount of the Equity Financing to an amount less than, when taken together with the available portion of the Financing and cash on hand at Parent, the Company and its Subsidiaries, the amount required to make all payments contemplated by this Agreement on the terms and conditions set forth herein; (ii) impose new or additional conditions or otherwise expand, adversely amend or adversely modify any of the conditions to the receipt of the Equity Financing or any other terms to the Equity Financing in a manner that would reasonably be expected to materially delay or prevent the Closing Date; or (iii) adversely impact the ability of Parent, Merger Sub or the Company, as applicable, to enforce its rights against the Guarantors under the Equity Commitment Letters. Prior to the Closing, each of Parent and Merger Sub shall not, without the prior written consent of the Company, agree to, or permit any withdrawal, rescindment, amendment, replacement, supplement or modification to be made to, or any waiver of
A-52

TABLE OF CONTENTS

any provision or remedy pursuant to or consent under, the Debt Financing Letters or the Preferred Equity Commitment Letter or the definitive agreements relating to the Debt Financing or the Preferred Equity Financing if such withdrawal, rescindment, amendment, replacement, supplement, modification, consent or waiver would, or would reasonably be expected to, (i) reduce the aggregate amount of the Debt Financing or the Preferred Equity Financing (or the cash proceeds available therefrom) when funded in accordance with the Financing Letters to be below the amount required to consummate the transactions contemplated by this Agreement; (ii) impose new or additional conditions precedent to the Debt Financing or the Preferred Equity Financing or otherwise adversely expand, amend or modify any of the existing conditions to the receipt of the Debt Financing or the Preferred Equity Financing; (iii) expand, amend, or modify any other terms to the Debt Financing or the Preferred Equity Financing in a manner that would reasonably be expected to prevent, materially delay or impair the Closing and the timely funding of the amount of the Debt Financing or the Preferred Equity Financing required to consummate the transactions contemplated by this Agreement; or (iv) adversely impact the ability of Parent or Merger Sub, as applicable, to enforce its rights against the other parties to the Debt Financing Letters or the Preferred Equity Commitment Letter or, in each case, the definitive agreements with respect thereto; provided that (subject to compliance with the other provisions of this Section 6.5(a)), Parent and Merger Sub may amend the Debt Commitment Letter to add additional lenders, arrangers, bookrunners, managers or agents that have not executed the Debt Commitment Letter as of the date of this Agreement. Parent shall promptly furnish to the Company after execution, true and complete copies of any material amendment, replacement, supplement, modification, consent or waiver relating to the Debt Financing Letters or any material definitive agreements relating to the Debt Financing or the Preferred Equity Financing. Upon any amendment, supplement or modification of the Debt Commitment Letter or the Preferred Equity Commitment Letter in accordance with this Section 6.5(a), references to the “Financing Letters” and, as applicable, “Debt Commitment Letter” and “Preferred Equity Commitment Letter” shall include such documents as permitted to be amended, supplemented or modified under this Section 6.5(a), and references to the “Financing”, “Preferred Equity Financing” and “Debt Financing” shall include the financing contemplated by the Preferred Equity Commitment Letter and the Debt Commitment Letter, as applicable, as permitted to be amended, supplemented or modified under this Section 6.5(a).
(b) Taking of Necessary Actions. Subject to the terms and conditions of this Agreement, each of Parent and Merger Sub shall use its reasonable best efforts to, and shall use its reasonable best efforts to cause its Representatives to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper and advisable to arrange, consummate and obtain the Debt Financing and the Preferred Equity Financing (or, in the event any portion or all of the Debt Financing or the Preferred Equity Financing becomes unavailable, Alternate Financing) on a timely basis, but in any event no later than the time the Closing is required to occur pursuant to Section 2.3, on the terms and conditions (including, to the extent required, the full exercise of any “market flex” or “securities demand” provisions in any Fee Letter) set forth in the Debt Financing Letters and the Preferred Equity Commitment Letter, respectively, including, using its reasonable best efforts to (i) maintain in effect the Debt Financing Letters and the Preferred Equity Commitment Letter in all material respects in accordance with the terms and subject to the conditions therein; (ii) negotiate, enter into, execute and deliver on the Closing Date (x) definitive agreements with respect to the Debt Financing contemplated by the Debt Financing Letters on a timely basis on the terms and subject only to the conditions (including any “market flex” or “securities demand” provisions in the related Fee Letter) set forth in the Debt Financing Letters or on other terms that are not materially less favorable from a conditionality and enforceability perspective (taken as a whole) to Parent than the terms and conditions related to conditionality and enforceability (taken as a whole) set forth in the Debt Commitment Letter (including, to the extent required by the related “market flex” provisions), subject to any amendments, modifications or supplements thereto, or replacements or waivers thereof permitted by Section 6.5(a) and (y) definitive agreements with respect to the Preferred Equity Financing contemplated by the Preferred Equity Financing Letters on a timely basis on the terms and subject only to the conditions set forth in the Preferred Equity Financing Letters or on other terms that are not materially less favorable from a conditionality and enforceability perspective (taken as a whole) to Parent than the terms and conditions related to conditionality and enforceability (taken as a whole) set forth in the Preferred Equity Financing Letters (provided that, in no event shall any of the agreements referred to in this clause (ii), without the consent of the Company, (A) reduce the aggregate amount of the Debt Financing or the Preferred Equity Financing (or the cash proceeds available therefrom) when funded in accordance with the Financing Letters to be below the amount required to consummate the transactions contemplated by this Agreement; (B) impose new or additional conditions precedent to the Debt Financing or the Preferred Equity
A-53

TABLE OF CONTENTS

Financing or otherwise adversely expand, amend or modify any of the existing conditions to the receipt of the Debt Financing or the Preferred Equity Financing; (C) expand, amend, or modify any other terms to the Debt Financing or the Preferred Equity Financing in a manner that would reasonably be expected to prevent, materially delay or impair the Closing and the timely funding of the amount of the Debt Financing or the Preferred Equity Financing in the amount required to consummate the transactions contemplated by this Agreement; or (D) adversely impact in any material respect the ability of Parent or Merger Sub, as applicable, to enforce its rights against the other parties to the Debt Financing Letters or the Preferred Equity Financing Letters or, in each case, the definitive agreements with respect thereto); (iii) satisfy on a timely basis (taking into account the expected timing of the Marketing Period, as applicable) (or obtain a waiver of) all conditions applicable to Parent or Merger Sub contained in the Debt Financing Letters and the Preferred Equity Financing Letters and such definitive agreements related thereto at or prior to the time the Closing is required to occur pursuant to Section 2.3 to the fullest extent such conditions are within its control; (iv) in the event that all conditions contained in the Debt Financing Letters and the Preferred Equity Financing Letters and any related definitive agreements have been satisfied (except those that, by their nature, are to be satisfied at the Closing) or waived, consummate the Debt Financing and the Preferred Equity Financing at or prior to the Closing; (v) comply in all material respects with its covenants or other obligations applicable to Parent and Merger Sub pursuant to the Debt Financing Letters and the Preferred Equity Financing Letters and the definitive documents relating to the Debt Financing and the Preferred Equity Financing, respectively, in accordance with the terms and conditions thereof at or prior to the time the Closing is required to occur pursuant to Section 2.3; and (vi) enforce its rights pursuant to the Debt Financing Letters and the Preferred Equity Financing Letters at or prior to the Closing. Each of Parent and Merger Sub acknowledge that they shall be fully responsible for obtaining the Equity Financing and each shall take (or cause to be taken) all reasonable actions, and do (or cause to be done) all reasonably things, in each case, reasonably necessary, proper or advisable to obtain the Equity Financing, including taking all reasonable actions to (i) maintain in effect the Equity Commitment Letters, (ii) satisfy on a timely basis (or obtain a waiver of) all conditions applicable to Parent and Merger Sub under the respective Equity Commitment Letters at or prior to the time the Closing is required to occur pursuant to Section 2.3 to the extent such conditions are within its control, and (iii) in the event that all conditions contained in the Equity Commitment Letters have been satisfied (except those that, by their nature, are to be satisfied at the Closing) or waived, consummate the Equity Financing at or prior to the Effective Time.
(c) Information. Parent shall keep the Company reasonably informed on a current basis and in reasonable detail of the status of its reasonable best efforts to arrange the Debt Financing and obtain the Preferred Equity Financing. Without limiting the generality of the foregoing, Parent and Merger Sub shall give the Company prompt notice in writing, but in any event within three (3) Business Days after the occurrence or discovery thereof, of (i) any material breach or default (or any event or circumstance that, with notice or lapse of time or both, would reasonably be expected to give rise to any material breach or default) by any party to the Debt Financing Letters or the Preferred Equity Financing Letters or definitive agreements related thereto; (ii) the receipt by Parent or Merger Sub of any written notice or written communication from any Financing Source with respect to any actual material breach, default, cancellation, early termination or repudiation (or written notice or written communications from Financing Sources to Parent or Merger Sub of any such actual material breach, default, cancellation, early termination or repudiation received by Parent or Merger Sub) by any party to the Debt Financing Letters or the Preferred Equity Financing Letters or any definitive agreements related thereto of any provisions of the Debt Financing Letters or the Preferred Equity Financing Letters or such definitive agreements related thereto and (iii) Parent or Merger Sub becoming aware of any fact, circumstance, event or other development that would reasonably be expected to result in Merger Sub not being able to timely obtain all or any portion of the Debt Financing or the Preferred Equity Financing in the amount required to consummate the transactions contemplated by this Agreement on the terms, in the manner or from the sources contemplated by the Debt Financing Letters or the Preferred Equity Financing Letters or any definitive agreements related thereto. Parent and Merger Sub shall provide any material information reasonably requested by the Company relating to any of the circumstances referred to in the previous sentence as promptly as reasonably practical after the date that the Company delivers a written request therefor to Parent.
(d) Alternate Financing. If any portion of the Debt Financing or the Preferred Equity Financing becomes unavailable on the terms and conditions (including any “market flex” or “securities demand” provisions in any Fee Letter) contemplated in the Debt Commitment Letter or Preferred Equity Commitment Letter, as applicable, and any related Fee Letter, Parent and Merger Sub shall promptly notify the Company in writing of
A-54

TABLE OF CONTENTS

such unavailability and use their respective reasonable best efforts to, as promptly as reasonably practicable following the occurrence of such event (and in any event on or prior to the Closing Date), (i) arrange and obtain the Debt Financing and the Preferred Equity Financing or such portion of the Debt Financing and the Preferred Equity Financing, as applicable, from the same or alternative sources (the “Alternate Debt Financing” or “Alternate Preferred Financing”, as applicable; each, an “Alternate Financing”) in an amount sufficient to provide aggregate net cash proceeds sufficient to, when taken with the available portion of the Financing to (A) consummate the Closing upon the terms contemplated by this Agreement and (B) pay all other amounts payable by Parent in connection with the consummation of the transactions contemplated by this Agreement; provided that, in no event shall Parent be required to, and in no event shall its reasonable best efforts be deemed or construed to require it to, obtain Alternate Financing that includes terms and conditions, taken as a whole, that are materially less favorable from a conditionality and enforceability perspective (taken as a whole) to Parent than the terms and conditions related to conditionality and enforceability, taken as a whole, set forth in the Debt Commitment Letter or the Preferred Equity Commitment Letter, as applicable, as of the date hereof (taking into account any “market flex” provisions applicable thereto contained in the applicable Fee Letter) or would require it to pay any fees or agree to pay any interest rate amounts or original issue discount, in either case, in excess of those contemplated by the Debt Commitment Letter or the Preferred Equity Commitment Letter, as applicable, as in effect on the date hereof (taking into account any “market flex” provisions applicable thereto contained in the applicable Fee Letter); provided, further, that such Alternate Financing shall not, without the prior written consent of the Company (1) provide for aggregate commitments, or aggregate net cash proceeds after giving effect to all fees, original issue discount and applicable “market flex,” that are less than the portion of the Financing being replaced or, when taken together with the remaining available portion of the Financing, less than the amount required to consummate the Transactions, (2) impose any new or additional conditions to funding or otherwise materially expand or materially adversely modify any conditions to funding, in each case, as compared to the conditions contained in the Debt Commitment Letter or the Preferred Equity Commitment Letter and related Fee Letter as of the date hereof, (3) adversely impact, in any material respect, the ability of Parent or Merger Sub, as applicable, to enforce its rights against the other parties to the Debt Commitment Letter or the Preferred Equity Commitment Letter or, in each case, the definitive agreements relating thereto, or (4) contain any terms that would reasonably be expected to prevent or materially delay the Closing or materially impair the ability of Parent or Merger Sub to consummate the Closing as contemplated in this Agreement and (ii) obtain one or more new financing commitment letters with respect to such Alternate Financing that satisfy the requirements of the foregoing clause (i) (the “New Commitment Letters”), which New Commitment Letters will replace the existing Debt Commitment Letters or Preferred Equity Commitment Letters, as applicable, in whole or in part. The existing Debt Commitment Letters and Preferred Equity Commitment Letters shall not be withdrawn, terminated, superseded or replaced unless and until the applicable New Commitment Letters have been duly executed and become effective. The pursuit or obtaining of any Alternate Financing shall not relieve Parent or Merger Sub of any obligation to maintain, preserve or enforce the then-existing Debt Commitment Letters or Preferred Equity Commitment Letters, as applicable, or to consummate the Closing when required by this Agreement. Parent will promptly provide to the Company a true, correct and complete executed copy of any New Commitment Letters (which shall be accompanied by any fee letter in connection therewith (which may be redacted in a customary manner solely with respect to fees and other economic provisions (including customary “market flex” terms); provided that no such redaction shall cover any terms that could adversely affect the conditionality, enforceability, availability or termination of the Debt Financing or the Preferred Equity Financing)) to the Company. Any reference in this Agreement to (X) the “Financing Letters”, the “Debt Commitment Letter” or the “Preferred Equity Commitment Letter”, as applicable, will be deemed to include the Debt Commitment Letter or the Preferred Equity Commitment Letter, as applicable, to the extent not superseded by a New Commitment Letter at the time in question and any New Commitment Letters (and any fee letter in connection therewith (which may be redacted in a customary manner solely with respect to fees and other economic provisions (including customary “market flex” terms); provided that no such redaction shall cover any terms that would adversely affect the conditionality, enforceability, availability or termination of the Debt Financing or the Preferred Equity Financing)) to the extent then in effect, (Y) the “Financing Letters” shall refer to such documents as otherwise amended or modified in accordance with the terms of this Agreement, and (Z) the “Financing” means the financing contemplated by the Financing Letters as amended or modified in accordance with the terms of this Agreement.
(e) No Financing Condition. Parent and Merger Sub each acknowledge and agree that none of the obtaining of the Financing or any Alternate Financing, the completion of any issuance of securities
A-55

TABLE OF CONTENTS

contemplated by the Financing or the Company or any of its Subsidiaries having or maintaining any available cash balances is a condition to the Closing, and, subject to Section 9.8(b), reaffirm their obligation to consummate the Transactions irrespective and independently of the availability of the Financing, the completion of any such issuance, or the Company or any of its Subsidiaries having or maintaining any available cash balances subject to the applicable conditions set forth in Section 7.1 and Section 7.2 and the termination rights set forth in Section 8.1.
6.6 Financing Cooperation.
(a) Cooperation. Following the date of this Agreement and prior to the earlier to occur of the valid termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall, and shall cause each of its Subsidiaries to use its respective reasonable best efforts and shall use its reasonable best efforts to cause its and their respective Representatives and other agents to, use their reasonable best efforts, to provide, subject to the limitations set forth in this Section 6.6, Parent and Merger Sub with all cooperation as is reasonably requested by Parent in connection with the Debt Financing and the Preferred Equity Financing. Without limiting the generality of the foregoing, such cooperation shall include using reasonable best efforts with respect to the following:
(i) causing senior management of the Company and advisors to participate in a reasonable number of virtual or telephonic customary and reasonable meetings, presentations, road shows, due diligence sessions (including causing the Company’s accountants and auditors to participate in such sessions or in separate diligence calls), drafting sessions and sessions with prospective lenders, rating agencies and in connection with other syndication activities, at times and locations to be mutually agreed;
(ii) providing customary assistance to Parent with the preparation of customary rating agency presentations, offering documents, private placement memoranda, bank information memoranda (including, to the extent necessary, a version of bank information memorandum that does not include material non-public information) and authorization letters relating thereto in customary form for a syndicated bank financing and executed by a senior officer of the Company authorizing the distribution of Company information to prospective lenders or investors, syndication documents and other syndication materials, including lender presentations and investor presentations for any portion of the Debt, and other similar documents required in connection with the Debt Financing and the Preferred Equity Financing;
(iii) assisting in the negotiation and preparation of (including by providing information for the completion of any schedules thereto) and executing and delivering definitive financing agreements, corporate authorizations and other certificates (including a certificate of the chief financial officer of or person performing similar functions for the Company with respect to solvency matters substantially in the form attached to the Debt Commitment Letter) as may be reasonably requested by Parent, and to the extent required by the Debt Financing and the Preferred Equity Financing, if requested by Parent, facilitating the pledging of, and perfection of security interests in, collateral, including, taking actions reasonably necessary to permit the Financing Sources to evaluate the Company’s current assets, cash management and accounting systems and policies and procedures relating thereto for the purpose of establishing collateral arrangements required to be established as of the Closing under the Debt Commitment Letter, it being understood that such documents will not take effect until the Effective Time;
(iv) furnishing Parent with the Required Financing Information;
(v) assisting in obtaining corporate and facility credit ratings;
(vi) (x) obtaining documents reasonably requested by Parent or its Financing Sources relating to the repayment of the existing indebtedness of the Company and its Subsidiaries and the release of related liens, including customary payoff letters and (y) at least four Business Days prior to the Closing Date, furnishing Parent and the Financing Sources promptly with all customary documentation and other information with respect to the Company that any Financing Source has reasonably requested at least nine Business Days prior to the Closing Date and that such Financing Source has determined is required by U.S. regulatory authorities pursuant to applicable “know your customer” and anti-money laundering rules and regulations, including the PATRIOT Act and the Beneficial Ownership Regulation (as defined in the
A-56

TABLE OF CONTENTS

Debt Commitment Letter), and that are required by paragraph 8 of Exhibit D of the Debt Commitment Letter (it being understood that the furnishing of the documents requested in this Section 6.6(a)(vi)(y) shall be required and not qualified by any “reasonable best efforts” standard set forth in this Section 6.6(a));
(vii) causing the Company’s independent auditors to provide customary assistance and cooperation in connection with the Debt Financing, including causing the Company’s independent auditors to furnish consents for use in materials related to the Debt Financing or any high yield, non-convertible debt securities issued in lieu of all or a portion thereof and to deliver customary “comfort letters” (which shall provide customary “negative assurance” and change period comfort) for a Rule 144A placement of securities with respect to financial information contained in the offering materials relating to the Debt Financing (and using reasonable best efforts to provide customary representations to such independent auditors in connection with the foregoing);
(viii) assisting in the taking of all corporate and other actions, subject to the occurrence of the Closing, reasonably necessary to permit the consummation of the Debt Financing and the Preferred Equity Financing on the Closing Date (including causing directors and officers who will continue to hold such offices and positions from and after the Closing to execute resolutions or consents of the Company with respect to entering into the definitive documentation for the Debt Financing and the Preferred Equity Financing and otherwise as necessary to authorize consummation of the Debt Financing and the Preferred Equity Financing, as applicable) and to permit the proceeds thereof to be made available to the Company and its Subsidiaries at the Closing; it being understood that no such corporate or other action will take effect prior to the Closing;
(ix) assisting in Parent’s and Merger Sub’s efforts to satisfy the conditions precedent set forth in any definitive document relating to the Debt Financing and the Preferred Equity Financing, in each case, to the extent such conditions require the cooperation, or are within the control, of the Company or its Subsidiaries (which for the avoidance of doubt shall include the delivery of customary CFO certificates or other “management comfort” with respect to historic financial information of the Company and its Subsidiaries to the extent set forth as a condition precedent in any definitive document relating to the Debt Financing); and
(x) providing authorization letters to the Financing Sources authorizing the distribution of information to prospective lenders or investors and containing a representation to the Financing Sources that the public side versions of such documents, if any, do not include material non-public information about the Company or securities.
(b) Obligations of the Company . Nothing in this Section 6.6 will require the Company or any of its Subsidiaries to (i) waive or amend any terms of this Agreement or to the extent not indemnified or reimbursed, agree to pay any fees or reimburse any expenses prior to the Effective Time; (ii) enter into any definitive agreement the effectiveness of which is not conditioned upon the Closing (except for the authorization letters contemplated by Section 6.6(a)(ix) and ratings agency engagement letters and CFO certificates or other “management comfort” in connection with the obligations set forth above); (iii) to the extent not indemnified or reimbursed, give any indemnities that are effective prior to the Effective Time; (iv) take any action (or inaction) that would unreasonably and materially interfere with the conduct of the business or the Company and its Subsidiaries or create a material risk of damage or destruction to any material property or material assets of the Company or any of its Subsidiaries; (v) cause any material representation or warranty or material covenant contained in this Agreement to be breached or cause any closing condition set forth in this Agreement to fail to be satisfied; (vi) cause the Company or any of its Subsidiaries to violate or waive any attorney-client or other applicable legal privilege or materially breach applicable Law; (vii) disclose or provide any information in connection with the Financing, the disclosure of which, in the reasonable judgment of the Company, could result in the disclosure of any trade secrets, customer-specific data or competitively sensitive information not otherwise required to be provided under this Agreement or the violation of any confidentiality obligation (provided that the Company shall use reasonable best efforts to notify Parent that information is being withheld on such basis and shall use reasonable best efforts to disclose any information being withheld, in each case, to the extent such notification or disclosure would not result in a breach of such confidentiality obligation); (viii) provide information required by this Section 6.6 that is not reasonably obtained from its books and records without undue effort or expense (provided that the Company and/or its Subsidiaries have used
A-57

TABLE OF CONTENTS

reasonable best efforts to do so without undue burden or expense) or (ix) provide any Excluded Information. In addition, no action, liability or obligation of the Company, any of its Subsidiaries or any of their respective Representatives pursuant to any certificate, agreement, arrangement, document or instrument relating to the Debt Financing will be effective until the Effective Time, and neither the Company nor any of its Subsidiaries will be required to take any action pursuant to any certificate, agreement, arrangement, document or instrument that is not contingent on the occurrence of the Closing or that must be effective prior to the Effective Time (other than as contemplated by Section 6.6(a)(ix) and except for the authorization letters contemplated by Section 6.6(a)(ix), ratings agency engagement letters and CFO certificates or other “management comfort” in connection with the obligations set forth above). Nothing in this Section 6.6 will require the Company, its Subsidiaries or their respective directors, officers or employees to execute, deliver or enter into, or perform any agreement, document or instrument, including any definitive financing document, with respect to any debt financing or adopt resolutions approving the agreements, documents or instruments pursuant to which any debt financing is obtained or pledge any collateral with respect to any debt financing that is not contingent on the occurrence of Closing (other than as contemplated by Section 6.6(a)(ix) and except for the authorization letters contemplated by Section 6.6(a)(ix), ratings agency engagement letters and CFO certificates or other “management comfort” in connection with the obligations set forth above). Nothing in this Section 6.6 shall require (x) the Company or any of its Subsidiaries to provide any documents, memoranda or other materials to the extent the Company’s counsel has not been afforded a reasonable opportunity to review and comment upon any documents or any memoranda or similar or related documents (including any private placement memoranda or similar documents, or any materials for rating agencies, that include information about the Company and any of its Subsidiaries) or (y) any officer or Representative of the Company or any of its Subsidiaries to deliver any certificate or take any other action under this Section 6.6 that would reasonably be expected to result in personal liability to such officer or Representative. The Company and its Subsidiaries and Representatives shall not be required to deliver any legal opinions. No cooperation pursuant to this Section 6.6 shall be required to the extent that the Company or any of its Subsidiaries or Representatives determine that such cooperation would result in a loss or waiver of any attorney-client privilege, attorney work product or other legal privilege (provided, that the Company and its Subsidiaries shall use reasonable best efforts to allow for cooperation in a manner that does not result in the events set out in this sentence). For all purposes under this Agreement (including satisfaction of the conditions to Closing under Article VII, any termination right of Parent under Section 8.1 and the Company’s obligations (and the obligations of its Subsidiaries and Representatives) under this Section 6.6), neither the Company nor any of its Subsidiaries or Representatives shall be deemed to have breached this Section 6.6 unless (i) the Company (or any of its Subsidiaries or Representatives) has materially breached its obligations under this Section 6.6, (ii) such breach was a proximate cause of the failure to obtain such Financing, (iii) Parent has notified the Company of such breach in writing, describing the information, assistance or other action required to cure such breach, and (iv) the Company has not cured such breach within the earlier of (x) ten Business Days following receipt of such notice (and to the extent the Company has commenced and diligently pursued such cure promptly following the receipt of notice, as may be extended by Parent in its reasonable discretion (with such extension not to be unreasonably withheld, delayed or conditioned)) and (y) the Termination Date.
(c) Company Indebtedness. At least three Business Days prior to the Effective Time, with respect to the Company Indebtedness to be repaid at the Effective Time, the Company shall deliver (A) to Parent draft payoff letters in customary form from the lenders (or their applicable representative) with respect to the Company Credit Agreement (i) setting forth the amounts required to pay off in full on the Closing Date the Company Indebtedness and all other obligations owing to such holder of Company Indebtedness (including all principal, accrued and unpaid interest, fees and other amounts outstanding under the Company Credit Agreement on the Closing Date) (other than any contingent reimbursement and indemnity obligations that expressly survive termination of the Company Credit Agreement), after taking into account any required credit support and any existing letters of credit and required credit support contemplated by the applicable payoff letter to remain in effect or outstanding following the release of the liens described in clause (iii) below, (ii) confirming the termination of all commitments to extend credit under the Company Credit Agreement upon payment of such Company Indebtedness and the provision of any required credit support and (iii) providing that upon payment of the required amounts in respect of such Company Indebtedness described in clause (i) and the provision of any required credit support, the termination and/or release of any related liens or other security interests and guarantees in connection with the Company Credit Agreement (other than the required credit support) (the “Payoff Letters”) and (B) to the agent or lenders under the Company Credit Agreement, any notices as may
A-58

TABLE OF CONTENTS

be required pursuant to the Company Credit Agreement (including conditional notices of prepayment and redemption). At or prior to the Effective Time, Parent shall provide (or cause to be provided) the funds necessary to repay and discharge in full the Company Indebtedness, either to the Company or directly, on behalf of the Company, to the applicable agent or lenders, in each case in accordance with the Payoff Letters, and in accordance with such Payoff Letters, such Company Indebtedness shall be repaid and discharged substantially concurrently with the Effective Time.
(d) Use of Logos. The Company hereby consents to the use of its and its Subsidiaries’ logos in connection with the Debt Financing so long as such logos: (i) are used solely in a manner that is not intended to, or reasonably likely to, harm or disparage the Company or any of its Subsidiaries or the reputation or goodwill of the Company or any of its Subsidiaries and (ii) are used solely in connection with a description of the Company or any of its Subsidiaries, its or their respective businesses and products, or the Merger.
(e) Confidentiality. All non-public or other confidential information provided by the Company, its Subsidiaries or any of their Representatives pursuant to this Agreement or otherwise shall be kept confidential in accordance with the Confidentiality Agreement, except that Parent and Merger Sub will be permitted to disclose such information to any Financing Sources, Equity Providers and prospective Financing Sources and Equity Providers and other financial institutions and investors that are or may become parties to or participate in the Financing and to any underwriters, initial purchasers or placement agents in connection with the Debt Financing (and, in each case, to their respective counsel, auditors and other advisors and representatives) so long as such Persons (i) agree to be bound by the Confidentiality Agreement as if parties thereto; or (ii) are subject to other customary confidentiality undertakings. The Parties agree that the Confidentiality Agreement is hereby amended to permit Parent and its Affiliates and Representatives (including Representatives of GTCR and Elliott) to engage and discuss with, and provide Confidential Information (including the terms of the Transactions) to, current, potential or prospective Financing Sources and Equity Providers and, in each case, to their respective counsel, auditors and other advisors and representatives. “Equity Providers” shall mean current, potential and prospective limited partners, co-investors and other financing sources, including unaffiliated third-party financing sources, of GTCR and its Affiliates and Elliott and its Affiliates who may participate in the Financing.
(f) Reimbursement. Promptly upon request by the Company, Parent shall reimburse the Company for any reasonable and documented out-of-pocket costs and expenses (including reasonable and documented out-of-pocket attorneys’ fees) incurred by the Company, its Subsidiaries or any of its Representatives in connection with the cooperation or obligations of the Company, its Subsidiaries and their Representatives contemplated by this Section 6.6.
(g) Indemnification. The Company, its Subsidiaries and their respective Representatives shall be indemnified and held harmless by Parent and Merger Sub from and against any and all liabilities, losses, damages, claims, costs, expenses (including attorneys’ fees), interest, awards, judgments, penalties and amounts paid in settlement suffered or incurred by them in connection with their cooperation in arranging the Debt Financing and/or the Preferred Equity Financing pursuant to this Agreement or the provision of information utilized in connection therewith, except to the extent finally determined by a court of competent jurisdiction to have resulted from (i) any material inaccuracy of fact contained in any Required Financing Information at the time furnished in writing to Parent by or on behalf of the Company pursuant to this Section 6.6 specifically for use in connection with the Debt Financing; provided that the Company shall not be responsible for any modifications, supplements, extrapolations, adjustments or other information prepared by Parent, its Financing Sources or their Representatives, or for any material inaccuracy resulting from the incorporation, presentation or use of the Required Financing Information in any financing materials prepared by any such Person or (ii) the willful misconduct, fraud or gross negligence of the Company, its Subsidiaries or their respective Representatives.
6.7 Anti-Takeover Laws. The Company and the Company Board shall (a) take all actions within their power to ensure that no “anti-takeover” statute or similar statute or regulation (or similar provision in the Charter and Bylaws (including, for the avoidance of doubt, Article XII, Section 2 of the Charter)) is or becomes applicable to the Merger; and (b) if any “anti-takeover” statute or similar statute or regulation (or similar provision in the Charter and
A-59

TABLE OF CONTENTS

Bylaws (including, for the avoidance of doubt, Article XII, Section 2 of the Charter)) becomes applicable to the Merger, take all actions within their power to ensure that the Merger may be consummated as promptly as reasonably practicable on the terms contemplated by this Agreement and otherwise to minimize the effect of such statute or regulation on the Merger.
6.8 Access. At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to Article VIII and the Effective Time, the Company shall afford Parent and its Representatives reasonable access, consistent with applicable Law, during normal business hours, upon reasonable advance request, to the properties, books and records and personnel of the Company, except that the Company may restrict or otherwise prohibit access to any documents or information to the extent that, in the Company’s reasonable judgment, (a) any applicable Law or Contract requires the Company to restrict or otherwise prohibit access to such documents or information or providing access to such documents or information would violate or cause a default pursuant to, or give a third Person the right terminate or accelerate the rights pursuant to, such Contract; (b) access to such documents or information would give rise to a material risk of waiving any attorney-client privilege, work product doctrine or other privilege applicable to such documents or information; (c) access would result in the disclosure of any trade secrets (including source code) of the Company or any of its Subsidiaries to any third Persons; or (d) such documents or information are reasonably pertinent to any adverse Legal Proceeding between the Company and its Affiliates, on the one hand, and Parent and its Affiliates, on the other hand; provided, that the Company shall inform Parent of the general nature of the information being withheld and, upon Parent’s request, use its reasonable best efforts to allow for any access or disclosure in a manner that does not result in the effects set out in clauses (a) through (d), including by making appropriate substitute arrangements. Nothing in this Section 6.8 shall be construed to require the Company, any of its Subsidiaries or any of their respective Representatives to prepare any reports, analyses, appraisals, opinions or other information, and the access provided pursuant to this Section 6.8 shall not include any invasive or environmental testing, sampling or analysis. Any investigation conducted pursuant to the access contemplated by this Section 6.8 shall be conducted in a manner that does not (i) unreasonably interfere with the conduct of the business of the Company and its Subsidiaries or otherwise result in any significant interference with the prompt and timely discharge by officers, employees and other authorized Representatives of the Company or any of its Subsidiaries of their normal duties or (ii) create a risk of damage or destruction to any property or assets of the Company or its Subsidiaries. Any access to the properties of the Company and its Subsidiaries will be subject to the Company’s reasonable security measures and insurance requirements and will not include the right to perform invasive or subsurface testing or any sampling, monitoring or analysis of soil, groundwater, building materials, indoor air, or other environmental media. Notwithstanding anything herein to the contrary, except in the ordinary course of business and not related to the Transaction, Parent and Merger Sub shall not, and shall cause their respective Representatives not to, contact any employee of the Company or any of its Subsidiaries not involved in the negotiation of the Transactions or any customer, technology or other partner, vendor or supplier of the Company in connection with the Merger or any of the other Transactions, in each case, without the Company’s prior written consent, and Parent and Merger Sub acknowledge and agree that any such contact shall be arranged and supervised by Representatives of the Company. All requests for access pursuant to this Section 6.8 must be directed to the Chief Legal Officer of the Company or other Person designated by the Company.
6.9 Section 16(b) Exemption. Prior to the Effective Time, the Company shall be permitted to take all such actions as may be reasonably necessary or advisable hereto to cause the Merger, and any dispositions of equity securities of the Company (including derivative securities) (including the disposition, cancellation, or deemed disposition and cancellation of Company Common Stock, Company Earnout Shares, Company Options, Company RSUs, Company PSUs or Company RSAs) in connection with the Merger by each individual who is a director or executive officer of the Company, to be exempt pursuant to Rule 16b-3 promulgated under the Exchange Act.
6.10 Directors’ and Officers’ Exculpation, Indemnification and Insurance.
(a) Indemnified Persons. During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the Surviving Corporation and its Subsidiaries shall (and Parent shall cause the Surviving Corporation and its Subsidiaries to) honor and fulfill, in all respects, the obligations of the Company and its Subsidiaries pursuant to any indemnification agreements in effect on the date of this Agreement between the Company and any of its Subsidiaries or Affiliates, on the one hand, and any of their respective current or former directors, officers, managers or partners (and any person who becomes a director, officer, manager or partner of the Company or any of its Subsidiaries prior to the Effective Time), on the other
A-60

TABLE OF CONTENTS

hand (each, together with such Person’s heirs, executors and administrators, an “Indemnified Person” and, collectively, the “Indemnified Persons”). In addition, during the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the Surviving Corporation and its Subsidiaries shall (and Parent shall cause the Surviving Corporation and its Subsidiaries to) cause the Organizational Documents of the Surviving Corporation and its Subsidiaries to contain provisions with respect to indemnification, exculpation and the advancement of expenses that are at least as favorable as the indemnification, exculpation and advancement of expenses provisions set forth in the Organizational Documents of the Company and its Subsidiaries, as of the date of this Agreement. During such six-year period, such provisions may not be repealed, amended or otherwise modified in any adverse manner except as required by applicable Law.
(b) Indemnification Obligation. Without limiting the generality of the provisions of Section 6.10(a), during the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) indemnify and hold harmless, to the fullest extent permitted by applicable Law, and any of its Subsidiaries in effect on the date of this Agreement shall, indemnify and hold harmless each Indemnified Person from and against any (x) reasonable and documented costs, fees and expenses (including reasonable attorneys’ fees and investigation expenses), and (y) judgments, fines, penalties, losses, claims, damages, liabilities and amounts paid in settlement or compromise in connection with any Legal Proceeding, whether civil, criminal, administrative or investigative, whenever asserted, to the extent that such Legal Proceeding arises, directly or indirectly, out of or pertains, directly or indirectly, to (i) the fact that an Indemnified Person is or was a director, officer, employee or agent of the Company or such Subsidiary; (ii) any action or omission, or alleged action or omission, in such Indemnified Person’s capacity as a director, officer, employee or agent of the Company or any of its Subsidiaries, or taken at the request of the Company or such Subsidiary (including in connection with serving at the request of the Company or such Subsidiary as a director, officer, employee, agent, trustee or fiduciary of another Person (including any employee benefit plan), regardless of whether such action or omission, or alleged action or omission, occurred prior to, at or after the Effective Time); and (iii) the Merger, as well as any actions taken by the Company, Parent or Merger Sub with respect thereto (including any disposition of assets of the Surviving Corporation or any of its Subsidiaries that is alleged to have rendered the Surviving Corporation or any of its Subsidiaries insolvent), except that if, at any time prior to the sixth anniversary of the Effective Time, any Indemnified Person delivers to Parent a written notice asserting a claim for indemnification pursuant to this Section 6.10(b), then the claim asserted in such notice will survive the sixth anniversary of the Effective Time until such claim is fully and finally resolved. In the event of any such Legal Proceeding, upon receipt of an undertaking by or on behalf of such Indemnified Person to repay any amount if it is ultimately determined by a court of competent jurisdiction in a final and non-appealable judgment that such Indemnified Person is not entitled to indemnification, the Surviving Corporation shall advance all fees and expenses (including fees and expenses of any counsel) as incurred by an Indemnified Person in the defense of such Legal Proceeding, it being understood that such undertaking shall be made without regard to such Indemnified Person’s ultimate entitlement to indemnification or ability to repay such advances, shall not include the posting of any collateral and no other form of undertaking shall be required. Notwithstanding anything to the contrary in this Agreement, none of Parent, the Surviving Corporation nor any of their respective Subsidiaries shall settle or otherwise compromise or consent to the entry of any judgment with respect to, or otherwise seek the termination of, any Legal Proceeding for which indemnification may be sought by an Indemnified Person pursuant to this Agreement unless such settlement, compromise, consent or termination includes an unconditional release of all Indemnified Persons from all liability arising out of, or relating to, such Legal Proceeding. Any determination required to be made with respect to whether the conduct of any Indemnified Person complies or complied with any applicable standard will be made by independent legal counsel selected by the Surviving Corporation (which counsel will be reasonably acceptable to such Indemnified Person), the fees and expenses of which shall be paid by the Surviving Corporation.
(c) D&O Insurance. During the period commencing at the Effective Time and ending on the sixth anniversary of the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) maintain in effect the Company’s current directors’ and officers’ liability insurance (“D&O Insurance”) in respect of acts or omissions occurring at or prior to the Effective Time on terms (including with respect to coverage, conditions, retentions, limits and amounts) that are equivalent to those of the D&O Insurance in effect as of immediately prior to the Effective Time. In satisfying its obligations pursuant to this Section 6.10(c), the Surviving Corporation will not be obligated to pay annual premiums in excess of
A-61

TABLE OF CONTENTS

300% of the amount paid by the Company for coverage for its last full fiscal year (such 300% amount, the “Maximum Annual Premium”). If the annual premiums of such insurance coverage exceed the Maximum Annual Premium, then the Surviving Corporation shall be obligated to obtain a policy with the greatest coverage available for a cost not exceeding the Maximum Annual Premium from an insurance carrier with the same or better credit rating as the Company’s current directors’ and officers’ liability insurance carrier. In satisfaction of the foregoing obligations, prior to the Effective Time the Company may (and at Parent’s request, the Company will) purchase a prepaid “tail” policy with respect to the D&O Insurance so long as the aggregate cost for such “tail” policy does not exceed the aggregate Maximum Annual Premium. If the Company elects to purchase such a “tail” policy prior to the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) maintain such “tail” policy in full force and effect for a period of no less than six years after the Effective Time and continue to honor its obligations thereunder. If the Company is unable to obtain the “tail” policy and Parent or the Surviving Corporation are unable to obtain the insurance described in this Section 6.10(c) for an annual cost less than or equal to the Maximum Annual Premium, Parent shall cause the Surviving Corporation to instead obtain as much comparable insurance as possible for an aggregate annual premium equal to the Maximum Annual Premium.
(d) Successors and Assigns. If Parent, the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and is not the continuing or Surviving Corporation or entity in such consolidation or merger; or (ii) transfers or conveys all or substantially all of its properties and assets to any Person, then proper provisions will be made to the extent such obligations are not otherwise assumed by operation of Law so that the successors and assigns of Parent, the Surviving Corporation or any of their respective successors or assigns shall assume all of the obligations of Parent and the Surviving Corporation set forth in this Section 6.10.
(e) No Impairment. The obligations set forth in this Section 6.10 may not be terminated, amended or otherwise modified in any manner that adversely affects any Indemnified Person (or any other Person who is a beneficiary pursuant to the D&O Insurance or the “tail” policy referred to in Section 6.10(c) (and their heirs and representatives), the “Other Indemnified Persons”) without the prior written consent of such affected Indemnified Person or Other Indemnified Person. Each of the Indemnified Persons or Other Indemnified Persons are intended to be third party beneficiaries of this Section 6.10, with full rights of enforcement as if a Party. The rights of the Indemnified Persons and Other Indemnified Persons pursuant to this Section 6.10 will be in addition to, and not in substitution for, any other rights that such Persons may have pursuant to (i) the Charter and Bylaws; (ii) the Organizational Documents of the Subsidiaries of the Company; (iii) any and all indemnification agreements entered into with the Company or any of its Subsidiaries; or (iv) applicable Law (whether at Law or in equity).
(f) Other Claims. Nothing in this Agreement is intended to, or will be construed to, release, waive or impair any rights to directors’ and officers’ insurance claims pursuant to any applicable insurance policy or indemnification agreement that is or has been in existence with respect to the Company or any of its Subsidiaries for any of their respective directors, officers or other employees, it being understood and agreed that the indemnification provided for in this Section 6.10 is not prior to or in substitution for any such claims pursuant to such policies or agreements.
6.11 Employee Matters.
(a) Employment; Benefits . For a period of one year following the Effective Time or, if shorter, the period of employment of the relevant Continuing Employee (the “Continuation Period”), the Surviving Corporation and its Subsidiaries shall (and Parent shall cause the Surviving Corporation and its Subsidiaries to) maintain for the benefit of each Continuing Employee (i) a base salary or wage rate, as applicable, target annual (or shorter-term) cash incentive compensation opportunities (including bonus and commission, but excluding retention, long-term incentive, change in control or transaction compensation or equity or equity-based incentive opportunities) that are, in each case, no less than those in effect for such Continuing Employee immediately before the Effective Time; (ii) severance and termination benefits that are no less favorable than those applicable to such Continuing Employee immediately before the Effective Time, as set forth on Section 6.11(a) of the Company Disclosure Letter; and (iii) all other employee benefit or compensation plans, programs, policies, agreements or arrangements (excluding any retention, long-term incentive, change in control or transaction compensation, equity or equity-based incentives, defined benefit pension plan, retiree health or retiree life insurance benefits or nonqualified deferred compensation benefits) that are substantially
A-62

TABLE OF CONTENTS

similar in the aggregate to those in effect for (or available to) employees of the Company and its Subsidiaries under the Employee Plans as of the Effective Time. For the avoidance of doubt, base salary or wage rate and target annual (or shorter-term) cash incentive compensation opportunities shall not be decreased during the Continuation Period for any Continuing Employee employed during that period.
(b) New Plans. With respect to each benefit or compensation plan, program, policy, arrangement or agreement that is made available to any Continuing Employee at or after the Effective Time (each such plan, a “New Plan”), the Surviving Corporation and its Subsidiaries shall (and Parent shall cause the Surviving Corporation and its Subsidiaries to) cause to be granted to such Continuing Employee credit for all service with the Company and its Subsidiaries prior to the Effective Time for purposes of eligibility to participate and vesting and, with respect to vacation and severance benefits, entitlement to benefits, in each case, where length of service is relevant, and to the same extent that such service was recognized prior to the Effective Time under the corresponding Employee Plan (such plans, the “Old Plans”), except (i) to the extent that it would result in retroactive contributions or duplication of coverage or benefits for the same period of service or (ii) with respect to any defined benefit pension plan. In addition, and without limiting the generality of the foregoing, Parent shall, or shall cause its Subsidiaries (including the Surviving Corporation) to take commercially reasonable efforts (i) to provide that each Continuing Employee will be immediately eligible to participate, without any waiting period, in any and all New Plans to the extent that coverage pursuant to any such New Plan replaces coverage pursuant to a corresponding Old Plan; (ii) for purposes of each New Plan providing life insurance, medical, dental, pharmaceutical, vision or disability benefits, to cause all waiting periods, pre-existing condition exclusions, evidence of insurability requirements and actively-at-work requirements of such New Plan to be waived for the Continuing Employees and their covered dependents; and (iii) for purposes of each New Plan providing medical, dental, pharmaceutical, or vision benefits, to cause any eligible expenses incurred by the Continuing Employees and their covered dependents during the portion of the plan year of the Old Plan ending on the date that Continuing Employees’ participation in the corresponding New Plan begins to be given full credit pursuant to such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such Continuing Employees and their covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan.
(c) Vacation Accrual. Any vacation or paid time off accrued but unused by a Continuing Employee as of immediately prior to the Effective Time will be credited to such Continuing Employee following the Effective Time in accordance with the applicable vacation or paid time off policy of the Surviving Corporation.
(d) Annual Bonuses . With respect to each Employee Plan that is an annual cash incentive compensation plan or arrangement as in effect as of the date of this Agreement and set forth on Section 6.11(d) of the Company Disclosure Letter, for the 2026 calendar year, Parent shall, or shall cause its Affiliates (including the Surviving Corporation and any of its respective Subsidiaries) to continue such plan following the Closing in good faith and in the ordinary course of business substantially consistent with the Company’s or its applicable Subsidiary’s past practice and each Continuing Employee shall be paid an amount based on actual performance for the full 2026 calendar year, which amount shall be paid at substantially the same time as annual bonuses have historically been paid by the Company or its applicable Subsidiaries (but in no event later than the 15th day of the 3rd month following the 2026 calendar year). The manner of calculating actual performance for such full 2026 calendar year shall be consistent with the Company’s or its applicable Subsidiary’s past practice prior to the Closing.
(e) No Third-Party Beneficiary Rights. Notwithstanding anything to the contrary set forth in this Agreement, this Section 6.11 will not be deemed to: (i) guarantee employment or service for any period of time for, or preclude the ability of Parent, the Surviving Corporation or any of their respective Subsidiaries to terminate any Continuing Employee or the employment or service of any other person; (ii) constitute the establishment or adoption of or amendment to any Employee Plan, New Plan or other benefit plan; (iii) create any third party beneficiary rights in any Continuing Employee (or beneficiary or dependent thereof); (iv) interfere with the right or limit the ability of Parent and its Subsidiaries to create, amend, modify or terminate any Employee Plan, New Plan or other benefit plan.
A-63

TABLE OF CONTENTS

6.12 Obligations of Merger Sub. Parent shall take all action necessary to cause Merger Sub and the Surviving Corporation to perform their respective obligations pursuant to this Agreement and to consummate the Merger upon the terms and subject to the conditions set forth in this Agreement. Parent and Merger Sub shall be jointly and severally liable for the failure by either of them to perform and discharge any of their respective covenants, agreements and obligations pursuant to this Agreement.
6.13 Notification of Certain Matters. Each of the Company and Parent will give prompt notice to the other (and will subsequently keep the other informed on a reasonably current basis of any material developments related to such notice) upon its becoming aware of the occurrence or existence of any change, event, effect, occurrence or development that (a) with respect to the Company, has had a Company Material Adverse Effect, (b) with respect to Parent or Merger Sub, has had or would reasonably be expected to have a Parent Material Adverse Effect and/or (c) is reasonably likely to result in any of the conditions set forth in Article VII not being able to be satisfied prior to the Termination Date. No notification given by any Party pursuant to this Section 6.13 shall limit or otherwise affect any of the representations, warranties, covenants, obligations or conditions contained in this Agreement. The Company’s or Parent’s failure to comply with this Section 6.13 will not be taken into account for purposes of determining whether any conditions set forth in Article VII to consummate the Merger have been satisfied.
6.14 Public Statements and Disclosure. The initial press release with respect to the execution of this Agreement shall be a joint press release in the form reasonably agreed to by the Parties. Following such initial press release, the Company and Parent shall consult with each other before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Merger and shall not issue any such press release or make any such public statement without the prior written consent of the other Party, except as such Party may reasonably conclude may be required by applicable Law, court process or by obligations pursuant to any listing agreement with any national securities exchange or national securities quotation system (and then only after as much advance notice as is feasible); provided that the Parties shall not be obligated to engage in such consultation or obtain the prior written consent of the other Party with respect to communications (including communications directed to employees, suppliers, customers, partners, vendors or stockholders) that are consistent with public statements previously made in accordance with this Section 6.14; provided, further, that the restrictions set forth in this Section 6.14 shall not apply to any release or public statement (i) made or proposed to be made by the Company with respect to an Acquisition Proposal, a Superior Proposal or a Company Board Recommendation Change or any action taken pursuant thereto or (ii) in connection with any dispute between the parties regarding this Agreement or the Merger. Notwithstanding the foregoing, Parent, Merger Sub and their respective Affiliates may provide ordinary course communications regarding this Agreement and the transactions contemplated hereby to existing or prospective general and limited partners, equity holders, members, managers and investors of any Affiliates of such Person, in each case, who are subject to customary confidentiality undertakings.
6.15 Transaction Litigation. Prior to the Effective Time, the Company will provide Parent with prompt notice of all Transaction Litigation against the Company and its Subsidiaries and its and their directors and executive officers (including by providing copies of all pleadings with respect thereto) and keep Parent reasonably informed with respect to the status thereof. The Company will (a) give Parent the opportunity to participate in (but not control) the defense, settlement or prosecution of such Transaction Litigation, including by giving Parent the opportunity to review and comment on all filings and responses to be made by the Company in connection with any Transaction Litigation and (b) consult with Parent with respect to the defense, settlement and prosecution of such Transaction Litigation. The Company may not compromise or settle or enter into any agreement, or consent to the entry of, any order or judgment with respect to such Transaction Litigation unless Parent has consented thereto in writing (which consent will not be unreasonably withheld, conditioned or delayed). For purposes of this Section 6.15, “participate” means that the Company shall keep Parent reasonably apprised of the proposed strategy and other significant decisions with respect to any such Transaction Litigation against the Company, its Subsidiaries or its or their directors or officers (to the extent that the attorney-client privilege is not undermined or otherwise adversely affected), and Parent may offer comments or suggestions with respect to such Transaction Litigation which the Company shall consider in good faith, but Parent shall not be afforded decision-making power or authority. Prior to the Effective Time, the Company shall control the defense of any such Transaction Litigation subject to this Section 6.15.
6.16 Stock Exchange Delisting; Deregistration. Prior to the Effective Time, the Company shall cooperate with Parent and use its reasonable best efforts to take, or cause to be taken, all actions and do, or cause to be done, all
A-64

TABLE OF CONTENTS

things reasonably necessary, proper or advisable on its part pursuant to applicable Law and the rules and regulations of Nasdaq to cause (a) the delisting of the Company Common Stock from Nasdaq as promptly as practicable after the Effective Time; and (b) the deregistration of the Company Common Stock pursuant to the Exchange Act as promptly as practicable after such delisting.
6.17 Additional Agreements. If at any time after the Effective Time any further action is necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full title to all properties, assets, rights, approvals, immunities and franchises of either of the Company or Merger Sub, then the proper officers and directors of each Party shall use their reasonable best efforts to take such action.
6.18 Parent Vote. Immediately following the execution and delivery of this Agreement, Parent, in its capacity as the sole stockholder of Merger Sub, shall execute and deliver to Merger Sub and the Company a written consent adopting this Agreement in accordance with the DGCL.
6.19 Certain Arrangements. Except as set forth on Section 6.19 of the Parent Disclosure Letter, prior to receipt of the Requisite Stockholder Approval, without the prior consent of the Company Board, neither Parent, Merger Sub nor any of their respective Affiliates, directly or indirectly, shall have any formal or informal discussions with respect to, or enter into any agreement, arrangement or understanding (in each case, whether oral or written), or authorize, commit or agree to enter into any agreement, arrangement or understanding (in each case, whether oral or written), described in Section 4.13 of this Agreement.
6.20 Termination of Agreements. At or prior to the Closing, the Company shall cause the termination, effective as of the Closing, of each Affiliate Agreement, other than the Affiliate Contracts or other Contracts set forth on Schedule 6.20, in its entirety without any further liability or obligation of the Company or any of its Subsidiaries from and after the Closing.
ARTICLE VII
CONDITIONS TO THE MERGER
7.1 Conditions to Each Party’s Obligations to Effect the Merger. The respective obligations of each Party to consummate the Merger are subject to the satisfaction (or waiver by Parent and the Company where permissible pursuant to applicable Law) at or prior to the Effective Time of each of the following conditions:
(a) Requisite Stockholder Approval. The Company’s receipt of the Requisite Stockholder Approval at the Company Stockholder Meeting.
(b) Antitrust Laws. The waiting periods (and any extensions thereof, including any agreement with any Governmental Entity to delay the Closing entered into in connection therewith) applicable to the Transactions pursuant to the HSR Act shall have expired or otherwise been terminated.
(c) No Prohibitive Laws or Injunctions. No Law, injunction or Order by any Governmental Authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger shall have been enacted, entered or promulgated and be continuing in effect.
7.2 Conditions to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger shall be subject to the satisfaction (or waiver by Parent where permissible pursuant to applicable Law) at or prior to the Effective Time of each of the following conditions:
(a) Representations and Warranties . (i) the representations and warranties of the Company set forth in the first sentence of Section 3.1 (Organization; Good Standing), Section 3.2 (Corporate Power; Enforceability), Section 3.3(a) (Company Board Approval), Section 3.7(d) (Company Capitalization; Other Rights) and Section 3.25 (Brokers) shall be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all material respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty shall be true and correct in all material respects only as of such specified date), (ii) the representations and warranties of the Company set forth in Section 3.7(a) (Company Capitalization; Capital Stock), Section 3.7(b) (Company Capitalization; Stock Reservation and Awards) and Section 3.7(c) (Company Capitalization; Company Securities) shall be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case
A-65

TABLE OF CONTENTS

such representation and warranty shall be true and correct in all respects only as of such specified date), except for de minimis inaccuracies, (iii) the representations and warranties of the Company set forth in Section 3.12(b) (Absence of Certain Changes) shall be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date, and (iv) the other representations and warranties of the Company set forth in Article III of this Agreement shall be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) on the date hereof and on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty shall be true and correct only as of such specified date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, have a Company Material Adverse Effect.
(b) Performance of Obligations of the Company. The Company shall have complied in all material respects with the covenants and obligations of this Agreement required to be performed and complied with by it at or prior to the Closing.
(c) Company Material Adverse Effect. Since the date of this Agreement, there shall not have occurred a Company Material Adverse Effect.
(d) Officer’s Certificate. Parent and Merger Sub shall have received a certificate of the Company, validly executed for and on behalf of the Company and in its name by a duly authorized executive officer thereof, certifying that the conditions set forth in Section 7.2(a), Section 7.2(b) and Section 7.2(c) have been satisfied.
(e) FIRPTA Certificate. At or prior to the Closing, the Company shall have delivered to Parent, in a form reasonably satisfactory to Parent, a certificate complying with Treasury Regulation Section 1.1445-2(c)(3), certifying that the Company is not, and has not been during the applicable period described in Section 897(c)(1)(A)(ii) of the Code, a “United States real property holding corporation” within the meaning of Section 897(c) of the Code, together with a copy of the notice to the IRS provided in accordance with Treasury Regulation Section 1.897-2(h)(2).
7.3 Conditions to the Company’s Obligations to Effect the Merger. The obligations of the Company to consummate the Merger are subject to the satisfaction (or waiver by the Company where permissible pursuant to applicable Law) at or prior to the Effective Time of each of the following conditions:
(a) Representations and Warranties. The representations and warranties of Parent and Merger Sub set forth in this Agreement shall be true and correct (disregarding all qualifications or limitations as to “materiality,” “Parent Material Adverse Effect” or words of similar import) as of the Closing Date as if made on and as of such date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty shall be true and correct only as of such specified date), except where the failure of any such representations and warranties to be so true and correct, individually or in the aggregate, would not reasonably be expected to prevent, materially delay, or have a material adverse effect on the ability of Parent or Merger Sub to perform its obligations under this Agreement or to consummate the Transactions (a “Parent Material Adverse Effect”).
(b) Performance of Obligations of Parent and Merger Sub. Parent and Merger Sub shall have complied in all material respects with the covenants and obligations of this Agreement required to be performed and complied with by Parent and Merger Sub at or prior to the Closing.
(c) Officer’s Certificate. The Company shall have received a certificate of Parent and Merger Sub, validly executed for and on behalf of Parent and Merger Sub and in their respective names by a duly authorized officer thereof, certifying that the conditions set forth in Section 7.3(a) and Section 7.3(b) have been satisfied.
ARTICLE VIII
TERMINATION, AMENDMENT AND WAIVER
8.1 Termination. This Agreement may be validly terminated only as follows (it being understood and agreed that this Agreement may not be terminated for any other reason or on any other basis):
(a) at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval) by mutual written agreement of Parent and the Company;
A-66

TABLE OF CONTENTS

(b) by either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval) if (i) any permanent injunction or other final and non-appealable judgment or Order issued by any court or other Governmental Authority of competent jurisdiction preventing the consummation of the Merger is in effect that, in each case, prohibits, makes illegal or enjoins the consummation of the Merger and has become final and non-appealable; or (ii) any statute, rule or regulation has been enacted, entered or enforced that prohibits, makes illegal or enjoins the consummation of the Merger (any of the foregoing in clauses (i) and (ii), a “Legal Restraint”); provided, however, that the right to terminate this Agreement pursuant to this Section 8.1(b) shall not be available to a Party if the issuance of such Legal Restraint was primarily due to the failure of such Party (treating Parent and Merger Sub as one party for this purpose) to perform any of its obligations under this Agreement or if such Party (treating Parent and Merger Sub as one party for this purpose) shall have failed to comply with its obligations under Section 6.2;
(c) by either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval) if the Effective Time has not occurred by 11:59 p.m., New York City time, on April 14, 2027 (the “Termination Date”); provided, that the right to terminate this Agreement pursuant to this Section 8.1(c) shall not be available to a Party (treating Parent and Merger Sub as one party for this purpose) if the failure of the Merger to be consummated prior to the Termination Date was primarily due to the failure of such Party (treating Parent and Merger Sub as one party for this purpose) to perform any of its obligations under this Agreement (for the avoidance of doubt, Parent’s failure to consummate the Closing due to the unavailability of the Debt Financing or the Preferred Equity Financing shall not in itself be deemed to be an action or failure to act solely for purposes of this Section 8.1(c);
(d) by either Parent or the Company, at any time prior to the Effective Time if the Company fails to obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment or postponement thereof) at which a vote is taken on the Merger;
(e) by Parent, if the Company has breached or failed to perform any of its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in Section 7.2(a) or (b), except that if such breach is capable of being cured prior to the Termination Date, Parent will not be entitled to terminate this Agreement prior to the delivery by Parent to the Company of written notice of such breach, delivered at least forty-five days prior to such termination, stating Parent’s intention to terminate this Agreement pursuant to this Section 8.1(e) and the basis for such termination, it being understood that Parent will not be entitled to terminate this Agreement if such breach has been cured prior to termination; provided that Parent shall not have the right to terminate this Agreement pursuant to this Section 8.1(e) if it or Merger Sub is then in material breach of any representations, warranties, covenants or other agreements contained in this Agreement that would result in a failure of a condition set forth in Section 7.3(a) or (b);
(f) by Parent, if at any time prior to the Company’s receipt of the Requisite Stockholder Approval, the Company Board (or a committee thereof) has effected a Company Board Recommendation Change;
(g) by the Company, if Parent or Merger Sub has breached or failed to perform any of its respective representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in Section 7.3(a) or (b), except that if such breach is capable of being cured prior to the Termination Date, the Company will not be entitled to terminate this Agreement pursuant to this Section 8.1(g) prior to the delivery by the Company to Parent of written notice of such breach, delivered at least forty-five days prior to such termination, stating the Company’s intention to terminate this Agreement pursuant to this Section 8.1(g) and the basis for such termination, it being understood that the Company will not be entitled to terminate this Agreement if such breach has been cured prior to termination; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section 8.1(g) if it is then in material breach of any representations, warranties, covenants or other agreements contained in this Agreement that would result in a failure of a condition set forth in Section 7.2(a) or (b);
(h) by the Company, at any time prior to receiving the Requisite Stockholder Approval, in accordance with Section 5.3(b), in order to substantially concurrently enter into an Alternative Acquisition Agreement providing
A-67

TABLE OF CONTENTS

for a Superior Proposal received after the date of this Agreement, if the Company (A) has complied in all material respects with Section 5.3 in connection with a Superior Proposal, and (B) pays to Parent in immediately available funds the Company Termination Fee in accordance with Section 8.3(b)(iii) substantially concurrently with such termination; or
(i) by the Company, (i) if all of the conditions set forth in Section 7.1 and Section 7.2 are satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied), (ii) the Company has irrevocably confirmed to Parent in writing that it is prepared to consummate the Closing, and (iii) Parent fails to consummate the Transactions by the date that is three Business Days after the later of (x) the first date on which Parent is required to consummate the Closing pursuant to Section 2.3 and (y) the date of such notice.
8.2 Manner and Notice of Termination; Effect of Termination.
(a) Manner of Termination. The Party terminating this Agreement pursuant to Section 8.1 (other than pursuant to Section 8.1(a)) must deliver prompt written notice thereof to the other Parties specifying the provision of Section 8.1 pursuant to which this Agreement is being terminated.
(b) Effect of Termination . Any valid termination of this Agreement pursuant to Section 8.1 will be effective immediately upon the delivery of written notice by the terminating Party to the other Parties (or as specified in the mutual written agreement of the Parent and the Company pursuant to Section 8.1(a)). In the event of the termination of this Agreement pursuant to Section 8.1, this Agreement shall be of no further force or effect without liability of any Party (or any partner, member, stockholder, director, officer, employee, Affiliate or Representative of such Party) to the other Parties, as applicable, except that Section 6.6(f) (Financing Cooperation; Reimbursement), Section 6.6(g) (Financing Cooperation; Indemnification), Section 6.14 (Public Statements and Disclosure), this Section 8.2 (Manner and Notice of Termination; Effect of Termination), Section 8.3 (Fees and Expenses) and Article IX (General Provisions) will each survive the termination of this Agreement. Notwithstanding the foregoing but subject to Section 8.3(e), no termination of this Agreement will relieve any Party from any liability for Fraud by such Party or any Willful and Material Breach of this Agreement by such Party prior to termination. In addition to the foregoing, no termination of this Agreement will affect the rights or obligations of any Party pursuant to the Confidentiality Agreement, which rights, obligations and agreements will survive the termination of this Agreement in accordance with their respective terms.
8.3 Fees and Expenses.
(a) General . Except as set forth in this Agreement, all fees and expenses incurred in connection with this Agreement and the Merger shall be paid by the Party incurring such fees and expenses whether or not the Merger is consummated. For the avoidance of doubt, Parent or the Surviving Corporation shall be responsible for all fees and expenses of the Payment Agent. Except as set forth in Section 2.10(e), Parent shall pay, or cause the Surviving Corporation to pay when due all (i) transfer, registration, stamp and documentary Taxes or fees (including any penalties and interest); and (ii) sales, use, indirect capital gains, real property transfer and other similar Taxes or fees (including any penalties and interest), in each case, imposed on the Company and its Subsidiaries arising out of or in connection with entering into this Agreement and the consummation of the Merger, and Parent shall file or cause to be filed all necessary Tax Returns and other documentation with respect to any such Taxes.
(b) Company Termination Fee.
(i) If (A) this Agreement is validly terminated pursuant to (x) Section 8.1(c) (Termination; Termination Date) (provided that at the Termination Date, all of the conditions set forth in Section 7.1 (other than the condition set forth in Section 7.1(a)) and Section 7.3 have been satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied as if such time were the Closing)), (y) Section 8.1(d) (Termination; Failure to Obtain Requisite Stockholder Approval) or (z) Section 8.1(e) (Termination; Material Breach); (B) following the execution and delivery of this Agreement and prior to such termination of this Agreement, any Person shall have publicly announced or provided to the Company Board or management of the Company an Acquisition Proposal and not publicly (in the case of an Acquisition Proposal that has been publicly announced) withdrawn such Acquisition Proposal at least five
A-68

TABLE OF CONTENTS

Business Days prior to the Company Stockholder Meeting or prior to the date of termination in the case of a termination pursuant to Section 8.1(c) (Termination Date) or Section 8.1(e) (Company Breach); and (C) within twelve months following such termination of this Agreement, either an Acquisition Transaction is consummated or the Company enters into a definitive agreement providing for the consummation of an Acquisition Transaction, then the Company shall promptly (and in any event within three Business Days) upon the earlier of entry into such definitive agreement or the consummation of such Acquisition Transaction pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent. For purposes of this Section 8.3(b)(i), all references to “20%” in the definition of “Acquisition Transaction” shall be deemed to be references to “50%.”
(ii) If this Agreement is validly terminated pursuant to Section 8.1(f) (Termination; Company Board Recommendation Change), then the Company must promptly (and in any event within three Business Days) following such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent.
(iii) If this Agreement is validly terminated pursuant to Section 8.1(h) (Termination; Superior Proposal), then the Company must substantially concurrently with such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent.
(c) Parent Termination Fee. If this Agreement is validly terminated (i) by the Company pursuant to Section 8.1(g) (Termination; Material Breach) or Section 8.1(i) (Termination; Failure to Close) or (ii) by the Company or Parent pursuant to Section 8.1(c) (Termination; Termination Date) (at a time at which the Company had, or would have had upon completion of the applicable notice and waiting periods, the right to terminate this Agreement pursuant to Section 8.1(g) (Termination; Material Breach) or Section 8.1(i) (Termination; Failure to Close)), then Parent shall promptly (and in any event within three Business Days) pay the Company a termination fee of $313,992,000 (the “Parent Termination Fee”) by wire transfer of immediately available funds to an account or accounts designated in writing by the Company. If the Parent Termination Fee is due pursuant to this Section 8.3(c) and Parent fails to pay such amount to the Company (or its designee) pursuant to the terms of this Section 8.3(c), then Parent shall also be liable for any reasonable and documented out-of-pocket costs and expenses (including attorneys’ fees) incurred by the Company and its respective Affiliates in connection with any Legal Proceeding or other action or proceeding to enforce the Company’s rights under this Section 8.3(c), together with interest on the Parent Termination Fee or any unpaid portion thereof at the prime rate, as published in The Wall Street Journal in effect on the date that such payment or portion thereof was required, in an aggregate amount not to exceed $7,500,000 (such costs, expenses and interest, as applicable, the “Enforcement Costs”).
(d) Single Payment Only. The Parties acknowledge and agree that in no event will the Company be required to pay the Company Termination Fee or Parent be required to pay the Parent Termination Fee, and the other amounts, if any, payable pursuant to and in accordance with Section 8.3(c), on more than one occasion, whether or not the Company Termination Fee or Parent Termination Fee, as applicable, may be payable pursuant to more than one provision of this Agreement at the same or at different times and upon the occurrence of different events.
(e) Sole Remedy.
(i) Notwithstanding anything to the contrary set forth in this Agreement (including this Article VIII) the Company expressly acknowledges and agrees that, (i) the Company’s receipt of the Parent Termination Fee, and the Enforcement Costs payable pursuant to and in accordance with Section 8.3(c) (including the Company’s right to enforce the Guarantees with respect thereto and receive the Parent Termination Fee and the Enforcement Costs from the Guarantors as set forth in such Guarantees) and (ii) the Company’s right to enforce its rights under the Confidentiality Agreement and the Reimbursement Obligations will be the sole and exclusive remedies of the Company, the Subsidiaries of the Company, their respective Affiliates or any of their respective former, current or future general or limited partners, stockholders, equityholders, members, managers, directors, officers, employees, agents or Affiliates (collectively, the “Company Related Parties”) against (A) Parent, Merger Sub or the Guarantors; (B) the direct or indirect former, current and future holders of any equity, controlling persons, Affiliates (other than Parent, Merger
A-69

TABLE OF CONTENTS

Sub or the Guarantors), Representatives, members, managers, general or limited partners, stockholders, directors, officers, employees, attorneys, agents, heirs, executors, administrators, trustees, representatives, successors and assignees of each of Parent, Merger Sub and the Guarantors or representatives of any of the foregoing (collectively, the “Parent Related Parties”); and (C) the Financing Sources in respect of this Agreement, any agreement executed in connection herewith (including the Financing Letters and the Guarantees) and the transactions contemplated hereby and thereby (including for any breach (whether a willful breach, Willful and Material Breach or otherwise)), the termination of this Agreement, the failure to consummate the Closing or any claims or actions under applicable Law arising out of any such breach, termination or failure; provided, that, the foregoing shall not limit or restrict the Company’s right to seek specific performance pursuant to and in accordance with Section 9.8(b) prior to the termination of this Agreement. None of the Company Related Parties shall seek to recover any other damages or seek any other remedy, whether based on a claim at law or in equity, in contract, tort or otherwise, with respect to any such losses or damages (including in respect of any oral representation made or alleged to be made in connection herewith). The Parties acknowledge and agree that, while the Company may pursue a grant of specific performance solely in accordance with Section 9.8(b)(ii) and payment of the Parent Termination Fee and the Enforcement Costs, in no event shall the Company or any Company Related Party, collectively, be entitled to obtain both (x) a grant of specific performance pursuant to Section 9.8(b)(ii) that results in the Closing occurring and (y) payment of the Parent Termination Fee and the Enforcement Costs (or damages of any kind). The Parent Related Parties and the Financing Sources are intended third-party beneficiaries of this Section 8.3(e)(i). In no event shall Parent, Merger Sub or the Guarantors have liability for monetary damages of any kind (including monetary damages in lieu of specific performance, the Parent Termination Fee and/or damages for Willful and Material Breach) in the aggregate in excess of the Parent Termination Fee, the Enforcement Costs plus any Reimbursement Obligations. If owed pursuant to Section 8.3(c), the Parent Termination Fee, the Enforcement Costs and the Reimbursement Obligations shall be the maximum aggregate liability of Parent and Merger Sub hereunder (and of the Guarantors under the Guarantees). Notwithstanding anything to the contrary herein, other than the obligation of the Parent to pay the Parent Termination Fee and the Enforcement Costs (and the respective obligations of the Guarantors under, and pursuant to the terms of, and subject to the limitations in, the Guarantees), in no event will any Parent Related Party or any other Person have any liability for monetary damages to the Company, the Company Related Parties or any other Person relating to or arising out of this Agreement or the transactions contemplated by this Agreement, including for Willful and Material Breach. Notwithstanding the foregoing, nothing in this Section 8.3(e)(i) will relieve Parent from any liability for Fraud prior to termination.
(ii) Subject to the final two sentences of this Section 8.3(e)(ii), Parent’s receipt of the Company Termination Fee, if owed pursuant to Section 8.3(b), and Parent’s right to specific performance pursuant to Section 9.8(b) will be the sole and exclusive remedies of Parent and Merger Sub and each of their respective Affiliates and the Parent Related Parties and the Financing Sources against (A) the Company, its Subsidiaries and each of their respective Affiliates; and (B) Company Related Parties in respect of this Agreement, any agreement executed in connection herewith and the transactions contemplated hereby and thereby, and upon payment of the Company Termination Fee, none of the Company Related Parties will have any further liability or obligation to Parent or Merger Sub or any Parent Related Parties or Financing Sources relating to or arising out of this Agreement, any agreement executed in connection herewith or the transactions contemplated hereby and thereby (except that the Parties (or their Affiliates) shall remain obligated with respect to, and Parent and Merger Sub and its Subsidiaries may be entitled to remedies with respect to, the Confidentiality Agreement, Willful and Material Breach, and Section 8.3(a), as applicable). The Parties acknowledge and agree that, while Parent may pursue a grant of specific performance in accordance with Section 9.8(b) and payment of the Company Termination Fee, in no event shall Parent or any Parent Related Party, collectively, be entitled to obtain both (x) a grant of specific performance pursuant to Section 9.8(b) that results in the Closing occurring and (y) payment of the Company Termination Fee in accordance with Section 8.3(b). The Company Related Parties are intended third party beneficiaries of this Section 8.3(e)(ii). In no event shall the Company or any of its Subsidiaries have liability for monetary damages (including monetary damages in lieu of specific performance) in the aggregate in excess of the amount of the Company Termination Fee, including for Willful and Material Breach. Notwithstanding the foregoing, nothing in this Section 8.3(e)(ii) will relieve the Company from any liability for Fraud prior to termination.
A-70

TABLE OF CONTENTS

(f) Acknowledgments. The Parties acknowledge that the agreements contained in this Section 8.3 are an integral part of this Agreement and that, without Section 8.3(b), Parent would not have entered into this Agreement and that, without Section 8.3(c), the Company would not have entered into this Agreement. The Company further acknowledges that the Parent Termination Fee shall not constitute a penalty but represents liquidated damages, in a reasonable amount that will compensate the Company for the disposition of its rights under this Agreement in the circumstances in which such amounts are due and payable, which amounts would otherwise be impossible to calculate with precision.
8.4 Amendment. Subject to applicable Law and subject to the other provisions of this Agreement, this Agreement may be amended by the Parties at any time by execution of an instrument in writing signed on behalf of each of Parent, Merger Sub and the Company (pursuant to authorized action by the Company Board), except that in the event that the Company has received the Requisite Stockholder Approval, no amendment may be made to this Agreement that requires the approval of the Company Stockholders pursuant to the DGCL without such approval. Notwithstanding anything to the contrary contained herein, Section 8.3(e), this last sentence of Section 8.4, the last sentence of Section 9.6, Section 9.10(b), Section 9.11 and Section 9.12(b) and the definition of “Financing Sources”, “Preferred Equity Financing Sources” and “Debt Financing Sources” (and any other provision or definition of this Agreement to the extent a modification, waiver or termination of such provision would modify the substance of any of the foregoing provisions) (collectively, the “Financing Sources Protection Provisions”) may not be amended, supplemented, waived or otherwise modified in any manner that is materially adverse to the Financing Sources without the prior written consent of such Financing Sources (such consent not to be unreasonably withheld, conditioned or delayed).
8.5 Extension; Waiver. At any time and from time to time prior to the Effective Time, Parent and the Company may, to the extent legally allowed and except as otherwise set forth herein, (a) extend the time for the performance of any of the obligations or other acts of the other Party, as applicable; (b) waive any inaccuracies in the representations and warranties of the other Party contained herein or in any document delivered pursuant hereto; and (c) subject to the requirements of applicable Law, waive compliance by the other Party with any of the agreements or conditions contained herein applicable to such Party (it being understood that Parent and Merger Sub shall be deemed a single Party solely for purposes of this Section 8.5). Any agreement on the part of a Party to any such extension or waiver will be valid only if set forth in an instrument in writing signed by such Party. Any delay in exercising any right pursuant to this Agreement shall not constitute a waiver of such right.
ARTICLE IX
GENERAL PROVISIONS
9.1 Survival of Representations, Warranties and Covenants. The representations, warranties and covenants of the Company, Parent and Merger Sub contained in this Agreement or in any certificate delivered pursuant to this Agreement will terminate at the Effective Time, except that any covenants that by their terms survive the Effective Time shall survive the Effective Time in accordance with their respective terms.
9.2 Notices. All notices and other communications hereunder must be in writing and will be deemed to have been duly delivered and received hereunder (i) four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid; (ii) one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service; or (iii) immediately upon delivery by electronic mail or by hand (with a written or electronic confirmation of delivery), in each case to the intended recipient as set forth below:
 
 
 
 
 
 
 
(a) if to Parent or Merger Sub to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mozart Parent, LLC c/o GTCR LLC
 
 
 
 
 
 
300 N. LaSalle Street, Suite 5600
 
 
 
 
 
 
Chicago, IL 60654
 
 
 
 
 
 
Attn:
 
 
Mark M. Anderson
Nelson Iginla
Jeffrey S. Wright
 
 
 
 
 
 
Email:
 
 
[***]
[***]
[***]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A-71

TABLE OF CONTENTS

 
 
 
 
 
 
 
with a copy (which will not constitute notice) to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Simpson Thacher & Bartlett LLP
 
 
 
 
 
 
425 Lexington Avenue
 
 
 
 
 
 
New York, NY 10017
 
 
 
 
 
 
Attn:
 
 
Elizabeth A. Cooper
Katherine M. Krause
 
 
 
 
 
 
Email:
 
 
ecooper@stblaw.com
katherine.krause@stblaw.com
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) if to the Company (prior to the Effective Time) to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCC Intelligent Solutions Holdings Inc.
 
 
 
 
 
 
167 N. Green Street, 9th Floor
 
 
 
 
 
 
Chicago, IL 60607
 
 
 
 
 
 
Attn:
 
 
Githesh Ramamurthy, Chief Executive Officer
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
 
 
 
 
 
 
 
with a copy (which will not constitute notice) to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c/o CCC Intelligent Solutions Holdings Inc.
 
 
 
 
 
 
167 N. Green Street, 9th Floor
 
 
 
 
 
 
Chicago, IL 60607
 
 
 
 
 
 
Attn:
 
 
Chief Legal Officer
 
 
 
 
 
 
Email:
 
 
[***]
 
 
 
 
 
 
 
 
 
 
 
 
 
with a copy (which will not constitute notice) to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kirkland & Ellis LLP
 
 
 
 
 
 
601 Lexington Avenue
 
 
 
 
 
 
New York, NY 10022
 
 
 
 
 
 
Attn:
 
 
Sarkis Jebejian, P.C.
Willard S. Boothby, P.C.
William A. Stanton
 
 
 
 
 
 
Email:
 
 
sarkis.jebejian@kirkland.com
willard.boothby@kirkland.com
william.stanton@kirkland.com
 
 
 
 
 
 
 
 
 
 
Any notice received at the addressee’s location on any Business Day after 5:00 p.m., addressee’s local time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressee’s local time, on the next Business Day. From time to time, any Party may provide notice to the other Parties of a change in its address or e-mail address through a notice given in accordance with this Section 9.2, except that notice of any change to the address or any of the other details specified in or pursuant to this Section 9.2 shall not be deemed to have been received until, and shall be deemed to have been received upon, the later of the date (A) specified in such notice; or (B) that is five Business Days after such notice would otherwise be deemed to have been received pursuant to this Section 9.2.
9.3 Assignment. No Party may assign either this Agreement or any of its rights, interests, or obligations hereunder, by operation of Law or otherwise, without the prior written approval of the other Parties except that Parent will have the right to assign all or any portion of its rights and obligations pursuant to this Agreement from and after the Effective Time to any of its Affiliates and the indemnification and other rights hereunder of a party may be assigned to any Financing Sources, solely for collateral security purposes effective as of or after the Closing.
A-72

TABLE OF CONTENTS

Subject to the preceding sentence, this Agreement shall be binding upon and shall inure to the benefit of, and be enforceable by, the Parties and their respective successors and permitted assigns. No assignment by any Party shall relieve such Party of any of its obligations hereunder. Any purported assignment of this Agreement without the consent required by this Section 9.3 is null and void.
9.4 Confidentiality. Parent, Merger Sub and the Company hereby acknowledge that GTCR and the Company have previously executed the Confidentiality Agreement, that shall continue in full force and effect in accordance with its terms (without limiting Section 6.6(e)). Each of Parent, Merger Sub and their respective Representatives shall hold and treat all documents and information concerning the Company and its Subsidiaries furnished or made available to Parent, Merger Sub or their respective Representatives in connection with the Merger in accordance with the Confidentiality Agreement. By executing this Agreement, each of Parent and Merger Sub agree to be bound by the terms and conditions of the Confidentiality Agreement as if they were parties thereto.
9.5 Entire Agreement. This Agreement and the documents and instruments and other agreements among the Parties as contemplated by or referred to herein, including the Confidentiality Agreement, the Company Disclosure Letter, the Guarantees and the Financing Letters, constitute the entire agreement among the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the Parties with respect to the subject matter hereof. The Confidentiality Agreement will (a) not be superseded; (b) survive any termination of this Agreement; and (c) continue in full force and effect until the earlier to occur of the Effective Time and the date on which the Confidentiality Agreement expires in accordance with its terms or is validly terminated by the parties thereto.
9.6 Third Party Beneficiaries. This Agreement is not intended to and shall not confer any rights or remedies upon any person other than the parties hereto and their respective successors and permitted assigns, except (a) as set forth in or as contemplated by Section 6.10 (Directors’ and Officers’ Exculpation, Indemnification and Insurance), (b) if the Closing occurs, for the right of the holders of Company Common Stock, Company Options, Company RSAs, Company RSUs or Company PSUs to receive the Per Share Price, the Closing Option Consideration, the Closing RSA Consideration, the Closing RSU Consideration and the Closing PSU Consideration, respectively, in each case after the Effective Time, and (c) as set forth in or contemplated by Section 8.3(e) (Sole Remedy). Notwithstanding anything to the contrary herein, the Financing Sources will be express third-party beneficiaries of, and will be entitled to rely on and may enforce, the Financing Sources Protection Provisions, in each case, to the extent related to the Financing Sources, the Debt Financing, the Debt Commitment Letter, the Fee Letters, the Preferred Equity Financing or the Preferred Equity Commitment Letter (as applicable).
9.7 Severability. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably to effect the intent of the Parties; provided that the parties intend that the remedies and limitations contained in Section 8.3(e), Section 9.8(b) and Section 9.12 be construed as an integral provision of this Agreement and that such remedies and limitations shall not be severable or subject to modification pursuant to the following sentence in any manner that increases or modifies any Parent Related Party’s or Financing Source’s liability or obligations hereunder. The Parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.
9.8 Remedies.
(a) Remedies Cumulative. Except as otherwise provided herein (including Section 8.3(d)), any and all remedies herein expressly conferred upon a Party shall be deemed cumulative with and not exclusive of any other remedy conferred hereby or by Law or equity upon such Party, and the exercise by a Party of any one remedy shall not preclude the exercise of any other remedy. The Company’s pursuit of an injunction, specific performance or other equitable remedies at any time shall not be deemed an election of remedies or waiver of the right to pursue any other right or remedy to which the Company is entitled pursuant to the terms of this Agreement, including the right to pursue the Parent Termination Fee. Although each Party may pursue both a grant of specific performance and monetary damages, under no circumstances shall (i) the Company be permitted or entitled to receive both a grant of specific performance that results in the occurrence of the Closing and monetary damages (including the Parent Termination Fee and the Enforcement Costs, if any, payable pursuant to and in accordance with Section 8.3(c), or any monetary damages in lieu of specific performance) or
A-73

TABLE OF CONTENTS

(ii) Parent be permitted or entitled to receive both a grant of specific performance that results in the occurrence of the Closing and monetary damages (including the Company Termination Fee, and other amounts, if any, payable pursuant to and in accordance with Section 8.3(b)). Notwithstanding the foregoing, nothing in this Agreement will relieve any Party from any liability for Fraud by such Party prior to termination.
(b) Specific Performance.
(i) The Parties acknowledge and agree that (A) irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the event that the Parties do not perform the provisions of this Agreement (including any Party failing to take such actions as are required of it hereunder in order to consummate the Transactions) in accordance with its specified terms or otherwise breach such provisions; (B) subject to Section 9.8(b)(ii), the Parties will be entitled, in addition to any other remedy to which they are entitled at Law or in equity, to an injunction, specific performance and other equitable relief to prevent breaches (or threatened breaches) of this Agreement and to enforce specifically the terms and provisions hereof; and (C) the right of specific enforcement is an integral part of the Merger and without that right, neither the Company nor Parent would have entered into this Agreement. Subject to Section 9.8(b)(ii), the Parties agree not to raise any objections to (1) the granting of an injunction, specific performance or other equitable relief to prevent or restrain breaches or threatened breaches of this Agreement by the Company, on the one hand, or Parent and Merger Sub, on the other hand; and (2) the specific performance of the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants, obligations and agreements of Parent and Merger Sub pursuant to this Agreement. Any Party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required to provide any bond or other security in connection with such injunction or enforcement, and each Party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security. The Parties further agree that, subject to the limitations set forth in this Agreement, including the last sentence of 9.8(a) (x) by seeking the remedies provided for in this Section 9.8, a Party shall not in any respect waive its right to seek any other form of relief that may be available to a Party under this Agreement, and (y) nothing set forth in this Section 9.8 shall require any Party to institute any Legal Proceeding for (or limit any Party’s right to institute any Legal Proceeding for) specific performance under this Section 9.8 prior to, or as a condition to, exercising any termination right under Article VIII (and pursuing damages after such termination), nor shall the commencement of any Legal Proceeding pursuant to this Section 9.8 or anything set forth in this Section 9.8 restrict or limit any Party’s right to terminate this Agreement in accordance with the terms of Article VIII or pursue any other remedies under this Agreement that may be available then or thereafter.
(ii) Notwithstanding Section 9.8(b)(i) or anything in this Agreement to the contrary, but subject in all respects to this Section 9.8(b)(ii), it is acknowledged and agreed that the Company will be entitled to an injunction, specific performance or other equitable remedies to enforce Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing, in accordance with and subject to the terms, conditions and limitations set forth in the Equity Commitment Letters, if, and only if, (i) all of the conditions set forth in Section 7.1 and Section 7.2 have been and continue to be satisfied (other than those conditions that by their terms are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing), (ii) Parent and Merger Sub fail to consummate the Merger on the date required pursuant to Section 2.3, (iii) the Debt Financing and the Preferred Equity Financing has been funded in full in accordance with the terms and conditions thereof or will be funded in full at the Closing in accordance with the terms and conditions thereof (for the avoidance of doubt, if the Debt Financing or the Preferred Equity Financing has not been funded and will not be funded at the Closing for any reason (including any breach of Section 6.5), the Company shall not be entitled to enforce Parent’s and Merger Sub’s obligation to consummate the Transactions and the Guarantors’ obligation to fund the Equity Financing pursuant to this Section 9.8) and (iv) the Company has irrevocably confirmed in writing that (x) all conditions set forth in Section 7.3 have been satisfied (other than those that, by their nature, are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing) and (y) if specific performance is granted and the Equity Financing, Debt Financing and Preferred Equity Financing are funded, the Company is ready, willing and able to consummate the Merger.
A-74

TABLE OF CONTENTS

9.9 Governing Law. Except as provided for in Section 9.10(b), this Agreement and all actions, proceedings, causes of action, claims or counterclaims (whether based on contract, tort, statute or otherwise) based upon, arising out of or relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement thereof (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in connection with this Agreement or as an inducement to enter into this Agreement), shall be governed by, and construed in accordance with the internal Laws of the State of Delaware, including its statutes of limitations, without giving effect to any choice or conflict of Laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws, including any statutes of limitations, of any jurisdiction other than the State of Delaware.
9.10 Consent to Jurisdiction.
(a) General Jurisdiction. Each of the Parties (a) irrevocably consents to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the Merger or the Guarantees, for and on behalf of itself or any of its properties or assets, in accordance with Section 9.2 or in such other manner as may be permitted by applicable Law, and nothing in this Section 9.10 will affect the right of any Party to serve legal process in any other manner permitted by applicable Law; (b) irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any other state or federal court within the State of Delaware) (the “Chosen Courts”) in the event that any dispute or controversy arises out of this Agreement, the Guarantees or the transactions contemplated hereby or thereby; (c) agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (d) agrees that any Legal Proceeding arising in connection with this Agreement, the Guarantees or the transactions contemplated hereby or thereby shall be brought, tried and determined only in the Chosen Courts; (e) waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim the same; and (f) agrees that it shall not bring any Legal Proceeding relating to this Agreement, the Guarantees or the transactions contemplated hereby or thereby in any court other than the Chosen Courts. Each of Parent, Merger Sub and the Company agrees that a final judgment in any Legal Proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.
(b) Jurisdiction for Financing Sources. Notwithstanding anything to the contrary contained in the foregoing, all disputes, actions, causes of action, claims, cross-claims or third-party claims of any kind or description against any of the Debt Financing Sources or the Preferred Equity Financing Sources under or in respect of any Debt Financing, the Debt Commitment Letter and the Fee Letters or the Preferred Equity Financing and Preferred Equity Commitment Letter, respectively, and the transactions and performance contemplated thereby related to this Agreement and the Transactions or the facts and circumstances leading to its execution, whether in law or in equity and whether in contract, tort or otherwise (including any dispute, action, cause of action, claim, cross-claim or third-party claim of any kind or description arising out of or relating in any way to any Debt Financing or the Preferred Equity Financing), will be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts executed in and to be performed entirely within such State, without regard to conflict of law principles that would result in the application of any Law other than the law of the State of New York, except as expressly set forth in the Debt Commitment Letter and the Preferred Equity Commitment Letter, and each of the Parties agrees that it will not bring or support any such action against the Financing Sources in any forum other than any New York state or federal court located in the Borough of Manhattan in the City of New York.
9.11 WAIVER OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE MERGER, THE GUARANTEES, THE FINANCING LETTERS OR THE FINANCING
A-75

TABLE OF CONTENTS

AND THE TRANSACTIONS CONTEMPLATED THEREBY AND THE PERFORMANCE CONTEMPLATED BY THE FINANCING LETTERS OR THE FINANCING. EACH PARTY ACKNOWLEDGES AND AGREES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (III) IT MAKES THIS WAIVER VOLUNTARILY; AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.11.
9.12 No Recourse.
(a) This Agreement may only be enforced against, and any claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the entities that are expressly identified as parties hereto and no Parent Related Parties (other than the Guarantors to the extent set forth in the Guarantees or the Equity Commitment Letters) shall have any liability for any obligations or liabilities of the parties to this Agreement (whether for indemnification or otherwise) or for any claim (whether in tort, contract or otherwise, including under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 or other Environmental Laws) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect of any oral representations made or alleged to be made in connection herewith. It is further understood that any certificate or certification contemplated by this Agreement and executed by an officer of a Party will be deemed to have been delivered only in such officer’s capacity as an officer of such Party (and not in his or her individual capacity) and will not entitle any Party to assert a claim against such officer in his or her individual capacity.
(b) The Company (on behalf of itself, its Subsidiaries, Affiliates and its Representatives) (a) hereby waives any claims or rights against any Debt Financing Source and Preferred Equity Financing Source relating to or arising out of the Debt Financing, the Debt Commitment Letter or the Fee Letters or the Preferred Equity Financing or the Preferred Equity Commitment Letter, respectively, or the transactions and performance contemplated thereby, this Agreement and the Transactions, whether at law or in equity and whether in tort, contract or otherwise and (b) hereby agrees to cause any action asserted against any Debt Financing Source or Preferred Equity Financing Source by or on behalf of the Company, its Subsidiaries, Affiliates or any of their respective Representatives in connection with the Debt Financing, the Debt Commitment Letter or the Fee Letters or the Preferred Equity Financing or the Preferred Equity Commitment Letter, respectively, or the transactions and performance contemplated thereby, this Agreement and the Transactions to be dismissed or otherwise terminated. In furtherance and not in limitation of the foregoing waivers and agreements, and notwithstanding anything to the contrary contained in this Agreement, it is acknowledged and agreed that no Debt Financing Source or Preferred Equity Financing Source will have any liability for any claims or damages to the Company, its Subsidiaries or its Representatives in connection with the Debt Financing, the Debt Commitment Letter or the Fee Letters, or the Preferred Equity Financing or the Preferred Equity Commitment Letter, respectively, or the transactions and performance contemplated thereby, this Agreement and the Transactions. Notwithstanding the foregoing, nothing in this Section 9.12(b) will in any way limit or modify the rights of Parent under this Agreement, the Debt Commitment Letter or the Preferred Equity Financing Source or the obligations of any Debt Financing Source or Preferred Equity Financing Source under the Debt Commitment Letter and the Preferred Equity Commitment Letter, respectively, owing to Parent or its respective Affiliates party to the Debt Commitment Letter or the Preferred Equity Commitment Letter, as applicable.
9.13 Company Disclosure Letter References. The Parties agree that the disclosure set forth in any particular section or subsection of the Company Disclosure Letter shall be deemed to be an exception to (or, as applicable, a disclosure for purposes of) (a) the representations and warranties (or covenants, as applicable) of the Company that are set forth in the corresponding Section or subsection of this Agreement; and (b) any other representations and warranties (or covenants, as applicable) of the Company that are set forth in this Agreement, but in the case of this clause (b) only if the relevance of that disclosure as an exception to (or a disclosure for purposes of) such other representations and warranties (or covenants, as applicable) is reasonably apparent on its face.
9.14 Counterparts. This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Parties, it being understood that all Parties need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg
A-76

TABLE OF CONTENTS

or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”), will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No Party may raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to the extent such defense relates to lack of authenticity.
[Signature page follows.]
A-77

TABLE OF CONTENTS

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed and delivered by their respective duly authorized officers as of the date first written above.
 
 
 
 
 
 
 
MOZART PARENT, LLC
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Mark M. Anderson
 
 
 
Name:
 
 
Mark M. Anderson
 
 
 
Title:
 
 
President
 
 
 
 
 
 
 
 
 
 
MOZART MERGER SUB (DE), INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Mark M. Anderson
 
 
 
Name:
 
 
Mark M. Anderson
 
 
 
Title:
 
 
President
 
 
 
 
 
 
 
[Signature Page to Agreement and Plan of Merger]
A-78

TABLE OF CONTENTS

 
 
 
 
 
 
 
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Githesh Ramamurthy
 
 
 
Name:
 
 
Githesh Ramamurthy
 
 
 
Title:
 
 
Chairman and Chief Executive Officer
 
 
 
 
 
 
 
[Signature Page to Agreement and Plan of Merger]
A-79

TABLE OF CONTENTS

Annex A-2
FIRST AMENDMENT TO THE
AGREEMENT AND PLAN OF MERGER
This FIRST AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made as of November 20, 2026, by and among Mozart Parent, LLC, a Delaware limited liability company (“Parent”), Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company”), and amends that certain Agreement and Plan of Merger, dated as of October 14, 2026, by and among Parent, Merger Sub and the Company (the “Merger Agreement”). Unless otherwise specified herein, capitalized terms used in this Amendment shall have the meanings set forth in the Merger Agreement.
WHEREAS, Section 8.4 of the Merger Agreement provides that the provisions of the Merger Agreement may be amended only in a writing signed on behalf of each of Parent, Merger Sub and the Company (pursuant to authorized action by the Company Board);
WHEREAS, the Company Board has authorized and approved the execution and delivery of this Amendment by the Company; 
WHEREAS, Parent, Merger Sub and the Company desire to amend certain provisions of the Merger Agreement as set forth herein; and
WHEREAS, concurrently with the execution of this Amendment, and as a condition and inducement to the Company’s willingness to enter into this Amendment, GTCR Fund XIV/A LP, GTCR Fund XIV/C LP, GTCR Co-Invest XIV/A LP and GTCR Co-Invest XIV/B LP (collectively, the “GTCR Investors”) are entering into an amendment to that certain Equity Commitment Letter, dated as of October 14, 2026, by and among the GTCR Investors and Parent (the “GTCR ECL Amendment”) to, among other things, increase the amount the GTCR Investors are committing to invest in Parent, directly or indirectly, at or immediately prior to the Closing. 
NOW, THEREFORE, in consideration of the premises set forth above, the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is acknowledged, the parties hereto agree as follows:
1.  Amendment to the Merger Agreement. Effective as of the date hereof, the Merger Agreement is hereby amended, supplemented and/or restated as follows:
(a)  Section 1.1 of the Merger Agreement is hereby amended as follows:
(i)  The defined term “Preferred Equity Financing Sources” in Section 1.1 of the Merger Agreement is hereby deleted in its entirety.
(ii)  The defined term “Financing Sources” in Section 1.1 of the Merger Agreement is hereby deleted in its entirety, and each reference in the Merger Agreement to “Financing Sources” is hereby deleted in its entirety and replaced with “Debt Financing Sources.”
(iii)  The following defined term “Amendment Date” is hereby added to Section 1.1 of the Merger Agreement immediately following the defined term “AI Technologies”.
““Amendment Date” means November 20, 2026.”
(iv)  The following defined term “Original Agreement Date” is hereby added to Section 1.1 of the Merger Agreement immediately following the defined term “Order”.
““Original Agreement Date” means October 14, 2026.”
(v)  The following defined term “Preferred Equity Commitment Letter” is hereby added to Section 1.1 of the Merger Agreement immediately following the defined term “Personal Information”.
““Preferred Equity Commitment Letter” means that duly executed preferred equity commitment letter, dated as of the Original Agreement Date, among Parent, Mozart Holdings, LLC and certain Persons party thereto from time to time (including all exhibits, schedules, term sheets, and annexes thereto, as may be amended or modified in accordance with the terms hereof).”
A-80

TABLE OF CONTENTS

(b)  The first two sentences in Section 4.12(a) of the Merger Agreement are hereby deleted in their entirety and replaced with the following:
“(a)  Financing Letters. As of the date of this Agreement, Parent has delivered to the Company true, correct and complete copies of (i) duly executed equity commitment letter, dated as of the date of this Agreement, between Parent and each Guarantor (collectively, the “Equity Commitment Letters”) pursuant to which such Guarantor has committed, subject to the terms and conditions therein, to invest in Parent, directly or indirectly, the amounts set forth therein for the purpose of funding a portion of the transactions contemplated hereby and thereby (the “Equity Financing”); and (ii) a duly executed debt commitment letter, dated as of the date of this Agreement, among Merger Sub and the Debt Financing Sources party thereto (including all exhibits, schedules, term sheets, and annexes thereto, as may be amended or modified in accordance with the terms hereof, collectively the “Debt Commitment Letter” and, together with the Equity Commitment Letters and the Fee Letters referenced below, the “Financing Letters”), pursuant to which the Debt Financing Sources providing commitments therein have committed, subject to the terms and conditions therein, to lend the amounts set forth therein for the purposes set forth therein (including the funding of a portion of the transactions contemplated hereby and thereby (including the repayment, prepayment or discharge of the outstanding Company Indebtedness)) (together with any Alternate Debt Financing, the “Debt Financing” and, together with the Equity Financing, the “Financing”). Parent has also delivered to the Company a true, correct and complete copy of any executed fee letter (which may be redacted in a customary manner solely with respect to fees and other economic provisions (including customary “market flex” terms); provided that no such redaction shall cover any terms that would adversely affect the conditionality, enforceability, availability or termination of the Debt Financing) in connection with the Debt Commitment Letter (any such letter, a “Fee Letter”, and together with the Debt Commitment Letter, the “Debt Financing Letters”).”
(c)  A new Section 4.12(e) is hereby added to the Merger Agreement to read as follows:
“(e)  Notwithstanding anything to the contrary in this Agreement, Parent makes the same representations and warranties made as of the Original Agreement Date and as set forth in Sections 4.12(a), 4.12(c) and 4.12(d) of this Agreement with respect to the Equity Commitment Letters, the Debt Commitment Letter or the Financing, respectively, as of the Amendment Date. Each of Parent and Merger Sub hereby represents and warrants to the Company that, as of the Amendment Date and after giving effect to the termination of the Preferred Equity Commitment Letter, (i) Parent has delivered to the Company a true, correct and complete copy of the Equity Commitment Letters, and there are no side letters or other Contracts relating to the termination of the Preferred Equity Commitment Letter or the Equity Commitment Letters that would adversely affect the conditionality, enforceability or availability of the Financing; and (ii) any fees, expenses, indemnification obligations or other amounts payable or obligations owing under any fee letter executed in connection with the Preferred Equity Commitment Letter (including any obligations under such fee letter or any provisions of the Preferred Equity Commitment Letter that survive the termination thereof) shall be borne solely by Parent and its Affiliates (other than the Company and its Subsidiaries), and none of the Company or any of its Subsidiaries shall have any liability or obligation in respect thereof, whether prior to or following the Closing.”
(d)  Each reference in the Merger Agreement to “Alternate Financing” is hereby deleted in its entirety and replaced with “Alternate Debt Financing.”
(e)  Except for the reference to “Preferred Equity Commitment Letter” set forth in new Section 4.12(e) of the Merger Agreement, each reference in the Merger Agreement to any of the “Alternate Preferred Financing,” “Preferred Equity Commitment Letter,” “Preferred Equity Financing,” “Preferred Equity Financing Letters” and “Preferred Equity Financing Sources” is hereby deleted in its entirety, and the parties hereto hereby agree that the Merger Agreement shall be read with such conforming changes (including to conjunctions, punctuation and the terms “respectively” and “as applicable”) as necessary to give effect to this Section 1(e).
2.  General Provisions.
(a)  Effect of Amendment. Except as expressly modified herein, all terms and conditions of the Merger Agreement and all other agreements contemplated thereby shall remain in full force and effect as originally constituted and are ratified and affirmed by the parties hereto. Any future amendment to the Merger Agreement shall be effected in accordance with the terms thereof. This Amendment represents the entire agreement between the parties hereto relating to the subject matter hereof and supersedes all prior understandings and agreements between the parties hereto relating to the subject matter hereof. Upon the effectiveness of this Amendment, (i) each reference in the Merger Agreement to
A-81

TABLE OF CONTENTS

“this Agreement”, “hereunder”, “hereof”, “herein” or words of similar import shall mean and be a reference to the Merger Agreement as amended hereby and (ii) each reference in any other document contemplated by the Merger Agreement to the “Merger Agreement” or “Agreement and Plan of Merger” shall mean and be a reference to the Merger Agreement as amended by this Amendment. The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any provision of the Merger Agreement or any other document contemplated by the Merger Agreement or any other documents, instruments and agreements executed or delivered in connection therewith or of any breach under any of the foregoing whether arising before or after the date hereof or as a result of performance hereunder.
(b)  Counterparts. This Amendment may be executed in one or more counterparts, all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties here and delivered to the other parties, it being understood that all parties hereto need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”), will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto may raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each party hereto forever waives any such defense, except to the extent such defense relates to lack of authenticity.
(c)  Miscellaneous. The provisions set forth in Section 9.2 (Notices), Section 9.7 (Severability), Section 9.8 (Remedies), Section 9.9 (Governing Law), Section 9.10 (Consent to Jurisdiction) and Section 9.11 (WAIVER of JURY TRIAL) of the Merger Agreement are hereby incorporated by reference into this Amendment, mutatis mutandis, and made a part of this Amendment as if set forth full herein.
*  *  *  *  *
A-82

TABLE OF CONTENTS

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written above.
 
 
 
 
 
 
 
MOZART PARENT, LLC
 
 
 
By:
 
 
/s/ Mark M. Anderson
 
 
 
Name:
 
 
Mark M. Anderson
 
 
 
Title:
 
 
President
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MOZART MERGER SUB (DE), INC.
 
 
 
By:
 
 
/s/ Mark M. Anderson
 
 
 
Name:
 
 
Mark M. Anderson
 
 
 
Title:
 
 
President
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
 
 
 
By:
 
 
/s/ Githesh Ramamurthy
 
 
 
Name:
 
 
Githesh Ramamurthy
 
 
 
Title:
 
 
Chairman and Chief Executive Officer
 
 
 
 
 
 
 
[Signature Page to First Amendment to Agreement and Plan of Merger]
A-83

TABLE OF CONTENTS

Annex B
Opinion of Morgan Stanley & Co. LLC
October 14, 2026
Board of Directors
CCC Intelligent Solutions Holdings Inc.
167 N. Green Street, 9th Floor
Chicago, Illinois 60607
Members of the Board:
We understand that CCC Intelligent Solutions Holdings Inc., a Delaware corporation (the “Company”), Mozart Parent, LLC, a Delaware limited liability company (“Parent”), and Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), propose to enter into an Agreement and Plan of Merger, substantially in the form of the draft dated October 14, 2026 (the “Merger Agreement”), which provides, among other things, for the merger (the “Merger”) of Merger Sub with and into the Company. Pursuant to the Merger, the Company will become a wholly owned subsidiary of Parent, and each outstanding share of common stock, par value $0.0001 per share, of the Company (the “Company Common Stock”), other than Owned Company Shares, Dissenting Company Shares or Company RSAs (each as defined in the Merger Agreement), will be converted into the right to receive $7.75 per share in cash, without interest (the “Consideration”). The terms and conditions of the Merger are more fully set forth in the Merger Agreement.
You have asked for our opinion as to whether the Consideration to be received by the holders of shares of the Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to the Merger Agreement is fair from a financial point of view to the holders of shares of the Company Common Stock.
For purposes of the opinion set forth herein, we have:
1)
Reviewed certain publicly available financial statements and other business and financial information of the Company;
2)
Reviewed certain internal financial statements and other financial and operating data concerning the Company;
3)
Reviewed certain financial projections prepared by the management of the Company;
4)
Discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company;
5)
Reviewed the reported prices and trading activity for the Company Common Stock;
6)
Compared the financial performance of the Company and the prices and trading activity of the Company Common Stock with that of certain other publicly-traded companies comparable with the Company and their securities;
7)
Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions;
8)
Participated in certain discussions and negotiations among representatives of the Company and Parent and their financial and legal advisors;
9)
Reviewed (a) the Merger Agreement, (b) the draft equity commitment letters and preferred equity commitment letter from certain investors substantially in the forms of the drafts dated October 14, 2026 and October 12, 2026, respectively, the executed Debt Commitment Letter from certain debt financing sources dated October 12, 2026 (collectively, the documents in this clause (b), the “Commitment Letters”), and (c) the draft limited guarantees substantially in the form of the drafts dated October 14, 2026 (the “Limited Guarantees”), and certain related documents; and
10)
Performed such other analyses and considered such other factors as we have deemed appropriate.
We have assumed and relied upon, without independent verification, the accuracy and completeness of the information that was publicly available or supplied or otherwise made available to us by the Company, and formed a
B-1

TABLE OF CONTENTS

substantial basis for this opinion. With respect to the financial projections, we have assumed that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of the Company of the future financial performance of the Company. In addition, we have assumed that the Merger will be consummated in accordance with the terms set forth in the Merger Agreement without any waiver, amendment or delay of any terms or conditions, including, among other things, that Parent will obtain financing in accordance with the terms set forth in the Commitment Letters and that the definitive Merger Agreement will not differ in any material respect from the draft thereof furnished to us. Morgan Stanley has assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the proposed Merger, no delays, limitations, conditions or restrictions will be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed Merger. We are not legal, tax, or regulatory advisors. We are financial advisors only and have relied upon, without independent verification, the assessment of the Company and its legal, tax, or regulatory advisors with respect to legal, tax, or regulatory matters. We express no opinion with respect to the fairness of the amount or nature of the compensation to any of the Company’s officers, directors or employees, or any class of such persons, relative to the Consideration to be received by the holders of shares of the Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) in the transaction. We do not express any view on, and this opinion does not address, any other term or aspect of the Merger Agreement or the transactions contemplated thereby other than with respect to the fairness, from a financial point of view, of the Consideration to be received by the holders of shares of Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) or any term or aspect of any other agreement or instrument contemplated by the Merger Agreement or entered into or amended in connection therewith. This opinion does not address the relative merits of the transactions contemplated by the Merger Agreement as compared to other business or financial strategies that might be available to the Company, nor does it address the underlying business decision of the Company to enter into the Merger Agreement or proceed with any other transaction contemplated by the Merger Agreement. We have not made any independent valuation or appraisal of the assets or liabilities of the Company, nor have we been furnished with any such valuations or appraisals. Our opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. Events occurring after the date hereof may affect this opinion and the assumptions used in preparing it, and we do not assume any obligation to update, revise or reaffirm this opinion.
We have acted as financial advisor to the Board of Directors of the Company in connection with this transaction and will receive a fee for our services, a substantial portion of which is contingent upon the closing of the Merger. In the two years prior to the date hereof, we have provided financial advisory services for the Company and have received fees in connection with such services. In the two years prior to the date hereof, we have provided financial advisory and financing services for GTCR (“GTCR”) (which we understand ultimately holds a significant equity ownership interest in Parent) and certain of its affiliates and their affiliated funds’ respective majority-controlled portfolio companies (collectively, the “GTCR Related Entities”) and have received fees in connection with such services. In the two years prior to the date hereof, we have not provided financial advisory or financing services for Elliott Management (“Elliott”) or certain controlled affiliates of Elliott (collectively, the “Elliott Related Entities”), nor have we received fees in connection with such services. As of the date of this opinion, so far as we are aware, we and/or our affiliates hold an aggregate interest of (x) between 3% and 4% in the Company Common Stock, (y) between 3% and 4% in the common stock of GTCR and certain GTCR Related Entities and (z) less than 1% in the common stock of Elliott and certain Elliott Related Entities, which interests are held in connection with our and/or our affiliates’ investment management business, wealth management business, including client discretionary accounts, or ordinary course trading activities, including hedging activities. Morgan Stanley may also seek to provide financial advisory and financing services to Parent, GTCR, the GTCR Related Entities, Elliott, the Elliott Related Entities and the Company and their respective affiliates in the future unrelated to the Merger and would expect to receive fees for the rendering of these services. In addition, Morgan Stanley, its affiliates, directors or officers, including individuals working with the Company in connection with this transaction, may have committed and may commit in the future to invest in private equity funds managed by the controlling sponsor of Parent.
Please note that Morgan Stanley is a global financial services firm engaged in the securities, investment management and individual wealth management businesses. Our securities business is engaged in securities underwriting, trading, hedging and brokerage activities, foreign exchange, commodities and derivatives trading, prime brokerage, as well as providing investment banking, financing and financial advisory services. Morgan Stanley, its affiliates, directors and officers may at any time invest on a principal basis or manage funds that invest,
B-2

TABLE OF CONTENTS

hold long or short positions, finance positions, and may trade or otherwise structure and effect transactions, for their own account or the accounts of its customers, in debt or equity securities or loans of the Company, or any other company, or any currency or commodity, or instrument that may be involved in this transaction, or any related derivative instrument.
This opinion has been approved by a committee of Morgan Stanley investment banking and other professionals in accordance with our customary practice. This opinion is for the information of the Board of Directors of the Company only and may not be used for any other purpose, or disclosed without our prior written consent, except that a copy of this opinion may be included in its entirety in any filing the Company is required to make with the Securities and Exchange Commission in connection with this transaction if such inclusion is required by applicable law. In addition, Morgan Stanley expresses no opinion or recommendation as to how the shareholders of the Company should vote at the shareholders’ meeting to be held in connection with the Merger.
Based on and subject to the foregoing, we are of the opinion on the date hereof that the Consideration to be received by the holders of shares of the Company Common Stock (other than holders of the Owned Company Shares, Dissenting Company Shares or Company RSAs) pursuant to the Merger Agreement is fair from a financial point of view to the holders of shares of the Company Common Stock.
(Signature page to follow)
B-3

TABLE OF CONTENTS

 
 
 
 
 
 
 
Very truly yours,
 
 
 
 
 
 
 
 
 
 
MORGAN STANLEY & CO. LLC
 
 
 
 
 
 
 
 
 
 
By:
 
 
/s/ Kris Caldwell
 
 
 
 
 
 
Kris Caldwell
 
 
 
 
 
 
Managing Director
 
 
 
 
 
 
 
B-4

TABLE OF CONTENTS


 

TABLE OF CONTENTS


 

Keep reading